ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0001503,ossification, 86/89,429/18614,2.13E-140,6.34E-137,3.35E-137,FGFR3/CHRDL1/CAT/IBSP/TMEM38B/BCL2/SATB2/BMP8B/HNRNPU/SMAD3/SBDS/ACHE/RPL38/SNAI1/CASR/TNC/MEN1/HIF1A/UFL1/CHRDL2/NF1/BMP6/ADAR/RHOA/GLI1/MGP/DHH/STC1/BMP1/SP7/BMPR1B/MAPK11/XYLT1/MAPK14/GIT1/COL1A2/FOXC1/SYNCRIP/ADAMTS12/DHX9/SFRP1/SHH/ZBTB40/GPC3/AXIN2/AMELX/BMP4/DCHS1/COL13A1/BMP7/THBS3/PHEX/FHL2/JUNB/COL1A1/PLXNB1/HSPE1/CCN2/SPP1/CYP24A1/IGFBP3/COMP/WWOX/ALYREF/MMP2/LRP5/FSTL3/SNAI2/CTHRC1/EXT2/GTPBP4/MSX2/ALPL/CTNNB1/SIRT7/BMP3/BMPR2/DDX21/TPM4/NOG/CDH11/MMP14/ROR2/IFITM1/TWIST1/VCAN,86
GO:0001649,osteoblast differentiation, 52/89,250/18614,1.64E-75,2.44E-72,1.29E-72,CAT/IBSP/SATB2/HNRNPU/SMAD3/ACHE/SNAI1/TNC/MEN1/UFL1/NF1/BMP6/ADAR/GLI1/DHH/SP7/BMPR1B/MAPK11/MAPK14/SYNCRIP/DHX9/SFRP1/SHH/AXIN2/AMELX/BMP4/BMP7/FHL2/JUNB/COL1A1/HSPE1/SPP1/CYP24A1/IGFBP3/WWOX/ALYREF/LRP5/SNAI2/CTHRC1/GTPBP4/MSX2/ALPL/CTNNB1/SIRT7/BMP3/BMPR2/DDX21/TPM4/NOG/IFITM1/TWIST1/VCAN,52
GO:0048705,skeletal system morphogenesis, 31/89,229/18614,3.52E-37,3.50E-34,1.85E-34,FGFR3/SATB2/SMAD3/BMP6/MGP/STC1/BMP1/BMPR1B/MAPK14/FOXC1/SFRP1/AXIN2/BMP4/COL13A1/BMP7/THBS3/COL1A1/CCN2/COMP/WWOX/TGFB3/MMP2/LRP5/EXT2/MSX2/ALPL/CTNNB1/BMPR2/NOG/MMP14/TWIST1,31
GO:0051216,cartilage development, 29/89,203/18614,2.01E-35,1.50E-32,7.91E-33,FGFR3/SATB2/BMP8B/SMAD3/SNAI1/HIF1A/CHRDL2/BMP6/MGP/STC1/BMP1/BMPR1B/MAPK14/ADAMTS12/AXIN2/AMELX/BMP4/BMP7/THBS3/COL1A1/CCN2/COMP/SNAI2/EXT2/MSX2/CTNNB1/BMP3/BMPR2/NOG,29
GO:0061448,connective tissue development, 31/89,275/18614,1.29E-34,7.69E-32,4.07E-32,FGFR3/SATB2/BMP8B/SMAD3/SNAI1/CASR/HIF1A/CHRDL2/BMP6/MGP/STC1/BMP1/BMPR1B/MAPK14/ADAMTS12/AXIN2/AMELX/BMP4/BMP7/THBS3/COL1A1/CCN2/COMP/LRP5/SNAI2/EXT2/MSX2/CTNNB1/BMP3/BMPR2/NOG,31
GO:0060348,bone development, 29/89,235/18614,1.71E-33,8.48E-31,4.48E-31,FGFR3/TMEM38B/SBDS/BMP6/RHOA/STC1/BMPR1B/MAPK11/XYLT1/MAPK14/FOXC1/ADAMTS12/AXIN2/BMP4/DCHS1/COL13A1/THBS3/PHEX/COL1A1/PLXNB1/COMP/TGFB3/LRP5/EXT2/MSX2/ALPL/BMPR2/MMP14/TWIST1,29
GO:0031214,biomineral tissue development, 26/89,173/18614,2.67E-32,1.14E-29,6.02E-30,FGFR3/IBSP/TMEM38B/SMAD3/SBDS/HIF1A/BMP6/MGP/SP7/BMPR1B/COL1A2/ZBTB40/GPC3/AXIN2/AMELX/BMP4/BMP7/PHEX/COL1A1/SPP1/COMP/MSX2/ALPL/BMPR2/ROR2/TWIST1,26
GO:0030282,bone mineralization, 21/89,121/18614,1.73E-27,6.46E-25,3.42E-25,FGFR3/IBSP/TMEM38B/SMAD3/SBDS/HIF1A/BMP6/MGP/BMPR1B/COL1A2/ZBTB40/GPC3/AXIN2/BMP4/BMP7/PHEX/COMP/ALPL/BMPR2/ROR2/TWIST1,21
GO:0060349,bone morphogenesis, 19/89,99/18614,8.35E-26,2.76E-23,1.46E-23,FGFR3/BMP6/STC1/BMPR1B/FOXC1/AXIN2/BMP4/COL13A1/THBS3/COL1A1/COMP/TGFB3/LRP5/EXT2/MSX2/ALPL/BMPR2/MMP14/TWIST1,19
GO:0060350,endochondral bone morphogenesis, 15/89,60/18614,2.02E-22,6.02E-20,3.19E-20,FGFR3/BMP6/STC1/BMPR1B/FOXC1/AXIN2/BMP4/COL13A1/THBS3/COL1A1/COMP/EXT2/ALPL/BMPR2/MMP14,15
GO:0002062,chondrocyte differentiation, 17/89,113/18614,3.12E-21,8.46E-19,4.47E-19,FGFR3/SMAD3/HIF1A/BMP6/BMPR1B/MAPK14/ADAMTS12/AXIN2/AMELX/BMP4/CCN2/COMP/SNAI2/EXT2/MSX2/CTNNB1/BMPR2,17
GO:0045667,regulation of osteoblast differentiation, 18/89,147/18614,9.23E-21,2.29E-18,1.21E-18,SMAD3/MEN1/BMP6/GLI1/BMPR1B/SFRP1/AXIN2/BMP4/BMP7/LRP5/SNAI2/CTHRC1/MSX2/CTNNB1/BMPR2/NOG/IFITM1/TWIST1,18
GO:0042476,odontogenesis, 16/89,135/18614,2.65E-18,6.08E-16,3.22E-16,RHOA/SP7/COL1A2/FOXC1/SHH/AXIN2/AMELX/BMP4/BMP7/PHEX/COL1A1/TGFB3/MSX2/ALPL/CTNNB1/TWIST1,16
GO:0060485,mesenchyme development, 20/89,320/18614,3.81E-17,8.12E-15,4.29E-15,BCL2/SMAD3/SNAI1/HIF1A/FOXC1/SFRP1/SHH/AXIN2/AMELX/BMP4/DCHS1/BMP7/COL1A1/TGFB3/SNAI2/MSX2/CTNNB1/BMPR2/NOG/TWIST1,20
GO:0001837,epithelial to mesenchymal transition, 16/89,172/18614,1.37E-16,2.72E-14,1.44E-14,SMAD3/SNAI1/HIF1A/FOXC1/SFRP1/AXIN2/AMELX/BMP4/BMP7/COL1A1/TGFB3/SNAI2/MSX2/CTNNB1/NOG/TWIST1,16
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway, 21/89,398/18614,1.74E-16,3.24E-14,1.71E-14,CHRDL1/BMP8B/SMAD3/MEN1/CHRDL2/BMP6/BMPR1B/MAPK14/COL1A2/SFRP1/SHH/GPC3/BMP4/BMP7/COMP/TGFB3/FSTL3/MSX2/BMP3/BMPR2/NOG,21
GO:0048762,mesenchymal cell differentiation, 18/89,255/18614,2.02E-16,3.53E-14,1.87E-14,BCL2/SMAD3/SNAI1/HIF1A/FOXC1/SFRP1/SHH/AXIN2/AMELX/BMP4/BMP7/COL1A1/TGFB3/SNAI2/MSX2/CTNNB1/NOG/TWIST1,18
GO:0007389,pattern specification process, 22/89,467/18614,3.21E-16,5.31E-14,2.81E-14,CHRDL1/SATB2/SMAD3/SNAI1/HIF1A/GLI1/STC1/BMP1/BMPR1B/FOXC1/SFRP1/SHH/GPC3/AXIN2/BMP4/DCHS1/BMP7/LRP5/MSX2/CTNNB1/BMPR2/NOG,22
GO:0071772,response to BMP, 16/89,187/18614,5.24E-16,7.80E-14,4.13E-14,CHRDL1/CHRDL2/BMP6/BMPR1B/ADAMTS12/SFRP1/GPC3/BMP4/BMP7/COMP/TGFB3/FSTL3/MSX2/BMP3/BMPR2/NOG,16
GO:0071773,cellular response to BMP stimulus, 16/89,187/18614,5.24E-16,7.80E-14,4.13E-14,CHRDL1/CHRDL2/BMP6/BMPR1B/ADAMTS12/SFRP1/GPC3/BMP4/BMP7/COMP/TGFB3/FSTL3/MSX2/BMP3/BMPR2/NOG,16
GO:0061035,regulation of cartilage development, 12/89,73/18614,9.60E-16,1.36E-13,7.20E-14,SMAD3/BMP6/BMP1/BMPR1B/ADAMTS12/AXIN2/BMP4/CCN2/SNAI2/CTNNB1/BMPR2/NOG,12
GO:0060562,epithelial tube morphogenesis, 19/89,334/18614,1.45E-15,1.97E-13,1.04E-13,BCL2/SMAD3/CASR/HIF1A/RHOA/ADAMTS12/SFRP1/SHH/GPC3/BMP4/DCHS1/BMP7/LRP5/CTHRC1/MSX2/CTNNB1/NOG/MMP14/TWIST1,19
GO:0030509,BMP signaling pathway, 15/89,176/18614,4.90E-15,6.35E-13,3.36E-13,CHRDL1/CHRDL2/BMP6/BMPR1B/SFRP1/GPC3/BMP4/BMP7/COMP/TGFB3/FSTL3/MSX2/BMP3/BMPR2/NOG,15
GO:0030278,regulation of ossification, 13/89,119/18614,1.42E-14,1.77E-12,9.35E-13,BCL2/SMAD3/HIF1A/BMP6/MGP/BMPR1B/MAPK14/SFRP1/BMP4/BMP7/COMP/BMPR2/TWIST1,13
GO:0061383,trabecula morphogenesis, 10/89,47/18614,1.66E-14,1.98E-12,1.05E-12,RHOA/SFRP1/BMP7/THBS3/FHL2/COL1A1/PLXNB1/MMP2/MSX2/NOG,10
GO:0022612,gland morphogenesis, 13/89,123/18614,2.21E-14,2.53E-12,1.34E-12,BCL2/TNC/GLI1/SFRP1/SHH/BMP4/BMP7/TGFB3/MMP2/LRP5/SNAI2/MSX2/NOG,13
GO:0007369,gastrulation, 15/89,196/18614,2.44E-14,2.69E-12,1.42E-12,MMP9/SMAD3/SNAI1/FOXC1/SFRP1/GPC3/BMP4/BMP7/MMP2/LRP5/EXT2/CTNNB1/BMPR2/NOG/MMP14,15
GO:0001657,ureteric bud development, 12/89,97/18614,3.39E-14,3.61E-12,1.91E-12,CAT/BCL2/SMAD3/FOXC1/SFRP1/SHH/GPC3/BMP4/DCHS1/BMP7/CTNNB1/NOG,12
GO:0072163,mesonephric epithelium development, 12/89,98/18614,3.85E-14,3.83E-12,2.02E-12,CAT/BCL2/SMAD3/FOXC1/SFRP1/SHH/GPC3/BMP4/DCHS1/BMP7/CTNNB1/NOG,12
GO:0072164,mesonephric tubule development, 12/89,98/18614,3.85E-14,3.83E-12,2.02E-12,CAT/BCL2/SMAD3/FOXC1/SFRP1/SHH/GPC3/BMP4/DCHS1/BMP7/CTNNB1/NOG,12
GO:0001763,morphogenesis of a branching structure, 15/89,203/18614,4.10E-14,3.94E-12,2.08E-12,BCL2/CASR/SFRP1/SHH/GPC3/BMP4/DCHS1/COL13A1/BMP7/LRP5/SNAI2/MSX2/CTNNB1/NOG/MMP14,15
GO:0048863,stem cell differentiation, 16/89,247/18614,4.23E-14,3.94E-12,2.09E-12,BCL2/HNRNPU/HIF1A/UFL1/SP7/MAPK14/FOXC1/SFRP1/SHH/BMP4/BMP7/SNAI2/MSX2/CTNNB1/NOG/TWIST1,16
GO:0033002,muscle cell proliferation, 16/89,249/18614,4.80E-14,4.33E-12,2.29E-12,MMP9/NF1/RHOA/GLI1/MAPK11/MAPK14/FOXC1/SHH/RUNX1/BMP4/IGFBP3/TGFB3/MMP2/CTNNB1/BMPR2/NOG,16
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway, 17/89,301/18614,5.98E-14,5.24E-12,2.77E-12,CHRDL1/BMP8B/SMAD3/MEN1/CHRDL2/BMP6/SFRP1/SHH/GPC3/BMP4/BMP7/TGFB3/FSTL3/MSX2/BMP3/BMPR2/NOG,17
GO:0001823,mesonephros development, 12/89,102/18614,6.31E-14,5.37E-12,2.84E-12,CAT/BCL2/SMAD3/FOXC1/SFRP1/SHH/GPC3/BMP4/DCHS1/BMP7/CTNNB1/NOG,12
GO:0033687,osteoblast proliferation, 9/89,36/18614,7.30E-14,6.04E-12,3.20E-12,BCL2/SMAD3/RHOA/SFRP1/AXIN2/JUNB/PLXNB1/LRP5/CTHRC1,9
GO:0033280,response to vitamin D, 9/89,37/18614,9.61E-14,7.74E-12,4.09E-12,CASR/STC1/SFRP1/BMP7/PHEX/SPP1/CYP24A1/SNAI2/ALPL,9
GO:0003007,heart morphogenesis, 16/89,262/18614,1.06E-13,8.30E-12,4.39E-12,SMAD3/SNAI1/HIF1A/FOXC1/SHH/AXIN2/BMP4/DCHS1/BMP7/FHL2/SNAI2/MSX2/CTNNB1/BMPR2/NOG/TWIST1,16
GO:0030198,extracellular matrix organization, 17/89,314/18614,1.19E-13,9.11E-12,4.82E-12,IBSP/TMEM38B/MMP9/SMAD3/NF1/BMP1/COL1A2/FOXC1/ADAMTS12/RUNX1/AXIN2/COL13A1/COL1A1/CCN2/COMP/MMP2/MMP14,17
GO:0043062,extracellular structure organization, 17/89,315/18614,1.26E-13,9.36E-12,4.95E-12,IBSP/TMEM38B/MMP9/SMAD3/NF1/BMP1/COL1A2/FOXC1/ADAMTS12/RUNX1/AXIN2/COL13A1/COL1A1/CCN2/COMP/MMP2/MMP14,17
GO:0045229,external encapsulating structure organization, 17/89,317/18614,1.39E-13,1.01E-11,5.35E-12,IBSP/TMEM38B/MMP9/SMAD3/NF1/BMP1/COL1A2/FOXC1/ADAMTS12/RUNX1/AXIN2/COL13A1/COL1A1/CCN2/COMP/MMP2/MMP14,17
GO:0035265,organ growth, 14/89,180/18614,1.52E-13,1.08E-11,5.72E-12,FGFR3/TMEM38B/BCL2/GLI1/STC1/MAPK11/MAPK14/FOXC1/SHH/RUNX1/THBS3/COMP/MSX2/NOG,14
GO:0010717,regulation of epithelial to mesenchymal transition, 12/89,110/18614,1.59E-13,1.09E-11,5.75E-12,SMAD3/SNAI1/FOXC1/SFRP1/AXIN2/BMP4/BMP7/COL1A1/TGFB3/CTNNB1/NOG/TWIST1,12
GO:0010718,positive regulation of epithelial to mesenchymal transition, 10/89,58/18614,1.61E-13,1.09E-11,5.75E-12,SMAD3/SNAI1/FOXC1/AXIN2/BMP4/BMP7/COL1A1/TGFB3/CTNNB1/TWIST1,10
GO:0061138,morphogenesis of a branching epithelium, 14/89,188/18614,2.78E-13,1.84E-11,9.74E-12,BCL2/CASR/SFRP1/SHH/GPC3/BMP4/DCHS1/BMP7/LRP5/SNAI2/MSX2/CTNNB1/NOG/MMP14,14
GO:0033273,response to vitamin, 11/89,88/18614,3.74E-13,2.42E-11,1.28E-11,CAT/CASR/STC1/SFRP1/BMP7/PHEX/COL1A1/SPP1/CYP24A1/SNAI2/ALPL,11
GO:0002076,osteoblast development, 7/89,17/18614,8.40E-13,5.33E-11,2.82E-11,SATB2/SMAD3/ACHE/MEN1/SHH/LRP5/MSX2,7
GO:0048608,reproductive structure development, 16/89,301/18614,8.96E-13,5.55E-11,2.93E-11,BCL2/TNC/BMP6/GLI1/DHH/BMPR1B/FOXC1/SFRP1/SHH/BMP4/BMP7/MMP2/CTNNB1/NOG/MMP14/ROR2,16
GO:0001704,formation of primary germ layer, 12/89,127/18614,9.12E-13,5.55E-11,2.93E-11,MMP9/SMAD3/SNAI1/FOXC1/BMP4/BMP7/MMP2/EXT2/CTNNB1/BMPR2/NOG/MMP14,12
GO:0061458,reproductive system development, 16/89,305/18614,1.10E-12,6.43E-11,3.40E-11,BCL2/TNC/BMP6/GLI1/DHH/BMPR1B/FOXC1/SFRP1/SHH/BMP4/BMP7/MMP2/CTNNB1/NOG/MMP14/ROR2,16
GO:0048706,embryonic skeletal system development, 12/89,129/18614,1.10E-12,6.43E-11,3.40E-11,SATB2/SMAD3/XYLT1/SHH/BMP4/BMP7/COL1A1/TGFB3/CTNNB1/NOG/MMP14/TWIST1,12
GO:0030850,prostate gland development, 9/89,48/18614,1.24E-12,7.12E-11,3.76E-11,TNC/GLI1/SFRP1/SHH/BMP4/BMP7/MMP2/CTNNB1/NOG,9
GO:0001822,kidney development, 16/89,310/18614,1.41E-12,7.46E-11,3.95E-11,CAT/BCL2/MMP9/SMAD3/NF1/BMP6/RHOA/FOXC1/SFRP1/SHH/GPC3/BMP4/DCHS1/BMP7/CTNNB1/NOG,16
GO:0060537,muscle tissue development, 18/89,426/18614,1.42E-12,7.46E-11,3.95E-11,BCL2/HNRNPU/SMAD3/NF1/RHOA/GLI1/MAPK11/MAPK14/FOXC1/SHH/RUNX1/BMP4/BMP7/FHL2/MSX2/CTNNB1/NOG/TWIST1,18
GO:0001958,endochondral ossification, 8/89,31/18614,1.43E-12,7.46E-11,3.95E-11,FGFR3/BMP6/FOXC1/BMP4/COL13A1/COL1A1/ALPL/MMP14,8
GO:0033688,regulation of osteoblast proliferation, 8/89,31/18614,1.43E-12,7.46E-11,3.95E-11,BCL2/SMAD3/RHOA/SFRP1/AXIN2/PLXNB1/LRP5/CTHRC1,8
GO:0036075,replacement ossification, 8/89,31/18614,1.43E-12,7.46E-11,3.95E-11,FGFR3/BMP6/FOXC1/BMP4/COL13A1/COL1A1/ALPL/MMP14,8
GO:0070167,regulation of biomineral tissue development, 11/89,101/18614,1.77E-12,9.08E-11,4.80E-11,SMAD3/HIF1A/BMP6/MGP/BMPR1B/AMELX/BMP4/BMP7/COMP/BMPR2/TWIST1,11
GO:0072001,renal system development, 16/89,320/18614,2.28E-12,1.15E-10,6.08E-11,CAT/BCL2/MMP9/SMAD3/NF1/BMP6/RHOA/FOXC1/SFRP1/SHH/GPC3/BMP4/DCHS1/BMP7/CTNNB1/NOG,16
GO:0045669,positive regulation of osteoblast differentiation, 10/89,75/18614,2.39E-12,1.19E-10,6.27E-11,BMP6/BMPR1B/BMP4/BMP7/LRP5/CTHRC1/MSX2/CTNNB1/BMPR2/IFITM1,10
GO:0048732,gland development, 18/89,441/18614,2.53E-12,1.24E-10,6.55E-11,BCL2/SMAD3/TNC/HIF1A/NF1/GLI1/FOXC1/SFRP1/SHH/BMP4/BMP7/TGFB3/MMP2/LRP5/SNAI2/MSX2/CTNNB1/NOG,18
GO:0003197,endocardial cushion development, 9/89,52/18614,2.68E-12,1.29E-10,6.82E-11,SNAI1/BMP4/DCHS1/BMP7/SNAI2/MSX2/BMPR2/NOG/TWIST1,9
GO:0032963,collagen metabolic process, 11/89,108/18614,3.73E-12,1.77E-10,9.34E-11,MMP9/HIF1A/COL1A2/RUNX1/AMELX/BMP4/COL1A1/CCN2/TGFB3/MMP2/MMP14,11
GO:0032330,regulation of chondrocyte differentiation, 9/89,54/18614,3.85E-12,1.79E-10,9.47E-11,SMAD3/BMP6/BMPR1B/ADAMTS12/AXIN2/BMP4/CCN2/SNAI2/CTNNB1,9
GO:0070482,response to oxygen levels, 16/89,333/18614,4.17E-12,1.91E-10,1.01E-10,CAT/BCL2/SMAD3/CASR/HIF1A/NF1/RHOA/STC1/SFRP1/BMP7/COL1A1/CCN2/TGFB3/MMP2/MMP14/TWIST1,16
GO:0030500,regulation of bone mineralization, 10/89,80/18614,4.65E-12,2.10E-10,1.11E-10,SMAD3/HIF1A/BMP6/MGP/BMPR1B/BMP4/BMP7/COMP/BMPR2/TWIST1,10
GO:0072073,kidney epithelium development, 12/89,146/18614,4.86E-12,2.16E-10,1.14E-10,CAT/BCL2/SMAD3/FOXC1/SFRP1/SHH/GPC3/BMP4/DCHS1/BMP7/CTNNB1/NOG,12
GO:0072132,mesenchyme morphogenesis, 9/89,57/18614,6.43E-12,2.82E-10,1.49E-10,SMAD3/SNAI1/FOXC1/DCHS1/BMP7/SNAI2/MSX2/NOG/TWIST1,9
GO:0035988,chondrocyte proliferation, 7/89,23/18614,1.03E-11,4.45E-10,2.35E-10,FGFR3/STC1/BMPR1B/CCN2/COMP/BMPR2/MMP14,7
GO:0003179,heart valve morphogenesis, 9/89,60/18614,1.04E-11,4.45E-10,2.35E-10,SNAI1/RHOA/AXIN2/BMP4/DCHS1/SNAI2/BMPR2/CDH11/TWIST1,9
GO:0007584,response to nutrient, 12/89,156/18614,1.07E-11,4.48E-10,2.37E-10,CAT/CASR/STC1/SFRP1/AMELX/BMP7/PHEX/COL1A1/SPP1/CYP24A1/SNAI2/ALPL,12
GO:0048754,branching morphogenesis of an epithelial tube, 12/89,157/18614,1.15E-11,4.76E-10,2.52E-10,BCL2/CASR/SHH/GPC3/BMP4/DCHS1/BMP7/LRP5/MSX2/CTNNB1/NOG/MMP14,12
GO:0003002,regionalization, 17/89,422/18614,1.36E-11,5.56E-10,2.94E-10,SMAD3/SNAI1/HIF1A/GLI1/BMP1/BMPR1B/FOXC1/SFRP1/SHH/GPC3/AXIN2/BMP4/LRP5/MSX2/CTNNB1/BMPR2/NOG,17
GO:0036293,response to decreased oxygen levels, 15/89,306/18614,1.57E-11,6.32E-10,3.35E-10,CAT/BCL2/SMAD3/CASR/HIF1A/NF1/RHOA/STC1/SFRP1/BMP7/CCN2/TGFB3/MMP2/MMP14/TWIST1,15
GO:0061430,bone trabecula morphogenesis, 6/89,13/18614,1.68E-11,6.68E-10,3.53E-10,SFRP1/THBS3/COL1A1/PLXNB1/MMP2/MSX2,6
GO:0014706,striated muscle tissue development, 14/89,259/18614,2.16E-11,8.48E-10,4.49E-10,HNRNPU/SMAD3/GLI1/MAPK11/MAPK14/FOXC1/SHH/RUNX1/BMP4/BMP7/FHL2/MSX2/NOG/TWIST1,14
GO:0003176,aortic valve development, 8/89,43/18614,2.51E-11,9.69E-10,5.13E-10,SNAI1/RHOA/AXIN2/BMP4/SNAI2/BMPR2/CDH11/TWIST1,8
GO:0001655,urogenital system development, 9/89,66/18614,2.56E-11,9.76E-10,5.16E-10,TNC/GLI1/SFRP1/SHH/BMP4/BMP7/MMP2/CTNNB1/NOG,9
GO:2000027,regulation of animal organ morphogenesis, 11/89,129/18614,2.65E-11,1.00E-09,5.30E-10,RHOA/SFRP1/SHH/GPC3/BMP4/BMP7/SNAI2/CTHRC1/CTNNB1/NOG/ROR2,11
GO:0060740,prostate gland epithelium morphogenesis, 7/89,26/18614,2.74E-11,1.02E-09,5.41E-10,TNC/SFRP1/SHH/BMP4/BMP7/MMP2/NOG,7
GO:0001654,eye development, 16/89,385/18614,3.67E-11,1.35E-09,7.15E-10,CHRDL1/BCL2/SMAD3/ACHE/HIF1A/NF1/BMP6/BMPR1B/FOXC1/SHH/BMP4/BMP7/LRP5/CTNNB1/BMPR2/TWIST1,16
GO:0048568,embryonic organ development, 17/89,453/18614,4.15E-11,1.51E-09,7.97E-10,SATB2/SMAD3/RPL38/SNAI1/HIF1A/GLI1/FOXC1/SHH/BMP4/BMP7/JUNB/TGFB3/CTHRC1/CTNNB1/NOG/MMP14/TWIST1,17
GO:0150063,visual system development, 16/89,389/18614,4.28E-11,1.54E-09,8.13E-10,CHRDL1/BCL2/SMAD3/ACHE/HIF1A/NF1/BMP6/BMPR1B/FOXC1/SHH/BMP4/BMP7/LRP5/CTNNB1/BMPR2/TWIST1,16
GO:0060512,prostate gland morphogenesis, 7/89,28/18614,4.90E-11,1.74E-09,9.20E-10,TNC/SFRP1/SHH/BMP4/BMP7/MMP2/NOG,7
GO:1905314,semi-lunar valve development, 8/89,47/18614,5.35E-11,1.86E-09,9.85E-10,SNAI1/RHOA/AXIN2/BMP4/SNAI2/BMPR2/CDH11/TWIST1,8
GO:0048880,sensory system development, 16/89,395/18614,5.38E-11,1.86E-09,9.85E-10,CHRDL1/BCL2/SMAD3/ACHE/HIF1A/NF1/BMP6/BMPR1B/FOXC1/SHH/BMP4/BMP7/LRP5/CTNNB1/BMPR2/TWIST1,16
GO:0048771,tissue remodeling, 12/89,181/18614,6.13E-11,2.10E-09,1.11E-09,HIF1A/NF1/FOXC1/SFRP1/RUNX1/SPP1/MMP2/LRP5/CTHRC1/CTNNB1/BMPR2/MMP14,12
GO:0070977,bone maturation, 7/89,29/18614,6.44E-11,2.18E-09,1.15E-09,FGFR3/RHOA/XYLT1/ADAMTS12/DCHS1/THBS3/PLXNB1,7
GO:0003170,heart valve development, 9/89,73/18614,6.53E-11,2.18E-09,1.16E-09,SNAI1/RHOA/AXIN2/BMP4/DCHS1/SNAI2/BMPR2/CDH11/TWIST1,9
GO:0048545,response to steroid hormone, 15/89,339/18614,6.67E-11,2.21E-09,1.17E-09,BCL2/HNRNPU/UFL1/BMP6/RHOA/STC1/SFRP1/AXIN2/BMP4/BMP7/COL1A1/CCN2/SPP1/TGFB3/ALPL,15
GO:0030324,lung development, 12/89,186/18614,8.43E-11,2.76E-09,1.46E-09,TMEM38B/GLI1/SHH/GPC3/BMP4/PHEX/CCN2/TGFB3/CTNNB1/BMPR2/NOG/MMP14,12
GO:0090287,regulation of cellular response to growth factor stimulus, 15/89,345/18614,8.53E-11,2.76E-09,1.46E-09,CHRDL1/SMAD3/MEN1/HIF1A/CHRDL2/ADAMTS12/SFRP1/GPC3/BMP4/TGFB3/FSTL3/MSX2/CTNNB1/BMPR2/NOG,15
GO:0048546,digestive tract morphogenesis, 8/89,50/18614,9.03E-11,2.89E-09,1.53E-09,BCL2/SMAD3/HIF1A/GLI1/SFRP1/SHH/BMP4/CTNNB1,8
GO:0030323,respiratory tube development, 12/89,190/18614,1.08E-10,3.42E-09,1.81E-09,TMEM38B/GLI1/SHH/GPC3/BMP4/PHEX/CCN2/TGFB3/CTNNB1/BMPR2/NOG/MMP14,12
GO:0001666,response to hypoxia, 14/89,293/18614,1.11E-10,3.50E-09,1.85E-09,CAT/BCL2/SMAD3/CASR/HIF1A/NF1/RHOA/STC1/SFRP1/BMP7/TGFB3/MMP2/MMP14/TWIST1,14
GO:0048562,embryonic organ morphogenesis, 14/89,294/18614,1.17E-10,3.62E-09,1.91E-09,SATB2/SMAD3/RPL38/HIF1A/GLI1/SHH/BMP4/BMP7/TGFB3/CTHRC1/CTNNB1/NOG/MMP14/TWIST1,14
GO:0050673,epithelial cell proliferation, 17/89,488/18614,1.32E-10,4.05E-09,2.14E-09,SMAD3/MEN1/HIF1A/NF1/BMP6/GLI1/SFRP1/SHH/GPC3/BMP4/IGFBP3/SNAI2/CTNNB1/BMPR2/NOG/MMP14/TWIST1,17
GO:0071695,anatomical structure maturation, 13/89,247/18614,1.66E-10,5.04E-09,2.67E-09,FGFR3/BCL2/HIF1A/NF1/RHOA/XYLT1/ADAMTS12/DCHS1/THBS3/PLXNB1/MMP2/MSX2/CTNNB1,13
GO:0048799,animal organ maturation, 7/89,33/18614,1.73E-10,5.22E-09,2.76E-09,FGFR3/RHOA/XYLT1/ADAMTS12/DCHS1/THBS3/PLXNB1,7
GO:0003151,outflow tract morphogenesis, 9/89,82/18614,1.90E-10,5.67E-09,3.00E-09,HIF1A/FOXC1/BMP4/BMP7/MSX2/CTNNB1/BMPR2/NOG/TWIST1,9
GO:0009952,anterior/posterior pattern specification, 12/89,209/18614,3.26E-10,9.60E-09,5.08E-09,SMAD3/FOXC1/SFRP1/SHH/GPC3/AXIN2/BMP4/LRP5/MSX2/CTNNB1/BMPR2/NOG,12
GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway, 10/89,122/18614,3.31E-10,9.66E-09,5.11E-09,BMP8B/MEN1/BMP6/GPC3/BMP4/BMP7/TGFB3/MSX2/BMP3/BMPR2,10
GO:0021700,developmental maturation, 14/89,319/18614,3.41E-10,9.86E-09,5.21E-09,FGFR3/CHRDL1/BCL2/HIF1A/NF1/RHOA/XYLT1/ADAMTS12/DCHS1/THBS3/PLXNB1/MMP2/MSX2/CTNNB1,14
GO:0060541,respiratory system development, 12/89,211/18614,3.63E-10,1.04E-08,5.50E-09,TMEM38B/GLI1/SHH/GPC3/BMP4/PHEX/CCN2/TGFB3/CTNNB1/BMPR2/NOG/MMP14,12
GO:0003180,aortic valve morphogenesis, 7/89,38/18614,5.03E-10,1.43E-08,7.54E-09,SNAI1/RHOA/AXIN2/BMP4/SNAI2/CDH11/TWIST1,7
GO:0016055,Wnt signaling pathway, 16/89,461/18614,5.20E-10,1.46E-08,7.73E-09,SMAD3/RHOA/GLI1/MAPK14/SFRP1/SHH/GPC3/AXIN2/COL1A1/WWOX/LRP5/SNAI2/CTHRC1/CTNNB1/NOG/ROR2,16
GO:0060346,bone trabecula formation, 5/89,10/18614,5.52E-10,1.53E-08,8.08E-09,SFRP1/THBS3/COL1A1/MMP2/MSX2,5
GO:0198738,cell-cell signaling by wnt, 16/89,463/18614,5.53E-10,1.53E-08,8.08E-09,SMAD3/RHOA/GLI1/MAPK14/SFRP1/SHH/GPC3/AXIN2/COL1A1/WWOX/LRP5/SNAI2/CTHRC1/CTNNB1/NOG/ROR2,16
GO:0060393,regulation of pathway-restricted SMAD protein phosphorylation, 8/89,63/18614,6.19E-10,1.69E-08,8.95E-09,BMP8B/BMP6/BMP4/BMP7/TGFB3/BMP3/BMPR2/NOG,8
GO:0030178,negative regulation of Wnt signaling pathway, 11/89,174/18614,6.74E-10,1.82E-08,9.65E-09,GLI1/MAPK14/SFRP1/SHH/GPC3/AXIN2/WWOX/SNAI2/CTHRC1/CTNNB1/NOG,11
GO:0002244,hematopoietic progenitor cell differentiation, 10/89,132/18614,7.21E-10,1.91E-08,1.01E-08,BCL2/SBDS/UFL1/ADAR/SP7/FOXC1/SFRP1/SHH/BMP4/FSTL3,10
GO:0009953,dorsal/ventral pattern formation, 9/89,95/18614,7.25E-10,1.91E-08,1.01E-08,GLI1/BMP1/BMPR1B/SFRP1/SHH/AXIN2/BMP4/CTNNB1/NOG,9
GO:0048704,embryonic skeletal system morphogenesis, 9/89,95/18614,7.25E-10,1.91E-08,1.01E-08,SATB2/SMAD3/BMP4/BMP7/TGFB3/CTNNB1/NOG/MMP14/TWIST1,9
GO:1905330,regulation of morphogenesis of an epithelium, 8/89,65/18614,8.01E-10,2.09E-08,1.11E-08,ADAMTS12/SFRP1/SHH/BMP4/BMP7/SNAI2/CTNNB1/NOG,8
GO:0048565,digestive tract development, 10/89,134/18614,8.36E-10,2.16E-08,1.15E-08,BCL2/SMAD3/HIF1A/GLI1/SFRP1/SHH/BMP4/DCHS1/TGFB3/CTNNB1,10
GO:0031667,response to nutrient levels, 16/89,477/18614,8.52E-10,2.19E-08,1.16E-08,CAT/BCL2/CASR/STC1/SP7/MAPK14/SFRP1/AMELX/BMP7/PHEX/COL1A1/SPP1/CYP24A1/SNAI2/ALPL/BMPR2,16
GO:0003203,endocardial cushion morphogenesis, 7/89,41/18614,8.85E-10,2.25E-08,1.19E-08,SNAI1/DCHS1/BMP7/SNAI2/MSX2/NOG/TWIST1,7
GO:0060389,pathway-restricted SMAD protein phosphorylation, 8/89,67/18614,1.03E-09,2.59E-08,1.37E-08,BMP8B/BMP6/BMP4/BMP7/TGFB3/BMP3/BMPR2/NOG,8
GO:0007498,mesoderm development, 10/89,137/18614,1.04E-09,2.60E-08,1.38E-08,SMAD3/RPL38/SNAI1/FOXC1/SHH/BMP4/BMP7/EXT2/BMPR2/NOG,10
GO:0048736,appendage development, 11/89,182/18614,1.09E-09,2.67E-08,1.41E-08,SHH/GPC3/BMP4/BMP7/COMP/LRP5/MSX2/CTNNB1/BMPR2/NOG/TWIST1,11
GO:0060173,limb development, 11/89,182/18614,1.09E-09,2.67E-08,1.41E-08,SHH/GPC3/BMP4/BMP7/COMP/LRP5/MSX2/CTNNB1/BMPR2/NOG/TWIST1,11
GO:0090090,negative regulation of canonical Wnt signaling pathway, 10/89,139/18614,1.20E-09,2.92E-08,1.55E-08,GLI1/MAPK14/SFRP1/SHH/GPC3/AXIN2/SNAI2/CTHRC1/CTNNB1/NOG,10
GO:0050678,regulation of epithelial cell proliferation, 15/89,419/18614,1.26E-09,3.01E-08,1.59E-08,SMAD3/MEN1/HIF1A/NF1/BMP6/GLI1/SFRP1/SHH/GPC3/BMP4/SNAI2/CTNNB1/BMPR2/NOG/TWIST1,15
GO:0010463,mesenchymal cell proliferation, 7/89,43/18614,1.26E-09,3.01E-08,1.59E-08,SHH/GPC3/BMP4/DCHS1/BMP7/LRP5/CTNNB1,7
GO:0060571,morphogenesis of an epithelial fold, 6/89,24/18614,1.26E-09,3.01E-08,1.59E-08,HIF1A/SHH/BMP4/BMP7/CTNNB1/NOG,6
GO:0007160,cell-matrix adhesion, 12/89,239/18614,1.51E-09,3.57E-08,1.89E-08,BCL2/SMAD3/NF1/RHOA/ADAMTS12/SFRP1/COL13A1/THBS3/CCN2/CTNNB1/CDH11/MMP14,12
GO:0031589,cell-substrate adhesion, 14/89,359/18614,1.58E-09,3.71E-08,1.96E-08,BCL2/SMAD3/MEN1/NF1/RHOA/ADAMTS12/SFRP1/COL13A1/THBS3/COL1A1/CCN2/CTNNB1/CDH11/MMP14,14
GO:1904888,cranial skeletal system development, 8/89,72/18614,1.85E-09,4.30E-08,2.28E-08,SMAD3/BMP4/TGFB3/MSX2/CTNNB1/NOG/MMP14/TWIST1,8
GO:0055123,digestive system development, 10/89,146/18614,1.94E-09,4.47E-08,2.36E-08,BCL2/SMAD3/HIF1A/GLI1/SFRP1/SHH/BMP4/DCHS1/TGFB3/CTNNB1,10
GO:0043931,ossification involved in bone maturation, 6/89,26/18614,2.15E-09,4.88E-08,2.58E-08,RHOA/XYLT1/ADAMTS12/DCHS1/THBS3/PLXNB1,6
GO:0060343,trabecula formation, 6/89,26/18614,2.15E-09,4.88E-08,2.58E-08,SFRP1/THBS3/FHL2/COL1A1/MMP2/MSX2,6
GO:0001707,mesoderm formation, 8/89,75/18614,2.57E-09,5.81E-08,3.07E-08,SMAD3/SNAI1/FOXC1/BMP4/BMP7/EXT2/BMPR2/NOG,8
GO:0007162,negative regulation of cell adhesion, 13/89,312/18614,2.88E-09,6.46E-08,3.42E-08,MEN1/NF1/BMP6/RHOA/SHH/RUNX1/BMP4/COL1A1/PLXNB1/MMP2/SNAI2/GTPBP4/MMP14,13
GO:0060070,canonical Wnt signaling pathway, 13/89,313/18614,3.00E-09,6.66E-08,3.53E-08,SMAD3/GLI1/MAPK14/SFRP1/SHH/GPC3/AXIN2/COL1A1/LRP5/SNAI2/CTHRC1/CTNNB1/NOG,13
GO:0048332,mesoderm morphogenesis, 8/89,77/18614,3.19E-09,7.03E-08,3.72E-08,SMAD3/SNAI1/FOXC1/BMP4/BMP7/EXT2/BMPR2/NOG,8
GO:0003272,endocardial cushion formation, 6/89,28/18614,3.49E-09,7.58E-08,4.01E-08,SNAI1/DCHS1/BMP7/SNAI2/MSX2/NOG,6
GO:0035116,embryonic hindlimb morphogenesis, 6/89,28/18614,3.49E-09,7.58E-08,4.01E-08,SHH/GPC3/BMP4/MSX2/CTNNB1/TWIST1,6
GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation, 7/89,50/18614,3.80E-09,8.20E-08,4.34E-08,BMP8B/BMP6/BMP4/BMP7/TGFB3/BMP3/BMPR2,7
GO:0060828,regulation of canonical Wnt signaling pathway, 12/89,260/18614,3.92E-09,8.40E-08,4.44E-08,SMAD3/GLI1/MAPK14/SFRP1/SHH/GPC3/AXIN2/COL1A1/SNAI2/CTHRC1/CTNNB1/NOG,12
GO:0072028,nephron morphogenesis, 8/89,80/18614,4.34E-09,9.23E-08,4.88E-08,BCL2/SHH/GPC3/BMP4/DCHS1/BMP7/CTNNB1/NOG,8
GO:0060688,regulation of morphogenesis of a branching structure, 7/89,51/18614,4.39E-09,9.27E-08,4.90E-08,SFRP1/SHH/BMP4/BMP7/SNAI2/CTNNB1/NOG,7
GO:0030510,regulation of BMP signaling pathway, 9/89,118/18614,5.05E-09,1.06E-07,5.60E-08,CHRDL1/CHRDL2/SFRP1/GPC3/BMP4/FSTL3/MSX2/BMPR2/NOG,9
GO:0021915,neural tube development, 10/89,163/18614,5.64E-09,1.17E-07,6.21E-08,HIF1A/NF1/SFRP1/SHH/BMP4/DCHS1/BMP7/CTHRC1/NOG/TWIST1,10
GO:0070169,positive regulation of biomineral tissue development, 7/89,53/18614,5.79E-09,1.19E-07,6.28E-08,SMAD3/BMP6/BMPR1B/AMELX/BMP4/BMP7/BMPR2,7
GO:0030326,embryonic limb morphogenesis, 9/89,120/18614,5.86E-09,1.19E-07,6.28E-08,SHH/GPC3/BMP4/BMP7/LRP5/MSX2/CTNNB1/NOG/TWIST1,9
GO:0032355,response to estradiol, 9/89,120/18614,5.86E-09,1.19E-07,6.28E-08,CAT/DHH/SFRP1/BMP7/COL1A1/CCN2/MMP2/MSX2/CTNNB1,9
GO:0035113,embryonic appendage morphogenesis, 9/89,120/18614,5.86E-09,1.19E-07,6.28E-08,SHH/GPC3/BMP4/BMP7/LRP5/MSX2/CTNNB1/NOG/TWIST1,9
GO:0033689,negative regulation of osteoblast proliferation, 5/89,15/18614,6.45E-09,1.29E-07,6.82E-08,BCL2/SMAD3/SFRP1/AXIN2/PLXNB1,5
GO:0060572,morphogenesis of an epithelial bud, 5/89,15/18614,6.45E-09,1.29E-07,6.82E-08,SHH/BMP4/BMP7/CTNNB1/NOG,5
GO:0061311,cell surface receptor signaling pathway involved in heart development, 6/89,31/18614,6.74E-09,1.34E-07,7.08E-08,SNAI1/BMP4/SNAI2/MSX2/CTNNB1/NOG,6
GO:0030111,regulation of Wnt signaling pathway, 13/89,338/18614,7.54E-09,1.48E-07,7.81E-08,SMAD3/GLI1/MAPK14/SFRP1/SHH/GPC3/AXIN2/COL1A1/WWOX/SNAI2/CTHRC1/CTNNB1/NOG,13
GO:0043010,camera-type eye development, 13/89,338/18614,7.54E-09,1.48E-07,7.81E-08,SMAD3/ACHE/HIF1A/NF1/BMPR1B/FOXC1/SHH/BMP4/BMP7/LRP5/CTNNB1/BMPR2/TWIST1,13
GO:0071295,cellular response to vitamin, 6/89,32/18614,8.26E-09,1.61E-07,8.51E-08,CASR/SFRP1/PHEX/COL1A1/CYP24A1/SNAI2,6
GO:0048864,stem cell development, 8/89,88/18614,9.33E-09,1.80E-07,9.54E-08,BCL2/HIF1A/FOXC1/SHH/BMP4/BMP7/SNAI2/TWIST1,8
GO:0061036,positive regulation of cartilage development, 6/89,33/18614,1.01E-08,1.92E-07,1.02E-07,SMAD3/BMP6/BMP1/BMPR1B/BMP4/BMPR2,6
GO:1903706,regulation of hemopoiesis, 14/89,415/18614,1.01E-08,1.92E-07,1.02E-07,HIF1A/NF1/RHOA/MAPK14/SFRP1/SHH/RUNX1/BMP4/JUNB/FSTL3/SNAI2/CTNNB1/MMP14/ROR2,14
GO:0002573,myeloid leukocyte differentiation, 11/89,227/18614,1.10E-08,2.09E-07,1.11E-07,MMP9/NF1/MAPK14/SFRP1/RUNX1/GPC3/BMP4/JUNB/FSTL3/CTNNB1/ROR2,11
GO:0042733,embryonic digit morphogenesis, 7/89,58/18614,1.11E-08,2.09E-07,1.11E-07,SHH/BMP4/LRP5/MSX2/CTNNB1/NOG/TWIST1,7
GO:0060395,SMAD protein signal transduction, 8/89,90/18614,1.12E-08,2.09E-07,1.11E-07,BMP8B/SMAD3/BMP6/BMP4/BMP7/TGFB3/BMP3/BMPR2,8
GO:0030099,myeloid cell differentiation, 14/89,421/18614,1.21E-08,2.24E-07,1.19E-07,MMP9/HIF1A/UFL1/NF1/ADAR/MAPK14/SFRP1/RUNX1/GPC3/BMP4/JUNB/FSTL3/CTNNB1/ROR2,14
GO:0009798,axis specification, 8/89,92/18614,1.33E-08,2.46E-07,1.30E-07,CHRDL1/STC1/SFRP1/SHH/GPC3/AXIN2/BMP4/CTNNB1,8
GO:0001658,branching involved in ureteric bud morphogenesis, 7/89,60/18614,1.41E-08,2.60E-07,1.37E-07,BCL2/SHH/GPC3/BMP4/DCHS1/CTNNB1/NOG,7
GO:0035137,hindlimb morphogenesis, 6/89,35/18614,1.46E-08,2.67E-07,1.41E-07,SHH/GPC3/BMP4/MSX2/CTNNB1/TWIST1,6
GO:0045668,negative regulation of osteoblast differentiation, 7/89,61/18614,1.59E-08,2.89E-07,1.53E-07,SMAD3/MEN1/SFRP1/AXIN2/LRP5/NOG/TWIST1,7
GO:0014033,neural crest cell differentiation, 8/89,95/18614,1.72E-08,3.10E-07,1.64E-07,HIF1A/FOXC1/SFRP1/SHH/BMP4/BMP7/SNAI2/TWIST1,8
GO:0097094,craniofacial suture morphogenesis, 5/89,18/18614,1.82E-08,3.27E-07,1.73E-07,BMP4/TGFB3/MSX2/MMP14/TWIST1,5
GO:0060993,kidney morphogenesis, 8/89,97/18614,2.03E-08,3.61E-07,1.91E-07,BCL2/SHH/GPC3/BMP4/DCHS1/BMP7/CTNNB1/NOG,8
GO:0048738,cardiac muscle tissue development, 11/89,243/18614,2.23E-08,3.95E-07,2.09E-07,HNRNPU/GLI1/MAPK11/MAPK14/FOXC1/RUNX1/BMP4/BMP7/FHL2/MSX2/NOG,11
GO:0030199,collagen fibril organization, 7/89,64/18614,2.24E-08,3.95E-07,2.09E-07,NF1/BMP1/COL1A2/FOXC1/ADAMTS12/COL1A1/COMP,7
GO:0060391,positive regulation of SMAD protein signal transduction, 5/89,19/18614,2.46E-08,4.31E-07,2.28E-07,BMP6/BMP4/BMP7/TGFB3/BMPR2,5
GO:0060675,ureteric bud morphogenesis, 7/89,66/18614,2.78E-08,4.85E-07,2.57E-07,BCL2/SHH/GPC3/BMP4/DCHS1/CTNNB1/NOG,7
GO:0072171,mesonephric tubule morphogenesis, 7/89,67/18614,3.10E-08,5.36E-07,2.84E-07,BCL2/SHH/GPC3/BMP4/DCHS1/CTNNB1/NOG,7
GO:0045926,negative regulation of growth, 11/89,252/18614,3.24E-08,5.50E-07,2.91E-07,FGFR3/BCL2/SMAD3/HIF1A/MAPK11/SFRP1/GPC3/BMP4/SPP1/BMPR2/NOG,11
GO:0001502,cartilage condensation, 5/89,20/18614,3.27E-08,5.50E-07,2.91E-07,MGP/BMP1/BMPR1B/MAPK14/CCN2,5
GO:0035107,appendage morphogenesis, 9/89,146/18614,3.27E-08,5.50E-07,2.91E-07,SHH/GPC3/BMP4/BMP7/LRP5/MSX2/CTNNB1/NOG/TWIST1,9
GO:0035108,limb morphogenesis, 9/89,146/18614,3.27E-08,5.50E-07,2.91E-07,SHH/GPC3/BMP4/BMP7/LRP5/MSX2/CTNNB1/NOG/TWIST1,9
GO:0045598,regulation of fat cell differentiation, 9/89,146/18614,3.27E-08,5.50E-07,2.91E-07,HNRNPU/SMAD3/MAPK14/SFRP1/AXIN2/BMP7/LRP5/SNAI2/MSX2,9
GO:0060973,cell migration involved in heart development, 5/89,21/18614,4.27E-08,7.15E-07,3.78E-07,BMP4/DCHS1/BMP7/SNAI2/TWIST1,5
GO:0001890,placenta development, 9/89,152/18614,4.64E-08,7.63E-07,4.04E-07,SNAI1/MEN1/HIF1A/STC1/MAPK14/BMP7/JUNB/SPP1/BMPR2,9
GO:0016331,morphogenesis of embryonic epithelium, 9/89,152/18614,4.64E-08,7.63E-07,4.04E-07,HIF1A/SFRP1/SHH/BMP4/BMP7/CTHRC1/CTNNB1/NOG/TWIST1,9
GO:0072006,nephron development, 9/89,152/18614,4.64E-08,7.63E-07,4.04E-07,BCL2/FOXC1/SHH/GPC3/BMP4/DCHS1/BMP7/CTNNB1/NOG,9
GO:0045600,positive regulation of fat cell differentiation, 7/89,71/18614,4.66E-08,7.63E-07,4.04E-07,HNRNPU/MAPK14/SFRP1/AXIN2/BMP7/LRP5/SNAI2,7
GO:0035148,tube formation, 9/89,154/18614,5.19E-08,8.45E-07,4.47E-07,HIF1A/SFRP1/SHH/BMP4/BMP7/CTHRC1/CTNNB1/NOG/TWIST1,9
GO:0030501,positive regulation of bone mineralization, 6/89,43/18614,5.33E-08,8.58E-07,4.54E-07,SMAD3/BMP6/BMPR1B/BMP4/BMP7/BMPR2,6
GO:0031670,cellular response to nutrient, 6/89,43/18614,5.33E-08,8.58E-07,4.54E-07,CASR/SFRP1/PHEX/COL1A1/CYP24A1/SNAI2,6
GO:0090596,sensory organ morphogenesis, 11/89,269/18614,6.31E-08,1.01E-06,5.35E-07,BCL2/RPL38/HIF1A/NF1/BMP4/BMP7/LRP5/CTHRC1/CTNNB1/NOG/TWIST1,11
GO:0072078,nephron tubule morphogenesis, 7/89,75/18614,6.85E-08,1.09E-06,5.78E-07,BCL2/SHH/GPC3/BMP4/DCHS1/CTNNB1/NOG,7
GO:0071305,cellular response to vitamin D, 5/89,23/18614,7.01E-08,1.11E-06,5.88E-07,CASR/SFRP1/PHEX/CYP24A1/SNAI2,5
GO:1903707,negative regulation of hemopoiesis, 8/89,115/18614,7.73E-08,1.22E-06,6.45E-07,NF1/SFRP1/SHH/RUNX1/BMP4/FSTL3/SNAI2/CTNNB1,8
GO:1901861,regulation of muscle tissue development, 6/89,46/18614,8.09E-08,1.27E-06,6.71E-07,BCL2/SMAD3/SHH/BMP4/CTNNB1/TWIST1,6
GO:0072088,nephron epithelium morphogenesis, 7/89,77/18614,8.24E-08,1.28E-06,6.79E-07,BCL2/SHH/GPC3/BMP4/DCHS1/CTNNB1/NOG,7
GO:0072009,nephron epithelium development, 8/89,116/18614,8.27E-08,1.28E-06,6.79E-07,BCL2/FOXC1/SHH/GPC3/BMP4/DCHS1/CTNNB1/NOG,8
GO:0098743,cell aggregation, 5/89,24/18614,8.82E-08,1.36E-06,7.21E-07,MGP/BMP1/BMPR1B/MAPK14/CCN2,5
GO:0001667,ameboidal-type cell migration, 14/89,496/18614,9.29E-08,1.43E-06,7.54E-07,MMP9/SNAI1/HIF1A/NF1/RHOA/STC1/SHH/GPC3/BMP4/BMP7/LRP5/SNAI2/BMPR2/TWIST1,14
GO:0061333,renal tubule morphogenesis, 7/89,79/18614,9.86E-08,1.51E-06,7.97E-07,BCL2/SHH/GPC3/BMP4/DCHS1/CTNNB1/NOG,7
GO:0031960,response to corticosteroid, 9/89,166/18614,9.91E-08,1.51E-06,7.97E-07,BCL2/HNRNPU/BMP6/RHOA/STC1/AXIN2/COL1A1/CCN2/ALPL,9
GO:0007548,sex differentiation, 11/89,283/18614,1.06E-07,1.60E-06,8.44E-07,BCL2/BMP6/DHH/BMPR1B/FOXC1/SFRP1/SHH/MMP2/CTNNB1/MMP14/ROR2,11
GO:0071774,response to fibroblast growth factor, 8/89,120/18614,1.08E-07,1.62E-06,8.57E-07,FGFR3/CASR/SFRP1/COL1A1/CCN2/EXT2/CTNNB1/NOG,8
GO:0014855,striated muscle cell proliferation, 7/89,81/18614,1.17E-07,1.75E-06,9.25E-07,GLI1/MAPK11/MAPK14/FOXC1/SHH/RUNX1/NOG,7
GO:0010721,negative regulation of cell development, 11/89,286/18614,1.17E-07,1.75E-06,9.25E-07,NF1/SFRP1/SHH/RUNX1/BMP4/BMP7/SPP1/FSTL3/SNAI2/CTNNB1/NOG,11
GO:0050679,positive regulation of epithelial cell proliferation, 10/89,225/18614,1.20E-07,1.79E-06,9.45E-07,HIF1A/NF1/BMP6/SFRP1/SHH/BMP4/CTNNB1/BMPR2/NOG/TWIST1,10
GO:0014032,neural crest cell development, 7/89,82/18614,1.28E-07,1.88E-06,9.97E-07,HIF1A/FOXC1/SHH/BMP4/BMP7/SNAI2/TWIST1,7
GO:0007492,endoderm development, 7/89,83/18614,1.39E-07,2.04E-06,1.08E-06,MMP9/SMAD3/BMP4/MMP2/CTNNB1/NOG/MMP14,7
GO:0032964,collagen biosynthetic process, 6/89,51/18614,1.53E-07,2.22E-06,1.17E-06,RUNX1/AMELX/BMP4/COL1A1/CCN2/TGFB3,6
GO:0045778,positive regulation of ossification, 6/89,51/18614,1.53E-07,2.22E-06,1.17E-06,SMAD3/BMP6/BMPR1B/BMP4/BMP7/BMPR2,6
GO:0003183,mitral valve morphogenesis, 4/89,11/18614,1.57E-07,2.23E-06,1.18E-06,AXIN2/DCHS1/BMPR2/TWIST1,4
GO:0060272,embryonic skeletal joint morphogenesis, 4/89,11/18614,1.57E-07,2.23E-06,1.18E-06,BMP4/BMP7/CTNNB1/NOG,4
GO:0060601,lateral sprouting from an epithelium, 4/89,11/18614,1.57E-07,2.23E-06,1.18E-06,SHH/BMP4/BMP7/NOG,4
GO:0001838,embryonic epithelial tube formation, 8/89,126/18614,1.57E-07,2.23E-06,1.18E-06,HIF1A/SFRP1/BMP4/BMP7/CTHRC1/CTNNB1/NOG/TWIST1,8
GO:0003206,cardiac chamber morphogenesis, 8/89,126/18614,1.57E-07,2.23E-06,1.18E-06,HIF1A/FOXC1/BMP4/BMP7/FHL2/MSX2/BMPR2/NOG,8
GO:0048660,regulation of smooth muscle cell proliferation, 9/89,176/18614,1.63E-07,2.31E-06,1.22E-06,MMP9/NF1/RHOA/BMP4/IGFBP3/TGFB3/MMP2/CTNNB1/BMPR2,9
GO:0032967,positive regulation of collagen biosynthetic process, 5/89,27/18614,1.66E-07,2.33E-06,1.23E-06,RUNX1/AMELX/BMP4/CCN2/TGFB3,5
GO:0048659,smooth muscle cell proliferation, 9/89,180/18614,1.98E-07,2.77E-06,1.46E-06,MMP9/NF1/RHOA/BMP4/IGFBP3/TGFB3/MMP2/CTNNB1/BMPR2,9
GO:0010714,positive regulation of collagen metabolic process, 5/89,28/18614,2.01E-07,2.80E-06,1.48E-06,RUNX1/AMELX/BMP4/CCN2/TGFB3,5
GO:0030336,negative regulation of cell migration, 12/89,375/18614,2.21E-07,3.06E-06,1.62E-06,BCL2/NF1/RHOA/STC1/SFRP1/SHH/BMP4/IGFBP3/GTPBP4/NOG/CDH11/IFITM1,12
GO:0003174,mitral valve development, 4/89,12/18614,2.35E-07,3.22E-06,1.70E-06,AXIN2/DCHS1/BMPR2/TWIST1,4
GO:0060442,branching involved in prostate gland morphogenesis, 4/89,12/18614,2.35E-07,3.22E-06,1.70E-06,SFRP1/SHH/BMP4/BMP7,4
GO:0003416,endochondral bone growth, 5/89,29/18614,2.42E-07,3.31E-06,1.75E-06,FGFR3/STC1/THBS3/COMP/MSX2,5
GO:2001233,regulation of apoptotic signaling pathway, 12/89,381/18614,2.62E-07,3.56E-06,1.88E-06,BCL2/MMP9/SNAI1/HIF1A/NF1/BMPR1B/SFRP1/BMP4/WWOX/SNAI2/CTNNB1/NOG,12
GO:0042475,odontogenesis of dentin-containing tooth, 7/89,91/18614,2.63E-07,3.56E-06,1.88E-06,FOXC1/SHH/AMELX/BMP4/BMP7/MSX2/CTNNB1,7
GO:0007565,female pregnancy, 9/89,187/18614,2.74E-07,3.69E-06,1.95E-06,BCL2/MMP9/MEN1/STC1/JUNB/SPP1/TGFB3/MMP2/BMPR2,9
GO:0001656,metanephros development, 7/89,92/18614,2.83E-07,3.80E-06,2.01E-06,BCL2/NF1/SHH/GPC3/BMP4/BMP7/CTNNB1,7
GO:0034505,tooth mineralization, 5/89,30/18614,2.89E-07,3.86E-06,2.04E-06,SP7/AMELX/COL1A1/MSX2/ALPL,5
GO:0035270,endocrine system development, 8/89,137/18614,3.00E-07,3.99E-06,2.11E-06,SMAD3/MEN1/NF1/BMP6/GLI1/SHH/BMP4/NOG,8
GO:0072175,epithelial tube formation, 8/89,138/18614,3.17E-07,4.20E-06,2.22E-06,HIF1A/SFRP1/BMP4/BMP7/CTHRC1/CTNNB1/NOG/TWIST1,8
GO:2000146,negative regulation of cell motility, 12/89,390/18614,3.36E-07,4.43E-06,2.34E-06,BCL2/NF1/RHOA/STC1/SFRP1/SHH/BMP4/IGFBP3/GTPBP4/NOG/CDH11/IFITM1,12
GO:2001053,regulation of mesenchymal cell apoptotic process, 4/89,13/18614,3.38E-07,4.43E-06,2.35E-06,HIF1A/SHH/BMP7/MSX2,4
GO:1902105,regulation of leukocyte differentiation, 11/89,319/18614,3.51E-07,4.58E-06,2.42E-06,NF1/RHOA/SFRP1/SHH/RUNX1/BMP4/JUNB/FSTL3/CTNNB1/MMP14/ROR2,11
GO:0072080,nephron tubule development, 7/89,96/18614,3.80E-07,4.94E-06,2.61E-06,BCL2/SHH/GPC3/BMP4/DCHS1/CTNNB1/NOG,7
GO:0061037,negative regulation of cartilage development, 5/89,32/18614,4.06E-07,5.23E-06,2.77E-06,ADAMTS12/BMP4/SNAI2/CTNNB1/NOG,5
GO:0098868,bone growth, 5/89,32/18614,4.06E-07,5.23E-06,2.77E-06,FGFR3/STC1/THBS3/COMP/MSX2,5
GO:0014020,primary neural tube formation, 7/89,97/18614,4.08E-07,5.23E-06,2.77E-06,HIF1A/SFRP1/BMP4/BMP7/CTHRC1/NOG/TWIST1,7
GO:0060038,cardiac muscle cell proliferation, 6/89,61/18614,4.53E-07,5.79E-06,3.06E-06,GLI1/MAPK11/MAPK14/FOXC1/RUNX1/NOG,6
GO:0048638,regulation of developmental growth, 11/89,328/18614,4.62E-07,5.88E-06,3.11E-06,FGFR3/BCL2/GLI1/MAPK11/MAPK14/FOXC1/RUNX1/BMP4/SPP1/BMPR2/NOG,11
GO:0002063,chondrocyte development, 5/89,33/18614,4.76E-07,6.04E-06,3.19E-06,BMPR1B/AXIN2/COMP/MSX2/BMPR2,5
GO:0061326,renal tubule development, 7/89,100/18614,5.02E-07,6.34E-06,3.35E-06,BCL2/SHH/GPC3/BMP4/DCHS1/CTNNB1/NOG,7
GO:0060317,cardiac epithelial to mesenchymal transition, 5/89,34/18614,5.56E-07,6.96E-06,3.68E-06,SNAI1/SNAI2/MSX2/NOG/TWIST1,5
GO:0060351,cartilage development involved in endochondral bone morphogenesis, 5/89,34/18614,5.56E-07,6.96E-06,3.68E-06,STC1/AXIN2/THBS3/COL1A1/COMP,5
GO:0030316,osteoclast differentiation, 7/89,102/18614,5.75E-07,7.16E-06,3.79E-06,NF1/MAPK14/SFRP1/GPC3/JUNB/FSTL3/CTNNB1,7
GO:0072498,embryonic skeletal joint development, 4/89,15/18614,6.40E-07,7.91E-06,4.19E-06,BMP4/BMP7/CTNNB1/NOG,4
GO:0097152,mesenchymal cell apoptotic process, 4/89,15/18614,6.40E-07,7.91E-06,4.19E-06,HIF1A/SHH/BMP7/MSX2,4
GO:0044703,multi-organism reproductive process, 9/89,207/18614,6.44E-07,7.93E-06,4.19E-06,BCL2/MMP9/MEN1/STC1/JUNB/SPP1/TGFB3/MMP2/BMPR2,9
GO:0001893,maternal placenta development, 5/89,35/18614,6.47E-07,7.93E-06,4.19E-06,MEN1/STC1/JUNB/SPP1/BMPR2,5
GO:0001841,neural tube formation, 7/89,105/18614,7.00E-07,8.55E-06,4.52E-06,HIF1A/SFRP1/BMP4/BMP7/CTHRC1/NOG/TWIST1,7
GO:0060218,hematopoietic stem cell differentiation, 5/89,36/18614,7.48E-07,9.10E-06,4.81E-06,BCL2/UFL1/SP7/FOXC1/SFRP1,5
GO:0046822,regulation of nucleocytoplasmic transport, 7/89,107/18614,7.96E-07,9.64E-06,5.10E-06,SMAD3/NF1/MAPK14/DHX9/SHH/BMP4/SIRT7,7
GO:0048592,eye morphogenesis, 8/89,157/18614,8.48E-07,1.02E-05,5.40E-06,BCL2/HIF1A/NF1/BMP4/BMP7/LRP5/CTNNB1/TWIST1,8
GO:0003188,heart valve formation, 4/89,16/18614,8.51E-07,1.02E-05,5.40E-06,RHOA/DCHS1/CDH11/TWIST1,4
GO:0048645,animal organ formation, 6/89,68/18614,8.69E-07,1.04E-05,5.50E-06,SHH/AXIN2/BMP4/BMP7/CTNNB1/NOG,6
GO:0040013,negative regulation of locomotion, 12/89,427/18614,8.76E-07,1.04E-05,5.52E-06,BCL2/NF1/RHOA/STC1/SFRP1/SHH/BMP4/IGFBP3/GTPBP4/NOG/CDH11/IFITM1,12
GO:0007517,muscle organ development, 11/89,351/18614,9.01E-07,1.06E-05,5.62E-06,BCL2/SMAD3/NF1/RHOA/MAPK14/FOXC1/SHH/BMP4/CTNNB1/NOG/TWIST1,11
GO:0060840,artery development, 7/89,109/18614,9.02E-07,1.06E-05,5.62E-06,NF1/FOXC1/SHH/BMP4/COMP/BMPR2/NOG,7
GO:1902106,negative regulation of leukocyte differentiation, 7/89,109/18614,9.02E-07,1.06E-05,5.62E-06,NF1/SFRP1/SHH/RUNX1/BMP4/FSTL3/CTNNB1,7
GO:0044706,multi-multicellular organism process, 9/89,216/18614,9.19E-07,1.08E-05,5.70E-06,BCL2/MMP9/MEN1/STC1/JUNB/SPP1/TGFB3/MMP2/BMPR2,9
GO:0045880,positive regulation of smoothened signaling pathway, 5/89,38/18614,9.89E-07,1.15E-05,6.10E-06,GLI1/DHH/SFRP1/SHH/GPC3,5
GO:0010720,positive regulation of cell development, 12/89,432/18614,9.90E-07,1.15E-05,6.10E-06,BCL2/HIF1A/UFL1/RHOA/SHH/RUNX1/BMP4/PLXNB1/CTNNB1/BMPR2/MMP14/ROR2,12
GO:0009880,embryonic pattern specification, 6/89,70/18614,1.03E-06,1.20E-05,6.34E-06,CHRDL1/SATB2/SMAD3/SHH/BMP7/CTNNB1,6
GO:0003198,epithelial to mesenchymal transition involved in endocardial cushion formation, 4/89,17/18614,1.11E-06,1.28E-05,6.76E-06,SNAI1/SNAI2/MSX2/NOG,4
GO:0043583,ear development, 9/89,221/18614,1.11E-06,1.28E-05,6.76E-06,BCL2/RPL38/SHH/BMP4/DCHS1/TGFB3/CTHRC1/NOG/TWIST1,9
GO:0060390,regulation of SMAD protein signal transduction, 5/89,39/18614,1.13E-06,1.29E-05,6.85E-06,BMP6/BMP4/BMP7/TGFB3/BMPR2,5
GO:0044344,cellular response to fibroblast growth factor stimulus, 7/89,113/18614,1.15E-06,1.31E-05,6.95E-06,FGFR3/SFRP1/COL1A1/CCN2/EXT2/CTNNB1/NOG,7
GO:0003205,cardiac chamber development, 8/89,166/18614,1.29E-06,1.47E-05,7.77E-06,HIF1A/FOXC1/BMP4/BMP7/FHL2/MSX2/BMPR2/NOG,8
GO:0097191,extrinsic apoptotic signaling pathway, 9/89,227/18614,1.39E-06,1.57E-05,8.32E-06,FGFR3/BCL2/SMAD3/NF1/BMPR1B/SFRP1/BMP4/WWOX/SNAI2,9
GO:0046661,male sex differentiation, 8/89,168/18614,1.41E-06,1.59E-05,8.41E-06,BCL2/BMP6/DHH/SFRP1/SHH/CTNNB1/MMP14/ROR2,8
GO:0003159,morphogenesis of an endothelium, 4/89,18/18614,1.42E-06,1.59E-05,8.41E-06,RHOA/ADAMTS12/BMP4/CTNNB1,4
GO:0061154,endothelial tube morphogenesis, 4/89,18/18614,1.42E-06,1.59E-05,8.41E-06,RHOA/ADAMTS12/BMP4/CTNNB1,4
GO:0032965,regulation of collagen biosynthetic process, 5/89,41/18614,1.46E-06,1.63E-05,8.61E-06,RUNX1/AMELX/BMP4/CCN2/TGFB3,5
GO:0051098,regulation of binding, 11/89,369/18614,1.47E-06,1.63E-05,8.63E-06,MMP9/SMAD3/FOXC1/DHX9/BMP4/CTHRC1/GTPBP4/MSX2/CTNNB1/NOG/TWIST1,11
GO:0031669,cellular response to nutrient levels, 9/89,230/18614,1.55E-06,1.71E-05,9.07E-06,BCL2/CASR/SP7/SFRP1/PHEX/COL1A1/CYP24A1/SNAI2/BMPR2,9
GO:0009314,response to radiation, 12/89,452/18614,1.59E-06,1.75E-05,9.27E-06,CAT/BCL2/MMP9/MEN1/HIF1A/NF1/MAPK11/MAPK14/SFRP1/MMP2/SNAI2/NOG,12
GO:0043200,response to amino acid, 7/89,120/18614,1.73E-06,1.90E-05,1.00E-05,BCL2/UFL1/RHOA/COL1A2/COL1A1/CCN2/MMP2,7
GO:0072089,stem cell proliferation, 7/89,121/18614,1.83E-06,2.00E-05,1.06E-05,HNRNPU/NF1/SHH/RUNX1/AXIN2/SNAI2/CTNNB1,7
GO:0032924,activin receptor signaling pathway, 5/89,44/18614,2.09E-06,2.28E-05,1.21E-05,SMAD3/MEN1/SHH/FSTL3/BMPR2,5
GO:0042326,negative regulation of phosphorylation, 11/89,383/18614,2.11E-06,2.29E-05,1.21E-05,HNRNPU/MEN1/NF1/ADAR/GIT1/SFRP1/BMP4/BMP7/IGFBP3/LRP5/NOG,11
GO:0043588,skin development, 10/89,308/18614,2.13E-06,2.30E-05,1.22E-05,BCL2/SNAI1/NF1/COL1A2/FOXC1/SHH/COL1A1/COMP/MSX2/CTNNB1,10
GO:0051090,regulation of DNA-binding transcription factor activity, 12/89,465/18614,2.13E-06,2.30E-05,1.22E-05,CAT/SMAD3/MEN1/UFL1/GLI1/DHX9/SHH/BMP7/LRP5/MSX2/CTNNB1/TWIST1,12
GO:0048844,artery morphogenesis, 6/89,80/18614,2.28E-06,2.45E-05,1.30E-05,NF1/FOXC1/BMP4/COMP/BMPR2/NOG,6
GO:0048701,embryonic cranial skeleton morphogenesis, 5/89,45/18614,2.34E-06,2.51E-05,1.33E-05,SMAD3/BMP4/TGFB3/MMP14/TWIST1,5
GO:0048593,camera-type eye morphogenesis, 7/89,127/18614,2.52E-06,2.70E-05,1.43E-05,HIF1A/NF1/BMP4/BMP7/LRP5/CTNNB1/TWIST1,7
GO:0031098,stress-activated protein kinase signaling cascade, 9/89,245/18614,2.60E-06,2.77E-05,1.46E-05,SMAD3/CASR/MEN1/RHOA/MAPK11/MAPK14/SFRP1/BMP4/CCN2,9
GO:0010712,regulation of collagen metabolic process, 5/89,46/18614,2.62E-06,2.77E-05,1.46E-05,RUNX1/AMELX/BMP4/CCN2/TGFB3,5
GO:0035272,exocrine system development, 5/89,46/18614,2.62E-06,2.77E-05,1.46E-05,FOXC1/SHH/BMP7/TGFB3/SNAI2,5
GO:0051149,positive regulation of muscle cell differentiation, 6/89,82/18614,2.64E-06,2.77E-05,1.47E-05,BCL2/MAPK11/MAPK14/SHH/BMP4/MMP14,6
GO:0045444,fat cell differentiation, 9/89,246/18614,2.69E-06,2.82E-05,1.49E-05,HNRNPU/SMAD3/MAPK14/SFRP1/AXIN2/BMP7/LRP5/SNAI2/MSX2,9
GO:0001701,in utero embryonic development, 11/89,398/18614,3.05E-06,3.19E-05,1.69E-05,SMAD3/SBDS/SNAI1/HIF1A/FOXC1/BMP7/JUNB/TGFB3/CTNNB1/NOG/TWIST1,11
GO:0009416,response to light stimulus, 10/89,323/18614,3.26E-06,3.39E-05,1.79E-05,CAT/BCL2/MMP9/MEN1/HIF1A/NF1/MAPK11/MAPK14/MMP2/NOG,10
GO:0048634,regulation of muscle organ development, 4/89,22/18614,3.34E-06,3.46E-05,1.83E-05,SMAD3/SHH/BMP4/TWIST1,4
GO:0072111,cell proliferation involved in kidney development, 4/89,22/18614,3.34E-06,3.46E-05,1.83E-05,SHH/GPC3/BMP4/BMP7,4
GO:0002683,negative regulation of immune system process, 12/89,487/18614,3.43E-06,3.54E-05,1.87E-05,NF1/ADAR/MAPK14/SFRP1/SHH/RUNX1/BMP4/TGFB3/FSTL3/SNAI2/CTNNB1/TWIST1,12
GO:0048041,focal adhesion assembly, 6/89,86/18614,3.49E-06,3.57E-05,1.89E-05,BCL2/SMAD3/RHOA/SFRP1/CDH11/MMP14,6
GO:0061053,somite development, 6/89,86/18614,3.49E-06,3.57E-05,1.89E-05,SMAD3/FOXC1/SFRP1/SHH/AXIN2/NOG,6
GO:0010171,body morphogenesis, 5/89,49/18614,3.60E-06,3.66E-05,1.94E-05,GPC3/COL1A1/TGFB3/MMP2/NOG,5
GO:0060043,regulation of cardiac muscle cell proliferation, 5/89,49/18614,3.60E-06,3.66E-05,1.94E-05,GLI1/MAPK11/MAPK14/RUNX1/NOG,5
GO:0071496,cellular response to external stimulus, 10/89,327/18614,3.63E-06,3.68E-05,1.95E-05,BCL2/CASR/BMP6/SP7/SFRP1/PHEX/COL1A1/CYP24A1/SNAI2/BMPR2,10
GO:0001101,response to acid chemical, 7/89,136/18614,3.98E-06,4.01E-05,2.12E-05,BCL2/UFL1/RHOA/COL1A2/COL1A1/CCN2/MMP2,7
GO:0046849,bone remodeling, 6/89,88/18614,3.99E-06,4.01E-05,2.12E-05,NF1/SFRP1/SPP1/LRP5/CTHRC1/CTNNB1,6
GO:0042692,muscle cell differentiation, 11/89,410/18614,4.05E-06,4.06E-05,2.15E-05,BCL2/HNRNPU/MAPK11/MAPK14/SHH/BMP4/FHL2/COMP/CTNNB1/BMPR2/MMP14,11
GO:0003158,endothelium development, 7/89,137/18614,4.18E-06,4.18E-05,2.21E-05,BMP6/RHOA/STC1/ADAMTS12/BMP4/CTNNB1/BMPR2,7
GO:2000177,regulation of neural precursor cell proliferation, 6/89,89/18614,4.26E-06,4.24E-05,2.24E-05,HIF1A/NF1/RHOA/GLI1/SHH/CTNNB1,6
GO:0031668,cellular response to extracellular stimulus, 9/89,261/18614,4.36E-06,4.33E-05,2.29E-05,BCL2/CASR/SP7/SFRP1/PHEX/COL1A1/CYP24A1/SNAI2/BMPR2,9
GO:0030539,male genitalia development, 4/89,24/18614,4.82E-06,4.76E-05,2.52E-05,BMP6/SHH/CTNNB1/ROR2,4
GO:0001942,hair follicle development, 6/89,91/18614,4.85E-06,4.76E-05,2.52E-05,BCL2/SNAI1/NF1/SHH/MSX2/CTNNB1,6
GO:0060021,roof of mouth development, 6/89,91/18614,4.85E-06,4.76E-05,2.52E-05,SATB2/SNAI1/SHH/TGFB3/SNAI2/TWIST1,6
GO:0051496,positive regulation of stress fiber assembly, 5/89,52/18614,4.86E-06,4.76E-05,2.52E-05,SMAD3/RHOA/SFRP1/CCN2/TGFB3,5
GO:0055017,cardiac muscle tissue growth, 6/89,92/18614,5.17E-06,5.05E-05,2.67E-05,GLI1/MAPK11/MAPK14/FOXC1/RUNX1/NOG,6
GO:0035296,regulation of tube diameter, 7/89,142/18614,5.30E-06,5.13E-05,2.71E-05,CASR/RHOA/FOXC1/COMP/MMP2/EXT2/BMPR2,7
GO:0051384,response to glucocorticoid, 7/89,142/18614,5.30E-06,5.13E-05,2.71E-05,BCL2/HNRNPU/BMP6/RHOA/STC1/AXIN2/ALPL,7
GO:0097746,blood vessel diameter maintenance, 7/89,142/18614,5.30E-06,5.13E-05,2.71E-05,CASR/RHOA/FOXC1/COMP/MMP2/EXT2/BMPR2,7
GO:0051155,positive regulation of striated muscle cell differentiation, 5/89,53/18614,5.34E-06,5.13E-05,2.72E-05,BCL2/MAPK14/SHH/BMP4/MMP14,5
GO:0060071,"Wnt signaling pathway, planar cell polarity pathway", 5/89,53/18614,5.34E-06,5.13E-05,2.72E-05,RHOA/SFRP1/GPC3/CTHRC1/ROR2,5
GO:0035150,regulation of tube size, 7/89,143/18614,5.55E-06,5.32E-05,2.81E-05,CASR/RHOA/FOXC1/COMP/MMP2/EXT2/BMPR2,7
GO:0003181,atrioventricular valve morphogenesis, 4/89,25/18614,5.72E-06,5.43E-05,2.87E-05,AXIN2/DCHS1/BMPR2/TWIST1,4
GO:0032331,negative regulation of chondrocyte differentiation, 4/89,25/18614,5.72E-06,5.43E-05,2.87E-05,ADAMTS12/BMP4/SNAI2/CTNNB1,4
GO:0046697,decidualization, 4/89,25/18614,5.72E-06,5.43E-05,2.87E-05,MEN1/STC1/JUNB/SPP1,4
GO:0022404,molting cycle process, 6/89,94/18614,5.85E-06,5.52E-05,2.92E-05,BCL2/SNAI1/NF1/SHH/MSX2/CTNNB1,6
GO:0022405,hair cycle process, 6/89,94/18614,5.85E-06,5.52E-05,2.92E-05,BCL2/SNAI1/NF1/SHH/MSX2/CTNNB1,6
GO:0006029,proteoglycan metabolic process, 6/89,95/18614,6.23E-06,5.83E-05,3.08E-05,BMPR1B/XYLT1/ADAMTS12/EXT2/CTNNB1/BMPR2,6
GO:1904705,regulation of vascular associated smooth muscle cell proliferation, 6/89,95/18614,6.23E-06,5.83E-05,3.08E-05,MMP9/NF1/RHOA/BMP4/TGFB3/MMP2,6
GO:0007044,cell-substrate junction assembly, 6/89,96/18614,6.61E-06,6.18E-05,3.27E-05,BCL2/SMAD3/RHOA/SFRP1/CDH11/MMP14,6
GO:1990874,vascular associated smooth muscle cell proliferation, 6/89,97/18614,7.02E-06,6.54E-05,3.46E-05,MMP9/NF1/RHOA/BMP4/TGFB3/MMP2,6
GO:0071383,cellular response to steroid hormone stimulus, 8/89,209/18614,7.16E-06,6.64E-05,3.51E-05,HNRNPU/UFL1/RHOA/STC1/SFRP1/AXIN2/BMP4/BMP7,8
GO:0071456,cellular response to hypoxia, 7/89,149/18614,7.28E-06,6.73E-05,3.56E-05,BCL2/CASR/HIF1A/STC1/SFRP1/BMP7/TWIST1,7
GO:0001541,ovarian follicle development, 5/89,57/18614,7.68E-06,7.04E-05,3.72E-05,BCL2/BMPR1B/FOXC1/MMP2/MMP14,5
GO:0001706,endoderm formation, 5/89,57/18614,7.68E-06,7.04E-05,3.72E-05,MMP9/MMP2/CTNNB1/NOG/MMP14,5
GO:0090175,regulation of establishment of planar polarity, 5/89,57/18614,7.68E-06,7.04E-05,3.72E-05,RHOA/SFRP1/GPC3/CTHRC1/ROR2,5
GO:0042060,wound healing, 11/89,439/18614,7.74E-06,7.05E-05,3.73E-05,SMAD3/HIF1A/NF1/RHOA/MAPK14/SHH/COL1A1/COMP/TGFB3/MSX2/NOG,11
GO:0045936,negative regulation of phosphate metabolic process, 11/89,439/18614,7.74E-06,7.05E-05,3.73E-05,HNRNPU/MEN1/NF1/ADAR/GIT1/SFRP1/BMP4/BMP7/IGFBP3/LRP5/NOG,11
GO:0048641,regulation of skeletal muscle tissue development, 4/89,27/18614,7.88E-06,7.16E-05,3.78E-05,BCL2/SHH/CTNNB1/TWIST1,4
GO:0010563,negative regulation of phosphorus metabolic process, 11/89,440/18614,7.91E-06,7.16E-05,3.79E-05,HNRNPU/MEN1/NF1/ADAR/GIT1/SFRP1/BMP4/BMP7/IGFBP3/LRP5/NOG,11
GO:0001755,neural crest cell migration, 5/89,58/18614,8.37E-06,7.49E-05,3.96E-05,HIF1A/SHH/BMP4/BMP7/TWIST1,5
GO:0042306,regulation of protein import into nucleus, 5/89,58/18614,8.37E-06,7.49E-05,3.96E-05,SMAD3/NF1/MAPK14/SHH/BMP4,5
GO:0035282,segmentation, 6/89,100/18614,8.38E-06,7.49E-05,3.96E-05,SMAD3/FOXC1/SFRP1/SHH/AXIN2/BMP4,6
GO:0060419,heart growth, 6/89,100/18614,8.38E-06,7.49E-05,3.96E-05,GLI1/MAPK11/MAPK14/FOXC1/RUNX1/NOG,6
GO:0045216,cell-cell junction organization, 8/89,214/18614,8.51E-06,7.57E-05,4.00E-05,SMAD3/SNAI1/BMP6/RHOA/TGFB3/SNAI2/CTNNB1/CDH11,8
GO:0045637,regulation of myeloid cell differentiation, 8/89,214/18614,8.51E-06,7.57E-05,4.00E-05,HIF1A/NF1/MAPK14/SFRP1/RUNX1/FSTL3/CTNNB1/ROR2,8
GO:0034329,cell junction assembly, 11/89,444/18614,8.62E-06,7.64E-05,4.04E-05,BCL2/SMAD3/ACHE/SNAI1/RHOA/SFRP1/PLXNB1/SNAI2/CTNNB1/CDH11/MMP14,11
GO:0009411,response to UV, 7/89,154/18614,9.04E-06,7.99E-05,4.23E-05,CAT/BCL2/MMP9/MEN1/MAPK11/MAPK14/MMP2,7
GO:0003171,atrioventricular valve development, 4/89,28/18614,9.16E-06,8.07E-05,4.27E-05,AXIN2/DCHS1/BMPR2/TWIST1,4
GO:0008585,female gonad development, 6/89,102/18614,9.39E-06,8.23E-05,4.35E-05,BCL2/BMPR1B/FOXC1/SFRP1/MMP2/MMP14,6
GO:0046620,regulation of organ growth, 6/89,102/18614,9.39E-06,8.23E-05,4.35E-05,GLI1/MAPK11/MAPK14/FOXC1/RUNX1/NOG,6
GO:2001236,regulation of extrinsic apoptotic signaling pathway, 7/89,156/18614,9.83E-06,8.59E-05,4.54E-05,BCL2/NF1/BMPR1B/SFRP1/BMP4/WWOX/SNAI2,7
GO:0090497,mesenchymal cell migration, 5/89,60/18614,9.90E-06,8.63E-05,4.56E-05,HIF1A/SHH/BMP4/BMP7/TWIST1,5
GO:0150115,cell-substrate junction organization, 6/89,103/18614,9.93E-06,8.63E-05,4.56E-05,BCL2/SMAD3/RHOA/SFRP1/CDH11/MMP14,6
GO:0030902,hindbrain development, 7/89,157/18614,1.03E-05,8.85E-05,4.68E-05,BCL2/GLI1/FOXC1/SHH/BMP7/CTNNB1/NOG,7
GO:0036294,cellular response to decreased oxygen levels, 7/89,157/18614,1.03E-05,8.85E-05,4.68E-05,BCL2/CASR/HIF1A/STC1/SFRP1/BMP7/TWIST1,7
GO:0003156,regulation of animal organ formation, 4/89,29/18614,1.06E-05,9.09E-05,4.81E-05,SHH/BMP4/BMP7/CTNNB1,4
GO:0060037,pharyngeal system development, 4/89,29/18614,1.06E-05,9.09E-05,4.81E-05,BMP4/BMP7/BMPR2/NOG,4
GO:0060135,maternal process involved in female pregnancy, 5/89,61/18614,1.07E-05,9.20E-05,4.87E-05,MEN1/STC1/JUNB/SPP1/BMPR2,5
GO:0010810,regulation of cell-substrate adhesion, 8/89,222/18614,1.11E-05,9.49E-05,5.02E-05,BCL2/SMAD3/MEN1/NF1/RHOA/SFRP1/COL1A1/MMP14,8
GO:0032233,positive regulation of actin filament bundle assembly, 5/89,62/18614,1.16E-05,9.91E-05,5.24E-05,SMAD3/RHOA/SFRP1/CCN2/TGFB3,5
GO:0046545,development of primary female sexual characteristics, 6/89,106/18614,1.17E-05,9.94E-05,5.26E-05,BCL2/BMPR1B/FOXC1/SFRP1/MMP2/MMP14,6
GO:0008544,epidermis development, 10/89,375/18614,1.21E-05,1.02E-04,5.39E-05,BCL2/SNAI1/NF1/GLI1/FOXC1/SHH/BMP4/CCN2/MSX2/CTNNB1,10
GO:0051147,regulation of muscle cell differentiation, 7/89,161/18614,1.21E-05,1.02E-04,5.39E-05,BCL2/MAPK11/MAPK14/SHH/BMP4/BMPR2/MMP14,7
GO:0003253,cardiac neural crest cell migration involved in outflow tract morphogenesis, 3/89,10/18614,1.24E-05,1.03E-04,5.43E-05,BMP4/BMP7/TWIST1,3
GO:0007440,foregut morphogenesis, 3/89,10/18614,1.24E-05,1.03E-04,5.43E-05,SMAD3/SHH/CTNNB1,3
GO:0060536,cartilage morphogenesis, 3/89,10/18614,1.24E-05,1.03E-04,5.43E-05,SNAI1/STC1/SNAI2,3
GO:0061626,pharyngeal arch artery morphogenesis, 3/89,10/18614,1.24E-05,1.03E-04,5.43E-05,BMP4/BMPR2/NOG,3
GO:0072203,cell proliferation involved in metanephros development, 3/89,10/18614,1.24E-05,1.03E-04,5.43E-05,SHH/GPC3/BMP7,3
GO:2001054,negative regulation of mesenchymal cell apoptotic process, 3/89,10/18614,1.24E-05,1.03E-04,5.43E-05,HIF1A/SHH/BMP7,3
GO:0048255,mRNA stabilization, 5/89,63/18614,1.26E-05,1.04E-04,5.52E-05,HNRNPU/MAPK14/SYNCRIP/DHX9/AXIN2,5
GO:0030166,proteoglycan biosynthetic process, 5/89,64/18614,1.36E-05,1.12E-04,5.95E-05,BMPR1B/XYLT1/EXT2/CTNNB1/BMPR2,5
GO:0050767,regulation of neurogenesis, 10/89,381/18614,1.39E-05,1.14E-04,6.03E-05,HIF1A/UFL1/NF1/SHH/BMP7/PLXNB1/SPP1/CTNNB1/BMPR2/NOG,10
GO:0010464,regulation of mesenchymal cell proliferation, 4/89,31/18614,1.39E-05,1.14E-04,6.03E-05,SHH/BMP4/LRP5/CTNNB1,4
GO:0060325,face morphogenesis, 4/89,31/18614,1.39E-05,1.14E-04,6.03E-05,COL1A1/TGFB3/MMP2/NOG,4
GO:0007519,skeletal muscle tissue development, 7/89,165/18614,1.42E-05,1.16E-04,6.12E-05,BCL2/NF1/RHOA/MAPK14/SHH/CTNNB1/TWIST1,7
GO:1902074,response to salt, 10/89,383/18614,1.45E-05,1.18E-04,6.24E-05,CAT/ACHE/CASR/UFL1/SHH/AMELX/PHEX/JUNB/COL1A1/ALPL,10
GO:0030856,regulation of epithelial cell differentiation, 7/89,166/18614,1.47E-05,1.20E-04,6.33E-05,MMP9/BMP6/FOXC1/BMP4/BMP7/MSX2/CTNNB1,7
GO:2001234,negative regulation of apoptotic signaling pathway, 8/89,233/18614,1.58E-05,1.27E-04,6.70E-05,BCL2/MMP9/SNAI1/HIF1A/BMP4/SNAI2/CTNNB1/NOG,8
GO:0010812,negative regulation of cell-substrate adhesion, 5/89,66/18614,1.58E-05,1.27E-04,6.70E-05,MEN1/NF1/RHOA/COL1A1/MMP14,5
GO:0007435,salivary gland morphogenesis, 4/89,32/18614,1.59E-05,1.27E-04,6.70E-05,SHH/BMP7/TGFB3/SNAI2,4
GO:0031069,hair follicle morphogenesis, 4/89,32/18614,1.59E-05,1.27E-04,6.70E-05,BCL2/SNAI1/SHH/CTNNB1,4
GO:0035115,embryonic forelimb morphogenesis, 4/89,32/18614,1.59E-05,1.27E-04,6.70E-05,SHH/MSX2/CTNNB1/TWIST1,4
GO:0045671,negative regulation of osteoclast differentiation, 4/89,32/18614,1.59E-05,1.27E-04,6.70E-05,NF1/SFRP1/FSTL3/CTNNB1,4
GO:0060439,trachea morphogenesis, 3/89,11/18614,1.70E-05,1.35E-04,7.13E-05,SHH/BMP4/CTNNB1,3
GO:0070934,CRD-mediated mRNA stabilization, 3/89,11/18614,1.70E-05,1.35E-04,7.13E-05,HNRNPU/SYNCRIP/DHX9,3
GO:0061564,axon development, 11/89,479/18614,1.75E-05,1.39E-04,7.33E-05,BCL2/TNC/BMPR1B/SHH/BMP7/PLXNB1/SPP1/MMP2/BMPR2/NOG/CDH11,11
GO:0051403,stress-activated MAPK cascade, 8/89,237/18614,1.78E-05,1.41E-04,7.46E-05,SMAD3/CASR/MEN1/MAPK11/MAPK14/SFRP1/BMP4/CCN2,8
GO:0055021,regulation of cardiac muscle tissue growth, 5/89,68/18614,1.83E-05,1.45E-04,7.65E-05,GLI1/MAPK11/MAPK14/RUNX1/NOG,5
GO:0071453,cellular response to oxygen levels, 7/89,172/18614,1.86E-05,1.46E-04,7.71E-05,BCL2/CASR/HIF1A/STC1/SFRP1/BMP7/TWIST1,7
GO:0042303,molting cycle, 6/89,115/18614,1.87E-05,1.46E-04,7.72E-05,BCL2/SNAI1/NF1/SHH/MSX2/CTNNB1,6
GO:0042633,hair cycle, 6/89,115/18614,1.87E-05,1.46E-04,7.72E-05,BCL2/SNAI1/NF1/SHH/MSX2/CTNNB1,6
GO:0033673,negative regulation of kinase activity, 8/89,239/18614,1.90E-05,1.48E-04,7.82E-05,HNRNPU/MEN1/NF1/ADAR/SFRP1/BMP4/BMP7/LRP5,8
GO:0030858,positive regulation of epithelial cell differentiation, 5/89,69/18614,1.97E-05,1.53E-04,8.09E-05,BMP6/FOXC1/BMP4/BMP7/CTNNB1,5
GO:0032835,glomerulus development, 5/89,69/18614,1.97E-05,1.53E-04,8.09E-05,BCL2/FOXC1/BMP4/BMP7/NOG,5
GO:0007431,salivary gland development, 4/89,34/18614,2.03E-05,1.57E-04,8.28E-05,SHH/BMP7/TGFB3/SNAI2,4
GO:1901797,negative regulation of signal transduction by p53 class mediator, 4/89,34/18614,2.03E-05,1.57E-04,8.28E-05,BCL2/SNAI1/SNAI2/TWIST1,4
GO:0030514,negative regulation of BMP signaling pathway, 5/89,70/18614,2.11E-05,1.62E-04,8.58E-05,CHRDL1/CHRDL2/SFRP1/FSTL3/NOG,5
GO:0043627,response to estrogen, 5/89,70/18614,2.11E-05,1.62E-04,8.58E-05,DHH/SFRP1/TGFB3/MMP2/MMP14,5
GO:0051099,positive regulation of binding, 7/89,176/18614,2.15E-05,1.65E-04,8.72E-05,MMP9/FOXC1/DHX9/BMP4/CTHRC1/CTNNB1/TWIST1,7
GO:0002065,columnar/cuboidal epithelial cell differentiation, 6/89,118/18614,2.16E-05,1.65E-04,8.73E-05,MEN1/HIF1A/BMP6/BMP4/BMP7/CTNNB1,6
GO:0009950,dorsal/ventral axis specification, 3/89,12/18614,2.25E-05,1.71E-04,9.03E-05,SFRP1/AXIN2/CTNNB1,3
GO:0061309,cardiac neural crest cell development involved in outflow tract morphogenesis, 3/89,12/18614,2.25E-05,1.71E-04,9.03E-05,BMP4/BMP7/TWIST1,3
GO:1900152,"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay", 3/89,12/18614,2.25E-05,1.71E-04,9.03E-05,HNRNPU/SYNCRIP/DHX9,3
GO:0046632,alpha-beta T cell differentiation, 6/89,119/18614,2.27E-05,1.71E-04,9.07E-05,BCL2/MEN1/RHOA/SHH/RUNX1/JUNB,6
GO:0060538,skeletal muscle organ development, 7/89,178/18614,2.31E-05,1.75E-04,9.23E-05,BCL2/NF1/RHOA/MAPK14/SHH/CTNNB1/TWIST1,7
GO:0008202,steroid metabolic process, 9/89,323/18614,2.40E-05,1.81E-04,9.55E-05,CAT/SNAI1/BMP6/DHH/SHH/SPP1/CYP24A1/LRP5/SNAI2,9
GO:0043489,RNA stabilization, 5/89,72/18614,2.43E-05,1.82E-04,9.60E-05,HNRNPU/MAPK14/SYNCRIP/DHX9/AXIN2,5
GO:0060411,cardiac septum morphogenesis, 5/89,72/18614,2.43E-05,1.82E-04,9.60E-05,BMP4/BMP7/MSX2/BMPR2/NOG,5
GO:0098773,skin epidermis development, 6/89,121/18614,2.49E-05,1.86E-04,9.84E-05,BCL2/SNAI1/NF1/SHH/MSX2/CTNNB1,6
GO:0048730,epidermis morphogenesis, 4/89,36/18614,2.56E-05,1.91E-04,1.01E-04,BCL2/SNAI1/SHH/CTNNB1,4
GO:0035567,non-canonical Wnt signaling pathway, 5/89,73/18614,2.59E-05,1.92E-04,1.02E-04,RHOA/SFRP1/GPC3/CTHRC1/ROR2,5
GO:1902373,negative regulation of mRNA catabolic process, 5/89,73/18614,2.59E-05,1.92E-04,1.02E-04,HNRNPU/MAPK14/SYNCRIP/DHX9/AXIN2,5
GO:0046660,female sex differentiation, 6/89,122/18614,2.61E-05,1.93E-04,1.02E-04,BCL2/BMPR1B/FOXC1/SFRP1/MMP2/MMP14,6
GO:0002761,regulation of myeloid leukocyte differentiation, 6/89,123/18614,2.74E-05,2.01E-04,1.06E-04,NF1/SFRP1/RUNX1/FSTL3/CTNNB1/ROR2,6
GO:0071901,negative regulation of protein serine/threonine kinase activity, 6/89,123/18614,2.74E-05,2.01E-04,1.06E-04,MEN1/NF1/SFRP1/BMP4/BMP7/LRP5,6
GO:0001736,establishment of planar polarity, 5/89,74/18614,2.77E-05,2.02E-04,1.07E-04,RHOA/SFRP1/GPC3/CTHRC1/ROR2,5
GO:0002067,glandular epithelial cell differentiation, 5/89,74/18614,2.77E-05,2.02E-04,1.07E-04,MEN1/HIF1A/BMP6/BMP4/CTNNB1,5
GO:0007164,establishment of tissue polarity, 5/89,74/18614,2.77E-05,2.02E-04,1.07E-04,RHOA/SFRP1/GPC3/CTHRC1/ROR2,5
GO:0060420,regulation of heart growth, 5/89,74/18614,2.77E-05,2.02E-04,1.07E-04,GLI1/MAPK11/MAPK14/RUNX1/NOG,5
GO:0060323,head morphogenesis, 4/89,37/18614,2.86E-05,2.08E-04,1.10E-04,COL1A1/TGFB3/MMP2/NOG,4
GO:0048662,negative regulation of smooth muscle cell proliferation, 5/89,75/18614,2.96E-05,2.14E-04,1.13E-04,RHOA/BMP4/IGFBP3/TGFB3/BMPR2,5
GO:0001952,regulation of cell-matrix adhesion, 6/89,125/18614,3.00E-05,2.17E-04,1.15E-04,BCL2/SMAD3/NF1/RHOA/SFRP1/MMP14,6
GO:0090288,negative regulation of cellular response to growth factor stimulus, 6/89,127/18614,3.28E-05,2.36E-04,1.25E-04,CHRDL1/CHRDL2/ADAMTS12/SFRP1/FSTL3/NOG,6
GO:0030098,lymphocyte differentiation, 10/89,422/18614,3.32E-05,2.39E-04,1.26E-04,BCL2/MEN1/RHOA/SFRP1/SHH/RUNX1/BMP4/JUNB/CTNNB1/MMP14,10
GO:0009895,negative regulation of catabolic process, 9/89,337/18614,3.35E-05,2.40E-04,1.27E-04,BCL2/HNRNPU/SMAD3/MAPK14/GIT1/SYNCRIP/DHX9/SHH/AXIN2,9
GO:0021536,diencephalon development, 5/89,77/18614,3.36E-05,2.41E-04,1.27E-04,GLI1/SHH/BMP4/CTNNB1/NOG,5
GO:0001933,negative regulation of protein phosphorylation, 9/89,341/18614,3.67E-05,2.62E-04,1.39E-04,MEN1/NF1/ADAR/SFRP1/BMP4/BMP7/IGFBP3/LRP5/NOG,9
GO:0042310,vasoconstriction, 5/89,79/18614,3.81E-05,2.71E-04,1.43E-04,CASR/RHOA/COMP/MMP2/BMPR2,5
GO:0035136,forelimb morphogenesis, 4/89,40/18614,3.91E-05,2.78E-04,1.47E-04,SHH/MSX2/CTNNB1/TWIST1,4
GO:0003018,vascular process in circulatory system, 8/89,265/18614,3.96E-05,2.81E-04,1.49E-04,CASR/BMP6/RHOA/FOXC1/COMP/MMP2/EXT2/BMPR2,8
GO:0045664,regulation of neuron differentiation, 7/89,194/18614,4.01E-05,2.84E-04,1.50E-04,BCL2/BMP6/RHOA/SFRP1/SHH/BMP4/BMP7,7
GO:0031016,pancreas development, 5/89,81/18614,4.29E-05,3.03E-04,1.60E-04,MEN1/BMP6/SHH/BMP4/CTNNB1,5
GO:0030513,positive regulation of BMP signaling pathway, 4/89,41/18614,4.32E-05,3.04E-04,1.61E-04,GPC3/BMP4/MSX2/BMPR2,4
GO:0002520,immune system development, 7/89,197/18614,4.43E-05,3.11E-04,1.64E-04,BCL2/SMAD3/SBDS/ADAR/SHH/LRP5/CTNNB1,7
GO:0043518,"negative regulation of DNA damage response, signal transduction by p53 class mediator", 3/89,15/18614,4.61E-05,3.20E-04,1.69E-04,SNAI1/SNAI2/TWIST1,3
GO:0048820,hair follicle maturation, 3/89,15/18614,4.61E-05,3.20E-04,1.69E-04,NF1/MSX2/CTNNB1,3
GO:0061307,cardiac neural crest cell differentiation involved in heart development, 3/89,15/18614,4.61E-05,3.20E-04,1.69E-04,BMP4/BMP7/TWIST1,3
GO:0061308,cardiac neural crest cell development involved in heart development, 3/89,15/18614,4.61E-05,3.20E-04,1.69E-04,BMP4/BMP7/TWIST1,3
GO:2000767,positive regulation of cytoplasmic translation, 3/89,15/18614,4.61E-05,3.20E-04,1.69E-04,HNRNPU/SYNCRIP/DHX9,3
GO:0014912,negative regulation of smooth muscle cell migration, 4/89,42/18614,4.76E-05,3.29E-04,1.74E-04,NF1/RHOA/BMP4/IGFBP3,4
GO:0071542,dopaminergic neuron differentiation, 4/89,42/18614,4.76E-05,3.29E-04,1.74E-04,HIF1A/SFRP1/SHH/CTNNB1,4
GO:0060428,lung epithelium development, 4/89,43/18614,5.23E-05,3.60E-04,1.91E-04,TMEM38B/SHH/BMP4/CTNNB1,4
GO:0035050,embryonic heart tube development, 5/89,85/18614,5.42E-05,3.71E-04,1.96E-04,SMAD3/HIF1A/FOXC1/SHH/CTNNB1,5
GO:0098586,cellular response to virus, 5/89,85/18614,5.42E-05,3.71E-04,1.96E-04,SMAD3/HIF1A/ADAR/MAPK11/MAPK14,5
GO:1902369,negative regulation of RNA catabolic process, 5/89,85/18614,5.42E-05,3.71E-04,1.96E-04,HNRNPU/MAPK14/SYNCRIP/DHX9/AXIN2,5
GO:0090336,positive regulation of brown fat cell differentiation, 3/89,16/18614,5.66E-05,3.86E-04,2.04E-04,HNRNPU/MAPK14/BMP7,3
GO:0000302,response to reactive oxygen species, 7/89,205/18614,5.70E-05,3.87E-04,2.05E-04,CAT/BCL2/MMP9/HIF1A/BMP7/COL1A1/MMP2,7
GO:0051348,negative regulation of transferase activity, 8/89,279/18614,5.70E-05,3.87E-04,2.05E-04,HNRNPU/MEN1/NF1/ADAR/SFRP1/BMP4/BMP7/LRP5,8
GO:2000241,regulation of reproductive process, 7/89,206/18614,5.87E-05,3.99E-04,2.11E-04,SNAI1/SFRP1/SHH/BMP4/BMP7/MSX2/CTNNB1,7
GO:0008589,regulation of smoothened signaling pathway, 5/89,87/18614,6.05E-05,4.09E-04,2.16E-04,GLI1/DHH/SFRP1/SHH/GPC3,5
GO:0034284,response to monosaccharide, 7/89,207/18614,6.05E-05,4.09E-04,2.16E-04,CAT/CASR/MEN1/HIF1A/RHOA/CCN2/LRP5,7
GO:1902692,regulation of neuroblast proliferation, 4/89,45/18614,6.26E-05,4.22E-04,2.23E-04,HIF1A/NF1/SHH/CTNNB1,4
GO:0010038,response to metal ion, 9/89,367/18614,6.47E-05,4.35E-04,2.30E-04,CAT/BCL2/MMP9/CASR/HIF1A/BMP6/SHH/AMELX/JUNB,9
GO:0071900,regulation of protein serine/threonine kinase activity, 9/89,369/18614,6.75E-05,4.53E-04,2.39E-04,MEN1/NF1/RHOA/SFRP1/BMP4/BMP7/LRP5/GTPBP4/ROR2,9
GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand, 4/89,46/18614,6.83E-05,4.57E-04,2.42E-04,BCL2/NF1/WWOX/SNAI2,4
GO:0016202,regulation of striated muscle tissue development, 3/89,17/18614,6.84E-05,4.57E-04,2.42E-04,SMAD3/BMP4/TWIST1,3
GO:0051960,regulation of nervous system development, 10/89,461/18614,6.97E-05,4.65E-04,2.46E-04,HIF1A/UFL1/NF1/SHH/BMP7/PLXNB1/SPP1/CTNNB1/BMPR2/NOG,10
GO:0010631,epithelial cell migration, 9/89,371/18614,7.03E-05,4.67E-04,2.47E-04,MMP9/SNAI1/HIF1A/NF1/RHOA/STC1/BMP4/SNAI2/BMPR2,9
GO:0045619,regulation of lymphocyte differentiation, 7/89,212/18614,7.04E-05,4.67E-04,2.47E-04,RHOA/SFRP1/SHH/RUNX1/BMP4/JUNB/MMP14,7
GO:0014910,regulation of smooth muscle cell migration, 5/89,90/18614,7.12E-05,4.71E-04,2.49E-04,BCL2/NF1/RHOA/BMP4/IGFBP3,5
GO:0007224,smoothened signaling pathway, 6/89,146/18614,7.15E-05,4.72E-04,2.50E-04,GLI1/DHH/SFRP1/SHH/GPC3/NOG,6
GO:0048286,lung alveolus development, 4/89,47/18614,7.44E-05,4.89E-04,2.59E-04,TMEM38B/BMP4/TGFB3/BMPR2,4
GO:0048806,genitalia development, 4/89,47/18614,7.44E-05,4.89E-04,2.59E-04,BMP6/SHH/CTNNB1/ROR2,4
GO:1901888,regulation of cell junction assembly, 7/89,214/18614,7.46E-05,4.89E-04,2.59E-04,SMAD3/SNAI1/RHOA/SFRP1/SNAI2/CTNNB1/MMP14,7
GO:0090132,epithelium migration, 9/89,374/18614,7.48E-05,4.89E-04,2.59E-04,MMP9/SNAI1/HIF1A/NF1/RHOA/STC1/BMP4/SNAI2/BMPR2,9
GO:0001843,neural tube closure, 5/89,91/18614,7.51E-05,4.89E-04,2.59E-04,SFRP1/BMP4/CTHRC1/NOG/TWIST1,5
GO:0072091,regulation of stem cell proliferation, 5/89,91/18614,7.51E-05,4.89E-04,2.59E-04,HNRNPU/NF1/SHH/SNAI2/CTNNB1,5
GO:0009612,response to mechanical stimulus, 7/89,215/18614,7.69E-05,5.00E-04,2.64E-04,BMP6/RHOA/MAPK14/COL1A1/MMP2/CTNNB1/MMP14,7
GO:0060606,tube closure, 5/89,92/18614,7.91E-05,5.13E-04,2.72E-04,SFRP1/BMP4/CTHRC1/NOG/TWIST1,5
GO:0035987,endodermal cell differentiation, 4/89,48/18614,8.09E-05,5.24E-04,2.77E-04,MMP9/MMP2/CTNNB1/MMP14,4
GO:0006469,negative regulation of protein kinase activity, 7/89,217/18614,8.15E-05,5.26E-04,2.78E-04,MEN1/NF1/ADAR/SFRP1/BMP4/BMP7/LRP5,7
GO:0061298,retina vasculature development in camera-type eye, 3/89,18/18614,8.19E-05,5.27E-04,2.79E-04,HIF1A/LRP5/BMPR2,3
GO:2000136,regulation of cell proliferation involved in heart morphogenesis, 3/89,18/18614,8.19E-05,5.27E-04,2.79E-04,BMP4/CTNNB1/BMPR2,3
GO:0090130,tissue migration, 9/89,379/18614,8.28E-05,5.31E-04,2.81E-04,MMP9/SNAI1/HIF1A/NF1/RHOA/STC1/BMP4/SNAI2/BMPR2,9
GO:0061351,neural precursor cell proliferation, 6/89,150/18614,8.30E-05,5.32E-04,2.81E-04,HIF1A/NF1/RHOA/GLI1/SHH/CTNNB1,6
GO:0001738,morphogenesis of a polarized epithelium, 5/89,94/18614,8.76E-05,5.59E-04,2.96E-04,RHOA/SFRP1/GPC3/CTHRC1/ROR2,5
GO:0051492,regulation of stress fiber assembly, 5/89,94/18614,8.76E-05,5.59E-04,2.96E-04,SMAD3/RHOA/SFRP1/CCN2/TGFB3,5
GO:1903131,mononuclear cell differentiation, 10/89,474/18614,8.78E-05,5.59E-04,2.96E-04,BCL2/MEN1/RHOA/SFRP1/SHH/RUNX1/BMP4/JUNB/CTNNB1/MMP14,10
GO:0030217,T cell differentiation, 8/89,300/18614,9.45E-05,6.00E-04,3.18E-04,BCL2/MEN1/RHOA/SHH/RUNX1/BMP4/JUNB/CTNNB1,8
GO:0048534,hematopoietic or lymphoid organ development, 5/89,96/18614,9.68E-05,6.08E-04,3.21E-04,BCL2/SBDS/SHH/LRP5/CTNNB1,5
GO:1903312,negative regulation of mRNA metabolic process, 5/89,96/18614,9.68E-05,6.08E-04,3.21E-04,HNRNPU/MAPK14/SYNCRIP/DHX9/AXIN2,5
GO:0045603,positive regulation of endothelial cell differentiation, 3/89,19/18614,9.69E-05,6.08E-04,3.21E-04,BMP6/BMP4/CTNNB1,3
GO:0060438,trachea development, 3/89,19/18614,9.69E-05,6.08E-04,3.21E-04,SHH/BMP4/CTNNB1,3
GO:0061323,cell proliferation involved in heart morphogenesis, 3/89,19/18614,9.69E-05,6.08E-04,3.21E-04,BMP4/CTNNB1/BMPR2,3
GO:0072074,kidney mesenchyme development, 3/89,19/18614,9.69E-05,6.08E-04,3.21E-04,SHH/BMP4/BMP7,3
GO:0014909,smooth muscle cell migration, 5/89,97/18614,1.02E-04,6.35E-04,3.36E-04,BCL2/NF1/RHOA/BMP4/IGFBP3,5
GO:0051153,regulation of striated muscle cell differentiation, 5/89,97/18614,1.02E-04,6.35E-04,3.36E-04,BCL2/MAPK14/SHH/BMP4/MMP14,5
GO:2001238,positive regulation of extrinsic apoptotic signaling pathway, 4/89,51/18614,1.03E-04,6.41E-04,3.39E-04,NF1/BMPR1B/SFRP1/WWOX,4
GO:0034504,protein localization to nucleus, 8/89,304/18614,1.04E-04,6.44E-04,3.41E-04,HNRNPU/SMAD3/NF1/MAPK14/SHH/BMP4/BMP7/COL1A1,8
GO:0008406,gonad development, 7/89,228/18614,1.11E-04,6.81E-04,3.60E-04,BCL2/DHH/BMPR1B/FOXC1/SFRP1/MMP2/MMP14,7
GO:0002762,negative regulation of myeloid leukocyte differentiation, 4/89,52/18614,1.11E-04,6.81E-04,3.60E-04,NF1/SFRP1/FSTL3/CTNNB1,4
GO:0031103,axon regeneration, 4/89,52/18614,1.11E-04,6.81E-04,3.60E-04,BCL2/TNC/SPP1/MMP2,4
GO:0060324,face development, 4/89,52/18614,1.11E-04,6.81E-04,3.60E-04,COL1A1/TGFB3/MMP2/NOG,4
GO:0060425,lung morphogenesis, 4/89,52/18614,1.11E-04,6.81E-04,3.60E-04,SHH/BMP4/CTNNB1/NOG,4
GO:2000677,regulation of transcription regulatory region DNA binding, 4/89,52/18614,1.11E-04,6.81E-04,3.60E-04,FOXC1/MSX2/CTNNB1/TWIST1,4
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway, 5/89,99/18614,1.12E-04,6.87E-04,3.63E-04,BCL2/MMP9/SNAI1/HIF1A/SNAI2,5
GO:0003417,growth plate cartilage development, 3/89,20/18614,1.14E-04,6.90E-04,3.65E-04,STC1/THBS3/COMP,3
GO:0042359,vitamin D metabolic process, 3/89,20/18614,1.14E-04,6.90E-04,3.65E-04,SNAI1/CYP24A1/SNAI2,3
GO:0048643,positive regulation of skeletal muscle tissue development, 3/89,20/18614,1.14E-04,6.90E-04,3.65E-04,BCL2/SHH/CTNNB1,3
GO:0055093,response to hyperoxia, 3/89,20/18614,1.14E-04,6.90E-04,3.65E-04,CAT/COL1A1/MMP2,3
GO:0051222,positive regulation of protein transport, 8/89,309/18614,1.16E-04,7.04E-04,3.72E-04,SMAD3/ACHE/CASR/HIF1A/BMP6/MAPK14/SHH/TGFB3,8
GO:0009948,anterior/posterior axis specification, 4/89,53/18614,1.20E-04,7.24E-04,3.83E-04,SHH/GPC3/BMP4/CTNNB1,4
GO:0016049,cell growth, 10/89,495/18614,1.25E-04,7.57E-04,4.01E-04,BCL2/SMAD3/TNC/RHOA/SFRP1/SPP1/IGFBP3/CTNNB1/BMPR2/MMP14,10
GO:0045137,development of primary sexual characteristics, 7/89,233/18614,1.27E-04,7.65E-04,4.05E-04,BCL2/DHH/BMPR1B/FOXC1/SFRP1/MMP2/MMP14,7
GO:2000179,positive regulation of neural precursor cell proliferation, 4/89,54/18614,1.29E-04,7.74E-04,4.10E-04,HIF1A/GLI1/SHH/CTNNB1,4
GO:0009743,response to carbohydrate, 7/89,234/18614,1.30E-04,7.83E-04,4.14E-04,CAT/CASR/MEN1/HIF1A/RHOA/CCN2/LRP5,7
GO:0010224,response to UV-B, 3/89,21/18614,1.32E-04,7.88E-04,4.17E-04,BCL2/MAPK11/MAPK14,3
GO:0032332,positive regulation of chondrocyte differentiation, 3/89,21/18614,1.32E-04,7.88E-04,4.17E-04,SMAD3/BMP6/BMPR1B,3
GO:0060445,branching involved in salivary gland morphogenesis, 3/89,21/18614,1.32E-04,7.88E-04,4.17E-04,SHH/BMP7/SNAI2,3
GO:0072593,reactive oxygen species metabolic process, 7/89,237/18614,0.000140968,8.40E-04,4.44E-04,CAT/BCL2/HIF1A/RHOA/MAPK14/BMP7/CCN2,7
GO:0110020,regulation of actomyosin structure organization, 5/89,104/18614,1.41E-04,8.41E-04,4.45E-04,SMAD3/RHOA/SFRP1/CCN2/TGFB3,5
GO:0009615,response to virus, 9/89,408/18614,1.45E-04,8.58E-04,4.54E-04,BCL2/SMAD3/HIF1A/ADAR/MAPK11/MAPK14/DHX9/DDX21/IFITM1,9
GO:0042063,gliogenesis, 8/89,320/18614,1.48E-04,8.74E-04,4.62E-04,UFL1/NF1/RHOA/SHH/CTNNB1/NOG/MMP14/ROR2,8
GO:0007566,embryo implantation, 4/89,57/18614,1.59E-04,9.38E-04,4.96E-04,MMP9/STC1/SPP1/MMP2,4
GO:0043388,positive regulation of DNA binding, 4/89,57/18614,1.59E-04,9.38E-04,4.96E-04,MMP9/FOXC1/CTNNB1/TWIST1,4
GO:0007568,aging, 6/89,169/18614,1.60E-04,9.39E-04,4.97E-04,CAT/CCN2/COMP/TGFB3/MMP2/ALPL,6
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway, 6/89,169/18614,1.60E-04,9.39E-04,4.97E-04,CHRDL1/CHRDL2/SFRP1/TGFB3/FSTL3/NOG,6
GO:0003279,cardiac septum development, 5/89,107/18614,1.62E-04,9.48E-04,5.01E-04,BMP4/BMP7/MSX2/BMPR2/NOG,5
GO:1904951,positive regulation of establishment of protein localization, 8/89,325/18614,1.64E-04,9.60E-04,5.08E-04,SMAD3/ACHE/CASR/HIF1A/BMP6/MAPK14/SHH/TGFB3,8
GO:0014013,regulation of gliogenesis, 5/89,108/18614,1.69E-04,9.84E-04,5.21E-04,UFL1/NF1/SHH/CTNNB1/NOG,5
GO:0032231,regulation of actin filament bundle assembly, 5/89,108/18614,1.69E-04,9.84E-04,5.21E-04,SMAD3/RHOA/SFRP1/CCN2/TGFB3,5
GO:0061005,cell differentiation involved in kidney development, 4/89,58/18614,1.70E-04,9.87E-04,5.22E-04,MMP9/SHH/BMP4/CTNNB1,4
GO:0002262,myeloid cell homeostasis, 6/89,171/18614,1.70E-04,9.87E-04,5.22E-04,HIF1A/UFL1/NF1/ADAR/MAPK14/BMP4,6
GO:1902905,positive regulation of supramolecular fiber organization, 6/89,171/18614,1.70E-04,9.87E-04,5.22E-04,SMAD3/RHOA/GIT1/SFRP1/CCN2/TGFB3,6
GO:0006913,nucleocytoplasmic transport, 8/89,328/18614,1.75E-04,0.00100811,5.33E-04,SMAD3/NF1/MAPK14/DHX9/SHH/BMP4/ALYREF/SIRT7,8
GO:0051169,nuclear transport, 8/89,328/18614,1.75E-04,0.00100811,5.33E-04,SMAD3/NF1/MAPK14/DHX9/SHH/BMP4/ALYREF/SIRT7,8
GO:0030038,contractile actin filament bundle assembly, 5/89,109/18614,1.76E-04,0.001013882,5.36E-04,SMAD3/RHOA/SFRP1/CCN2/TGFB3,5
GO:0043149,stress fiber assembly, 5/89,109/18614,1.76E-04,0.001013882,5.36E-04,SMAD3/RHOA/SFRP1/CCN2/TGFB3,5
GO:0001558,regulation of cell growth, 9/89,420/18614,1.80E-04,0.001031086,5.45E-04,BCL2/SMAD3/TNC/RHOA/SFRP1/SPP1/IGFBP3/BMPR2/MMP14,9
GO:0031102,neuron projection regeneration, 4/89,59/18614,1.82E-04,0.001041582,5.51E-04,BCL2/TNC/SPP1/MMP2,4
GO:0014812,muscle cell migration, 5/89,110/18614,1.84E-04,0.001052102,5.57E-04,BCL2/NF1/RHOA/BMP4/IGFBP3,5
GO:0062012,regulation of small molecule metabolic process, 8/89,331/18614,1.86E-04,0.001060282,5.61E-04,SNAI1/HIF1A/BMP6/GIT1/IGFBP3/SNAI2/SIRT7/TWIST1,8
GO:0071347,cellular response to interleukin-1, 5/89,111/18614,1.92E-04,0.001093417,5.78E-04,HIF1A/MAPK11/ADAMTS12/SFRP1/MMP2,5
GO:0046631,alpha-beta T cell activation, 6/89,175/18614,1.93E-04,0.001097159,5.80E-04,BCL2/MEN1/RHOA/SHH/RUNX1/JUNB,6
GO:0043407,negative regulation of MAP kinase activity, 4/89,60/18614,1.94E-04,0.001097159,5.80E-04,NF1/SFRP1/BMP4/BMP7,4
GO:0045620,negative regulation of lymphocyte differentiation, 4/89,60/18614,1.94E-04,0.001097159,5.80E-04,SFRP1/SHH/RUNX1/BMP4,4
GO:0046824,positive regulation of nucleocytoplasmic transport, 4/89,60/18614,1.94E-04,0.001097159,5.80E-04,SMAD3/MAPK14/DHX9/SHH,4
GO:0016485,protein processing, 7/89,250/18614,1.96E-04,0.001104658,5.84E-04,DHH/BMP1/SHH/RUNX1/PHEX/COMP/MMP14,7
GO:0002053,positive regulation of mesenchymal cell proliferation, 3/89,24/18614,1.99E-04,0.001111461,5.88E-04,SHH/LRP5/CTNNB1,3
GO:0002320,lymphoid progenitor cell differentiation, 3/89,24/18614,1.99E-04,0.001111461,5.88E-04,BCL2/SHH/BMP4,3
GO:0070233,negative regulation of T cell apoptotic process, 3/89,24/18614,1.99E-04,0.001111461,5.88E-04,BCL2/HIF1A/BMP4,3
GO:0090335,regulation of brown fat cell differentiation, 3/89,24/18614,1.99E-04,0.001111461,5.88E-04,HNRNPU/MAPK14/BMP7,3
GO:1901863,positive regulation of muscle tissue development, 3/89,24/18614,1.99E-04,0.001111461,5.88E-04,BCL2/SHH/CTNNB1,3
GO:0031330,negative regulation of cellular catabolic process, 7/89,251/18614,2.01E-04,0.00111927,5.92E-04,BCL2/HNRNPU/MAPK14/SYNCRIP/DHX9/SHH/AXIN2,7
GO:0007409,axonogenesis, 9/89,427/18614,2.03E-04,0.001129072,5.97E-04,BCL2/BMPR1B/SHH/BMP7/PLXNB1/SPP1/BMPR2/NOG/CDH11,9
GO:0043434,response to peptide hormone, 9/89,427/18614,2.03E-04,0.001129072,5.97E-04,CAT/MEN1/SP7/MAPK14/BMP7/PHEX/COL1A1/CCN2/ALPL,9
GO:0050680,negative regulation of epithelial cell proliferation, 6/89,177/18614,2.05E-04,0.001139564,6.03E-04,MEN1/NF1/SFRP1/GPC3/BMP4/SNAI2,6
GO:0019229,regulation of vasoconstriction, 4/89,61/18614,2.07E-04,0.001145969,6.06E-04,CASR/RHOA/MMP2/BMPR2,4
GO:0071214,cellular response to abiotic stimulus, 8/89,339/18614,2.18E-04,0.001205348,6.38E-04,MMP9/BMP6/MAPK11/MAPK14/SFRP1/COL1A1/MMP2/SNAI2,8
GO:0104004,cellular response to environmental stimulus, 8/89,339/18614,2.18E-04,0.001205348,6.38E-04,MMP9/BMP6/MAPK11/MAPK14/SFRP1/COL1A1/MMP2/SNAI2,8
GO:0003148,outflow tract septum morphogenesis, 3/89,25/18614,2.25E-04,0.001237764,6.55E-04,BMP4/MSX2/BMPR2,3
GO:2000679,positive regulation of transcription regulatory region DNA binding, 3/89,25/18614,2.25E-04,0.001237764,6.55E-04,FOXC1/CTNNB1/TWIST1,3
GO:0001938,positive regulation of endothelial cell proliferation, 5/89,115/18614,2.26E-04,0.001242398,6.57E-04,HIF1A/NF1/BMP6/BMP4/BMPR2,5
GO:0006979,response to oxidative stress, 9/89,434/18614,2.29E-04,0.001254993,6.64E-04,CAT/BCL2/MMP9/HIF1A/BMP7/COL1A1/MMP2/CTNNB1/MMP14,9
GO:0048640,negative regulation of developmental growth, 5/89,116/18614,2.36E-04,0.001288767,6.82E-04,FGFR3/MAPK11/BMP4/SPP1/NOG,5
GO:0045927,positive regulation of growth, 7/89,258/18614,2.37E-04,0.001294861,6.85E-04,BCL2/RHOA/GLI1/MAPK14/SFRP1/BMPR2/MMP14,7
GO:0051893,regulation of focal adhesion assembly, 4/89,64/18614,2.49E-04,0.001354932,7.17E-04,SMAD3/RHOA/SFRP1/MMP14,4
GO:0090109,regulation of cell-substrate junction assembly, 4/89,64/18614,2.49E-04,0.001354932,7.17E-04,SMAD3/RHOA/SFRP1/MMP14,4
GO:0032925,regulation of activin receptor signaling pathway, 3/89,26/18614,2.54E-04,0.001369122,7.24E-04,MEN1/SHH/FSTL3,3
GO:0048745,smooth muscle tissue development, 3/89,26/18614,2.54E-04,0.001369122,7.24E-04,NF1/SHH/BMP4,3
GO:0060561,apoptotic process involved in morphogenesis, 3/89,26/18614,2.54E-04,0.001369122,7.24E-04,FOXC1/BMP7/LRP5,3
GO:1900151,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay", 3/89,26/18614,2.54E-04,0.001369122,7.24E-04,HNRNPU/SYNCRIP/DHX9,3
GO:1903522,regulation of blood circulation, 7/89,261/18614,2.55E-04,0.001371646,7.26E-04,TMEM38B/CASR/RHOA/STC1/CCN2/MMP2/BMPR2,7
GO:0045446,endothelial cell differentiation, 5/89,119/18614,2.65E-04,0.001427585,7.55E-04,BMP6/STC1/BMP4/CTNNB1/BMPR2,5
GO:0001894,tissue homeostasis, 7/89,263/18614,2.67E-04,0.001428997,7.56E-04,BCL2/NF1/FOXC1/CCN2/SPP1/COMP/CTNNB1,7
GO:0060249,anatomical structure homeostasis, 7/89,263/18614,2.67E-04,0.001428997,7.56E-04,BCL2/NF1/FOXC1/CCN2/SPP1/COMP/CTNNB1,7
GO:0051101,regulation of DNA binding, 5/89,120/18614,2.76E-04,0.001474951,7.80E-04,MMP9/FOXC1/MSX2/CTNNB1/TWIST1,5
GO:0008217,regulation of blood pressure, 6/89,187/18614,2.76E-04,0.001474951,7.80E-04,SMAD3/RHOA/COL1A2/LRP5/EXT2/BMPR2,6
GO:0001756,somitogenesis, 4/89,66/18614,2.81E-04,0.001495768,7.91E-04,SMAD3/FOXC1/SFRP1/AXIN2,4
GO:0036296,response to increased oxygen levels, 3/89,27/18614,2.84E-04,0.001510323,0.000798909,CAT/COL1A1/MMP2,3
GO:1904753,negative regulation of vascular associated smooth muscle cell migration, 3/89,27/18614,2.84E-04,0.001510323,0.000798909,NF1/RHOA/BMP4,3
GO:0038034,signal transduction in absence of ligand, 4/89,67/18614,2.97E-04,0.001573704,8.32E-04,BCL2/NF1/WWOX/SNAI2,4
GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand, 4/89,67/18614,2.97E-04,0.001573704,8.32E-04,BCL2/NF1/WWOX/SNAI2,4
GO:0031099,regeneration, 6/89,190/18614,3.01E-04,0.001586506,8.39E-04,BCL2/TNC/GLI1/RUNX1/SPP1/MMP2,6
GO:0051495,positive regulation of cytoskeleton organization, 6/89,190/18614,3.01E-04,0.001586506,8.39E-04,SMAD3/RHOA/GIT1/SFRP1/CCN2/TGFB3,6
GO:0071478,cellular response to radiation, 6/89,191/18614,3.09E-04,0.001628861,8.62E-04,MMP9/MAPK11/MAPK14/SFRP1/MMP2/SNAI2,6
GO:0035019,somatic stem cell population maintenance, 4/89,68/18614,3.15E-04,0.001651329,8.73E-04,SFRP1/BMP7/LRP5/NOG,4
GO:0045670,regulation of osteoclast differentiation, 4/89,68/18614,3.15E-04,0.001651329,8.73E-04,NF1/SFRP1/FSTL3/CTNNB1,4
GO:0003401,axis elongation, 3/89,28/18614,3.17E-04,0.00165911,8.78E-04,SFRP1/SHH/BMP4,3
GO:0045686,negative regulation of glial cell differentiation, 3/89,28/18614,3.17E-04,0.00165911,8.78E-04,NF1/CTNNB1/NOG,3
GO:0150116,regulation of cell-substrate junction organization, 4/89,69/18614,3.33E-04,0.001737414,9.19E-04,SMAD3/RHOA/SFRP1/MMP14,4
GO:0009749,response to glucose, 6/89,194/18614,3.36E-04,0.0017488,9.25E-04,CASR/MEN1/HIF1A/RHOA/CCN2/LRP5,6
GO:0043433,negative regulation of DNA-binding transcription factor activity, 6/89,194/18614,3.36E-04,0.0017488,9.25E-04,CAT/MEN1/UFL1/BMP7/MSX2/TWIST1,6
GO:0071560,cellular response to transforming growth factor beta stimulus, 7/89,274/18614,3.42E-04,0.001773445,9.38E-04,SMAD3/MEN1/COL1A2/SFRP1/COL1A1/WWOX/TGFB3,7
GO:0003231,cardiac ventricle development, 5/89,126/18614,3.46E-04,0.001791738,9.48E-04,HIF1A/FOXC1/BMP4/BMPR2/NOG,5
GO:0050708,regulation of protein secretion, 7/89,275/18614,3.49E-04,0.001806495,9.56E-04,ACHE/CASR/HIF1A/BMP6/SFRP1/TGFB3/LRP5,7
GO:0014823,response to activity, 4/89,70/18614,3.52E-04,0.001809247,9.57E-04,CAT/HIF1A/BMP6/MMP2,4
GO:0002052,positive regulation of neuroblast proliferation, 3/89,29/18614,3.53E-04,0.001809247,9.57E-04,HIF1A/SHH/CTNNB1,3
GO:0044342,type B pancreatic cell proliferation, 3/89,29/18614,3.53E-04,0.001809247,9.57E-04,MEN1/SFRP1/IGFBP3,3
GO:0060441,epithelial tube branching involved in lung morphogenesis, 3/89,29/18614,3.53E-04,0.001809247,9.57E-04,SHH/BMP4/CTNNB1,3
GO:2000765,regulation of cytoplasmic translation, 3/89,29/18614,3.53E-04,0.001809247,9.57E-04,HNRNPU/SYNCRIP/DHX9,3
GO:0009746,response to hexose, 6/89,199/18614,3.85E-04,0.001971902,0.001043069,CASR/MEN1/HIF1A/RHOA/CCN2/LRP5,6
GO:0050808,synapse organization, 9/89,466/18614,3.86E-04,0.001973333,0.001043826,CHRDL1/ACHE/TNC/NF1/RHOA/MAPK14/PLXNB1/CTNNB1/ROR2,9
GO:0071559,response to transforming growth factor beta, 7/89,280/18614,3.89E-04,0.001985565,0.001050296,SMAD3/MEN1/COL1A2/SFRP1/COL1A1/WWOX/TGFB3,7
GO:0002360,T cell lineage commitment, 3/89,30/18614,3.91E-04,0.001986249,0.001050658,BCL2/RHOA/SHH,3
GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage, 3/89,30/18614,3.91E-04,0.001986249,0.001050658,BCL2/SNAI1/SNAI2,3
GO:0045165,cell fate commitment, 7/89,281/18614,3.98E-04,0.002018118,0.001067516,BCL2/RHOA/DHH/SFRP1/SHH/BMP4/CTNNB1,7
GO:0030218,erythrocyte differentiation, 5/89,130/18614,3.99E-04,0.002023127,0.001070165,HIF1A/UFL1/ADAR/MAPK14/BMP4,5
GO:0001935,endothelial cell proliferation, 6/89,201/18614,4.06E-04,0.002054857,0.001086949,HIF1A/NF1/BMP6/BMP4/BMPR2/MMP14,6
GO:0007405,neuroblast proliferation, 4/89,73/18614,4.13E-04,0.002082935,0.001101801,HIF1A/NF1/SHH/CTNNB1,4
GO:0046637,regulation of alpha-beta T cell differentiation, 4/89,73/18614,4.13E-04,0.002082935,0.001101801,RHOA/SHH/RUNX1/JUNB,4
GO:0009306,protein secretion, 8/89,373/18614,4.15E-04,0.002084432,0.001102594,ACHE/CASR/HIF1A/BMP6/SFRP1/COMP/TGFB3/LRP5,8
GO:0043542,endothelial cell migration, 7/89,283/18614,4.15E-04,0.002084432,0.001102594,HIF1A/NF1/RHOA/STC1/BMP4/SNAI2/BMPR2,7
GO:0035592,establishment of protein localization to extracellular region, 8/89,374/18614,4.22E-04,0.002117004,0.001119823,ACHE/CASR/HIF1A/BMP6/SFRP1/COMP/TGFB3/LRP5,8
GO:0003309,type B pancreatic cell differentiation, 3/89,31/18614,4.31E-04,0.00215471,0.001139768,MEN1/BMP6/BMP4,3
GO:0010039,response to iron ion, 3/89,31/18614,4.31E-04,0.00215471,0.001139768,BCL2/HIF1A/BMP6,3
GO:0051145,smooth muscle cell differentiation, 4/89,74/18614,4.35E-04,0.002171927,0.001148875,SHH/BMP4/COMP/CTNNB1,4
GO:1900180,regulation of protein localization to nucleus, 5/89,134/18614,4.59E-04,0.002285794,0.001209107,SMAD3/NF1/MAPK14/SHH/BMP4,5
GO:0033032,regulation of myeloid cell apoptotic process, 3/89,32/18614,4.74E-04,0.002353054,0.001244686,BCL2/NF1/SNAI2,3
GO:0061384,heart trabecula morphogenesis, 3/89,32/18614,4.74E-04,0.002353054,0.001244686,BMP7/FHL2/NOG,3
GO:0043401,steroid hormone mediated signaling pathway, 5/89,135/18614,4.75E-04,0.002353054,0.001244686,UFL1/RHOA/SFRP1/BMP4/BMP7,5
GO:0034599,cellular response to oxidative stress, 7/89,290/18614,4.80E-04,0.002375978,0.001256811,CAT/BCL2/MMP9/HIF1A/BMP7/MMP2/CTNNB1,7
GO:0050810,regulation of steroid biosynthetic process, 4/89,76/18614,4.82E-04,0.002380302,0.001259099,SNAI1/BMP6/DHH/SNAI2,4
GO:0071692,protein localization to extracellular region, 8/89,382/18614,4.86E-04,0.002394778,0.001266756,ACHE/CASR/HIF1A/BMP6/SFRP1/COMP/TGFB3/LRP5,8
GO:0030879,mammary gland development, 5/89,136/18614,4.91E-04,0.002417668,0.001278864,HIF1A/BMP4/TGFB3/LRP5/MSX2,5
GO:0045685,regulation of glial cell differentiation, 4/89,77/18614,5.06E-04,0.002489246,0.001316726,NF1/SHH/CTNNB1/NOG,4
GO:0015012,heparan sulfate proteoglycan biosynthetic process, 3/89,33/18614,5.20E-04,0.00254193,0.001344594,XYLT1/EXT2/CTNNB1,3
GO:0048710,regulation of astrocyte differentiation, 3/89,33/18614,5.20E-04,0.00254193,0.001344594,NF1/SHH/NOG,3
GO:0090279,regulation of calcium ion import, 3/89,33/18614,5.20E-04,0.00254193,0.001344594,CASR/STC1/CTNNB1,3
GO:0010632,regulation of epithelial cell migration, 7/89,295/18614,5.32E-04,0.002595858,0.00137312,MMP9/HIF1A/NF1/RHOA/STC1/BMP4/BMPR2,7
GO:0034101,erythrocyte homeostasis, 5/89,139/18614,5.42E-04,0.002644413,0.001398805,HIF1A/UFL1/ADAR/MAPK14/BMP4,5
GO:0051146,striated muscle cell differentiation, 7/89,297/18614,5.53E-04,0.002693253,0.001424639,BCL2/HNRNPU/MAPK14/SHH/BMP4/FHL2/MMP14,7
GO:0009799,specification of symmetry, 5/89,140/18614,5.60E-04,0.00272322,0.001440491,SMAD3/HIF1A/SHH/BMP4/CTNNB1,5
GO:0022407,regulation of cell-cell adhesion, 9/89,491/18614,5.63E-04,0.002732466,0.001445381,BMP6/RHOA/MAPK14/SHH/RUNX1/BMP4/BMP7/FSTL3/GTPBP4,9
GO:0060914,heart formation, 3/89,34/18614,5.68E-04,0.002751211,0.001455297,AXIN2/BMP4/CTNNB1,3
GO:0070555,response to interleukin-1, 5/89,141/18614,5.79E-04,0.002799119,0.001480638,HIF1A/MAPK11/ADAMTS12/SFRP1/MMP2,5
GO:0010212,response to ionizing radiation, 5/89,143/18614,6.17E-04,0.002979196,0.001575893,BCL2/MEN1/MAPK14/SFRP1/SNAI2,5
GO:0030900,forebrain development, 8/89,397/18614,6.25E-04,0.003014205,0.001594412,HIF1A/NF1/RHOA/GLI1/SHH/BMP4/CTNNB1/NOG,8
GO:0048872,homeostasis of number of cells, 7/89,304/18614,6.35E-04,0.00305637,0.001616716,BCL2/HIF1A/UFL1/NF1/ADAR/MAPK14/BMP4,7
GO:0014065,phosphatidylinositol 3-kinase signaling, 5/89,144/18614,6.37E-04,0.003059984,0.001618627,CAT/NF1/PLXNB1/ROR2/TWIST1,5
GO:0043523,regulation of neuron apoptotic process, 6/89,219/18614,6.39E-04,0.003064145,0.001620828,BCL2/HIF1A/NF1/RHOA/TGFB3/CTNNB1,6
GO:2001021,negative regulation of response to DNA damage stimulus, 4/89,82/18614,6.43E-04,0.003078135,0.001628229,BCL2/SNAI1/SNAI2/TWIST1,4
GO:0009100,glycoprotein metabolic process, 8/89,401/18614,6.68E-04,0.00319228,0.001688607,BCL2/HIF1A/BMPR1B/XYLT1/ADAMTS12/EXT2/CTNNB1/BMPR2,8
GO:0002068,glandular epithelial cell development, 3/89,36/18614,6.73E-04,0.003202832,0.001694189,HIF1A/BMP6/BMP4,3
GO:1900368,regulation of post-transcriptional gene silencing by RNA, 3/89,36/18614,6.73E-04,0.003202832,0.001694189,ADAR/DHX9/BMP4,3
GO:1905332,positive regulation of morphogenesis of an epithelium, 3/89,36/18614,6.73E-04,0.003202832,0.001694189,BMP4/CTNNB1/NOG,3
GO:0030177,positive regulation of Wnt signaling pathway, 5/89,146/18614,6.78E-04,0.003215757,0.001701026,SMAD3/SFRP1/SHH/GPC3/COL1A1,5
GO:0050714,positive regulation of protein secretion, 5/89,146/18614,6.78E-04,0.003215757,0.001701026,ACHE/CASR/HIF1A/BMP6/TGFB3,5
GO:0033157,regulation of intracellular protein transport, 6/89,224/18614,7.19E-04,0.00340412,0.001800663,SMAD3/NF1/MAPK14/SHH/BMP4/SIRT7,6
GO:0051053,negative regulation of DNA metabolic process, 5/89,148/18614,7.21E-04,0.003408911,0.001803198,HNRNPU/MEN1/GTPBP4/BMPR2/TWIST1,5
GO:2001020,regulation of response to DNA damage stimulus, 7/89,311/18614,7.26E-04,0.003418818,0.001808438,BCL2/SNAI1/DHX9/AXIN2/SNAI2/SIRT7/TWIST1,7
GO:0010092,specification of animal organ identity, 3/89,37/18614,7.30E-04,0.003418818,0.001808438,AXIN2/BMP4/CTNNB1,3
GO:0035883,enteroendocrine cell differentiation, 3/89,37/18614,7.30E-04,0.003418818,0.001808438,MEN1/BMP6/BMP4,3
GO:0043516,"regulation of DNA damage response, signal transduction by p53 class mediator", 3/89,37/18614,7.30E-04,0.003418818,0.001808438,SNAI1/SNAI2/TWIST1,3
GO:0060147,regulation of post-transcriptional gene silencing, 3/89,37/18614,7.30E-04,0.003418818,0.001808438,ADAR/DHX9/BMP4,3
GO:2000279,negative regulation of DNA biosynthetic process, 3/89,37/18614,7.30E-04,0.003418818,0.001808438,HNRNPU/MEN1/BMPR2,3
GO:0007411,axon guidance, 6/89,225/18614,7.36E-04,0.003434983,0.001816989,BMPR1B/SHH/BMP7/PLXNB1/BMPR2/NOG,6
GO:0097485,neuron projection guidance, 6/89,225/18614,7.36E-04,0.003434983,0.001816989,BMPR1B/SHH/BMP7/PLXNB1/BMPR2/NOG,6
GO:0050768,negative regulation of neurogenesis, 5/89,150/18614,7.66E-04,0.003557538,0.001881817,NF1/BMP7/SPP1/CTNNB1/NOG,5
GO:2000377,regulation of reactive oxygen species metabolic process, 5/89,150/18614,7.66E-04,0.003557538,0.001881817,BCL2/HIF1A/RHOA/MAPK14/BMP7,5
GO:0008543,fibroblast growth factor receptor signaling pathway, 4/89,86/18614,7.69E-04,0.003557538,0.001881817,FGFR3/CCN2/CTNNB1/NOG,4
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors, 4/89,86/18614,7.69E-04,0.003557538,0.001881817,BCL2/NF1/BMPR1B/SFRP1,4
GO:0033077,T cell differentiation in thymus, 4/89,86/18614,7.69E-04,0.003557538,0.001881817,BCL2/SHH/BMP4/CTNNB1,4
GO:0034103,regulation of tissue remodeling, 4/89,86/18614,7.69E-04,0.003557538,0.001881817,NF1/SFRP1/RUNX1/SPP1,4
GO:0033028,myeloid cell apoptotic process, 3/89,38/18614,7.90E-04,0.003630578,0.001920452,BCL2/NF1/SNAI2,3
GO:0060966,regulation of gene silencing by RNA, 3/89,38/18614,7.90E-04,0.003630578,0.001920452,ADAR/DHX9/BMP4,3
GO:0070229,negative regulation of lymphocyte apoptotic process, 3/89,38/18614,7.90E-04,0.003630578,0.001920452,BCL2/HIF1A/BMP4,3
GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage, 3/89,38/18614,7.90E-04,0.003630578,0.001920452,BCL2/SNAI1/SNAI2,3
GO:0048145,regulation of fibroblast proliferation, 4/89,87/18614,8.03E-04,0.003675537,0.001944234,NF1/DHX9/SFRP1/CTNNB1,4
GO:0048678,response to axon injury, 4/89,87/18614,8.03E-04,0.003675537,0.001944234,BCL2/TNC/SPP1/MMP2,4
GO:0048708,astrocyte differentiation, 4/89,87/18614,8.03E-04,0.003675537,0.001944234,NF1/SHH/NOG/ROR2,4
GO:0050727,regulation of inflammatory response, 8/89,414/18614,8.21E-04,0.003752674,0.001985037,MMP9/SMAD3/TNC/UFL1/MAPK14/GIT1/ADAMTS12/DHX9,8
GO:0030279,negative regulation of ossification, 3/89,39/18614,8.53E-04,0.003871787,0.002048044,BCL2/HIF1A/SFRP1,3
GO:0042307,positive regulation of protein import into nucleus, 3/89,39/18614,8.53E-04,0.003871787,0.002048044,SMAD3/MAPK14/SHH,3
GO:0060251,regulation of glial cell proliferation, 3/89,39/18614,8.53E-04,0.003871787,0.002048044,UFL1/NF1/SHH,3
GO:0070232,regulation of T cell apoptotic process, 3/89,39/18614,8.53E-04,0.003871787,0.002048044,BCL2/HIF1A/BMP4,3
GO:0010594,regulation of endothelial cell migration, 6/89,232/18614,8.63E-04,0.003905733,0.002065999,HIF1A/NF1/RHOA/STC1/BMP4/BMPR2,6
GO:0050769,positive regulation of neurogenesis, 6/89,232/18614,8.63E-04,0.003905733,0.002065999,HIF1A/UFL1/SHH/PLXNB1/CTNNB1/BMPR2,6
GO:0001892,embryonic placenta development, 4/89,89/18614,8.75E-04,0.003954045,0.002091555,SNAI1/HIF1A/BMP7/JUNB,4
GO:0060041,retina development in camera-type eye, 5/89,155/18614,8.88E-04,0.004006581,0.002119345,ACHE/HIF1A/BMPR1B/LRP5/BMPR2,5
GO:0060560,developmental growth involved in morphogenesis, 6/89,234/18614,9.02E-04,0.004064829,0.002150156,SFRP1/SHH/BMP4/SPP1/CTNNB1/BMPR2,6
GO:2000106,regulation of leukocyte apoptotic process, 4/89,90/18614,9.12E-04,0.004104298,0.002171034,BCL2/HIF1A/NF1/BMP4,4
GO:0051961,negative regulation of nervous system development, 5/89,156/18614,9.14E-04,0.004105182,0.002171501,NF1/BMP7/SPP1/CTNNB1/NOG,5
GO:0071392,cellular response to estradiol stimulus, 3/89,40/18614,9.19E-04,0.004121054,0.002179897,SFRP1/MMP2/MSX2,3
GO:0010001,glial cell differentiation, 6/89,235/18614,9.22E-04,0.00413054,0.002184915,NF1/RHOA/SHH/CTNNB1/NOG/ROR2,6
GO:0007043,cell-cell junction assembly, 5/89,157/18614,9.40E-04,0.00420541,0.002224519,SNAI1/RHOA/SNAI2/CTNNB1/CDH11,5
GO:0030901,midbrain development, 4/89,91/18614,9.51E-04,0.004245404,0.002245674,RHOA/SFRP1/SHH/CTNNB1,4
GO:1902742,apoptotic process involved in development, 3/89,41/18614,9.88E-04,0.004365966,0.002309447,FOXC1/BMP7/LRP5,3
GO:0045666,positive regulation of neuron differentiation, 4/89,92/18614,9.90E-04,0.004365966,0.002309447,BMP6/RHOA/BMP4/BMP7,4
GO:0014012,peripheral nervous system axon regeneration, 2/89,10/18614,9.92E-04,0.004365966,0.002309447,TNC/MMP2,2
GO:0033085,negative regulation of T cell differentiation in thymus, 2/89,10/18614,9.92E-04,0.004365966,0.002309447,SHH/BMP4,2
GO:0033197,response to vitamin E, 2/89,10/18614,9.92E-04,0.004365966,0.002309447,CAT/COL1A1,2
GO:0042368,vitamin D biosynthetic process, 2/89,10/18614,9.92E-04,0.004365966,0.002309447,SNAI1/SNAI2,2
GO:0046886,positive regulation of hormone biosynthetic process, 2/89,10/18614,9.92E-04,0.004365966,0.002309447,HIF1A/BMP6,2
GO:0048340,paraxial mesoderm morphogenesis, 2/89,10/18614,9.92E-04,0.004365966,0.002309447,SMAD3/FOXC1,2
GO:0060768,regulation of epithelial cell proliferation involved in prostate gland development, 2/89,10/18614,9.92E-04,0.004365966,0.002309447,SHH/CTNNB1,2
GO:0062042,regulation of cardiac epithelial to mesenchymal transition, 2/89,10/18614,9.92E-04,0.004365966,0.002309447,NOG/TWIST1,2
GO:0034644,cellular response to UV, 4/89,93/18614,0.00103092,0.00452299,0.002392507,MMP9/MAPK11/MAPK14/MMP2,4
GO:0051781,positive regulation of cell division, 4/89,93/18614,0.00103092,0.00452299,0.002392507,CAT/RHOA/SHH/TGFB3,4
GO:0035051,cardiocyte differentiation, 5/89,161/18614,0.001052125,0.004602467,0.002434548,HNRNPU/BMP4/BMP7/FHL2/TWIST1,5
GO:0051017,actin filament bundle assembly, 5/89,161/18614,0.001052125,0.004602467,0.002434548,SMAD3/RHOA/SFRP1/CCN2/TGFB3,5
GO:0021983,pituitary gland development, 3/89,42/18614,0.001059979,0.004630025,0.002449125,GLI1/BMP4/NOG,3
GO:0032386,regulation of intracellular transport, 7/89,332/18614,0.001063144,0.00463027,0.002449255,SMAD3/NF1/MAPK14/DHX9/SHH/BMP4/SIRT7,7
GO:0051604,protein maturation, 7/89,332/18614,0.001063144,0.00463027,0.002449255,DHH/BMP1/SHH/RUNX1/PHEX/COMP/MMP14,7
GO:0006606,protein import into nucleus, 5/89,163/18614,0.00111167,0.004834546,0.00255731,SMAD3/NF1/MAPK14/SHH/BMP4,5
GO:0045638,negative regulation of myeloid cell differentiation, 4/89,95/18614,0.001115952,0.004846095,0.002563419,NF1/SFRP1/FSTL3/CTNNB1,4
GO:0006775,fat-soluble vitamin metabolic process, 3/89,43/18614,0.001135558,0.004902648,0.002593333,SNAI1/CYP24A1/SNAI2,3
GO:0048713,regulation of oligodendrocyte differentiation, 3/89,43/18614,0.001135558,0.004902648,0.002593333,NF1/SHH/CTNNB1,3
GO:0060412,ventricular septum morphogenesis, 3/89,43/18614,0.001135558,0.004902648,0.002593333,BMP4/BMPR2/NOG,3
GO:0071364,cellular response to epidermal growth factor stimulus, 3/89,43/18614,0.001135558,0.004902648,0.002593333,FOXC1/COL1A1/SNAI2,3
GO:0030307,positive regulation of cell growth, 5/89,164/18614,0.001142363,0.004924889,0.002605099,BCL2/RHOA/SFRP1/BMPR2/MMP14,5
GO:0061572,actin filament bundle organization, 5/89,165/18614,0.00117368,0.005052589,0.002672648,SMAD3/RHOA/SFRP1/CCN2/TGFB3,5
GO:0022412,cellular process involved in reproduction in multicellular organism, 8/89,438/18614,0.001179457,0.005070132,0.002681927,BCL2/GLI1/DHH/BMPR1B/FOXC1/SFRP1/BMP4/CTNNB1,8
GO:0046883,regulation of hormone secretion, 6/89,247/18614,0.00119161,0.005086678,0.002690679,CASR/HIF1A/BMP6/SFRP1/SPP1/LRP5,6
GO:1903321,negative regulation of protein modification by small protein conjugation or removal, 4/89,97/18614,0.00120579,0.005086678,0.002690679,UFL1/GTPBP4/CTNNB1/SIRT7,4
GO:0003139,secondary heart field specification, 2/89,11/18614,0.001208919,0.005086678,0.002690679,AXIN2/BMP4,2
GO:0021936,regulation of cerebellar granule cell precursor proliferation, 2/89,11/18614,0.001208919,0.005086678,0.002690679,GLI1/SHH,2
GO:0044848,biological phase, 2/89,11/18614,0.001208919,0.005086678,0.002690679,MSX2/CTNNB1,2
GO:0060767,epithelial cell proliferation involved in prostate gland development, 2/89,11/18614,0.001208919,0.005086678,0.002690679,SHH/CTNNB1,2
GO:0061314,Notch signaling involved in heart development, 2/89,11/18614,0.001208919,0.005086678,0.002690679,SNAI1/SNAI2,2
GO:0070601,centromeric sister chromatid cohesion, 2/89,11/18614,0.001208919,0.005086678,0.002690679,AXIN2/CTNNB1,2
GO:0071492,cellular response to UV-A, 2/89,11/18614,0.001208919,0.005086678,0.002690679,MMP9/MMP2,2
GO:0072124,regulation of glomerular mesangial cell proliferation, 2/89,11/18614,0.001208919,0.005086678,0.002690679,BMP4/BMP7,2
GO:0072205,metanephric collecting duct development, 2/89,11/18614,0.001208919,0.005086678,0.002690679,SHH/BMP4,2
GO:0090184,positive regulation of kidney development, 2/89,11/18614,0.001208919,0.005086678,0.002690679,BMP4/NOG,2
GO:2000672,negative regulation of motor neuron apoptotic process, 2/89,11/18614,0.001208919,0.005086678,0.002690679,BCL2/RHOA,2
GO:2000833,positive regulation of steroid hormone secretion, 2/89,11/18614,0.001208919,0.005086678,0.002690679,BMP6/SPP1,2
GO:2001241,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand, 2/89,11/18614,0.001208919,0.005086678,0.002690679,NF1/WWOX,2
GO:0009410,response to xenobiotic stimulus, 8/89,440/18614,0.001214184,0.005101628,0.002698587,CAT/BCL2/RHOA/SFRP1/AMELX/COL1A1/MMP2/CTNNB1,8
GO:0051170,import into nucleus, 5/89,168/18614,0.001271454,0.005334734,0.002821892,SMAD3/NF1/MAPK14/SHH/BMP4,5
GO:0014014,negative regulation of gliogenesis, 3/89,45/18614,0.00129673,0.005402738,0.002857864,NF1/CTNNB1/NOG,3
GO:0030574,collagen catabolic process, 3/89,45/18614,0.00129673,0.005402738,0.002857864,MMP9/MMP2/MMP14,3
GO:0032781,positive regulation of ATP-dependent activity, 3/89,45/18614,0.00129673,0.005402738,0.002857864,HNRNPU/CASR/DHX9,3
GO:0060443,mammary gland morphogenesis, 3/89,45/18614,0.00129673,0.005402738,0.002857864,BMP4/LRP5/MSX2,3
GO:1904706,negative regulation of vascular associated smooth muscle cell proliferation, 3/89,45/18614,0.00129673,0.005402738,0.002857864,RHOA/BMP4/TGFB3,3
GO:0019218,regulation of steroid metabolic process, 4/89,99/18614,0.001300578,0.005403655,0.002858349,SNAI1/BMP6/DHH/SNAI2,4
GO:0048661,positive regulation of smooth muscle cell proliferation, 4/89,99/18614,0.001300578,0.005403655,0.002858349,MMP9/NF1/BMP4/MMP2,4
GO:0007254,JNK cascade, 5/89,170/18614,0.001339901,0.005559285,0.002940672,SMAD3/CASR/MEN1/SFRP1/CCN2,5
GO:0010830,regulation of myotube differentiation, 3/89,46/18614,0.001382431,0.005727762,0.003029791,BCL2/MAPK14/MMP14,3
GO:0048015,phosphatidylinositol-mediated signaling, 5/89,172/18614,0.001411035,0.005838157,0.003088186,CAT/NF1/PLXNB1/ROR2/TWIST1,5
GO:0045765,regulation of angiogenesis, 7/89,349/18614,0.001417282,0.00584776,0.003093266,HIF1A/NF1/FOXC1/SFRP1/RUNX1/CTNNB1/TWIST1,7
GO:0062197,cellular response to chemical stress, 7/89,349/18614,0.001417282,0.00584776,0.003093266,CAT/BCL2/MMP9/HIF1A/BMP7/MMP2/CTNNB1,7
GO:0003337,mesenchymal to epithelial transition involved in metanephros morphogenesis, 2/89,12/18614,0.001446196,0.005851407,0.003095195,BMP4/CTNNB1,2
GO:0010936,negative regulation of macrophage cytokine production, 2/89,12/18614,0.001446196,0.005851407,0.003095195,TGFB3/TWIST1,2
GO:0030656,regulation of vitamin metabolic process, 2/89,12/18614,0.001446196,0.005851407,0.003095195,SNAI1/SNAI2,2
GO:0033083,regulation of immature T cell proliferation, 2/89,12/18614,0.001446196,0.005851407,0.003095195,SHH/BMP4,2
GO:0033084,regulation of immature T cell proliferation in thymus, 2/89,12/18614,0.001446196,0.005851407,0.003095195,SHH/BMP4,2
GO:0043589,skin morphogenesis, 2/89,12/18614,0.001446196,0.005851407,0.003095195,COL1A2/COL1A1,2
GO:0070561,vitamin D receptor signaling pathway, 2/89,12/18614,0.001446196,0.005851407,0.003095195,CYP24A1/SNAI2,2
GO:0071493,cellular response to UV-B, 2/89,12/18614,0.001446196,0.005851407,0.003095195,MAPK11/MAPK14,2
GO:0072110,glomerular mesangial cell proliferation, 2/89,12/18614,0.001446196,0.005851407,0.003095195,BMP4/BMP7,2
GO:0072178,nephric duct morphogenesis, 2/89,12/18614,0.001446196,0.005851407,0.003095195,GPC3/BMP4,2
GO:0097264,self proteolysis, 2/89,12/18614,0.001446196,0.005851407,0.003095195,DHH/SHH,2
GO:1902337,regulation of apoptotic process involved in morphogenesis, 2/89,12/18614,0.001446196,0.005851407,0.003095195,FOXC1/BMP7,2
GO:1904338,regulation of dopaminergic neuron differentiation, 2/89,12/18614,0.001446196,0.005851407,0.003095195,SFRP1/SHH,2
GO:0072331,signal transduction by p53 class mediator, 5/89,173/18614,0.001447629,0.005851407,0.003095195,BCL2/SNAI1/WWOX/SNAI2/TWIST1,5
GO:2001242,regulation of intrinsic apoptotic signaling pathway, 5/89,173/18614,0.001447629,0.005851407,0.003095195,BCL2/MMP9/SNAI1/HIF1A/SNAI2,5
GO:0031018,endocrine pancreas development, 3/89,47/18614,0.001471612,0.005916239,0.003129489,MEN1/BMP6/BMP4,3
GO:0035196,miRNA processing, 3/89,47/18614,0.001471612,0.005916239,0.003129489,SMAD3/ADAR/BMP4,3
GO:0045601,regulation of endothelial cell differentiation, 3/89,47/18614,0.001471612,0.005916239,0.003129489,BMP6/BMP4/CTNNB1,3
GO:0070849,response to epidermal growth factor, 3/89,47/18614,0.001471612,0.005916239,0.003129489,FOXC1/COL1A1/SNAI2,3
GO:0045639,positive regulation of myeloid cell differentiation, 4/89,103/18614,0.001505576,0.006036487,0.003193096,HIF1A/MAPK14/RUNX1/ROR2,4
GO:0048144,fibroblast proliferation, 4/89,103/18614,0.001505576,0.006036487,0.003193096,NF1/DHX9/SFRP1/CTNNB1,4
GO:0051402,neuron apoptotic process, 6/89,259/18614,0.001517881,0.006077646,0.003214868,BCL2/HIF1A/NF1/RHOA/TGFB3/CTNNB1,6
GO:0048017,inositol lipid-mediated signaling, 5/89,176/18614,0.001561616,0.006213503,0.003286731,CAT/NF1/PLXNB1/ROR2/TWIST1,5
GO:1901342,regulation of vasculature development, 7/89,355/18614,0.001562208,0.006213503,0.003286731,HIF1A/NF1/FOXC1/SFRP1/RUNX1/CTNNB1/TWIST1,7
GO:0008542,visual learning, 3/89,48/18614,0.001564326,0.006213503,0.003286731,HIF1A/NF1/NOG,3
GO:0035850,epithelial cell differentiation involved in kidney development, 3/89,48/18614,0.001564326,0.006213503,0.003286731,MMP9/BMP4/CTNNB1,3
GO:0048538,thymus development, 3/89,48/18614,0.001564326,0.006213503,0.003286731,BCL2/SHH/CTNNB1,3
GO:0070509,calcium ion import, 3/89,48/18614,0.001564326,0.006213503,0.003286731,CASR/STC1/CTNNB1,3
GO:0019827,stem cell population maintenance, 5/89,177/18614,0.00160104,0.006350865,0.003359391,SFRP1/BMP7/LRP5/CTNNB1/NOG,5
GO:0090068,positive regulation of cell cycle process, 6/89,262/18614,0.001609173,0.006374637,0.003371966,HNRNPU/RHOA/GLI1/CCN2/LRP5/MSX2,6
GO:0006766,vitamin metabolic process, 4/89,105/18614,0.001616073,0.006384988,0.003377441,SNAI1/CYP24A1/SNAI2/ALPL,4
GO:0032784,regulation of DNA-templated transcription elongation, 4/89,105/18614,0.001616073,0.006384988,0.003377441,HNRNPU/SHH/ALYREF/CTNNB1,4
GO:0046850,regulation of bone remodeling, 3/89,49/18614,0.001660623,0.006543644,0.003461364,NF1/SFRP1/SPP1,3
GO:1904752,regulation of vascular associated smooth muscle cell migration, 3/89,49/18614,0.001660623,0.006543644,0.003461364,NF1/RHOA/BMP4,3
GO:1901796,regulation of signal transduction by p53 class mediator, 4/89,106/18614,0.001673383,0.006585216,0.003483355,BCL2/SNAI1/SNAI2/TWIST1,4
GO:0007219,Notch signaling pathway, 5/89,179/18614,0.001682081,0.006609009,0.00349594,SNAI1/FOXC1/BMP7/SNAI2/MMP14,5
GO:0021978,telencephalon regionalization, 2/89,13/18614,0.001703833,0.006609009,0.00349594,SHH/BMP4,2
GO:0033079,immature T cell proliferation, 2/89,13/18614,0.001703833,0.006609009,0.00349594,SHH/BMP4,2
GO:0033080,immature T cell proliferation in thymus, 2/89,13/18614,0.001703833,0.006609009,0.00349594,SHH/BMP4,2
GO:0033690,positive regulation of osteoblast proliferation, 2/89,13/18614,0.001703833,0.006609009,0.00349594,LRP5/CTHRC1,2
GO:0042362,fat-soluble vitamin biosynthetic process, 2/89,13/18614,0.001703833,0.006609009,0.00349594,SNAI1/SNAI2,2
GO:0051481,negative regulation of cytosolic calcium ion concentration, 2/89,13/18614,0.001703833,0.006609009,0.00349594,BCL2/SMAD3,2
GO:0070243,regulation of thymocyte apoptotic process, 2/89,13/18614,0.001703833,0.006609009,0.00349594,HIF1A/BMP4,2
GO:0090177,establishment of planar polarity involved in neural tube closure, 2/89,13/18614,0.001703833,0.006609009,0.00349594,SFRP1/CTHRC1,2
GO:1901862,negative regulation of muscle tissue development, 2/89,13/18614,0.001703833,0.006609009,0.00349594,BMP4/TWIST1,2
GO:1904748,regulation of apoptotic process involved in development, 2/89,13/18614,0.001703833,0.006609009,0.00349594,FOXC1/BMP7,2
GO:0045580,regulation of T cell differentiation, 5/89,180/18614,0.001723713,0.006677425,0.00353213,RHOA/SHH/RUNX1/BMP4/JUNB,5
GO:0051924,regulation of calcium ion transport, 6/89,266/18614,0.001737335,0.006721455,0.003555421,TMEM38B/BCL2/CASR/RHOA/STC1/CTNNB1,6
GO:0002066,columnar/cuboidal epithelial cell development, 3/89,50/18614,0.001760552,0.006784843,0.003588951,HIF1A/BMP6/BMP4,3
GO:0045581,negative regulation of T cell differentiation, 3/89,50/18614,0.001760552,0.006784843,0.003588951,SHH/RUNX1/BMP4,3
GO:2000378,negative regulation of reactive oxygen species metabolic process, 3/89,50/18614,0.001760552,0.006784843,0.003588951,BCL2/HIF1A/RHOA,3
GO:0098727,maintenance of cell number, 5/89,181/18614,0.001766097,0.006797419,0.003595603,SFRP1/BMP7/LRP5/CTNNB1/NOG,5
GO:1903829,positive regulation of protein localization, 8/89,468/18614,0.001792113,0.006888651,0.003643862,SMAD3/ACHE/CASR/HIF1A/BMP6/MAPK14/SHH/TGFB3,8
GO:0043409,negative regulation of MAPK cascade, 5/89,183/18614,0.001853154,0.007114106,0.003763119,MEN1/NF1/SFRP1/BMP4/BMP7,5
GO:0045058,T cell selection, 3/89,51/18614,0.001864163,0.007119667,0.003766061,BCL2/RHOA/SHH,3
GO:0061082,myeloid leukocyte cytokine production, 3/89,51/18614,0.001864163,0.007119667,0.003766061,TGFB3/DDX21/TWIST1,3
GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation, 3/89,51/18614,0.001864163,0.007119667,0.003766061,MMP9/NF1/MMP2,3
GO:1904738,vascular associated smooth muscle cell migration, 3/89,51/18614,0.001864163,0.007119667,0.003766061,NF1/RHOA/BMP4,3
GO:0021537,telencephalon development, 6/89,270/18614,0.001873118,0.007144709,0.003779308,HIF1A/NF1/RHOA/SHH/BMP4/CTNNB1,6
GO:1902107,positive regulation of leukocyte differentiation, 5/89,184/18614,0.001897844,0.007220532,0.003819415,RHOA/SHH/RUNX1/MMP14/ROR2,5
GO:1903708,positive regulation of hemopoiesis, 5/89,184/18614,0.001897844,0.007220532,0.003819415,RHOA/SHH/RUNX1/MMP14/ROR2,5
GO:0051091,positive regulation of DNA-binding transcription factor activity, 6/89,271/18614,0.001908288,0.007251008,0.003835536,CAT/SMAD3/DHX9/SHH/LRP5/CTNNB1,6
GO:0045445,myoblast differentiation, 4/89,110/18614,0.001916786,0.007264767,0.003842814,MAPK14/SHH/BMP4/IGFBP3,4
GO:0090263,positive regulation of canonical Wnt signaling pathway, 4/89,110/18614,0.001916786,0.007264767,0.003842814,SMAD3/SFRP1/GPC3/COL1A1,4
GO:0001936,regulation of endothelial cell proliferation, 5/89,185/18614,0.001943318,0.007355966,0.003891055,HIF1A/NF1/BMP6/BMP4/BMPR2,5
GO:0022602,ovulation cycle process, 3/89,52/18614,0.001971503,0.007434312,0.003932498,BMPR1B/TGFB3/MMP2,3
GO:0046638,positive regulation of alpha-beta T cell differentiation, 3/89,52/18614,0.001971503,0.007434312,0.003932498,RHOA/SHH/RUNX1,3
GO:0048013,ephrin receptor signaling pathway, 3/89,52/18614,0.001971503,0.007434312,0.003932498,MMP9/GIT1/MMP2,3
GO:0048715,negative regulation of oligodendrocyte differentiation, 2/89,14/18614,0.001981635,0.007444249,0.003937754,NF1/CTNNB1,2
GO:0070141,response to UV-A, 2/89,14/18614,0.001981635,0.007444249,0.003937754,MMP9/MMP2,2
GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors, 2/89,14/18614,0.001981635,0.007444249,0.003937754,BMPR1B/SFRP1,2
GO:0043405,regulation of MAP kinase activity, 5/89,186/18614,0.001989586,0.007464706,0.003948575,NF1/SFRP1/BMP4/BMP7/ROR2,5
GO:0051302,regulation of cell division, 5/89,187/18614,0.002036655,0.007631692,0.004036905,CAT/RHOA/GIT1/SHH/TGFB3,5
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling, 4/89,112/18614,0.002047232,0.007661688,0.004052772,CAT/PLXNB1/ROR2/TWIST1,4
GO:0035065,regulation of histone acetylation, 3/89,53/18614,0.002082619,0.00777459,0.004112493,SNAI2/DDX21/TWIST1,3
GO:0050873,brown fat cell differentiation, 3/89,53/18614,0.002082619,0.00777459,0.004112493,HNRNPU/MAPK14/BMP7,3
GO:0018205,peptidyl-lysine modification, 7/89,374/18614,0.002098732,0.007824936,0.004139124,MEN1/SHH/SNAI2/CTNNB1/SIRT7/DDX21/TWIST1,7
GO:0045785,positive regulation of cell adhesion, 8/89,482/18614,0.00215318,0.008017903,0.004241197,IBSP/SMAD3/RHOA/SFRP1/SHH/RUNX1/BMP7/FSTL3,8
GO:0023061,signal release, 8/89,483/18614,0.002181015,0.008111252,0.004290576,CASR/HIF1A/NF1/BMP6/GIT1/SFRP1/SPP1/LRP5,8
GO:0046634,regulation of alpha-beta T cell activation, 4/89,114/18614,0.002183694,0.008111252,0.004290576,RHOA/SHH/RUNX1/JUNB,4
GO:0007632,visual behavior, 3/89,54/18614,0.002197558,0.008122241,0.004296389,HIF1A/NF1/NOG,3
GO:0014009,glial cell proliferation, 3/89,54/18614,0.002197558,0.008122241,0.004296389,UFL1/NF1/SHH,3
GO:0030857,negative regulation of epithelial cell differentiation, 3/89,54/18614,0.002197558,0.008122241,0.004296389,MMP9/MSX2/CTNNB1,3
GO:0071385,cellular response to glucocorticoid stimulus, 3/89,54/18614,0.002197558,0.008122241,0.004296389,HNRNPU/STC1/AXIN2,3
GO:0030308,negative regulation of cell growth, 5/89,191/18614,0.002233109,0.008243411,0.004360483,BCL2/SMAD3/SFRP1/SPP1/BMPR2,5
GO:0051962,positive regulation of nervous system development, 6/89,280/18614,0.002247826,0.008287469,0.004383789,HIF1A/UFL1/SHH/PLXNB1/CTNNB1/BMPR2,6
GO:0032352,positive regulation of hormone metabolic process, 2/89,15/18614,0.002279406,0.008298726,0.004389743,HIF1A/BMP6,2
GO:0042074,cell migration involved in gastrulation, 2/89,15/18614,0.002279406,0.008298726,0.004389743,GPC3/LRP5,2
GO:0043374,"CD8-positive, alpha-beta T cell differentiation", 2/89,15/18614,0.002279406,0.008298726,0.004389743,BCL2/RUNX1,2
GO:0070278,extracellular matrix constituent secretion, 2/89,15/18614,0.002279406,0.008298726,0.004389743,TMEM38B/CCN2,2
GO:0072075,metanephric mesenchyme development, 2/89,15/18614,0.002279406,0.008298726,0.004389743,SHH/BMP7,2
GO:0072283,metanephric renal vesicle morphogenesis, 2/89,15/18614,0.002279406,0.008298726,0.004389743,BMP4/CTNNB1,2
GO:0090280,positive regulation of calcium ion import, 2/89,15/18614,0.002279406,0.008298726,0.004389743,CASR/STC1,2
GO:1901722,regulation of cell proliferation involved in kidney development, 2/89,15/18614,0.002279406,0.008298726,0.004389743,BMP4/BMP7,2
GO:2000052,positive regulation of non-canonical Wnt signaling pathway, 2/89,15/18614,0.002279406,0.008298726,0.004389743,SFRP1/GPC3,2
GO:2000671,regulation of motor neuron apoptotic process, 2/89,15/18614,0.002279406,0.008298726,0.004389743,BCL2/RHOA,2
GO:0009755,hormone-mediated signaling pathway, 5/89,192/18614,0.002284309,0.008298726,0.004389743,UFL1/RHOA/SFRP1/BMP4/BMP7,5
GO:0055001,muscle cell development, 5/89,192/18614,0.002284309,0.008298726,0.004389743,BCL2/HNRNPU/BMP4/FHL2/COMP,5
GO:0043525,positive regulation of neuron apoptotic process, 3/89,55/18614,0.002316365,0.008404935,0.004445924,NF1/RHOA/CTNNB1,3
GO:0048839,inner ear development, 5/89,193/18614,0.002336359,0.00846717,0.004478844,SHH/BMP4/DCHS1/TGFB3/CTHRC1,5
GO:0001819,positive regulation of cytokine production, 8/89,489/18614,0.00235404,0.008520883,0.004507257,SMAD3/HIF1A/MAPK11/MAPK14/DHX9/RUNX1/DDX21/TWIST1,8
GO:0071887,leukocyte apoptotic process, 4/89,117/18614,0.002399974,0.008676604,0.004589628,BCL2/HIF1A/NF1/BMP4,4
GO:0038066,p38MAPK cascade, 3/89,56/18614,0.002439084,0.008784323,0.004646607,MAPK11/MAPK14/BMP4,3
GO:0070231,T cell apoptotic process, 3/89,56/18614,0.002439084,0.008784323,0.004646607,BCL2/HIF1A/BMP4,3
GO:2000107,negative regulation of leukocyte apoptotic process, 3/89,56/18614,0.002439084,0.008784323,0.004646607,BCL2/HIF1A/BMP4,3
GO:0043488,regulation of mRNA stability, 5/89,195/18614,0.002443046,0.008784323,0.004646607,HNRNPU/MAPK14/SYNCRIP/DHX9/AXIN2,5
GO:0090066,regulation of anatomical structure size, 8/89,492/18614,0.002444513,0.008784323,0.004646607,CASR/RHOA/FOXC1/SPP1/COMP/MMP2/EXT2/BMPR2,8
GO:0140014,mitotic nuclear division, 6/89,286/18614,0.002498302,0.008966797,0.00474313,HNRNPU/RHOA/BMP4/BMP7/LRP5/SIRT7,6
GO:0043410,positive regulation of MAPK cascade, 8/89,495/18614,0.002537698,0.009097236,0.004812128,FGFR3/CASR/BMP4/CCN2/IGFBP3/TGFB3/CTNNB1/ROR2,8
GO:0034332,adherens junction organization, 3/89,57/18614,0.002565758,0.009155419,0.004842904,BMP6/CTNNB1/CDH11,3
GO:0021534,cell proliferation in hindbrain, 2/89,16/18614,0.002596955,0.009155419,0.004842904,GLI1/SHH,2
GO:0021924,cell proliferation in external granule layer, 2/89,16/18614,0.002596955,0.009155419,0.004842904,GLI1/SHH,2
GO:0021930,cerebellar granule cell precursor proliferation, 2/89,16/18614,0.002596955,0.009155419,0.004842904,GLI1/SHH,2
GO:0038092,nodal signaling pathway, 2/89,16/18614,0.002596955,0.009155419,0.004842904,SMAD3/SHH,2
GO:0042249,establishment of planar polarity of embryonic epithelium, 2/89,16/18614,0.002596955,0.009155419,0.004842904,SFRP1/CTHRC1,2
GO:0048712,negative regulation of astrocyte differentiation, 2/89,16/18614,0.002596955,0.009155419,0.004842904,NF1/NOG,2
GO:0060033,anatomical structure regression, 2/89,16/18614,0.002596955,0.009155419,0.004842904,GLI1/LRP5,2
GO:0061469,regulation of type B pancreatic cell proliferation, 2/89,16/18614,0.002596955,0.009155419,0.004842904,MEN1/SFRP1,2
GO:0072044,collecting duct development, 2/89,16/18614,0.002596955,0.009155419,0.004842904,SHH/BMP4,2
GO:0072176,nephric duct development, 2/89,16/18614,0.002596955,0.009155419,0.004842904,GPC3/BMP4,2
GO:2000095,"regulation of Wnt signaling pathway, planar cell polarity pathway", 2/89,16/18614,0.002596955,0.009155419,0.004842904,SFRP1/GPC3,2
GO:2000637,positive regulation of miRNA-mediated gene silencing, 2/89,16/18614,0.002596955,0.009155419,0.004842904,DHX9/BMP4,2
GO:2000696,regulation of epithelial cell differentiation involved in kidney development, 2/89,16/18614,0.002596955,0.009155419,0.004842904,MMP9/CTNNB1,2
GO:0071897,DNA biosynthetic process, 5/89,198/18614,0.002609666,0.009189354,0.004860855,HNRNPU/MEN1/CCN2/CTNNB1/BMPR2,5
GO:1903532,positive regulation of secretion by cell, 6/89,289/18614,0.002631155,0.009254085,0.004895096,ACHE/CASR/HIF1A/BMP6/SPP1/TGFB3,6
GO:0030225,macrophage differentiation, 3/89,58/18614,0.00269643,0.009461324,0.005004718,MMP9/BMP4/ROR2,3
GO:0048010,vascular endothelial growth factor receptor signaling pathway, 3/89,58/18614,0.00269643,0.009461324,0.005004718,HIF1A/MAPK14/FOXC1,3
GO:2000278,regulation of DNA biosynthetic process, 4/89,121/18614,0.002710701,0.009500209,0.005025287,HNRNPU/MEN1/CTNNB1/BMPR2,4
GO:0008347,glial cell migration, 3/89,59/18614,0.002831141,0.009887421,0.005230108,NF1/CTNNB1/MMP14,3
GO:0070228,regulation of lymphocyte apoptotic process, 3/89,59/18614,0.002831141,0.009887421,0.005230108,BCL2/HIF1A/BMP4,3
GO:1903053,regulation of extracellular matrix organization, 3/89,59/18614,0.002831141,0.009887421,0.005230108,SMAD3/RUNX1/AXIN2,3
GO:0031032,actomyosin structure organization, 5/89,202/18614,0.002844475,0.009922356,0.005248588,SMAD3/RHOA/SFRP1/CCN2/TGFB3,5
GO:0042471,ear morphogenesis, 4/89,123/18614,0.002875953,0.010020426,0.005300464,RPL38/CTHRC1/NOG/TWIST1,4
GO:0010831,positive regulation of myotube differentiation, 2/89,17/18614,0.002934089,0.010104799,0.005345094,MAPK14/MMP14,2
GO:0035729,cellular response to hepatocyte growth factor stimulus, 2/89,17/18614,0.002934089,0.010104799,0.005345094,CASR/ADAMTS12,2
GO:0036005,response to macrophage colony-stimulating factor, 2/89,17/18614,0.002934089,0.010104799,0.005345094,SPP1/ALPL,2
GO:0042481,regulation of odontogenesis, 2/89,17/18614,0.002934089,0.010104799,0.005345094,SHH/BMP4,2
GO:0060148,positive regulation of post-transcriptional gene silencing, 2/89,17/18614,0.002934089,0.010104799,0.005345094,DHX9/BMP4,2
GO:0072109,glomerular mesangium development, 2/89,17/18614,0.002934089,0.010104799,0.005345094,BMP4/BMP7,2
GO:0072189,ureter development, 2/89,17/18614,0.002934089,0.010104799,0.005345094,SHH/BMP4,2
GO:1900370,positive regulation of post-transcriptional gene silencing by RNA, 2/89,17/18614,0.002934089,0.010104799,0.005345094,DHX9/BMP4,2
GO:1904948,midbrain dopaminergic neuron differentiation, 2/89,17/18614,0.002934089,0.010104799,0.005345094,SFRP1/CTNNB1,2
GO:2001267,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway, 2/89,17/18614,0.002934089,0.010104799,0.005345094,MMP9/SMAD3,2
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process, 4/89,124/18614,0.002961111,0.010181164,0.005385489,SMAD3/RHOA/HSPE1/CCN2,4
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process, 5/89,204/18614,0.002967452,0.010181164,0.005385489,MMP9/SMAD3/RHOA/HSPE1/CCN2,5
GO:0002011,morphogenesis of an epithelial sheet, 3/89,60/18614,0.002969933,0.010181164,0.005385489,RHOA/BMP7/MSX2,3
GO:0045604,regulation of epidermal cell differentiation, 3/89,60/18614,0.002969933,0.010181164,0.005385489,FOXC1/BMP4/MSX2,3
GO:0022408,negative regulation of cell-cell adhesion, 5/89,205/18614,0.003030362,0.010376377,0.00548875,BMP6/SHH/RUNX1/BMP4/GTPBP4,5
GO:0030522,intracellular receptor signaling pathway, 6/89,299/18614,0.003112621,0.010634366,0.005625217,UFL1/RHOA/SFRP1/CYP24A1/SNAI2/TWIST1,6
GO:1905517,macrophage migration, 3/89,61/18614,0.003112846,0.010634366,0.005625217,MMP2/MMP14/ROR2,3
GO:0021987,cerebral cortex development, 4/89,126/18614,0.003136573,0.010703153,0.005661603,HIF1A/NF1/RHOA/CTNNB1,4
GO:0043487,regulation of RNA stability, 5/89,207/18614,0.003159068,0.01076758,0.005695683,HNRNPU/MAPK14/SYNCRIP/DHX9/AXIN2,5
GO:0097193,intrinsic apoptotic signaling pathway, 6/89,301/18614,0.003216334,0.010936257,0.005784907,BCL2/MMP9/SNAI1/HIF1A/WWOX/SNAI2,6
GO:0045786,negative regulation of cell cycle, 7/89,404/18614,0.003224771,0.010936257,0.005784907,BCL2/MEN1/MAPK14/FOXC1/BMP4/BMP7/CTNNB1,7
GO:0003014,renal system process, 4/89,127/18614,0.003226912,0.010936257,0.005784907,BCL2/RHOA/STC1/BMP4,4
GO:0014902,myotube differentiation, 4/89,127/18614,0.003226912,0.010936257,0.005784907,BCL2/MAPK14/SHH/MMP14,4
GO:0071482,cellular response to light stimulus, 4/89,127/18614,0.003226912,0.010936257,0.005784907,MMP9/MAPK11/MAPK14/MMP2,4
GO:0022617,extracellular matrix disassembly, 3/89,62/18614,0.003259918,0.010977326,0.005806631,MMP9/MMP2/MMP14,3
GO:2000756,regulation of peptidyl-lysine acetylation, 3/89,62/18614,0.003259918,0.010977326,0.005806631,SNAI2/DDX21/TWIST1,3
GO:0001946,lymphangiogenesis, 2/89,18/18614,0.003290618,0.010977326,0.005806631,FOXC1/BMPR2,2
GO:0003128,heart field specification, 2/89,18/18614,0.003290618,0.010977326,0.005806631,AXIN2/BMP4,2
GO:0007063,regulation of sister chromatid cohesion, 2/89,18/18614,0.003290618,0.010977326,0.005806631,AXIN2/CTNNB1,2
GO:0020027,hemoglobin metabolic process, 2/89,18/18614,0.003290618,0.010977326,0.005806631,CAT/HIF1A,2
GO:0033033,negative regulation of myeloid cell apoptotic process, 2/89,18/18614,0.003290618,0.010977326,0.005806631,BCL2/SNAI2,2
GO:0035455,response to interferon-alpha, 2/89,18/18614,0.003290618,0.010977326,0.005806631,ADAR/IFITM1,2
GO:0048339,paraxial mesoderm development, 2/89,18/18614,0.003290618,0.010977326,0.005806631,SMAD3/FOXC1,2
GO:0060044,negative regulation of cardiac muscle cell proliferation, 2/89,18/18614,0.003290618,0.010977326,0.005806631,MAPK11/NOG,2
GO:0060602,branch elongation of an epithelium, 2/89,18/18614,0.003290618,0.010977326,0.005806631,SHH/BMP4,2
GO:0072077,renal vesicle morphogenesis, 2/89,18/18614,0.003290618,0.010977326,0.005806631,BMP4/CTNNB1,2
GO:0090594,inflammatory response to wounding, 2/89,18/18614,0.003290618,0.010977326,0.005806631,HIF1A/GIT1,2
GO:2000811,negative regulation of anoikis, 2/89,18/18614,0.003290618,0.010977326,0.005806631,BCL2/SNAI2,2
GO:0048511,rhythmic process, 6/89,303/18614,0.00332261,0.011071649,0.005856525,HNRNPU/BMPR1B/DHX9/TGFB3/MMP2/TWIST1,6
GO:0006354,DNA-templated transcription elongation, 4/89,129/18614,0.003412886,0.011347083,0.00600222,HNRNPU/SHH/ALYREF/CTNNB1,4
GO:0042542,response to hydrogen peroxide, 4/89,129/18614,0.003412886,0.011347083,0.00600222,CAT/BCL2/COL1A1/MMP2,4
GO:0046879,hormone secretion, 6/89,305/18614,0.003431488,0.011396213,0.006028208,CASR/HIF1A/BMP6/SFRP1/SPP1/LRP5,6
GO:0061013,regulation of mRNA catabolic process, 5/89,212/18614,0.003498058,0.011604359,0.006138311,HNRNPU/MAPK14/SYNCRIP/DHX9/AXIN2,5
GO:0045621,positive regulation of lymphocyte differentiation, 4/89,130/18614,0.003508554,0.011626232,0.006149881,RHOA/SHH/RUNX1/MMP14,4
GO:0045453,bone resorption, 3/89,64/18614,0.003566693,0.011779577,0.006230995,NF1/SPP1/CTNNB1,3
GO:0050918,positive chemotaxis, 3/89,64/18614,0.003566693,0.011779577,0.006230995,SMAD3/CASR/BMP4,3
GO:0071384,cellular response to corticosteroid stimulus, 3/89,64/18614,0.003566693,0.011779577,0.006230995,HNRNPU/STC1/AXIN2,3
GO:0030903,notochord development, 2/89,19/18614,0.003666354,0.012028709,0.006362777,GLI1/NOG,2
GO:0034244,negative regulation of transcription elongation by RNA polymerase II, 2/89,19/18614,0.003666354,0.012028709,0.006362777,HNRNPU/SHH,2
GO:0035728,response to hepatocyte growth factor, 2/89,19/18614,0.003666354,0.012028709,0.006362777,CASR/ADAMTS12,2
GO:0060039,pericardium development, 2/89,19/18614,0.003666354,0.012028709,0.006362777,SMAD3/BMP7,2
GO:0070242,thymocyte apoptotic process, 2/89,19/18614,0.003666354,0.012028709,0.006362777,HIF1A/BMP4,2
GO:0072087,renal vesicle development, 2/89,19/18614,0.003666354,0.012028709,0.006362777,BMP4/CTNNB1,2
GO:0001947,heart looping, 3/89,65/18614,0.00372647,0.012212492,0.006459992,SMAD3/HIF1A/SHH,3
GO:0060972,left/right pattern formation, 4/89,134/18614,0.003909486,0.012798197,0.00676981,SMAD3/SNAI1/HIF1A/SHH,4
GO:1901215,negative regulation of neuron death, 5/89,219/18614,0.004015614,0.013118988,0.006939498,BCL2/HIF1A/RHOA/TGFB3/CTNNB1,5
GO:0009914,hormone transport, 6/89,315/18614,0.004016286,0.013118988,0.006939498,CASR/HIF1A/BMP6/SFRP1/SPP1/LRP5,6
GO:0045682,regulation of epidermis development, 3/89,67/18614,0.004058984,0.013164352,0.006963494,FOXC1/BMP4/MSX2,3
GO:0009110,vitamin biosynthetic process, 2/89,20/18614,0.004061108,0.013164352,0.006963494,SNAI1/SNAI2,2
GO:0042474,middle ear morphogenesis, 2/89,20/18614,0.004061108,0.013164352,0.006963494,RPL38/NOG,2
GO:0060231,mesenchymal to epithelial transition, 2/89,20/18614,0.004061108,0.013164352,0.006963494,BMP4/CTNNB1,2
GO:0070166,enamel mineralization, 2/89,20/18614,0.004061108,0.013164352,0.006963494,AMELX/MSX2,2
GO:0072079,nephron tubule formation, 2/89,20/18614,0.004061108,0.013164352,0.006963494,CTNNB1/NOG,2
GO:0097709,connective tissue replacement, 2/89,20/18614,0.004061108,0.013164352,0.006963494,HIF1A/RUNX1,2
GO:0071333,cellular response to glucose stimulus, 4/89,136/18614,0.004121133,0.013344409,0.007058737,CASR/MEN1/HIF1A/LRP5,4
GO:0051047,positive regulation of secretion, 6/89,317/18614,0.004141603,0.013396129,0.007086096,ACHE/CASR/HIF1A/BMP6/SPP1/TGFB3,6
GO:0000288,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay", 3/89,68/18614,0.00423179,0.013628653,0.007209093,HNRNPU/SYNCRIP/DHX9,3
GO:0048663,neuron fate commitment, 3/89,68/18614,0.00423179,0.013628653,0.007209093,SHH/BMP4/CTNNB1,3
GO:0061180,mammary gland epithelium development, 3/89,68/18614,0.00423179,0.013628653,0.007209093,HIF1A/LRP5/MSX2,3
GO:1902893,regulation of miRNA transcription, 3/89,68/18614,0.00423179,0.013628653,0.007209093,SMAD3/HIF1A/BMP4,3
GO:0007281,germ cell development, 6/89,319/18614,0.004269797,0.013736204,0.007265984,BCL2/GLI1/DHH/BMPR1B/BMP4/CTNNB1,6
GO:0046887,positive regulation of hormone secretion, 4/89,138/18614,0.004340405,0.01393326,0.00737022,CASR/HIF1A/BMP6/SPP1,4
GO:0071331,cellular response to hexose stimulus, 4/89,138/18614,0.004340405,0.01393326,0.00737022,CASR/MEN1/HIF1A/LRP5,4
GO:0061614,miRNA transcription, 3/89,69/18614,0.004409007,0.014138248,0.007478652,SMAD3/HIF1A/BMP4,3
GO:0009855,determination of bilateral symmetry, 4/89,139/18614,0.004452939,0.014241574,0.007533307,SMAD3/HIF1A/SHH/CTNNB1,4
GO:0002089,lens morphogenesis in camera-type eye, 2/89,21/18614,0.004474694,0.014241574,0.007533307,BMP4/CTNNB1,2
GO:0007398,ectoderm development, 2/89,21/18614,0.004474694,0.014241574,0.007533307,SHH/CTNNB1,2
GO:0090189,regulation of branching involved in ureteric bud morphogenesis, 2/89,21/18614,0.004474694,0.014241574,0.007533307,BMP4/NOG,2
GO:0097049,motor neuron apoptotic process, 2/89,21/18614,0.004474694,0.014241574,0.007533307,BCL2/RHOA,2
GO:1903204,negative regulation of oxidative stress-induced neuron death, 2/89,21/18614,0.004474694,0.014241574,0.007533307,HIF1A/CTNNB1,2
GO:2000738,positive regulation of stem cell differentiation, 2/89,21/18614,0.004474694,0.014241574,0.007533307,SP7/FOXC1,2
GO:0043271,negative regulation of monoatomic ion transport, 4/89,140/18614,0.004567426,0.014490269,0.007664858,BCL2/MMP9/STC1/TWIST1,4
GO:0071326,cellular response to monosaccharide stimulus, 4/89,140/18614,0.004567426,0.014490269,0.007664858,CASR/MEN1/HIF1A/LRP5,4
GO:2001235,positive regulation of apoptotic signaling pathway, 4/89,140/18614,0.004567426,0.014490269,0.007664858,NF1/BMPR1B/SFRP1/WWOX,4
GO:0061371,determination of heart left/right asymmetry, 3/89,70/18614,0.004590668,0.01454851,0.007695666,SMAD3/HIF1A/SHH,3
GO:0009101,glycoprotein biosynthetic process, 6/89,324/18614,0.004603132,0.014572509,0.007708361,BCL2/BMPR1B/XYLT1/EXT2/CTNNB1/BMPR2,6
GO:0034470,ncRNA processing, 7/89,432/18614,0.004647429,0.014697126,0.007774279,SMAD3/SBDS/ADAR/BMP4/GTPBP4/SIRT7/DDX21,7
GO:0031056,regulation of histone modification, 4/89,141/18614,0.004683882,0.014781023,0.007818657,SNAI2/CTNNB1/DDX21/TWIST1,4
GO:0045727,positive regulation of translation, 4/89,141/18614,0.004683882,0.014781023,0.007818657,HNRNPU/RHOA/SYNCRIP/DHX9,4
GO:0003143,embryonic heart tube morphogenesis, 3/89,71/18614,0.004776804,0.015026504,0.007948509,SMAD3/HIF1A/SHH,3
GO:0003208,cardiac ventricle morphogenesis, 3/89,71/18614,0.004776804,0.015026504,0.007948509,HIF1A/FOXC1/NOG,3
GO:0070918,regulatory ncRNA processing, 3/89,71/18614,0.004776804,0.015026504,0.007948509,SMAD3/ADAR/BMP4,3
GO:2001056,positive regulation of cysteine-type endopeptidase activity, 4/89,142/18614,0.004802323,0.015090843,0.007982542,SMAD3/RHOA/HSPE1/CCN2,4
GO:1901214,regulation of neuron death, 6/89,327/18614,0.004812144,0.01510577,0.007990437,BCL2/HIF1A/NF1/RHOA/TGFB3/CTNNB1,6
GO:0003228,atrial cardiac muscle tissue development, 2/89,22/18614,0.004906927,0.01529052,0.008088164,BMP4/NOG,2
GO:0023019,signal transduction involved in regulation of gene expression, 2/89,22/18614,0.004906927,0.01529052,0.008088164,SMAD3/MSX2,2
GO:0032785,"negative regulation of DNA-templated transcription, elongation", 2/89,22/18614,0.004906927,0.01529052,0.008088164,HNRNPU/SHH,2
GO:0048485,sympathetic nervous system development, 2/89,22/18614,0.004906927,0.01529052,0.008088164,NF1/CTNNB1,2
GO:0060444,branching involved in mammary gland duct morphogenesis, 2/89,22/18614,0.004906927,0.01529052,0.008088164,LRP5/MSX2,2
GO:2000810,regulation of bicellular tight junction assembly, 2/89,22/18614,0.004906927,0.01529052,0.008088164,SNAI1/SNAI2,2
GO:2000831,regulation of steroid hormone secretion, 2/89,22/18614,0.004906927,0.01529052,0.008088164,BMP6/SPP1,2
GO:0030330,"DNA damage response, signal transduction by p53 class mediator", 3/89,72/18614,0.004967447,0.01541461,0.008153803,SNAI1/SNAI2/TWIST1,3
GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway, 3/89,72/18614,0.004967447,0.01541461,0.008153803,UFL1/RHOA/SFRP1,3
GO:0045665,negative regulation of neuron differentiation, 3/89,72/18614,0.004967447,0.01541461,0.008153803,RHOA/SHH/BMP7,3
GO:0046635,positive regulation of alpha-beta T cell activation, 3/89,72/18614,0.004967447,0.01541461,0.008153803,RHOA/SHH/RUNX1,3
GO:0008584,male gonad development, 4/89,144/18614,0.005045217,0.015639647,0.00827284,BCL2/DHH/SFRP1/MMP14,4
GO:0043462,regulation of ATP-dependent activity, 3/89,73/18614,0.005162628,0.015975664,0.008450582,HNRNPU/CASR/DHX9,3
GO:0046546,development of primary male sexual characteristics, 4/89,145/18614,0.005169701,0.015975664,0.008450582,BCL2/DHH/SFRP1/MMP14,4
GO:0051783,regulation of nuclear division, 4/89,145/18614,0.005169701,0.015975664,0.008450582,BMP4/BMP7/LRP5/MSX2,4
GO:0007015,actin filament organization, 7/89,442/18614,0.005256266,0.016226338,0.00858318,BCL2/SMAD3/RHOA/SFRP1/CCN2/TGFB3/TPM4,7
GO:0050807,regulation of synapse organization, 5/89,234/18614,0.005305789,0.016345342,0.008646129,NF1/RHOA/MAPK14/CTNNB1/ROR2,5
GO:2000116,regulation of cysteine-type endopeptidase activity, 5/89,234/18614,0.005305789,0.016345342,0.008646129,MMP9/SMAD3/RHOA/HSPE1/CCN2,5
GO:0002363,alpha-beta T cell lineage commitment, 2/89,23/18614,0.005357625,0.016384121,0.008666642,BCL2/RHOA,2
GO:0003177,pulmonary valve development, 2/89,23/18614,0.005357625,0.016384121,0.008666642,BMP4/BMPR2,2
GO:0021904,dorsal/ventral neural tube patterning, 2/89,23/18614,0.005357625,0.016384121,0.008666642,SHH/BMP4,2
GO:0036303,lymph vessel morphogenesis, 2/89,23/18614,0.005357625,0.016384121,0.008666642,FOXC1/BMPR2,2
GO:1900120,regulation of receptor binding, 2/89,23/18614,0.005357625,0.016384121,0.008666642,MMP9/NOG,2
GO:0003281,ventricular septum development, 3/89,74/18614,0.005362376,0.016384121,0.008666642,BMP4/BMPR2/NOG,3
GO:0035924,cellular response to vascular endothelial growth factor stimulus, 3/89,74/18614,0.005362376,0.016384121,0.008666642,MAPK14/FOXC1/ADAMTS12,3
GO:0045661,regulation of myoblast differentiation, 3/89,74/18614,0.005362376,0.016384121,0.008666642,MAPK14/BMP4/IGFBP3,3
GO:0071356,cellular response to tumor necrosis factor, 5/89,235/18614,0.005401088,0.016485492,0.008720263,MAPK14/ADAMTS12/DHX9/SFRP1/COL1A1,5
GO:0042698,ovulation cycle, 3/89,75/18614,0.00556672,0.016938978,0.008960142,BMPR1B/TGFB3/MMP2,3
GO:0071479,cellular response to ionizing radiation, 3/89,75/18614,0.00556672,0.016938978,0.008960142,MAPK14/SFRP1/SNAI2,3
GO:2000242,negative regulation of reproductive process, 3/89,75/18614,0.00556672,0.016938978,0.008960142,SNAI1/BMP4/BMP7,3
GO:0000280,nuclear division, 7/89,450/18614,0.005785148,0.017567743,0.009292737,HNRNPU/RHOA/BMP4/BMP7/LRP5/MSX2/SIRT7,7
GO:0031331,positive regulation of cellular catabolic process, 7/89,450/18614,0.005785148,0.017567743,0.009292737,HNRNPU/HIF1A/UFL1/SYNCRIP/DHX9/AXIN2/TWIST1,7
GO:0001759,organ induction, 2/89,24/18614,0.005826603,0.017603905,0.009311866,BMP4/CTNNB1,2
GO:0003323,type B pancreatic cell development, 2/89,24/18614,0.005826603,0.017603905,0.009311866,BMP6/BMP4,2
GO:0021871,forebrain regionalization, 2/89,24/18614,0.005826603,0.017603905,0.009311866,SHH/BMP4,2
GO:0043369,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment", 2/89,24/18614,0.005826603,0.017603905,0.009311866,BCL2/SHH,2
GO:0072202,cell differentiation involved in metanephros development, 2/89,24/18614,0.005826603,0.017603905,0.009311866,BMP4/CTNNB1,2
GO:0009913,epidermal cell differentiation, 5/89,240/18614,0.005895848,0.017777056,0.009403457,GLI1/FOXC1/BMP4/MSX2/CTNNB1,5
GO:0050803,regulation of synapse structure or activity, 5/89,240/18614,0.005895848,0.017777056,0.009403457,NF1/RHOA/MAPK14/CTNNB1/ROR2,5
GO:0003012,muscle system process, 7/89,452/18614,0.005923398,0.017824043,0.009428311,TMEM38B/SMAD3/RHOA/STC1/CCN2/COMP/TPM4,7
GO:0010975,regulation of neuron projection development, 7/89,452/18614,0.005923398,0.017824043,0.009428311,RHOA/SFRP1/BMP7/PLXNB1/SPP1/BMPR2/ROR2,7
GO:0043297,apical junction assembly, 3/89,77/18614,0.00598931,0.017986043,0.009514004,SNAI1/RHOA/SNAI2,3
GO:1901983,regulation of protein acetylation, 3/89,77/18614,0.00598931,0.017986043,0.009514004,SNAI2/DDX21/TWIST1,3
GO:0007612,learning, 4/89,152/18614,0.00609918,0.018260762,0.009659321,HIF1A/NF1/GIT1/NOG,4
GO:0034614,cellular response to reactive oxygen species, 4/89,152/18614,0.00609918,0.018260762,0.009659321,CAT/MMP9/BMP7/MMP2,4
GO:0071322,cellular response to carbohydrate stimulus, 4/89,152/18614,0.00609918,0.018260762,0.009659321,CASR/MEN1/HIF1A/LRP5,4
GO:0019216,regulation of lipid metabolic process, 6/89,344/18614,0.006131222,0.018332366,0.009697197,FGFR3/SNAI1/BMP6/DHH/SNAI2/TWIST1,6
GO:0006816,calcium ion transport, 7/89,455/18614,0.006135404,0.018332366,0.009697197,TMEM38B/BCL2/CASR/RHOA/STC1/CCN2/CTNNB1,7
GO:0045930,negative regulation of mitotic cell cycle, 5/89,243/18614,0.006207609,0.018510981,0.009791678,BCL2/FOXC1/BMP4/BMP7/CTNNB1,5
GO:0055117,regulation of cardiac muscle contraction, 3/89,78/18614,0.00620761,0.018510981,0.009791678,TMEM38B/STC1/CCN2,3
GO:0007292,female gamete generation, 4/89,153/18614,0.006240437,0.018590263,0.009833616,BCL2/BMPR1B/MMP2/CTNNB1,4
GO:0006706,steroid catabolic process, 2/89,25/18614,0.006313682,0.01869628,0.009889695,SPP1/CYP24A1,2
GO:0046885,regulation of hormone biosynthetic process, 2/89,25/18614,0.006313682,0.01869628,0.009889695,HIF1A/BMP6,2
GO:0050927,positive regulation of positive chemotaxis, 2/89,25/18614,0.006313682,0.01869628,0.009889695,SMAD3/CASR,2
GO:0072273,metanephric nephron morphogenesis, 2/89,25/18614,0.006313682,0.01869628,0.009889695,BMP4/CTNNB1,2
GO:0097186,amelogenesis, 2/89,25/18614,0.006313682,0.01869628,0.009889695,AMELX/MSX2,2
GO:2000209,regulation of anoikis, 2/89,25/18614,0.006313682,0.01869628,0.009889695,BCL2/SNAI2,2
GO:2000736,regulation of stem cell differentiation, 3/89,79/18614,0.006430615,0.019023637,0.010062856,HNRNPU/SP7/FOXC1,3
GO:0070661,leukocyte proliferation, 6/89,348/18614,0.006476538,0.019140482,0.010124663,BCL2/NF1/SHH/BMP4/JUNB/CTNNB1,6
GO:0043524,negative regulation of neuron apoptotic process, 4/89,155/18614,0.006529451,0.019277734,0.010197264,BCL2/HIF1A/RHOA/TGFB3,4
GO:0006936,muscle contraction, 6/89,349/18614,0.006565038,0.019363612,0.010242691,TMEM38B/RHOA/STC1/CCN2/COMP/TPM4,6
GO:0070227,lymphocyte apoptotic process, 3/89,80/18614,0.006658351,0.019600028,0.010367747,BCL2/HIF1A/BMP4,3
GO:0071230,cellular response to amino acid stimulus, 3/89,80/18614,0.006658351,0.019600028,0.010367747,COL1A2/COL1A1/MMP2,3
GO:0010259,multicellular organism aging, 2/89,26/18614,0.006818681,0.019895054,0.010523805,COMP/ALPL,2
GO:0014829,vascular associated smooth muscle contraction, 2/89,26/18614,0.006818681,0.019895054,0.010523805,RHOA/COMP,2
GO:0035994,response to muscle stretch, 2/89,26/18614,0.006818681,0.019895054,0.010523805,MAPK14/CTNNB1,2
GO:0048596,embryonic camera-type eye morphogenesis, 2/89,26/18614,0.006818681,0.019895054,0.010523805,BMP7/TWIST1,2
GO:0050926,regulation of positive chemotaxis, 2/89,26/18614,0.006818681,0.019895054,0.010523805,SMAD3/CASR,2
GO:0051894,positive regulation of focal adhesion assembly, 2/89,26/18614,0.006818681,0.019895054,0.010523805,SMAD3/SFRP1,2
GO:0072010,glomerular epithelium development, 2/89,26/18614,0.006818681,0.019895054,0.010523805,FOXC1/BMP4,2
GO:2000050,regulation of non-canonical Wnt signaling pathway, 2/89,26/18614,0.006818681,0.019895054,0.010523805,SFRP1/GPC3,2
GO:2000647,negative regulation of stem cell proliferation, 2/89,26/18614,0.006818681,0.019895054,0.010523805,NF1/SNAI2,2
GO:0001678,intracellular glucose homeostasis, 4/89,157/18614,0.006827223,0.019900488,0.01052668,CASR/MEN1/HIF1A/LRP5,4
GO:0120193,tight junction organization, 3/89,81/18614,0.006890843,0.0200467,0.010604021,SNAI1/TGFB3/SNAI2,3
GO:2000628,regulation of miRNA metabolic process, 3/89,81/18614,0.006890843,0.0200467,0.010604021,SMAD3/HIF1A/BMP4,3
GO:0045787,positive regulation of cell cycle, 6/89,354/18614,0.007020812,0.020404878,0.010793485,HNRNPU/RHOA/GLI1/CCN2/LRP5/MSX2,6
GO:0002181,cytoplasmic translation, 4/89,159/18614,0.007133867,0.020713245,0.010956601,HNRNPU/RPL38/SYNCRIP/DHX9,4
GO:0033081,regulation of T cell differentiation in thymus, 2/89,27/18614,0.007341421,0.021253736,0.011242502,SHH/BMP4,2
GO:0035929,steroid hormone secretion, 2/89,27/18614,0.007341421,0.021253736,0.011242502,BMP6/SPP1,2
GO:0046639,negative regulation of alpha-beta T cell differentiation, 2/89,27/18614,0.007341421,0.021253736,0.011242502,SHH/RUNX1,2
GO:0001570,vasculogenesis, 3/89,83/18614,0.007370189,0.021295627,0.011264661,SHH/JUNB/CTNNB1,3
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling, 3/89,83/18614,0.007370189,0.021295627,0.011264661,CAT/PLXNB1/ROR2,3
GO:0018393,internal peptidyl-lysine acetylation, 4/89,161/18614,0.00744949,0.021485278,0.01136498,SHH/SNAI2/DDX21/TWIST1,4
GO:0090257,regulation of muscle system process, 5/89,254/18614,0.007450249,0.021485278,0.01136498,TMEM38B/SMAD3/RHOA/STC1/CCN2,5
GO:1903320,regulation of protein modification by small protein conjugation or removal, 5/89,255/18614,0.007571207,0.021812983,0.011538325,HIF1A/UFL1/GTPBP4/CTNNB1/SIRT7,5
GO:0016570,histone modification, 7/89,475/18614,0.007697245,0.022133296,0.011707759,MEN1/UFL1/SNAI2/CTNNB1/SIRT7/DDX21/TWIST1,7
GO:0022613,ribonucleoprotein complex biogenesis, 7/89,475/18614,0.007697245,0.022133296,0.011707759,SBDS/RPL38/ADAR/DHX9/GTPBP4/SIRT7/DDX21,7
GO:0006475,internal protein amino acid acetylation, 4/89,163/18614,0.0077742,0.022297876,0.011794817,SHH/SNAI2/DDX21/TWIST1,4
GO:0050796,regulation of insulin secretion, 4/89,163/18614,0.0077742,0.022297876,0.011794817,CASR/HIF1A/SFRP1/LRP5,4
GO:0034612,response to tumor necrosis factor, 5/89,257/18614,0.007817225,0.022297876,0.011794817,MAPK14/ADAMTS12/DHX9/SFRP1/COL1A1,5
GO:0031397,negative regulation of protein ubiquitination, 3/89,85/18614,0.007868838,0.022297876,0.011794817,UFL1/GTPBP4/SIRT7,3
GO:0055013,cardiac muscle cell development, 3/89,85/18614,0.007868838,0.022297876,0.011794817,HNRNPU/BMP4/FHL2,3
GO:0001702,gastrulation with mouth forming second, 2/89,28/18614,0.007881727,0.022297876,0.011794817,LRP5/CTNNB1,2
GO:0010894,negative regulation of steroid biosynthetic process, 2/89,28/18614,0.007881727,0.022297876,0.011794817,SNAI1/SNAI2,2
GO:0016540,protein autoprocessing, 2/89,28/18614,0.007881727,0.022297876,0.011794817,DHH/SHH,2
GO:0030325,adrenal gland development, 2/89,28/18614,0.007881727,0.022297876,0.011794817,SMAD3/NF1,2
GO:0032104,regulation of response to extracellular stimulus, 2/89,28/18614,0.007881727,0.022297876,0.011794817,BCL2/SNAI2,2
GO:0032107,regulation of response to nutrient levels, 2/89,28/18614,0.007881727,0.022297876,0.011794817,BCL2/SNAI2,2
GO:0036037,"CD8-positive, alpha-beta T cell activation", 2/89,28/18614,0.007881727,0.022297876,0.011794817,BCL2/RUNX1,2
GO:0045606,positive regulation of epidermal cell differentiation, 2/89,28/18614,0.007881727,0.022297876,0.011794817,FOXC1/BMP4,2
GO:0060479,lung cell differentiation, 2/89,28/18614,0.007881727,0.022297876,0.011794817,TMEM38B/CTNNB1,2
GO:0060487,lung epithelial cell differentiation, 2/89,28/18614,0.007881727,0.022297876,0.011794817,TMEM38B/CTNNB1,2
GO:0150146,cell junction disassembly, 2/89,28/18614,0.007881727,0.022297876,0.011794817,TGFB3/SNAI2,2
GO:1903055,positive regulation of extracellular matrix organization, 2/89,28/18614,0.007881727,0.022297876,0.011794817,SMAD3/RUNX1,2
GO:0045862,positive regulation of proteolysis, 6/89,365/18614,0.008103846,0.02285716,0.012090659,SMAD3/RHOA/AXIN2/HSPE1/CCN2/MMP14,6
GO:0048639,positive regulation of developmental growth, 4/89,165/18614,0.008108103,0.02285716,0.012090659,BCL2/GLI1/MAPK14/BMPR2,4
GO:0050792,regulation of viral process, 4/89,165/18614,0.008108103,0.02285716,0.012090659,BCL2/ADAR/DHX9/IFITM1,4
GO:0008306,associative learning, 3/89,86/18614,0.008125456,0.02285716,0.012090659,HIF1A/NF1/NOG,3
GO:0045069,regulation of viral genome replication, 3/89,86/18614,0.008125456,0.02285716,0.012090659,BCL2/ADAR/IFITM1,3
GO:1900182,positive regulation of protein localization to nucleus, 3/89,86/18614,0.008125456,0.02285716,0.012090659,SMAD3/MAPK14/SHH,3
GO:0002088,lens development in camera-type eye, 3/89,87/18614,0.008386964,0.023504014,0.012432822,SMAD3/BMP4/CTNNB1,3
GO:0032092,positive regulation of protein binding, 3/89,87/18614,0.008386964,0.023504014,0.012432822,MMP9/BMP4/CTHRC1,3
GO:0034243,regulation of transcription elongation by RNA polymerase II, 3/89,87/18614,0.008386964,0.023504014,0.012432822,HNRNPU/SHH/CTNNB1,3
GO:2000243,positive regulation of reproductive process, 3/89,87/18614,0.008386964,0.023504014,0.012432822,SHH/MSX2/CTNNB1,3
GO:0051051,negative regulation of transport, 7/89,483/18614,0.008398178,0.023513319,0.012437745,BCL2/MMP9/NF1/STC1/SFRP1/SHH/TWIST1,7
GO:0003209,cardiac atrium morphogenesis, 2/89,29/18614,0.00843942,0.023562356,0.012463683,BMPR2/NOG,2
GO:0030878,thyroid gland development, 2/89,29/18614,0.00843942,0.023562356,0.012463683,SMAD3/SHH,2
GO:0072012,glomerulus vasculature development, 2/89,29/18614,0.00843942,0.023562356,0.012463683,BMP4/BMP7,2
GO:0051250,negative regulation of lymphocyte activation, 4/89,168/18614,0.008626421,0.0240619,0.012727925,SFRP1/SHH/RUNX1/BMP4,4
GO:0031058,positive regulation of histone modification, 3/89,88/18614,0.008653384,0.024114528,0.012755763,SNAI2/CTNNB1/DDX21,3
GO:0050804,modulation of chemical synaptic transmission, 7/89,487/18614,0.008765834,0.024405065,0.012909448,CHRDL1/ACHE/NF1/GIT1/NOG/CDH11/ROR2,7
GO:0034250,positive regulation of amide metabolic process, 4/89,169/18614,0.008803902,0.024488165,0.012953405,HNRNPU/RHOA/SYNCRIP/DHX9,4
GO:0022411,cellular component disassembly, 7/89,488/18614,0.008859575,0.024597088,0.013011021,MMP9/HIF1A/UFL1/TGFB3/MMP2/SNAI2/MMP14,7
GO:0099177,regulation of trans-synaptic signaling, 7/89,488/18614,0.008859575,0.024597088,0.013011021,CHRDL1/ACHE/NF1/GIT1/NOG/CDH11/ROR2,7
GO:0043367,"CD4-positive, alpha-beta T cell differentiation", 3/89,89/18614,0.008924733,0.024731889,0.013082326,MEN1/RUNX1/JUNB,3
GO:0071229,cellular response to acid chemical, 3/89,89/18614,0.008924733,0.024731889,0.013082326,COL1A2/COL1A1/MMP2,3
GO:0070997,neuron death, 6/89,373/18614,0.00896386,0.02477277,0.013103951,BCL2/HIF1A/NF1/RHOA/TGFB3/CTNNB1,6
GO:0009267,cellular response to starvation, 4/89,170/18614,0.008983758,0.02477277,0.013103951,BCL2/SP7/SFRP1/BMPR2,4
GO:0008209,androgen metabolic process, 2/89,30/18614,0.009014328,0.02477277,0.013103951,SHH/SPP1,2
GO:0035066,positive regulation of histone acetylation, 2/89,30/18614,0.009014328,0.02477277,0.013103951,SNAI2/DDX21,2
GO:0045907,positive regulation of vasoconstriction, 2/89,30/18614,0.009014328,0.02477277,0.013103951,CASR/RHOA,2
GO:0055022,negative regulation of cardiac muscle tissue growth, 2/89,30/18614,0.009014328,0.02477277,0.013103951,MAPK11/NOG,2
GO:0060045,positive regulation of cardiac muscle cell proliferation, 2/89,30/18614,0.009014328,0.02477277,0.013103951,GLI1/MAPK14,2
GO:0060603,mammary gland duct morphogenesis, 2/89,30/18614,0.009014328,0.02477277,0.013103951,LRP5/MSX2,2
GO:0061117,negative regulation of heart growth, 2/89,30/18614,0.009014328,0.02477277,0.013103951,MAPK11/NOG,2
GO:0010950,positive regulation of endopeptidase activity, 4/89,171/18614,0.009166,0.025166373,0.013312153,SMAD3/RHOA/HSPE1/CCN2,4
GO:0006402,mRNA catabolic process, 5/89,268/18614,0.009270672,0.025383578,0.013427047,HNRNPU/MAPK14/SYNCRIP/DHX9/AXIN2,5
GO:0070663,regulation of leukocyte proliferation, 5/89,268/18614,0.009270672,0.025383578,0.013427047,BCL2/NF1/SHH/BMP4/CTNNB1,5
GO:0110053,regulation of actin filament organization, 5/89,268/18614,0.009270672,0.025383578,0.013427047,SMAD3/RHOA/SFRP1/CCN2/TGFB3,5
GO:1902903,regulation of supramolecular fiber organization, 6/89,376/18614,0.00930266,0.025447772,0.013461004,SMAD3/RHOA/GIT1/SFRP1/CCN2/TGFB3,6
GO:0018394,peptidyl-lysine acetylation, 4/89,172/18614,0.009350642,0.025555562,0.013518022,SHH/SNAI2/DDX21/TWIST1,4
GO:0050863,regulation of T cell activation, 6/89,377/18614,0.009417607,0.025714988,0.013602352,RHOA/SHH/RUNX1/BMP4/JUNB/CTNNB1,6
GO:0006937,regulation of muscle contraction, 4/89,173/18614,0.009537696,0.026019044,0.013763187,TMEM38B/RHOA/STC1/CCN2,4
GO:0001945,lymph vessel development, 2/89,31/18614,0.009606276,0.026062928,0.013786401,FOXC1/BMPR2,2
GO:0045939,negative regulation of steroid metabolic process, 2/89,31/18614,0.009606276,0.026062928,0.013786401,SNAI1/SNAI2,2
GO:0061437,renal system vasculature development, 2/89,31/18614,0.009606276,0.026062928,0.013786401,BMP4/BMP7,2
GO:0061440,kidney vasculature development, 2/89,31/18614,0.009606276,0.026062928,0.013786401,BMP4/BMP7,2
GO:0150117,positive regulation of cell-substrate junction organization, 2/89,31/18614,0.009606276,0.026062928,0.013786401,SMAD3/SFRP1,2
GO:1903203,regulation of oxidative stress-induced neuron death, 2/89,31/18614,0.009606276,0.026062928,0.013786401,HIF1A/CTNNB1,2
GO:0048285,organelle fission, 7/89,497/18614,0.009736838,0.026393121,0.013961061,HNRNPU/RHOA/BMP4/BMP7/LRP5/MSX2/SIRT7,7
GO:0055006,cardiac cell development, 3/89,92/18614,0.009768551,0.026430983,0.013981089,HNRNPU/BMP4/FHL2,3
GO:1901216,positive regulation of neuron death, 3/89,92/18614,0.009768551,0.026430983,0.013981089,NF1/RHOA/CTNNB1,3
GO:0032868,response to insulin, 5/89,272/18614,0.009842572,0.026607097,0.014074248,CAT/SP7/MAPK14/COL1A1/ALPL,5
GO:0006694,steroid biosynthetic process, 4/89,175/18614,0.009919085,0.026789624,0.014170798,SNAI1/BMP6/DHH/SNAI2,4
GO:0050886,endocrine process, 3/89,93/18614,0.010059805,0.027120506,0.014345823,BMP6/RHOA/SPP1,3
GO:1903035,negative regulation of response to wounding, 3/89,93/18614,0.010059805,0.027120506,0.014345823,SMAD3/GIT1/SPP1,3
GO:0001764,neuron migration, 4/89,176/18614,0.010113445,0.027215856,0.014396261,SATB2/RHOA/CTNNB1/TWIST1,4
GO:0010634,positive regulation of epithelial cell migration, 4/89,176/18614,0.010113445,0.027215856,0.014396261,MMP9/HIF1A/BMP4/BMPR2,4
GO:0003338,metanephros morphogenesis, 2/89,32/18614,0.010215091,0.027464582,0.014527828,BMP4/CTNNB1,2
GO:1900407,regulation of cellular response to oxidative stress, 3/89,94/18614,0.010356078,0.027818537,0.014715058,HIF1A/BMP7/CTNNB1,3
GO:0032970,regulation of actin filament-based process, 6/89,387/18614,0.010623677,0.028511652,0.015081692,SMAD3/RHOA/STC1/SFRP1/CCN2/TGFB3,6
GO:0045684,positive regulation of epidermis development, 2/89,33/18614,0.010840604,0.028963371,0.015320636,FOXC1/BMP4,2
GO:0048147,negative regulation of fibroblast proliferation, 2/89,33/18614,0.010840604,0.028963371,0.015320636,NF1/SFRP1,2
GO:0060795,cell fate commitment involved in formation of primary germ layer, 2/89,33/18614,0.010840604,0.028963371,0.015320636,BMP4/CTNNB1,2
GO:0090183,regulation of kidney development, 2/89,33/18614,0.010840604,0.028963371,0.015320636,BMP4/NOG,2
GO:1903715,regulation of aerobic respiration, 2/89,33/18614,0.010840604,0.028963371,0.015320636,HIF1A/RHOA,2
GO:0032088,negative regulation of NF-kappaB transcription factor activity, 3/89,96/18614,0.010963746,0.029213773,0.01545309,CAT/UFL1/BMP7,3
GO:0048477,oogenesis, 3/89,96/18614,0.010963746,0.029213773,0.01545309,BCL2/BMPR1B/CTNNB1,3
GO:0070664,negative regulation of leukocyte proliferation, 3/89,96/18614,0.010963746,0.029213773,0.01545309,NF1/SHH/BMP4,3
GO:0006942,regulation of striated muscle contraction, 3/89,97/18614,0.01127517,0.029989938,0.015863655,TMEM38B/STC1/CCN2,3
GO:0010586,miRNA metabolic process, 3/89,97/18614,0.01127517,0.029989938,0.015863655,SMAD3/HIF1A/BMP4,3
GO:0046890,regulation of lipid biosynthetic process, 4/89,182/18614,0.011331639,0.03011325,0.015928883,SNAI1/BMP6/DHH/SNAI2,4
GO:0050900,leukocyte migration, 6/89,393/18614,0.011397997,0.030244733,0.015998433,SBDS/NF1/RHOA/MMP2/MMP14/ROR2,6
GO:0001782,B cell homeostasis, 2/89,34/18614,0.011482643,0.030244733,0.015998433,BCL2/HIF1A,2
GO:0009954,proximal/distal pattern formation, 2/89,34/18614,0.011482643,0.030244733,0.015998433,GLI1/CTNNB1,2
GO:0034405,response to fluid shear stress, 2/89,34/18614,0.011482643,0.030244733,0.015998433,TGFB3/MMP2,2
GO:0036475,neuron death in response to oxidative stress, 2/89,34/18614,0.011482643,0.030244733,0.015998433,HIF1A/CTNNB1,2
GO:0045577,regulation of B cell differentiation, 2/89,34/18614,0.011482643,0.030244733,0.015998433,SFRP1/MMP14,2
GO:0045648,positive regulation of erythrocyte differentiation, 2/89,34/18614,0.011482643,0.030244733,0.015998433,HIF1A/MAPK14,2
GO:0060964,regulation of miRNA-mediated gene silencing, 2/89,34/18614,0.011482643,0.030244733,0.015998433,DHX9/BMP4,2
GO:0099171,presynaptic modulation of chemical synaptic transmission, 2/89,34/18614,0.011482643,0.030244733,0.015998433,GIT1/NOG,2
GO:0110110,positive regulation of animal organ morphogenesis, 2/89,34/18614,0.011482643,0.030244733,0.015998433,BMP4/CTNNB1,2
GO:0050867,positive regulation of cell activation, 6/89,394/18614,0.011530838,0.030344846,0.016051389,BCL2/RHOA/SHH/RUNX1/CCN2/MMP14,6
GO:0006109,regulation of carbohydrate metabolic process, 4/89,183/18614,0.011543449,0.030351221,0.016054762,HIF1A/GIT1/IGFBP3/SIRT7,4
GO:0032642,regulation of chemokine production, 3/89,98/18614,0.011591673,0.030451142,0.016107616,HIF1A/SNAI2/TWIST1,3
GO:0021543,pallium development, 4/89,184/18614,0.011757796,0.030833163,0.016309692,HIF1A/NF1/RHOA/CTNNB1,4
GO:0042770,signal transduction in response to DNA damage, 4/89,184/18614,0.011757796,0.030833163,0.016309692,SNAI1/MAPK14/SNAI2/TWIST1,4
GO:0032602,chemokine production, 3/89,99/18614,0.01191327,0.031103972,0.016452941,HIF1A/SNAI2/TWIST1,3
GO:0036473,cell death in response to oxidative stress, 3/89,99/18614,0.01191327,0.031103972,0.016452941,BCL2/HIF1A/CTNNB1,3
GO:1990868,response to chemokine, 3/89,99/18614,0.01191327,0.031103972,0.016452941,HIF1A/RHOA/FOXC1,3
GO:1990869,cellular response to chemokine, 3/89,99/18614,0.01191327,0.031103972,0.016452941,HIF1A/RHOA/FOXC1,3
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway, 3/89,99/18614,0.01191327,0.031103972,0.016452941,BCL2/BMP4/SNAI2,3
GO:0010952,positive regulation of peptidase activity, 4/89,185/18614,0.01197469,0.031236954,0.016523284,SMAD3/RHOA/HSPE1/CCN2,4
GO:0002719,negative regulation of cytokine production involved in immune response, 2/89,35/18614,0.012141041,0.031395972,0.016607399,TGFB3/TWIST1,2
GO:0031128,developmental induction, 2/89,35/18614,0.012141041,0.031395972,0.016607399,BMP4/CTNNB1,2
GO:0043276,anoikis, 2/89,35/18614,0.012141041,0.031395972,0.016607399,BCL2/SNAI2,2
GO:0045879,negative regulation of smoothened signaling pathway, 2/89,35/18614,0.012141041,0.031395972,0.016607399,GLI1/GPC3,2
GO:0045943,positive regulation of transcription by RNA polymerase I, 2/89,35/18614,0.012141041,0.031395972,0.016607399,SIRT7/DDX21,2
GO:0048048,embryonic eye morphogenesis, 2/89,35/18614,0.012141041,0.031395972,0.016607399,BMP7/TWIST1,2
GO:0071425,hematopoietic stem cell proliferation, 2/89,35/18614,0.012141041,0.031395972,0.016607399,RUNX1/SNAI2,2
GO:0090162,establishment of epithelial cell polarity, 2/89,35/18614,0.012141041,0.031395972,0.016607399,RHOA/SHH,2
GO:1901099,negative regulation of signal transduction in absence of ligand, 2/89,35/18614,0.012141041,0.031395972,0.016607399,BCL2/SNAI2,2
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand, 2/89,35/18614,0.012141041,0.031395972,0.016607399,BCL2/SNAI2,2
GO:0006006,glucose metabolic process, 4/89,187/18614,0.012416164,0.032079579,0.016969004,MAPK14/IGFBP3/LRP5/SIRT7,4
GO:0048709,oligodendrocyte differentiation, 3/89,101/18614,0.012571795,0.032453533,0.017166813,NF1/SHH/CTNNB1,3
GO:0001569,branching involved in blood vessel morphogenesis, 2/89,36/18614,0.012815629,0.032997199,0.017454394,SHH/CTNNB1,2
GO:0003161,cardiac conduction system development, 2/89,36/18614,0.012815629,0.032997199,0.017454394,BMP4/MSX2,2
GO:2000758,positive regulation of peptidyl-lysine acetylation, 2/89,36/18614,0.012815629,0.032997199,0.017454394,SNAI2/DDX21,2
GO:0021510,spinal cord development, 3/89,102/18614,0.012908748,0.033179603,0.017550879,NF1/SHH/NOG,3
GO:1904063,negative regulation of cation transmembrane transport, 3/89,102/18614,0.012908748,0.033179603,0.017550879,BCL2/MMP9/TWIST1,3
GO:0001776,leukocyte homeostasis, 3/89,103/18614,0.013250843,0.033970965,0.017969483,BCL2/HIF1A/NF1,3
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage, 3/89,103/18614,0.013250843,0.033970965,0.017969483,BCL2/SNAI1/SNAI2,3
GO:1902882,regulation of response to oxidative stress, 3/89,103/18614,0.013250843,0.033970965,0.017969483,HIF1A/BMP7/CTNNB1,3
GO:0003230,cardiac atrium development, 2/89,37/18614,0.013506242,0.034330287,0.018159552,BMPR2/NOG,2
GO:0010934,macrophage cytokine production, 2/89,37/18614,0.013506242,0.034330287,0.018159552,TGFB3/TWIST1,2
GO:0010935,regulation of macrophage cytokine production, 2/89,37/18614,0.013506242,0.034330287,0.018159552,TGFB3/TWIST1,2
GO:0031076,embryonic camera-type eye development, 2/89,37/18614,0.013506242,0.034330287,0.018159552,BMP7/TWIST1,2
GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway, 2/89,37/18614,0.013506242,0.034330287,0.018159552,RHOA/SFRP1,2
GO:0044319,"wound healing, spreading of cells", 2/89,37/18614,0.013506242,0.034330287,0.018159552,RHOA/MSX2,2
GO:0045746,negative regulation of Notch signaling pathway, 2/89,37/18614,0.013506242,0.034330287,0.018159552,BMP7/MMP14,2
GO:0046326,positive regulation of glucose import, 2/89,37/18614,0.013506242,0.034330287,0.018159552,MAPK14/GPC3,2
GO:0055023,positive regulation of cardiac muscle tissue growth, 2/89,37/18614,0.013506242,0.034330287,0.018159552,GLI1/MAPK14,2
GO:0090505,epiboly involved in wound healing, 2/89,37/18614,0.013506242,0.034330287,0.018159552,RHOA/MSX2,2
GO:0090276,regulation of peptide hormone secretion, 4/89,192/18614,0.013565161,0.034450651,0.01822322,CASR/HIF1A/SFRP1/LRP5,4
GO:0032872,regulation of stress-activated MAPK cascade, 4/89,193/18614,0.013802807,0.03502433,0.018526677,MEN1/SFRP1/BMP4/CCN2,4
GO:0042254,ribosome biogenesis, 5/89,298/18614,0.014161882,0.035904891,0.018992464,SBDS/RPL38/GTPBP4/SIRT7/DDX21,5
GO:0000578,embryonic axis specification, 2/89,38/18614,0.014212715,0.035911517,0.018995968,CHRDL1/CTNNB1,2
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway, 2/89,38/18614,0.014212715,0.035911517,0.018995968,CTNNB1/NOG,2
GO:0043368,positive T cell selection, 2/89,38/18614,0.014212715,0.035911517,0.018995968,BCL2/SHH,2
GO:0090504,epiboly, 2/89,38/18614,0.014212715,0.035911517,0.018995968,RHOA/MSX2,2
GO:0002791,regulation of peptide secretion, 4/89,195/18614,0.014286025,0.036066161,0.01907777,CASR/HIF1A/SFRP1/LRP5,4
GO:0070302,regulation of stress-activated protein kinase signaling cascade, 4/89,196/18614,0.014531615,0.036655108,0.019389303,MEN1/SFRP1/BMP4/CCN2,4
GO:0032526,response to retinoic acid, 3/89,107/18614,0.014670859,0.036912575,0.019525494,BMP6/COL1A1/MMP2,3
GO:0062014,negative regulation of small molecule metabolic process, 3/89,107/18614,0.014670859,0.036912575,0.019525494,SNAI1/GIT1/SNAI2,3
GO:1901655,cellular response to ketone, 3/89,107/18614,0.014670859,0.036912575,0.019525494,SFRP1/AXIN2/SPP1,3
GO:0030073,insulin secretion, 4/89,197/18614,0.014779872,0.037092872,0.019620865,CASR/HIF1A/SFRP1/LRP5,4
GO:0032388,positive regulation of intracellular transport, 4/89,197/18614,0.014779872,0.037092872,0.019620865,SMAD3/MAPK14/DHX9/SHH,4
GO:0090087,regulation of peptide transport, 4/89,197/18614,0.014779872,0.037092872,0.019620865,CASR/HIF1A/SFRP1/LRP5,4
GO:0021532,neural tube patterning, 2/89,39/18614,0.014934884,0.037230977,0.019693918,SHH/BMP4,2
GO:0031281,positive regulation of cyclase activity, 2/89,39/18614,0.014934884,0.037230977,0.019693918,NF1/MAPK14,2
GO:0032350,regulation of hormone metabolic process, 2/89,39/18614,0.014934884,0.037230977,0.019693918,HIF1A/BMP6,2
GO:0044060,regulation of endocrine process, 2/89,39/18614,0.014934884,0.037230977,0.019693918,BMP6/SPP1,2
GO:0045616,regulation of keratinocyte differentiation, 2/89,39/18614,0.014934884,0.037230977,0.019693918,FOXC1/MSX2,2
GO:0045740,positive regulation of DNA replication, 2/89,39/18614,0.014934884,0.037230977,0.019693918,GLI1/DHX9,2
GO:0046329,negative regulation of JNK cascade, 2/89,39/18614,0.014934884,0.037230977,0.019693918,MEN1/SFRP1,2
GO:0046621,negative regulation of organ growth, 2/89,39/18614,0.014934884,0.037230977,0.019693918,MAPK11/NOG,2
GO:0090398,cellular senescence, 3/89,108/18614,0.01503882,0.037458734,0.019814393,MAPK11/MAPK14/TWIST1,3
GO:0051607,defense response to virus, 5/89,303/18614,0.015118252,0.037625123,0.019902408,BCL2/ADAR/DHX9/DDX21/IFITM1,5
GO:0140546,defense response to symbiont, 5/89,304/18614,0.015314598,0.03808196,0.020144059,BCL2/ADAR/DHX9/DDX21/IFITM1,5
GO:0001708,cell fate specification, 3/89,109/18614,0.015411982,0.038260245,0.020238366,DHH/SHH/CTNNB1,3
GO:0034766,negative regulation of monoatomic ion transmembrane transport, 3/89,109/18614,0.015411982,0.038260245,0.020238366,BCL2/MMP9/TWIST1,3
GO:0071248,cellular response to metal ion, 4/89,200/18614,0.015540731,0.038547741,0.020390441,MMP9/BMP6/SHH/JUNB,4
GO:0001953,negative regulation of cell-matrix adhesion, 2/89,40/18614,0.015672585,0.038810167,0.020529256,NF1/MMP14,2
GO:0071634,regulation of transforming growth factor beta production, 2/89,40/18614,0.015672585,0.038810167,0.020529256,SMAD3/HIF1A,2
GO:0006368,transcription elongation by RNA polymerase II, 3/89,110/18614,0.015790352,0.03906011,0.020661467,HNRNPU/SHH/CTNNB1,3
GO:0043393,regulation of protein binding, 4/89,201/18614,0.015799743,0.03906011,0.020661467,MMP9/BMP4/CTHRC1/NOG,4
GO:0010959,regulation of metal ion transport, 6/89,423/18614,0.015877633,0.039220123,0.020746108,TMEM38B/BCL2/CASR/RHOA/STC1/CTNNB1,6
GO:0002695,negative regulation of leukocyte activation, 4/89,202/18614,0.016061465,0.039641346,0.020968921,SFRP1/SHH/RUNX1/BMP4,4
GO:0052547,regulation of peptidase activity, 6/89,425/18614,0.016214099,0.039984935,0.021150668,MMP9/SMAD3/RHOA/GPC3/HSPE1/CCN2,6
GO:0060421,positive regulation of heart growth, 2/89,41/18614,0.016425658,0.040439698,0.021391222,GLI1/MAPK14,2
GO:0072210,metanephric nephron development, 2/89,41/18614,0.016425658,0.040439698,0.021391222,BMP4/CTNNB1,2
GO:0043473,pigmentation, 3/89,112/18614,0.016562746,0.040743534,0.021551941,BCL2/NF1/SNAI2,3
GO:1902075,cellular response to salt, 4/89,204/18614,0.016593076,0.040784466,0.021573593,ACHE/SHH/JUNB/COL1A1,4
GO:0045124,regulation of bone resorption, 2/89,42/18614,0.017193942,0.042191724,0.022317984,NF1/SPP1,2
GO:0085029,extracellular matrix assembly, 2/89,42/18614,0.017193942,0.042191724,0.022317984,SMAD3/COL1A2,2
GO:0042594,response to starvation, 4/89,207/18614,0.017411029,0.042689265,0.022581166,BCL2/SP7/SFRP1/BMPR2,4
GO:0006473,protein acetylation, 4/89,208/18614,0.017689189,0.043299995,0.022904222,SHH/SNAI2/DDX21/TWIST1,4
GO:1901654,response to ketone, 4/89,208/18614,0.017689189,0.043299995,0.022904222,SFRP1/AXIN2/SPP1/TGFB3,4
GO:0022037,metencephalon development, 3/89,115/18614,0.01776057,0.043367817,0.022940097,BCL2/GLI1/FOXC1,3
GO:0030518,intracellular steroid hormone receptor signaling pathway, 3/89,115/18614,0.01776057,0.043367817,0.022940097,UFL1/RHOA/SFRP1,3
GO:0035710,"CD4-positive, alpha-beta T cell activation", 3/89,115/18614,0.01776057,0.043367817,0.022940097,MEN1/RUNX1/JUNB,3
GO:0010719,negative regulation of epithelial to mesenchymal transition, 2/89,43/18614,0.017977278,0.043682145,0.023106366,SFRP1/NOG,2
GO:0014002,astrocyte development, 2/89,43/18614,0.017977278,0.043682145,0.023106366,NF1/ROR2,2
GO:0032735,positive regulation of interleukin-12 production, 2/89,43/18614,0.017977278,0.043682145,0.023106366,MAPK11/MAPK14,2
GO:0045663,positive regulation of myoblast differentiation, 2/89,43/18614,0.017977278,0.043682145,0.023106366,MAPK14/IGFBP3,2
GO:0051150,regulation of smooth muscle cell differentiation, 2/89,43/18614,0.017977278,0.043682145,0.023106366,SHH/BMP4,2
GO:0071604,transforming growth factor beta production, 2/89,43/18614,0.017977278,0.043682145,0.023106366,SMAD3/HIF1A,2
GO:0010948,negative regulation of cell cycle process, 5/89,317/18614,0.018024428,0.043761018,0.023148087,BCL2/MEN1/MAPK14/BMP4/BMP7,5
GO:0045582,positive regulation of T cell differentiation, 3/89,116/18614,0.018170329,0.044079323,0.02331646,RHOA/SHH/RUNX1,3
GO:0002064,epithelial cell development, 4/89,210/18614,0.018253818,0.044245829,0.023404536,HIF1A/BMP6/STC1/BMP4,4
GO:0006401,RNA catabolic process, 5/89,319/18614,0.018467718,0.044727911,0.023659541,HNRNPU/MAPK14/SYNCRIP/DHX9/AXIN2,5
GO:0007088,regulation of mitotic nuclear division, 3/89,117/18614,0.018585338,0.044939709,0.023771575,BMP4/BMP7/LRP5,3
GO:0030203,glycosaminoglycan metabolic process, 3/89,117/18614,0.018585338,0.044939709,0.023771575,XYLT1/FOXC1/EXT2,3
GO:0001709,cell fate determination, 2/89,44/18614,0.018775507,0.04528926,0.023956475,BMP4/CTNNB1,2
GO:0010828,positive regulation of glucose transmembrane transport, 2/89,44/18614,0.018775507,0.04528926,0.023956475,MAPK14/GPC3,2
GO:0035329,hippo signaling, 2/89,44/18614,0.018775507,0.04528926,0.023956475,MAPK14/DCHS1,2
GO:0022409,positive regulation of cell-cell adhesion, 5/89,321/18614,0.018918172,0.045596469,0.024118978,RHOA/SHH/RUNX1/BMP7/FSTL3,5
GO:0006282,regulation of DNA repair, 4/89,214/18614,0.019416522,0.046719385,0.024712962,DHX9/AXIN2/SIRT7/TWIST1,4
GO:0002718,regulation of cytokine production involved in immune response, 3/89,119/18614,0.019431124,0.046719385,0.024712962,TGFB3/DDX21/TWIST1,3
GO:0021782,glial cell development, 3/89,119/18614,0.019431124,0.046719385,0.024712962,NF1/SHH/ROR2,3
GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress, 2/89,45/18614,0.019588474,0.046983947,0.024852907,BCL2/HIF1A,2
GO:0046636,negative regulation of alpha-beta T cell activation, 2/89,45/18614,0.019588474,0.046983947,0.024852907,SHH/RUNX1,2
GO:0048483,autonomic nervous system development, 2/89,45/18614,0.019588474,0.046983947,0.024852907,NF1/CTNNB1,2
GO:0002367,cytokine production involved in immune response, 3/89,121/18614,0.020297955,0.048604237,0.025709985,TGFB3/DDX21/TWIST1,3
GO:0051251,positive regulation of lymphocyte activation, 5/89,327/18614,0.020312949,0.048604237,0.025709985,BCL2/RHOA/SHH/RUNX1/MMP14,5
GO:0055074,calcium ion homeostasis, 5/89,327/18614,0.020312949,0.048604237,0.025709985,TMEM38B/BCL2/CASR/STC1/ALPL,5
GO:0006356,regulation of transcription by RNA polymerase I, 2/89,46/18614,0.020416021,0.048772515,0.025798998,SIRT7/DDX21,2
GO:0055010,ventricular cardiac muscle tissue morphogenesis, 2/89,46/18614,0.020416021,0.048772515,0.025798998,FOXC1/NOG,2
GO:0006364,rRNA processing, 4/89,218/18614,0.020624199,0.049190943,0.026020333,SBDS/GTPBP4/SIRT7/DDX21,4
GO:0007179,transforming growth factor beta receptor signaling pathway, 4/89,218/18614,0.020624199,0.049190943,0.026020333,SMAD3/MEN1/COL1A2/TGFB3,4
GO:1903311,regulation of mRNA metabolic process, 5/89,329/18614,0.020792484,0.049552647,0.026211662,HNRNPU/MAPK14/SYNCRIP/DHX9/AXIN2,5
GO:0061157,mRNA destabilization, 3/89,123/18614,0.021185852,0.050299894,0.026606929,HNRNPU/SYNCRIP/DHX9,3
GO:0002701,negative regulation of production of molecular mediator of immune response, 2/89,47/18614,0.021257995,0.050299894,0.026606929,TGFB3/TWIST1,2
GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules, 2/89,47/18614,0.021257995,0.050299894,0.026606929,DCHS1/CDH11,2
GO:0030521,androgen receptor signaling pathway, 2/89,47/18614,0.021257995,0.050299894,0.026606929,RHOA/SFRP1,2
GO:0045646,regulation of erythrocyte differentiation, 2/89,47/18614,0.021257995,0.050299894,0.026606929,HIF1A/MAPK14,2
GO:0051972,regulation of telomerase activity, 2/89,47/18614,0.021257995,0.050299894,0.026606929,MEN1/CTNNB1,2
GO:0060711,labyrinthine layer development, 2/89,47/18614,0.021257995,0.050299894,0.026606929,BMP7/JUNB,2
GO:0140353,lipid export from cell, 2/89,47/18614,0.021257995,0.050299894,0.026606929,BMP6/SPP1,2
GO:1901985,positive regulation of protein acetylation, 2/89,47/18614,0.021257995,0.050299894,0.026606929,SNAI2/DDX21,2
GO:0070374,positive regulation of ERK1 and ERK2 cascade, 4/89,222/18614,0.021877275,0.051724129,0.027360302,FGFR3/CASR/BMP4/CCN2,4
GO:0006110,regulation of glycolytic process, 2/89,48/18614,0.022114241,0.05199552,0.027503858,HIF1A/GIT1,2
GO:0021795,cerebral cortex cell migration, 2/89,48/18614,0.022114241,0.05199552,0.027503858,RHOA/CTNNB1,2
GO:0035094,response to nicotine, 2/89,48/18614,0.022114241,0.05199552,0.027503858,BCL2/MMP2,2
GO:0042311,vasodilation, 2/89,48/18614,0.022114241,0.05199552,0.027503858,CASR/EXT2,2
GO:0044331,cell-cell adhesion mediated by cadherin, 2/89,48/18614,0.022114241,0.05199552,0.027503858,BMP6/CDH11,2
GO:0046717,acid secretion, 2/89,48/18614,0.022114241,0.05199552,0.027503858,CASR/NF1,2
GO:0060976,coronary vasculature development, 2/89,48/18614,0.022114241,0.05199552,0.027503858,GPC3/BMP4,2
GO:0071222,cellular response to lipopolysaccharide, 4/89,224/18614,0.022520963,0.052870162,0.027966514,BMP6/RHOA/MAPK14/GIT1,4
GO:0052548,regulation of endopeptidase activity, 5/89,336/18614,0.022529165,0.052870162,0.027966514,MMP9/SMAD3/RHOA/HSPE1/CCN2,5
GO:0000956,nuclear-transcribed mRNA catabolic process, 3/89,126/18614,0.022557226,0.052870162,0.027966514,HNRNPU/SYNCRIP/DHX9,3
GO:0006022,aminoglycan metabolic process, 3/89,126/18614,0.022557226,0.052870162,0.027966514,XYLT1/FOXC1/EXT2,3
GO:0050866,negative regulation of cell activation, 4/89,225/18614,0.022847115,0.053507511,0.02830365,SFRP1/SHH/RUNX1/BMP4,4
GO:0043330,response to exogenous dsRNA, 2/89,49/18614,0.022984608,0.053712734,0.028412206,DHX9/DDX21,2
GO:0045933,positive regulation of muscle contraction, 2/89,49/18614,0.022984608,0.053712734,0.028412206,RHOA/CCN2,2
GO:0050779,RNA destabilization, 3/89,127/18614,0.023024895,0.053712734,0.028412206,HNRNPU/SYNCRIP/DHX9,3
GO:0055007,cardiac muscle cell differentiation, 3/89,127/18614,0.023024895,0.053712734,0.028412206,HNRNPU/BMP4/FHL2,3
GO:0061014,positive regulation of mRNA catabolic process, 3/89,127/18614,0.023024895,0.053712734,0.028412206,HNRNPU/SYNCRIP/DHX9,3
GO:0019318,hexose metabolic process, 4/89,228/18614,0.023842869,0.055464573,0.029338869,MAPK14/IGFBP3/LRP5/SIRT7,4
GO:0001974,blood vessel remodeling, 2/89,50/18614,0.023868944,0.055464573,0.029338869,FOXC1/BMPR2,2
GO:0043457,regulation of cellular respiration, 2/89,50/18614,0.023868944,0.055464573,0.029338869,HIF1A/RHOA,2
GO:0090102,cochlea development, 2/89,50/18614,0.023868944,0.055464573,0.029338869,DCHS1/CTHRC1,2
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors, 2/89,50/18614,0.023868944,0.055464573,0.029338869,BMPR1B/SFRP1,2
GO:0007368,determination of left/right symmetry, 3/89,129/18614,0.023976049,0.055626674,0.029424615,SMAD3/HIF1A/SHH,3
GO:0019079,viral genome replication, 3/89,129/18614,0.023976049,0.055626674,0.029424615,BCL2/ADAR/IFITM1,3
GO:0007052,mitotic spindle organization, 3/89,130/18614,0.024459533,0.056660147,0.029971287,HNRNPU/SBDS/RHOA,3
GO:0050864,regulation of B cell activation, 3/89,130/18614,0.024459533,0.056660147,0.029971287,BCL2/SFRP1/MMP14,3
GO:0032873,negative regulation of stress-activated MAPK cascade, 2/89,51/18614,0.024767098,0.057150414,0.030230621,MEN1/SFRP1,2
GO:0060612,adipose tissue development, 2/89,51/18614,0.024767098,0.057150414,0.030230621,CASR/LRP5,2
GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus, 2/89,51/18614,0.024767098,0.057150414,0.030230621,HIF1A/LRP5,2
GO:0070303,negative regulation of stress-activated protein kinase signaling cascade, 2/89,51/18614,0.024767098,0.057150414,0.030230621,MEN1/SFRP1,2
GO:1902895,positive regulation of miRNA transcription, 2/89,51/18614,0.024767098,0.057150414,0.030230621,SMAD3/HIF1A,2
GO:0071241,cellular response to inorganic substance, 4/89,231/18614,0.024864683,0.057331184,0.030326242,MMP9/BMP6/SHH/JUNB,4
GO:0032496,response to lipopolysaccharide, 5/89,345/18614,0.024897359,0.057362128,0.030342611,BMP6/RHOA/MAPK14/GIT1/ALPL,5
GO:0010595,positive regulation of endothelial cell migration, 3/89,131/18614,0.024948287,0.057390693,0.030357721,HIF1A/BMP4/BMPR2,3
GO:0050868,negative regulation of T cell activation, 3/89,131/18614,0.024948287,0.057390693,0.030357721,SHH/RUNX1/BMP4,3
GO:0032956,regulation of actin cytoskeleton organization, 5/89,346/18614,0.025170016,0.057856078,0.030603893,SMAD3/RHOA/SFRP1/CCN2/TGFB3,5
GO:0035315,hair cell differentiation, 2/89,52/18614,0.025678922,0.058889536,0.031150558,BMP4/CTNNB1,2
GO:0046622,positive regulation of organ growth, 2/89,52/18614,0.025678922,0.058889536,0.031150558,GLI1/MAPK14,2
GO:0048599,oocyte development, 2/89,52/18614,0.025678922,0.058889536,0.031150558,BCL2/CTNNB1,2
GO:0042886,amide transport, 5/89,349/18614,0.025999527,0.059578915,0.031515216,CASR/HIF1A/NF1/SFRP1/LRP5,5
GO:0032210,regulation of telomere maintenance via telomerase, 2/89,53/18614,0.026604267,0.060871053,0.032198712,HNRNPU/CTNNB1,2
GO:2000648,positive regulation of stem cell proliferation, 2/89,53/18614,0.026604267,0.060871053,0.032198712,HNRNPU/CTNNB1,2
GO:0043467,regulation of generation of precursor metabolites and energy, 3/89,135/18614,0.026955963,0.061628407,0.032599327,HIF1A/RHOA/GIT1,3
GO:0071219,cellular response to molecule of bacterial origin, 4/89,237/18614,0.02698702,0.061652096,0.032611858,BMP6/RHOA/MAPK14/GIT1,4
GO:0031346,positive regulation of cell projection organization, 5/89,353/18614,0.027132619,0.06193722,0.032762679,BMP7/PLXNB1/TGFB3/BMPR2/ROR2,5
GO:0030072,peptide hormone secretion, 4/89,238/18614,0.027350999,0.062387922,0.033001085,CASR/HIF1A/SFRP1/LRP5,4
GO:0006275,regulation of DNA replication, 3/89,136/18614,0.027471034,0.062613781,0.033120556,GLI1/DHX9/GTPBP4,3
GO:0046686,response to cadmium ion, 2/89,54/18614,0.027542986,0.062681861,0.033156568,CAT/MMP9,2
GO:1904645,response to amyloid-beta, 2/89,54/18614,0.027542986,0.062681861,0.033156568,MMP9/MMP2,2
GO:0050670,regulation of lymphocyte proliferation, 4/89,239/18614,0.027717919,0.063031818,0.033341684,BCL2/SHH/BMP4/CTNNB1,4
GO:0042445,hormone metabolic process, 4/89,241/18614,0.0284606,0.064552403,0.034146021,HIF1A/BMP6/SHH/SPP1,4
GO:0097529,myeloid leukocyte migration, 4/89,241/18614,0.0284606,0.064552403,0.034146021,NF1/MMP2/MMP14/ROR2,4
GO:0003229,ventricular cardiac muscle tissue development, 2/89,55/18614,0.028494934,0.064552403,0.034146021,FOXC1/NOG,2
GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation", 2/89,55/18614,0.028494934,0.064552403,0.034146021,RUNX1/JUNB,2
GO:1903202,negative regulation of oxidative stress-induced cell death, 2/89,55/18614,0.028494934,0.064552403,0.034146021,HIF1A/CTNNB1,2
GO:0060048,cardiac muscle contraction, 3/89,138/18614,0.028516937,0.064553158,0.03414642,TMEM38B/STC1/CCN2,3
GO:0046328,regulation of JNK cascade, 3/89,139/18614,0.029047761,0.065704843,0.034755623,MEN1/SFRP1/CCN2,3
GO:0002790,peptide secretion, 4/89,243/18614,0.029215091,0.065983137,0.03490283,CASR/HIF1A/SFRP1/LRP5,4
GO:0032944,regulation of mononuclear cell proliferation, 4/89,243/18614,0.029215091,0.065983137,0.03490283,BCL2/SHH/BMP4/CTNNB1,4
GO:0001954,positive regulation of cell-matrix adhesion, 2/89,56/18614,0.029459966,0.066158407,0.034995542,SMAD3/SFRP1,2
GO:0009994,oocyte differentiation, 2/89,56/18614,0.029459966,0.066158407,0.034995542,BCL2/CTNNB1,2
GO:0010559,regulation of glycoprotein biosynthetic process, 2/89,56/18614,0.029459966,0.066158407,0.034995542,BCL2/CTNNB1,2
GO:0043331,response to dsRNA, 2/89,56/18614,0.029459966,0.066158407,0.034995542,DHX9/DDX21,2
GO:0045839,negative regulation of mitotic nuclear division, 2/89,56/18614,0.029459966,0.066158407,0.034995542,BMP4/BMP7,2
GO:0060986,endocrine hormone secretion, 2/89,56/18614,0.029459966,0.066158407,0.034995542,BMP6/SPP1,2
GO:0140962,multicellular organismal-level chemical homeostasis, 2/89,56/18614,0.029459966,0.066158407,0.034995542,BMP6/EXT2,2
GO:0042176,regulation of protein catabolic process, 5/89,361/18614,0.029492569,0.066158407,0.034995542,SMAD3/UFL1/SHH/GPC3/AXIN2,5
GO:0050878,regulation of body fluid levels, 5/89,361/18614,0.029492569,0.066158407,0.034995542,HIF1A/MAPK14/SHH/COMP/EXT2,5
GO:1904019,epithelial cell apoptotic process, 3/89,140/18614,0.029583826,0.066313182,0.035077413,BCL2/ADAR/BMPR2,3
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process, 3/89,141/18614,0.030125129,0.06747576,0.035692377,UFL1/SHH/AXIN2,3
GO:0002931,response to ischemia, 2/89,57/18614,0.030437937,0.067971975,0.035954858,BCL2/CASR,2
GO:0010332,response to gamma radiation, 2/89,57/18614,0.030437937,0.067971975,0.035954858,BCL2/MEN1,2
GO:0043470,regulation of carbohydrate catabolic process, 2/89,57/18614,0.030437937,0.067971975,0.035954858,HIF1A/GIT1,2
GO:0048168,regulation of neuronal synaptic plasticity, 2/89,57/18614,0.030437937,0.067971975,0.035954858,NF1/NOG,2
GO:0001889,liver development, 3/89,142/18614,0.030671665,0.068391384,0.036176711,SMAD3/NF1/GLI1,3
GO:0006986,response to unfolded protein, 3/89,142/18614,0.030671665,0.068391384,0.036176711,UFL1/HSPE1/COMP,3
GO:0060047,heart contraction, 4/89,247/18614,0.030759618,0.068536203,0.036253316,TMEM38B/STC1/CCN2/EXT2,4
GO:0002237,response to molecule of bacterial origin, 5/89,366/18614,0.031031692,0.06909074,0.036546647,BMP6/RHOA/MAPK14/GIT1/ALPL,5
GO:0042593,glucose homeostasis, 4/89,248/18614,0.031153174,0.069309414,0.036662318,CASR/MEN1/HIF1A/LRP5,4
GO:0014074,response to purine-containing compound, 3/89,143/18614,0.031223427,0.069310424,0.036662852,TMEM38B/STC1/COL1A1,3
GO:0050921,positive regulation of chemotaxis, 3/89,143/18614,0.031223427,0.069310424,0.036662852,SMAD3/CASR/BMPR2,3
GO:1903900,regulation of viral life cycle, 3/89,143/18614,0.031223427,0.069310424,0.036662852,BCL2/ADAR/IFITM1,3
GO:0001836,release of cytochrome c from mitochondria, 2/89,58/18614,0.031428705,0.069714157,0.036876413,BCL2/MMP9,2
GO:0033500,carbohydrate homeostasis, 4/89,249/18614,0.031549704,0.069930483,0.036990842,CASR/MEN1/HIF1A/LRP5,4
GO:0042552,myelination, 3/89,144/18614,0.03178041,0.070389474,0.037233633,NF1/DHH/CTNNB1,3
GO:0043543,protein acylation, 4/89,250/18614,0.031949213,0.070710777,0.037403591,SHH/SNAI2/DDX21/TWIST1,4
GO:0061008,hepaticobiliary system development, 3/89,145/18614,0.032342608,0.071513924,0.037828428,SMAD3/NF1/GLI1,3
GO:0002763,positive regulation of myeloid leukocyte differentiation, 2/89,59/18614,0.032432129,0.071513924,0.037828428,RUNX1/ROR2,2
GO:0007062,sister chromatid cohesion, 2/89,59/18614,0.032432129,0.071513924,0.037828428,AXIN2/CTNNB1,2
GO:0046324,regulation of glucose import, 2/89,59/18614,0.032432129,0.071513924,0.037828428,MAPK14/GPC3,2
GO:0051785,positive regulation of nuclear division, 2/89,59/18614,0.032432129,0.071513924,0.037828428,LRP5/MSX2,2
GO:0097305,response to alcohol, 4/89,252/18614,0.032757175,0.072177237,0.038179299,CAT/RHOA/SFRP1/CTNNB1,4
GO:0007272,ensheathment of neurons, 3/89,146/18614,0.032910015,0.072353457,0.038272513,NF1/DHH/CTNNB1,3
GO:0008366,axon ensheathment, 3/89,146/18614,0.032910015,0.072353457,0.038272513,NF1/DHH/CTNNB1,3
GO:0062013,positive regulation of small molecule metabolic process, 3/89,146/18614,0.032910015,0.072353457,0.038272513,HIF1A/BMP6/TWIST1,3
GO:0042255,ribosome assembly, 2/89,60/18614,0.033448066,0.073373925,0.038812305,SBDS/RPL38,2
GO:0055008,cardiac muscle tissue morphogenesis, 2/89,60/18614,0.033448066,0.073373925,0.038812305,FOXC1/NOG,2
GO:2000630,positive regulation of miRNA metabolic process, 2/89,60/18614,0.033448066,0.073373925,0.038812305,SMAD3/HIF1A,2
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway, 3/89,148/18614,0.034060426,0.074662258,0.03949379,SMAD3/MEN1/TGFB3,3
GO:0005996,monosaccharide metabolic process, 4/89,256/18614,0.034408944,0.075186774,0.039771241,MAPK14/IGFBP3/LRP5/SIRT7,4
GO:0022029,telencephalon cell migration, 2/89,61/18614,0.034476379,0.075186774,0.039771241,RHOA/CTNNB1,2
GO:0031279,regulation of cyclase activity, 2/89,61/18614,0.034476379,0.075186774,0.039771241,NF1/MAPK14,2
GO:0032786,"positive regulation of DNA-templated transcription, elongation", 2/89,61/18614,0.034476379,0.075186774,0.039771241,ALYREF/CTNNB1,2
GO:0035773,insulin secretion involved in cellular response to glucose stimulus, 2/89,61/18614,0.034476379,0.075186774,0.039771241,HIF1A/LRP5,2
GO:0045599,negative regulation of fat cell differentiation, 2/89,61/18614,0.034476379,0.075186774,0.039771241,SMAD3/MSX2,2
GO:1904356,regulation of telomere maintenance via telomere lengthening, 2/89,61/18614,0.034476379,0.075186774,0.039771241,HNRNPU/CTNNB1,2
GO:0002696,positive regulation of leukocyte activation, 5/89,377/18614,0.034593776,0.075387606,0.039877474,BCL2/RHOA/SHH/RUNX1/MMP14,5
GO:0051592,response to calcium ion, 3/89,149/18614,0.034643416,0.075440597,0.039905505,CASR/AMELX/JUNB,3
GO:0016072,rRNA metabolic process, 4/89,257/18614,0.034829367,0.075790127,0.040090394,SBDS/GTPBP4/SIRT7/DDX21,4
GO:1903038,negative regulation of leukocyte cell-cell adhesion, 3/89,150/18614,0.035231586,0.076599596,0.040518576,SHH/RUNX1/BMP4,3
GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling, 4/89,258/18614,0.035252785,0.076599596,0.040518576,UFL1/RHOA/CTNNB1/DDX21,4
GO:0043506,regulation of JUN kinase activity, 2/89,62/18614,0.035516928,0.076949038,0.040703419,SFRP1/ROR2,2
GO:0060113,inner ear receptor cell differentiation, 2/89,62/18614,0.035516928,0.076949038,0.040703419,BMP4/CTHRC1,2
GO:1903018,regulation of glycoprotein metabolic process, 2/89,62/18614,0.035516928,0.076949038,0.040703419,BCL2/CTNNB1,2
GO:1904036,negative regulation of epithelial cell apoptotic process, 2/89,62/18614,0.035516928,0.076949038,0.040703419,BCL2/ADAR,2
GO:0003015,heart process, 4/89,259/18614,0.035679201,0.077188337,0.040829999,TMEM38B/STC1/CCN2/EXT2,4
GO:0015833,peptide transport, 4/89,259/18614,0.035679201,0.077188337,0.040829999,CASR/HIF1A/SFRP1/LRP5,4
GO:0010821,regulation of mitochondrion organization, 3/89,151/18614,0.035824927,0.077279116,0.040878019,MMP9/HIF1A/SIRT7,3
GO:0016525,negative regulation of angiogenesis, 3/89,151/18614,0.035824927,0.077279116,0.040878019,NF1/FOXC1/CTNNB1,3
GO:0045834,positive regulation of lipid metabolic process, 3/89,151/18614,0.035824927,0.077279116,0.040878019,FGFR3/BMP6/TWIST1,3
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus, 3/89,151/18614,0.035824927,0.077279116,0.040878019,SMAD3/MEN1/TGFB3,3
GO:0010675,regulation of cellular carbohydrate metabolic process, 3/89,152/18614,0.036423432,0.078456547,0.04150084,GIT1/IGFBP3/SIRT7,3
GO:0043535,regulation of blood vessel endothelial cell migration, 3/89,152/18614,0.036423432,0.078456547,0.04150084,HIF1A/NF1/RHOA,3
GO:0031638,zymogen activation, 2/89,63/18614,0.036569575,0.078600839,0.041577165,RUNX1/MMP14,2
GO:0051784,negative regulation of nuclear division, 2/89,63/18614,0.036569575,0.078600839,0.041577165,BMP4/BMP7,2
GO:0070542,response to fatty acid, 2/89,63/18614,0.036569575,0.078600839,0.041577165,CAT/CCN2,2
GO:0016573,histone acetylation, 3/89,153/18614,0.037027092,0.079298137,0.041946012,SNAI2/DDX21/TWIST1,3
GO:0030183,B cell differentiation, 3/89,153/18614,0.037027092,0.079298137,0.041946012,BCL2/SFRP1/MMP14,3
GO:0032368,regulation of lipid transport, 3/89,153/18614,0.037027092,0.079298137,0.041946012,BMP6/SHH/SPP1,3
GO:0034763,negative regulation of transmembrane transport, 3/89,153/18614,0.037027092,0.079298137,0.041946012,BCL2/MMP9/TWIST1,3
GO:2000181,negative regulation of blood vessel morphogenesis, 3/89,153/18614,0.037027092,0.079298137,0.041946012,NF1/FOXC1/CTNNB1,3
GO:0006360,transcription by RNA polymerase I, 2/89,64/18614,0.037634184,0.080141059,0.042391889,SIRT7/DDX21,2
GO:0021885,forebrain cell migration, 2/89,64/18614,0.037634184,0.080141059,0.042391889,RHOA/CTNNB1,2
GO:0032615,interleukin-12 production, 2/89,64/18614,0.037634184,0.080141059,0.042391889,MAPK11/MAPK14,2
GO:0032655,regulation of interleukin-12 production, 2/89,64/18614,0.037634184,0.080141059,0.042391889,MAPK11/MAPK14,2
GO:0048524,positive regulation of viral process, 2/89,64/18614,0.037634184,0.080141059,0.042391889,ADAR/DHX9,2
GO:0051055,negative regulation of lipid biosynthetic process, 2/89,64/18614,0.037634184,0.080141059,0.042391889,SNAI1/SNAI2,2
GO:0051568,histone H3-K4 methylation, 2/89,64/18614,0.037634184,0.080141059,0.042391889,MEN1/CTNNB1,2
GO:1901343,negative regulation of vasculature development, 3/89,154/18614,0.037635898,0.080141059,0.042391889,NF1/FOXC1/CTNNB1,3
GO:0071216,cellular response to biotic stimulus, 4/89,264/18614,0.037856298,0.080552793,0.042609682,BMP6/RHOA/MAPK14/GIT1,4
GO:0044272,sulfur compound biosynthetic process, 3/89,155/18614,0.038249841,0.081158317,0.042929984,XYLT1/EXT2/CTNNB1,3
GO:0050770,regulation of axonogenesis, 3/89,155/18614,0.038249841,0.081158317,0.042929984,PLXNB1/SPP1/BMPR2,3
GO:0070507,regulation of microtubule cytoskeleton organization, 3/89,155/18614,0.038249841,0.081158317,0.042929984,HNRNPU/RHOA/GIT1,3
GO:0090316,positive regulation of intracellular protein transport, 3/89,155/18614,0.038249841,0.081158317,0.042929984,SMAD3/MAPK14/SHH,3
GO:0006879,intracellular iron ion homeostasis, 2/89,65/18614,0.038710619,0.081960863,0.043354503,HIF1A/BMP6,2
GO:0031663,lipopolysaccharide-mediated signaling pathway, 2/89,65/18614,0.038710619,0.081960863,0.043354503,BMP6/MAPK14,2
GO:0048857,neural nucleus development, 2/89,65/18614,0.038710619,0.081960863,0.043354503,BCL2/RHOA,2
GO:0007605,sensory perception of sound, 3/89,156/18614,0.038868912,0.082237563,0.043500868,RPL38/COL1A1/SNAI2,3
GO:0060760,positive regulation of response to cytokine stimulus, 2/89,66/18614,0.039798746,0.084145113,0.044509897,HIF1A/DHX9,2
GO:0042446,hormone biosynthetic process, 2/89,67/18614,0.040898431,0.086225355,0.045610274,HIF1A/BMP6,2
GO:0042490,mechanoreceptor differentiation, 2/89,67/18614,0.040898431,0.086225355,0.045610274,BMP4/CTHRC1,2
GO:0060193,positive regulation of lipase activity, 2/89,67/18614,0.040898431,0.086225355,0.045610274,FGFR3/RHOA,2
GO:0070613,regulation of protein processing, 2/89,67/18614,0.040898431,0.086225355,0.045610274,RUNX1/MMP14,2
GO:1902850,microtubule cytoskeleton organization involved in mitosis, 3/89,161/18614,0.042040834,0.088508583,0.046818024,HNRNPU/SBDS/RHOA,3
GO:1990845,adaptive thermogenesis, 3/89,161/18614,0.042040834,0.088508583,0.046818024,HNRNPU/ACHE/ALPL,3
GO:0016052,carbohydrate catabolic process, 3/89,162/18614,0.042690459,0.089812767,0.047507893,HIF1A/GIT1/LRP5,3
GO:0006081,cellular aldehyde metabolic process, 2/89,69/18614,0.043131946,0.090358696,0.047796671,BMP6/ALPL,2
GO:0007004,telomere maintenance via telomerase, 2/89,69/18614,0.043131946,0.090358696,0.047796671,HNRNPU/CTNNB1,2
GO:0014015,positive regulation of gliogenesis, 2/89,69/18614,0.043131946,0.090358696,0.047796671,UFL1/SHH,2
GO:0042093,T-helper cell differentiation, 2/89,69/18614,0.043131946,0.090358696,0.047796671,MEN1/JUNB,2
GO:0042273,ribosomal large subunit biogenesis, 2/89,69/18614,0.043131946,0.090358696,0.047796671,RPL38/GTPBP4,2
GO:0070830,bicellular tight junction assembly, 2/89,69/18614,0.043131946,0.090358696,0.047796671,SNAI1/SNAI2,2
GO:0051100,negative regulation of binding, 3/89,163/18614,0.043345139,0.09074151,0.047999166,GTPBP4/MSX2/NOG,3
GO:0007611,learning or memory, 4/89,276/18614,0.043388039,0.090767535,0.048012932,HIF1A/NF1/GIT1/NOG,4
GO:0035966,response to topologically incorrect protein, 3/89,164/18614,0.044004862,0.091993323,0.048661332,UFL1/HSPE1/COMP,3
GO:0032722,positive regulation of chemokine production, 2/89,70/18614,0.044265512,0.092408523,0.048880959,HIF1A/TWIST1,2
GO:0051148,negative regulation of muscle cell differentiation, 2/89,70/18614,0.044265512,0.092408523,0.048880959,SHH/BMPR2,2
GO:0006260,DNA replication, 4/89,278/18614,0.044352132,0.092524511,0.048942313,GLI1/DHX9/ALYREF/GTPBP4,4
GO:0051168,nuclear export, 3/89,166/18614,0.045339392,0.094451781,0.049961773,DHX9/ALYREF/SIRT7,3
GO:1903313,positive regulation of mRNA metabolic process, 3/89,166/18614,0.045339392,0.094451781,0.049961773,HNRNPU/SYNCRIP/DHX9,3
GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response", 2/89,71/18614,0.045410113,0.094466987,0.049969817,MEN1/JUNB,2
GO:1903317,regulation of protein maturation, 2/89,71/18614,0.045410113,0.094466987,0.049969817,RUNX1/MMP14,2
GO:0000380,"alternative mRNA splicing, via spliceosome", 2/89,72/18614,0.046565617,0.094602043,0.050041257,HNRNPU/DHX9,2
GO:0002260,lymphocyte homeostasis, 2/89,72/18614,0.046565617,0.094602043,0.050041257,BCL2/HIF1A,2
GO:0002287,alpha-beta T cell activation involved in immune response, 2/89,72/18614,0.046565617,0.094602043,0.050041257,MEN1/JUNB,2
GO:0002293,alpha-beta T cell differentiation involved in immune response, 2/89,72/18614,0.046565617,0.094602043,0.050041257,MEN1/JUNB,2
GO:0006024,glycosaminoglycan biosynthetic process, 2/89,72/18614,0.046565617,0.094602043,0.050041257,XYLT1/EXT2,2
GO:0042130,negative regulation of T cell proliferation, 2/89,72/18614,0.046565617,0.094602043,0.050041257,SHH/BMP4,2
GO:0051926,negative regulation of calcium ion transport, 2/89,72/18614,0.046565617,0.094602043,0.050041257,BCL2/STC1,2
GO:0090307,mitotic spindle assembly, 2/89,72/18614,0.046565617,0.094602043,0.050041257,HNRNPU/RHOA,2
GO:0002934,desmosome organization, 1/89,10/18614,0.046808799,0.094602043,0.050041257,SNAI2,1
GO:0003056,regulation of vascular associated smooth muscle contraction, 1/89,10/18614,0.046808799,0.094602043,0.050041257,RHOA,1
GO:0003129,heart induction, 1/89,10/18614,0.046808799,0.094602043,0.050041257,BMP4,1
GO:0031666,positive regulation of lipopolysaccharide-mediated signaling pathway, 1/89,10/18614,0.046808799,0.094602043,0.050041257,BMP6,1
GO:0033034,positive regulation of myeloid cell apoptotic process, 1/89,10/18614,0.046808799,0.094602043,0.050041257,NF1,1
GO:0042135,neurotransmitter catabolic process, 1/89,10/18614,0.046808799,0.094602043,0.050041257,ACHE,1
GO:0042363,fat-soluble vitamin catabolic process, 1/89,10/18614,0.046808799,0.094602043,0.050041257,CYP24A1,1
GO:0043587,tongue morphogenesis, 1/89,10/18614,0.046808799,0.094602043,0.050041257,CTNNB1,1
GO:0048263,determination of dorsal identity, 1/89,10/18614,0.046808799,0.094602043,0.050041257,CTNNB1,1
GO:0048664,neuron fate determination, 1/89,10/18614,0.046808799,0.094602043,0.050041257,CTNNB1,1
GO:0048671,negative regulation of collateral sprouting, 1/89,10/18614,0.046808799,0.094602043,0.050041257,SPP1,1
GO:0048865,stem cell fate commitment, 1/89,10/18614,0.046808799,0.094602043,0.050041257,SFRP1,1
GO:0051974,negative regulation of telomerase activity, 1/89,10/18614,0.046808799,0.094602043,0.050041257,MEN1,1
GO:0055015,ventricular cardiac muscle cell development, 1/89,10/18614,0.046808799,0.094602043,0.050041257,FHL2,1
GO:0060452,positive regulation of cardiac muscle contraction, 1/89,10/18614,0.046808799,0.094602043,0.050041257,CCN2,1
GO:0060502,epithelial cell proliferation involved in lung morphogenesis, 1/89,10/18614,0.046808799,0.094602043,0.050041257,BMP4,1
GO:0060525,prostate glandular acinus development, 1/89,10/18614,0.046808799,0.094602043,0.050041257,SFRP1,1
GO:0061299,retina vasculature morphogenesis in camera-type eye, 1/89,10/18614,0.046808799,0.094602043,0.050041257,LRP5,1
GO:0070099,regulation of chemokine-mediated signaling pathway, 1/89,10/18614,0.046808799,0.094602043,0.050041257,HIF1A,1
GO:0070391,response to lipoteichoic acid, 1/89,10/18614,0.046808799,0.094602043,0.050041257,MAPK14,1
GO:0070562,regulation of vitamin D receptor signaling pathway, 1/89,10/18614,0.046808799,0.094602043,0.050041257,SNAI2,1
GO:0071223,cellular response to lipoteichoic acid, 1/89,10/18614,0.046808799,0.094602043,0.050041257,MAPK14,1
GO:0071374,cellular response to parathyroid hormone stimulus, 1/89,10/18614,0.046808799,0.094602043,0.050041257,PHEX,1
GO:0071803,positive regulation of podosome assembly, 1/89,10/18614,0.046808799,0.094602043,0.050041257,RHOA,1
GO:0072172,mesonephric tubule formation, 1/89,10/18614,0.046808799,0.094602043,0.050041257,NOG,1
GO:0097113,AMPA glutamate receptor clustering, 1/89,10/18614,0.046808799,0.094602043,0.050041257,CHRDL1,1
GO:0097688,glutamate receptor clustering, 1/89,10/18614,0.046808799,0.094602043,0.050041257,CHRDL1,1
GO:0098885,modification of postsynaptic actin cytoskeleton, 1/89,10/18614,0.046808799,0.094602043,0.050041257,RHOA,1
GO:0098976,excitatory chemical synaptic transmission, 1/89,10/18614,0.046808799,0.094602043,0.050041257,CHRDL1,1
GO:2000048,negative regulation of cell-cell adhesion mediated by cadherin, 1/89,10/18614,0.046808799,0.094602043,0.050041257,BMP6,1
GO:2000121,regulation of removal of superoxide radicals, 1/89,10/18614,0.046808799,0.094602043,0.050041257,BMP7,1
GO:2000234,positive regulation of rRNA processing, 1/89,10/18614,0.046808799,0.094602043,0.050041257,SIRT7,1
GO:2000271,positive regulation of fibroblast apoptotic process, 1/89,10/18614,0.046808799,0.094602043,0.050041257,SFRP1,1
GO:2001269,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway, 1/89,10/18614,0.046808799,0.094602043,0.050041257,SMAD3,1
GO:0031348,negative regulation of defense response, 4/89,284/18614,0.047316606,0.095563505,0.050549837,SMAD3/ADAR/MAPK14/GIT1,4
GO:0060415,muscle tissue morphogenesis, 2/89,73/18614,0.047731899,0.096271717,0.050924458,FOXC1/NOG,2
GO:0071260,cellular response to mechanical stimulus, 2/89,73/18614,0.047731899,0.096271717,0.050924458,BMP6/COL1A1,2
GO:0050806,positive regulation of synaptic transmission, 3/89,170/18614,0.048068441,0.096819395,0.05121416,NF1/NOG/ROR2,3
GO:1903034,regulation of response to wounding, 3/89,170/18614,0.048068441,0.096819395,0.05121416,SMAD3/GIT1/SPP1,3
GO:0007159,leukocyte cell-cell adhesion, 5/89,415/18614,0.048803392,0.098233314,0.051962075,RHOA/SHH/RUNX1/BMP4/BMP7,5
GO:0006023,aminoglycan biosynthetic process, 2/89,74/18614,0.04890883,0.098312689,0.052004062,XYLT1/EXT2,2
GO:1903578,regulation of ATP metabolic process, 2/89,74/18614,0.04890883,0.098312689,0.052004062,HIF1A/GIT1,2
GO:0006278,RNA-templated DNA biosynthetic process, 2/89,75/18614,0.050096285,0.099887477,0.052837071,HNRNPU/CTNNB1,2
GO:0010822,positive regulation of mitochondrion organization, 2/89,75/18614,0.050096285,0.099887477,0.052837071,MMP9/HIF1A,2
GO:0046323,glucose import, 2/89,75/18614,0.050096285,0.099887477,0.052837071,MAPK14/GPC3,2
GO:0120192,tight junction assembly, 2/89,75/18614,0.050096285,0.099887477,0.052837071,SNAI1/SNAI2,2
GO:2000058,regulation of ubiquitin-dependent protein catabolic process, 3/89,173/18614,0.050167317,0.099887477,0.052837071,UFL1/SHH/AXIN2,3
GO:0044262,cellular carbohydrate metabolic process, 4/89,290/18614,0.050389224,0.099887477,0.052837071,GIT1/IGFBP3/EXT2/SIRT7,4
GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process, 2/89,76/18614,0.051294139,0.099887477,0.052837071,SMAD3/HSPE1,2
GO:0007422,peripheral nervous system development, 2/89,76/18614,0.051294139,0.099887477,0.052837071,NF1/RUNX1,2
GO:0050772,positive regulation of axonogenesis, 2/89,76/18614,0.051294139,0.099887477,0.052837071,PLXNB1/BMPR2,2
GO:0060337,type I interferon-mediated signaling pathway, 2/89,76/18614,0.051294139,0.099887477,0.052837071,ADAR/IFITM1,2
GO:0001547,antral ovarian follicle growth, 1/89,11/18614,0.051368787,0.099887477,0.052837071,BMPR1B,1
GO:0002158,osteoclast proliferation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,JUNB,1
GO:0003263,cardioblast proliferation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,CTNNB1,1
GO:0003264,regulation of cardioblast proliferation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,CTNNB1,1
GO:0007406,negative regulation of neuroblast proliferation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,NF1,1
GO:0010624,regulation of Schwann cell proliferation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,NF1,1
GO:0010968,regulation of microtubule nucleation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,GIT1,1
GO:0014010,Schwann cell proliferation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,NF1,1
GO:0014745,negative regulation of muscle adaptation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,SMAD3,1
GO:0021548,pons development, 1/89,11/18614,0.051368787,0.099887477,0.052837071,BCL2,1
GO:0021781,glial cell fate commitment, 1/89,11/18614,0.051368787,0.099887477,0.052837071,CTNNB1,1
GO:0022605,mammalian oogenesis stage, 1/89,11/18614,0.051368787,0.099887477,0.052837071,BMPR1B,1
GO:0030167,proteoglycan catabolic process, 1/89,11/18614,0.051368787,0.099887477,0.052837071,ADAMTS12,1
GO:0030210,heparin biosynthetic process, 1/89,11/18614,0.051368787,0.099887477,0.052837071,EXT2,1
GO:0032000,positive regulation of fatty acid beta-oxidation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,TWIST1,1
GO:0032342,aldosterone biosynthetic process, 1/89,11/18614,0.051368787,0.099887477,0.052837071,BMP6,1
GO:0033089,positive regulation of T cell differentiation in thymus, 1/89,11/18614,0.051368787,0.099887477,0.052837071,SHH,1
GO:0033234,negative regulation of protein sumoylation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,CTNNB1,1
GO:0035878,nail development, 1/89,11/18614,0.051368787,0.099887477,0.052837071,MSX2,1
GO:0038063,collagen-activated tyrosine kinase receptor signaling pathway, 1/89,11/18614,0.051368787,0.099887477,0.052837071,COL1A1,1
GO:0042487,regulation of odontogenesis of dentin-containing tooth, 1/89,11/18614,0.051368787,0.099887477,0.052837071,BMP4,1
GO:0045060,negative thymic T cell selection, 1/89,11/18614,0.051368787,0.099887477,0.052837071,SHH,1
GO:0048262,determination of dorsal/ventral asymmetry, 1/89,11/18614,0.051368787,0.099887477,0.052837071,CTNNB1,1
GO:0048742,regulation of skeletal muscle fiber development, 1/89,11/18614,0.051368787,0.099887477,0.052837071,BCL2,1
GO:0051987,positive regulation of attachment of spindle microtubules to kinetochore, 1/89,11/18614,0.051368787,0.099887477,0.052837071,HNRNPU,1
GO:0060020,Bergmann glial cell differentiation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,SHH,1
GO:0060174,limb bud formation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,SHH,1
GO:0060433,bronchus development, 1/89,11/18614,0.051368787,0.099887477,0.052837071,BMP4,1
GO:0060736,prostate gland growth, 1/89,11/18614,0.051368787,0.099887477,0.052837071,SHH,1
GO:0060742,epithelial cell differentiation involved in prostate gland development, 1/89,11/18614,0.051368787,0.099887477,0.052837071,CTNNB1,1
GO:0060900,embryonic camera-type eye formation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,TWIST1,1
GO:0061418,regulation of transcription from RNA polymerase II promoter in response to hypoxia, 1/89,11/18614,0.051368787,0.099887477,0.052837071,HIF1A,1
GO:0071313,cellular response to caffeine, 1/89,11/18614,0.051368787,0.099887477,0.052837071,TMEM38B,1
GO:0090179,planar cell polarity pathway involved in neural tube closure, 1/89,11/18614,0.051368787,0.099887477,0.052837071,SFRP1,1
GO:1901203,positive regulation of extracellular matrix assembly, 1/89,11/18614,0.051368787,0.099887477,0.052837071,SMAD3,1
GO:1901856,negative regulation of cellular respiration, 1/89,11/18614,0.051368787,0.099887477,0.052837071,RHOA,1
GO:1904238,pericyte cell differentiation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,BMP4,1
GO:1905244,regulation of modification of synaptic structure, 1/89,11/18614,0.051368787,0.099887477,0.052837071,RHOA,1
GO:2000727,positive regulation of cardiac muscle cell differentiation, 1/89,11/18614,0.051368787,0.099887477,0.052837071,BMP4,1
GO:2000826,regulation of heart morphogenesis, 1/89,11/18614,0.051368787,0.099887477,0.052837071,BMP4,1
GO:0007249,I-kappaB kinase/NF-kappaB signaling, 4/89,293/18614,0.051965997,0.100982848,0.053416485,UFL1/RHOA/CTNNB1/DDX21,4
GO:0010827,regulation of glucose transmembrane transport, 2/89,77/18614,0.052502268,0.101825687,0.053862318,MAPK14/GPC3,2
GO:0071357,cellular response to type I interferon, 2/89,77/18614,0.052502268,0.101825687,0.053862318,ADAR/IFITM1,2
GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation", 2/89,77/18614,0.052502268,0.101825687,0.053862318,RUNX1/JUNB,2
GO:0021953,central nervous system neuron differentiation, 3/89,177/18614,0.05303458,0.102724325,0.054337667,BMPR1B/SHH/CDH11,3
GO:0060759,regulation of response to cytokine stimulus, 3/89,177/18614,0.05303458,0.102724325,0.054337667,HIF1A/ADAR/DHX9,3
GO:0002534,cytokine production involved in inflammatory response, 2/89,78/18614,0.053720548,0.10385043,0.054933338,HIF1A/MAPK14,2
GO:0008088,axo-dendritic transport, 2/89,78/18614,0.053720548,0.10385043,0.054933338,HNRNPU/HIF1A,2
GO:1900015,regulation of cytokine production involved in inflammatory response, 2/89,78/18614,0.053720548,0.10385043,0.054933338,HIF1A/MAPK14,2
GO:0008361,regulation of cell size, 3/89,178/18614,0.05376358,0.103866216,0.054941688,RHOA/SPP1/BMPR2,3
GO:0043534,blood vessel endothelial cell migration, 3/89,179/18614,0.054497425,0.105147558,0.055619475,HIF1A/NF1/RHOA,3
GO:0050954,sensory perception of mechanical stimulus, 3/89,179/18614,0.054497425,0.105147558,0.055619475,RPL38/COL1A1/SNAI2,3
GO:1903201,regulation of oxidative stress-induced cell death, 2/89,79/18614,0.054948858,0.105210082,0.055652548,HIF1A/CTNNB1,2
GO:0001553,luteinization, 1/89,12/18614,0.055907204,0.105210082,0.055652548,MMP2,1
GO:0002069,columnar/cuboidal epithelial cell maturation, 1/89,12/18614,0.055907204,0.105210082,0.055652548,HIF1A,1
GO:0002732,positive regulation of dendritic cell cytokine production, 1/89,12/18614,0.055907204,0.105210082,0.055652548,DDX21,1
GO:0003163,sinoatrial node development, 1/89,12/18614,0.055907204,0.105210082,0.055652548,BMP4,1
GO:0003306,Wnt signaling pathway involved in heart development, 1/89,12/18614,0.055907204,0.105210082,0.055652548,CTNNB1,1
GO:0006705,mineralocorticoid biosynthetic process, 1/89,12/18614,0.055907204,0.105210082,0.055652548,BMP6,1
GO:0009111,vitamin catabolic process, 1/89,12/18614,0.055907204,0.105210082,0.055652548,CYP24A1,1
GO:0009650,UV protection, 1/89,12/18614,0.055907204,0.105210082,0.055652548,CAT,1
GO:0014051,gamma-aminobutyric acid secretion, 1/89,12/18614,0.055907204,0.105210082,0.055652548,NF1,1
GO:0014854,response to inactivity, 1/89,12/18614,0.055907204,0.105210082,0.055652548,CAT,1
GO:0021794,thalamus development, 1/89,12/18614,0.055907204,0.105210082,0.055652548,SHH,1
GO:0032782,bile acid secretion, 1/89,12/18614,0.055907204,0.105210082,0.055652548,CASR,1
GO:0032926,negative regulation of activin receptor signaling pathway, 1/89,12/18614,0.055907204,0.105210082,0.055652548,FSTL3,1
GO:0033327,Leydig cell differentiation, 1/89,12/18614,0.055907204,0.105210082,0.055652548,DHH,1
GO:0033629,negative regulation of cell adhesion mediated by integrin, 1/89,12/18614,0.055907204,0.105210082,0.055652548,SNAI2,1
GO:0035112,genitalia morphogenesis, 1/89,12/18614,0.055907204,0.105210082,0.055652548,CTNNB1,1
GO:0042447,hormone catabolic process, 1/89,12/18614,0.055907204,0.105210082,0.055652548,SPP1,1
GO:0043383,negative T cell selection, 1/89,12/18614,0.055907204,0.105210082,0.055652548,SHH,1
GO:0046831,regulation of RNA export from nucleus, 1/89,12/18614,0.055907204,0.105210082,0.055652548,DHX9,1
GO:0048681,negative regulation of axon regeneration, 1/89,12/18614,0.055907204,0.105210082,0.055652548,SPP1,1
GO:0051549,positive regulation of keratinocyte migration, 1/89,12/18614,0.055907204,0.105210082,0.055652548,MMP9,1
GO:0051798,positive regulation of hair follicle development, 1/89,12/18614,0.055907204,0.105210082,0.055652548,MSX2,1
GO:0060394,negative regulation of pathway-restricted SMAD protein phosphorylation, 1/89,12/18614,0.055907204,0.105210082,0.055652548,NOG,1
GO:0060788,ectodermal placode formation, 1/89,12/18614,0.055907204,0.105210082,0.055652548,CTNNB1,1
GO:0070170,regulation of tooth mineralization, 1/89,12/18614,0.055907204,0.105210082,0.055652548,AMELX,1
GO:0070932,histone H3 deacetylation, 1/89,12/18614,0.055907204,0.105210082,0.055652548,SIRT7,1
GO:0071394,cellular response to testosterone stimulus, 1/89,12/18614,0.055907204,0.105210082,0.055652548,SPP1,1
GO:0071697,ectodermal placode morphogenesis, 1/89,12/18614,0.055907204,0.105210082,0.055652548,CTNNB1,1
GO:0072015,podocyte development, 1/89,12/18614,0.055907204,0.105210082,0.055652548,BMP4,1
GO:0072182,regulation of nephron tubule epithelial cell differentiation, 1/89,12/18614,0.055907204,0.105210082,0.055652548,CTNNB1,1
GO:0072497,mesenchymal stem cell differentiation, 1/89,12/18614,0.055907204,0.105210082,0.055652548,CTNNB1,1
GO:0090178,regulation of establishment of planar polarity involved in neural tube closure, 1/89,12/18614,0.055907204,0.105210082,0.055652548,SFRP1,1
GO:0097048,dendritic cell apoptotic process, 1/89,12/18614,0.055907204,0.105210082,0.055652548,BCL2,1
GO:0097084,vascular associated smooth muscle cell development, 1/89,12/18614,0.055907204,0.105210082,0.055652548,COMP,1
GO:1903867,extraembryonic membrane development, 1/89,12/18614,0.055907204,0.105210082,0.055652548,BMP7,1
GO:1904672,regulation of somatic stem cell population maintenance, 1/89,12/18614,0.055907204,0.105210082,0.055652548,BMP7,1
GO:1904953,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation, 1/89,12/18614,0.055907204,0.105210082,0.055652548,CTNNB1,1
GO:2000668,regulation of dendritic cell apoptotic process, 1/89,12/18614,0.055907204,0.105210082,0.055652548,BCL2,1
GO:0002292,T cell differentiation involved in immune response, 2/89,80/18614,0.056187076,0.105603344,0.05586057,MEN1/JUNB,2
GO:0048644,muscle organ morphogenesis, 2/89,80/18614,0.056187076,0.105603344,0.05586057,FOXC1/NOG,2
GO:0006941,striated muscle contraction, 3/89,182/18614,0.05672788,0.106485416,0.056327156,TMEM38B/STC1/CCN2,3
GO:1905952,regulation of lipid localization, 3/89,182/18614,0.05672788,0.106485416,0.056327156,BMP6/SHH/SPP1,3
GO:0006874,intracellular calcium ion homeostasis, 4/89,303/18614,0.057415944,0.107677225,0.056957582,TMEM38B/BCL2/CASR/STC1,4
GO:0010833,telomere maintenance via telomere lengthening, 2/89,81/18614,0.057435082,0.107677225,0.056957582,HNRNPU/CTNNB1,2
GO:0042129,regulation of T cell proliferation, 3/89,183/18614,0.057480954,0.107695448,0.056967222,SHH/BMP4/CTNNB1,3
GO:0048469,cell maturation, 3/89,184/18614,0.058238797,0.109046747,0.057682013,BCL2/HIF1A/CTNNB1,3
GO:0046928,regulation of neurotransmitter secretion, 2/89,82/18614,0.058692756,0.109827715,0.058095118,NF1/GIT1,2
GO:0045766,positive regulation of angiogenesis, 3/89,185/18614,0.059001392,0.110197584,0.058290766,HIF1A/RUNX1/TWIST1,3
GO:0099173,postsynapse organization, 3/89,185/18614,0.059001392,0.110197584,0.058290766,CHRDL1/NF1/ROR2,3
GO:1904018,positive regulation of vasculature development, 3/89,185/18614,0.059001392,0.110197584,0.058290766,HIF1A/RUNX1/TWIST1,3
GO:0046651,lymphocyte proliferation, 4/89,306/18614,0.059108883,0.110329175,0.058360373,BCL2/SHH/BMP4/CTNNB1,4
GO:0032024,positive regulation of insulin secretion, 2/89,83/18614,0.05995998,0.11056729,0.058486328,CASR/HIF1A,2
GO:0034340,response to type I interferon, 2/89,83/18614,0.05995998,0.11056729,0.058486328,ADAR/IFITM1,2
GO:0050871,positive regulation of B cell activation, 2/89,83/18614,0.05995998,0.11056729,0.058486328,BCL2/MMP14,2
GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator, 2/89,83/18614,0.05995998,0.11056729,0.058486328,BCL2/WWOX,2
GO:0002566,somatic diversification of immune receptors via somatic mutation, 1/89,13/18614,0.060424152,0.11056729,0.058486328,ADAR,1
GO:0003084,positive regulation of systemic arterial blood pressure, 1/89,13/18614,0.060424152,0.11056729,0.058486328,RHOA,1
GO:0005513,detection of calcium ion, 1/89,13/18614,0.060424152,0.11056729,0.058486328,CASR,1
GO:0007183,SMAD protein complex assembly, 1/89,13/18614,0.060424152,0.11056729,0.058486328,SMAD3,1
GO:0032341,aldosterone metabolic process, 1/89,13/18614,0.060424152,0.11056729,0.058486328,BMP6,1
GO:0032621,interleukin-18 production, 1/89,13/18614,0.060424152,0.11056729,0.058486328,DHX9,1
GO:0032661,regulation of interleukin-18 production, 1/89,13/18614,0.060424152,0.11056729,0.058486328,DHX9,1
GO:0034333,adherens junction assembly, 1/89,13/18614,0.060424152,0.11056729,0.058486328,CTNNB1,1
GO:0034616,response to laminar fluid shear stress, 1/89,13/18614,0.060424152,0.11056729,0.058486328,TGFB3,1
GO:0035331,negative regulation of hippo signaling, 1/89,13/18614,0.060424152,0.11056729,0.058486328,MAPK14,1
GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway, 1/89,13/18614,0.060424152,0.11056729,0.058486328,IGFBP3,1
GO:0045605,negative regulation of epidermal cell differentiation, 1/89,13/18614,0.060424152,0.11056729,0.058486328,MSX2,1
GO:0045683,negative regulation of epidermis development, 1/89,13/18614,0.060424152,0.11056729,0.058486328,MSX2,1
GO:0048012,hepatocyte growth factor receptor signaling pathway, 1/89,13/18614,0.060424152,0.11056729,0.058486328,ADAMTS12,1
GO:0048853,forebrain morphogenesis, 1/89,13/18614,0.060424152,0.11056729,0.058486328,NF1,1
GO:0060707,trophoblast giant cell differentiation, 1/89,13/18614,0.060424152,0.11056729,0.058486328,SNAI1,1
GO:0070486,leukocyte aggregation, 1/89,13/18614,0.060424152,0.11056729,0.058486328,BMP7,1
GO:0070571,negative regulation of neuron projection regeneration, 1/89,13/18614,0.060424152,0.11056729,0.058486328,SPP1,1
GO:0071107,response to parathyroid hormone, 1/89,13/18614,0.060424152,0.11056729,0.058486328,PHEX,1
GO:0071481,cellular response to X-ray, 1/89,13/18614,0.060424152,0.11056729,0.058486328,SFRP1,1
GO:0071696,ectodermal placode development, 1/89,13/18614,0.060424152,0.11056729,0.058486328,CTNNB1,1
GO:0071801,regulation of podosome assembly, 1/89,13/18614,0.060424152,0.11056729,0.058486328,RHOA,1
GO:0072310,glomerular epithelial cell development, 1/89,13/18614,0.060424152,0.11056729,0.058486328,BMP4,1
GO:0090235,regulation of metaphase plate congression, 1/89,13/18614,0.060424152,0.11056729,0.058486328,HNRNPU,1
GO:0098935,dendritic transport, 1/89,13/18614,0.060424152,0.11056729,0.058486328,HNRNPU,1
GO:1900121,negative regulation of receptor binding, 1/89,13/18614,0.060424152,0.11056729,0.058486328,NOG,1
GO:1902065,response to L-glutamate, 1/89,13/18614,0.060424152,0.11056729,0.058486328,UFL1,1
GO:1903599,positive regulation of autophagy of mitochondrion, 1/89,13/18614,0.060424152,0.11056729,0.058486328,HIF1A,1
GO:0050728,negative regulation of inflammatory response, 3/89,187/18614,0.060540776,0.11071269,0.05856324,SMAD3/MAPK14/GIT1,3
GO:0002700,regulation of production of molecular mediator of immune response, 3/89,189/18614,0.062098978,0.113492549,0.060033691,TGFB3/DDX21/TWIST1,3
GO:0006096,glycolytic process, 2/89,85/18614,0.062522607,0.114196718,0.060406172,HIF1A/GIT1,2
GO:0032102,negative regulation of response to external stimulus, 5/89,446/18614,0.062624791,0.114313268,0.060467823,SMAD3/ADAR/MAPK14/GIT1/SPP1,5
GO:0034655,nucleobase-containing compound catabolic process, 5/89,447/18614,0.063104176,0.115117783,0.060893384,HNRNPU/MAPK14/SYNCRIP/DHX9/AXIN2,5
GO:0032943,mononuclear cell proliferation, 4/89,313/18614,0.063162405,0.115153491,0.060912272,BCL2/SHH/BMP4/CTNNB1,4
GO:0006757,ATP generation from ADP, 2/89,86/18614,0.063817778,0.116277162,0.061506656,HIF1A/GIT1,2
GO:0070372,regulation of ERK1 and ERK2 cascade, 4/89,315/18614,0.064347,0.116573764,0.061663548,FGFR3/CASR/BMP4/CCN2,4
GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling, 3/89,192/18614,0.064471273,0.116573764,0.061663548,RHOA/CTNNB1/DDX21,3
GO:0001833,inner cell mass cell proliferation, 1/89,14/18614,0.06491973,0.116573764,0.061663548,SBDS,1
GO:0008212,mineralocorticoid metabolic process, 1/89,14/18614,0.06491973,0.116573764,0.061663548,BMP6,1
GO:0021819,layer formation in cerebral cortex, 1/89,14/18614,0.06491973,0.116573764,0.061663548,CTNNB1,1
GO:0030238,male sex determination, 1/89,14/18614,0.06491973,0.116573764,0.061663548,DHH,1
GO:0031000,response to caffeine, 1/89,14/18614,0.06491973,0.116573764,0.061663548,TMEM38B,1
GO:0034309,primary alcohol biosynthetic process, 1/89,14/18614,0.06491973,0.116573764,0.061663548,BMP6,1
GO:0042541,hemoglobin biosynthetic process, 1/89,14/18614,0.06491973,0.116573764,0.061663548,HIF1A,1
GO:0042762,regulation of sulfur metabolic process, 1/89,14/18614,0.06491973,0.116573764,0.061663548,CTNNB1,1
GO:0045059,positive thymic T cell selection, 1/89,14/18614,0.06491973,0.116573764,0.061663548,SHH,1
GO:0048711,positive regulation of astrocyte differentiation, 1/89,14/18614,0.06491973,0.116573764,0.061663548,SHH,1
GO:0051547,regulation of keratinocyte migration, 1/89,14/18614,0.06491973,0.116573764,0.061663548,MMP9,1
GO:0055012,ventricular cardiac muscle cell differentiation, 1/89,14/18614,0.06491973,0.116573764,0.061663548,FHL2,1
GO:0060019,radial glial cell differentiation, 1/89,14/18614,0.06491973,0.116573764,0.061663548,RHOA,1
GO:0061029,eyelid development in camera-type eye, 1/89,14/18614,0.06491973,0.116573764,0.061663548,TWIST1,1
GO:0071285,cellular response to lithium ion, 1/89,14/18614,0.06491973,0.116573764,0.061663548,SHH,1
GO:0071415,cellular response to purine-containing compound, 1/89,14/18614,0.06491973,0.116573764,0.061663548,TMEM38B,1
GO:0072160,nephron tubule epithelial cell differentiation, 1/89,14/18614,0.06491973,0.116573764,0.061663548,CTNNB1,1
GO:1902287,semaphorin-plexin signaling pathway involved in axon guidance, 1/89,14/18614,0.06491973,0.116573764,0.061663548,PLXNB1,1
GO:1903798,regulation of miRNA maturation, 1/89,14/18614,0.06491973,0.116573764,0.061663548,BMP4,1
GO:1903894,regulation of IRE1-mediated unfolded protein response, 1/89,14/18614,0.06491973,0.116573764,0.061663548,UFL1,1
GO:1905203,regulation of connective tissue replacement, 1/89,14/18614,0.06491973,0.116573764,0.061663548,RUNX1,1
GO:2000288,positive regulation of myoblast proliferation, 1/89,14/18614,0.06491973,0.116573764,0.061663548,CTNNB1,1
GO:0032370,positive regulation of lipid transport, 2/89,87/18614,0.065122032,0.116866586,0.061818441,BMP6/SPP1,2
GO:0050890,cognition, 4/89,317/18614,0.065543294,0.117551759,0.062180874,HIF1A/NF1/GIT1/NOG,4
GO:0072594,establishment of protein localization to organelle, 5/89,453/18614,0.066024388,0.118343352,0.0625996,SMAD3/NF1/MAPK14/SHH/BMP4,5
GO:0061136,regulation of proteasomal protein catabolic process, 3/89,194/18614,0.066075932,0.118364524,0.062610799,UFL1/SHH/AXIN2,3
GO:0032273,positive regulation of protein polymerization, 2/89,88/18614,0.066435256,0.118865243,0.062875662,RHOA/GIT1,2
GO:0050672,negative regulation of lymphocyte proliferation, 2/89,88/18614,0.066435256,0.118865243,0.062875662,SHH/BMP4,2
GO:0009060,aerobic respiration, 3/89,196/18614,0.067698935,0.120867729,0.06393491,CAT/HIF1A/RHOA,3
GO:0032945,negative regulation of mononuclear cell proliferation, 2/89,89/18614,0.067757337,0.120867729,0.06393491,SHH/BMP4,2
GO:0051591,response to cAMP, 2/89,89/18614,0.067757337,0.120867729,0.06393491,STC1/COL1A1,2
GO:0055072,iron ion homeostasis, 2/89,89/18614,0.067757337,0.120867729,0.06393491,HIF1A/BMP6,2
GO:0060191,regulation of lipase activity, 2/89,89/18614,0.067757337,0.120867729,0.06393491,FGFR3/RHOA,2
GO:0006403,RNA localization, 3/89,197/18614,0.068517271,0.121317395,0.064172767,HNRNPU/DHX9/ALYREF,3
GO:0007416,synapse assembly, 3/89,197/18614,0.068517271,0.121317395,0.064172767,ACHE/PLXNB1/CTNNB1,3
GO:0006405,RNA export from nucleus, 2/89,90/18614,0.069088163,0.121317395,0.064172767,DHX9/ALYREF,2
GO:0007051,spindle organization, 3/89,198/18614,0.06934014,0.121317395,0.064172767,HNRNPU/SBDS/RHOA,3
GO:0000463,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)", 1/89,15/18614,0.069394039,0.121317395,0.064172767,GTPBP4,1
GO:0001711,endodermal cell fate commitment, 1/89,15/18614,0.069394039,0.121317395,0.064172767,CTNNB1,1
GO:0003413,chondrocyte differentiation involved in endochondral bone morphogenesis, 1/89,15/18614,0.069394039,0.121317395,0.064172767,AXIN2,1
GO:0007567,parturition, 1/89,15/18614,0.069394039,0.121317395,0.064172767,MMP2,1
GO:0010457,centriole-centriole cohesion, 1/89,15/18614,0.069394039,0.121317395,0.064172767,CTNNB1,1
GO:0014029,neural crest formation, 1/89,15/18614,0.069394039,0.121317395,0.064172767,SFRP1,1
GO:0032239,regulation of nucleobase-containing compound transport, 1/89,15/18614,0.069394039,0.121317395,0.064172767,DHX9,1
GO:0034116,positive regulation of heterotypic cell-cell adhesion, 1/89,15/18614,0.069394039,0.121317395,0.064172767,BMP7,1
GO:0035067,negative regulation of histone acetylation, 1/89,15/18614,0.069394039,0.121317395,0.064172767,TWIST1,1
GO:0035358,regulation of peroxisome proliferator activated receptor signaling pathway, 1/89,15/18614,0.069394039,0.121317395,0.064172767,TWIST1,1
GO:0042308,negative regulation of protein import into nucleus, 1/89,15/18614,0.069394039,0.121317395,0.064172767,NF1,1
GO:0045820,negative regulation of glycolytic process, 1/89,15/18614,0.069394039,0.121317395,0.064172767,GIT1,1
GO:0045989,positive regulation of striated muscle contraction, 1/89,15/18614,0.069394039,0.121317395,0.064172767,CCN2,1
GO:0048070,regulation of developmental pigmentation, 1/89,15/18614,0.069394039,0.121317395,0.064172767,BCL2,1
GO:0048368,lateral mesoderm development, 1/89,15/18614,0.069394039,0.121317395,0.064172767,SHH,1
GO:0048934,peripheral nervous system neuron differentiation, 1/89,15/18614,0.069394039,0.121317395,0.064172767,RUNX1,1
GO:0048935,peripheral nervous system neuron development, 1/89,15/18614,0.069394039,0.121317395,0.064172767,RUNX1,1
GO:0060026,convergent extension, 1/89,15/18614,0.069394039,0.121317395,0.064172767,SFRP1,1
GO:0060347,heart trabecula formation, 1/89,15/18614,0.069394039,0.121317395,0.064172767,FHL2,1
GO:0060413,atrial septum morphogenesis, 1/89,15/18614,0.069394039,0.121317395,0.064172767,BMPR2,1
GO:0060766,negative regulation of androgen receptor signaling pathway, 1/89,15/18614,0.069394039,0.121317395,0.064172767,SFRP1,1
GO:0070885,negative regulation of calcineurin-NFAT signaling cascade, 1/89,15/18614,0.069394039,0.121317395,0.064172767,FHL2,1
GO:0070920,regulation of production of small RNA involved in gene silencing by RNA, 1/89,15/18614,0.069394039,0.121317395,0.064172767,BMP4,1
GO:0071380,cellular response to prostaglandin E stimulus, 1/89,15/18614,0.069394039,0.121317395,0.064172767,SFRP1,1
GO:0071639,positive regulation of monocyte chemotactic protein-1 production, 1/89,15/18614,0.069394039,0.121317395,0.064172767,TWIST1,1
GO:0106057,negative regulation of calcineurin-mediated signaling, 1/89,15/18614,0.069394039,0.121317395,0.064172767,FHL2,1
GO:0120305,regulation of pigmentation, 1/89,15/18614,0.069394039,0.121317395,0.064172767,BCL2,1
GO:1900102,negative regulation of endoplasmic reticulum unfolded protein response, 1/89,15/18614,0.069394039,0.121317395,0.064172767,UFL1,1
GO:1901836,regulation of transcription of nucleolar large rRNA by RNA polymerase I, 1/89,15/18614,0.069394039,0.121317395,0.064172767,SIRT7,1
GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, 1/89,15/18614,0.069394039,0.121317395,0.064172767,BCL2,1
GO:0070098,chemokine-mediated signaling pathway, 2/89,91/18614,0.07042762,0.122937918,0.065029969,HIF1A/FOXC1,2
GO:0000377,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile", 4/89,325/18614,0.070444789,0.122937918,0.065029969,HNRNPU/SYNCRIP/DHX9/ALYREF,4
GO:0000398,"mRNA splicing, via spliceosome", 4/89,325/18614,0.070444789,0.122937918,0.065029969,HNRNPU/SYNCRIP/DHX9/ALYREF,4
GO:0009791,post-embryonic development, 2/89,92/18614,0.071775599,0.125187067,0.066219692,BCL2/BMP4,2
GO:0097553,calcium ion transmembrane import into cytosol, 3/89,201/18614,0.071835762,0.125218687,0.066236418,TMEM38B/BCL2/CCN2,3
GO:0000375,"RNA splicing, via transesterification reactions", 4/89,329/18614,0.072964827,0.12686894,0.067109345,HNRNPU/SYNCRIP/DHX9/ALYREF,4
GO:0032465,regulation of cytokinesis, 2/89,93/18614,0.073131991,0.12686894,0.067109345,RHOA/GIT1,2
GO:1900542,regulation of purine nucleotide metabolic process, 2/89,93/18614,0.073131991,0.12686894,0.067109345,HIF1A/GIT1,2
GO:0002903,negative regulation of B cell apoptotic process, 1/89,16/18614,0.073847177,0.12686894,0.067109345,BCL2,1
GO:0014857,regulation of skeletal muscle cell proliferation, 1/89,16/18614,0.073847177,0.12686894,0.067109345,SHH,1
GO:0030202,heparin metabolic process, 1/89,16/18614,0.073847177,0.12686894,0.067109345,EXT2,1
GO:0030852,regulation of granulocyte differentiation, 1/89,16/18614,0.073847177,0.12686894,0.067109345,RUNX1,1
GO:0031054,pre-miRNA processing, 1/89,16/18614,0.073847177,0.12686894,0.067109345,ADAR,1
GO:0038065,collagen-activated signaling pathway, 1/89,16/18614,0.073847177,0.12686894,0.067109345,COL1A1,1
GO:0043508,negative regulation of JUN kinase activity, 1/89,16/18614,0.073847177,0.12686894,0.067109345,SFRP1,1
GO:0045579,positive regulation of B cell differentiation, 1/89,16/18614,0.073847177,0.12686894,0.067109345,MMP14,1
GO:0045651,positive regulation of macrophage differentiation, 1/89,16/18614,0.073847177,0.12686894,0.067109345,ROR2,1
GO:0046184,aldehyde biosynthetic process, 1/89,16/18614,0.073847177,0.12686894,0.067109345,BMP6,1
GO:0046321,positive regulation of fatty acid oxidation, 1/89,16/18614,0.073847177,0.12686894,0.067109345,TWIST1,1
GO:0060576,intestinal epithelial cell development, 1/89,16/18614,0.073847177,0.12686894,0.067109345,HIF1A,1
GO:0060841,venous blood vessel development, 1/89,16/18614,0.073847177,0.12686894,0.067109345,BMPR2,1
GO:0072578,neurotransmitter-gated ion channel clustering, 1/89,16/18614,0.073847177,0.12686894,0.067109345,CHRDL1,1
GO:0090030,regulation of steroid hormone biosynthetic process, 1/89,16/18614,0.073847177,0.12686894,0.067109345,BMP6,1
GO:0097091,synaptic vesicle clustering, 1/89,16/18614,0.073847177,0.12686894,0.067109345,CTNNB1,1
GO:1901741,positive regulation of myoblast fusion, 1/89,16/18614,0.073847177,0.12686894,0.067109345,MAPK14,1
GO:1902033,regulation of hematopoietic stem cell proliferation, 1/89,16/18614,0.073847177,0.12686894,0.067109345,SNAI2,1
GO:1902285,semaphorin-plexin signaling pathway involved in neuron projection guidance, 1/89,16/18614,0.073847177,0.12686894,0.067109345,PLXNB1,1
GO:2000232,regulation of rRNA processing, 1/89,16/18614,0.073847177,0.12686894,0.067109345,SIRT7,1
GO:2000345,regulation of hepatocyte proliferation, 1/89,16/18614,0.073847177,0.12686894,0.067109345,GLI1,1
GO:2000846,regulation of corticosteroid hormone secretion, 1/89,16/18614,0.073847177,0.12686894,0.067109345,BMP6,1
GO:0003073,regulation of systemic arterial blood pressure, 2/89,94/18614,0.074496684,0.127763743,0.067582666,RHOA/BMPR2,2
GO:0006140,regulation of nucleotide metabolic process, 2/89,94/18614,0.074496684,0.127763743,0.067582666,HIF1A/GIT1,2
GO:0046031,ADP metabolic process, 2/89,94/18614,0.074496684,0.127763743,0.067582666,HIF1A/GIT1,2
GO:0007265,Ras protein signal transduction, 4/89,333/18614,0.075530647,0.129462484,0.068481242,NF1/RHOA/GIT1/COL1A2,4
GO:1903510,mucopolysaccharide metabolic process, 2/89,96/18614,0.077250547,0.132334319,0.070000345,XYLT1/EXT2,2
GO:0002730,regulation of dendritic cell cytokine production, 1/89,17/18614,0.078279246,0.132421279,0.070046344,DDX21,1
GO:0006089,lactate metabolic process, 1/89,17/18614,0.078279246,0.132421279,0.070046344,HIF1A,1
GO:0010566,regulation of ketone biosynthetic process, 1/89,17/18614,0.078279246,0.132421279,0.070046344,BMP6,1
GO:0014067,negative regulation of phosphatidylinositol 3-kinase signaling, 1/89,17/18614,0.078279246,0.132421279,0.070046344,TWIST1,1
GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway, 1/89,17/18614,0.078279246,0.132421279,0.070046344,HIF1A,1
GO:0031053,primary miRNA processing, 1/89,17/18614,0.078279246,0.132421279,0.070046344,SMAD3,1
GO:0033189,response to vitamin A, 1/89,17/18614,0.078279246,0.132421279,0.070046344,CAT,1
GO:0045198,establishment of epithelial cell apical/basal polarity, 1/89,17/18614,0.078279246,0.132421279,0.070046344,RHOA,1
GO:0045836,positive regulation of meiotic nuclear division, 1/89,17/18614,0.078279246,0.132421279,0.070046344,MSX2,1
GO:0048557,embryonic digestive tract morphogenesis, 1/89,17/18614,0.078279246,0.132421279,0.070046344,SHH,1
GO:0050872,white fat cell differentiation, 1/89,17/18614,0.078279246,0.132421279,0.070046344,SNAI2,1
GO:0051895,negative regulation of focal adhesion assembly, 1/89,17/18614,0.078279246,0.132421279,0.070046344,MMP14,1
GO:0060253,negative regulation of glial cell proliferation, 1/89,17/18614,0.078279246,0.132421279,0.070046344,NF1,1
GO:0061548,ganglion development, 1/89,17/18614,0.078279246,0.132421279,0.070046344,CTNNB1,1
GO:0070206,protein trimerization, 1/89,17/18614,0.078279246,0.132421279,0.070046344,COL1A2,1
GO:0071360,cellular response to exogenous dsRNA, 1/89,17/18614,0.078279246,0.132421279,0.070046344,DHX9,1
GO:0150118,negative regulation of cell-substrate junction organization, 1/89,17/18614,0.078279246,0.132421279,0.070046344,MMP14,1
GO:1900006,positive regulation of dendrite development, 1/89,17/18614,0.078279246,0.132421279,0.070046344,BMP7,1
GO:1901201,regulation of extracellular matrix assembly, 1/89,17/18614,0.078279246,0.132421279,0.070046344,SMAD3,1
GO:1902036,regulation of hematopoietic stem cell differentiation, 1/89,17/18614,0.078279246,0.132421279,0.070046344,FOXC1,1
GO:1902165,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, 1/89,17/18614,0.078279246,0.132421279,0.070046344,BCL2,1
GO:1990403,embryonic brain development, 1/89,17/18614,0.078279246,0.132421279,0.070046344,CTNNB1,1
GO:0008593,regulation of Notch signaling pathway, 2/89,97/18614,0.078639503,0.132804466,0.070249037,BMP7/MMP14,2
GO:0099175,regulation of postsynapse organization, 2/89,97/18614,0.078639503,0.132804466,0.070249037,NF1/ROR2,2
GO:1902807,negative regulation of cell cycle G1/S phase transition, 2/89,97/18614,0.078639503,0.132804466,0.070249037,BCL2/MEN1,2
GO:0048167,regulation of synaptic plasticity, 3/89,209/18614,0.078685624,0.132807067,0.070250412,CHRDL1/NF1/NOG,3
GO:0097306,cellular response to alcohol, 2/89,98/18614,0.080036333,0.134933919,0.071375444,SFRP1/CTNNB1,2
GO:0120162,positive regulation of cold-induced thermogenesis, 2/89,98/18614,0.080036333,0.134933919,0.071375444,ACHE/ALPL,2
GO:0001505,regulation of neurotransmitter levels, 3/89,211/18614,0.08044156,0.135540388,0.071696246,ACHE/NF1/GIT1,3
GO:0070371,ERK1 and ERK2 cascade, 4/89,341/18614,0.080798276,0.13606448,0.071973473,FGFR3/CASR/BMP4/CCN2,4
GO:0010596,negative regulation of endothelial cell migration, 2/89,99/18614,0.081440932,0.136473422,0.072189789,RHOA/STC1,2
GO:0051588,regulation of neurotransmitter transport, 2/89,99/18614,0.081440932,0.136473422,0.072189789,NF1/GIT1,2
GO:0098869,cellular oxidant detoxification, 2/89,99/18614,0.081440932,0.136473422,0.072189789,CAT/BMP7,2
GO:0008016,regulation of heart contraction, 3/89,213/18614,0.082214575,0.136473422,0.072189789,TMEM38B/STC1/CCN2,3
GO:0031396,regulation of protein ubiquitination, 3/89,213/18614,0.082214575,0.136473422,0.072189789,UFL1/GTPBP4/SIRT7,3
GO:0042098,T cell proliferation, 3/89,213/18614,0.082214575,0.136473422,0.072189789,SHH/BMP4/CTNNB1,3
GO:0001710,mesodermal cell fate commitment, 1/89,18/18614,0.082690341,0.136473422,0.072189789,BMP4,1
GO:0002371,dendritic cell cytokine production, 1/89,18/18614,0.082690341,0.136473422,0.072189789,DDX21,1
GO:0009642,response to light intensity, 1/89,18/18614,0.082690341,0.136473422,0.072189789,CAT,1
GO:0010522,regulation of calcium ion transport into cytosol, 1/89,18/18614,0.082690341,0.136473422,0.072189789,BCL2,1
GO:0010612,regulation of cardiac muscle adaptation, 1/89,18/18614,0.082690341,0.136473422,0.072189789,SMAD3,1
GO:0010755,regulation of plasminogen activation, 1/89,18/18614,0.082690341,0.136473422,0.072189789,RUNX1,1
GO:0015812,gamma-aminobutyric acid transport, 1/89,18/18614,0.082690341,0.136473422,0.072189789,NF1,1
GO:0019081,viral translation, 1/89,18/18614,0.082690341,0.136473422,0.072189789,DHX9,1
GO:0019896,axonal transport of mitochondrion, 1/89,18/18614,0.082690341,0.136473422,0.072189789,HIF1A,1
GO:0021513,spinal cord dorsal/ventral patterning, 1/89,18/18614,0.082690341,0.136473422,0.072189789,SHH,1
GO:0030206,chondroitin sulfate biosynthetic process, 1/89,18/18614,0.082690341,0.136473422,0.072189789,XYLT1,1
GO:0036003,positive regulation of transcription from RNA polymerase II promoter in response to stress, 1/89,18/18614,0.082690341,0.136473422,0.072189789,HIF1A,1
GO:0043117,positive regulation of vascular permeability, 1/89,18/18614,0.082690341,0.136473422,0.072189789,BMP6,1
GO:0045064,T-helper 2 cell differentiation, 1/89,18/18614,0.082690341,0.136473422,0.072189789,MEN1,1
GO:0045780,positive regulation of bone resorption, 1/89,18/18614,0.082690341,0.136473422,0.072189789,SPP1,1
GO:0045945,positive regulation of transcription by RNA polymerase III, 1/89,18/18614,0.082690341,0.136473422,0.072189789,DDX21,1
GO:0046851,negative regulation of bone remodeling, 1/89,18/18614,0.082690341,0.136473422,0.072189789,SFRP1,1
GO:0051988,regulation of attachment of spindle microtubules to kinetochore, 1/89,18/18614,0.082690341,0.136473422,0.072189789,HNRNPU,1
GO:0060149,negative regulation of post-transcriptional gene silencing, 1/89,18/18614,0.082690341,0.136473422,0.072189789,ADAR,1
GO:0060644,mammary gland epithelial cell differentiation, 1/89,18/18614,0.082690341,0.136473422,0.072189789,HIF1A,1
GO:0060967,negative regulation of gene silencing by RNA, 1/89,18/18614,0.082690341,0.136473422,0.072189789,ADAR,1
GO:0061709,reticulophagy, 1/89,18/18614,0.082690341,0.136473422,0.072189789,UFL1,1
GO:0071391,cellular response to estrogen stimulus, 1/89,18/18614,0.082690341,0.136473422,0.072189789,SFRP1,1
GO:0090190,positive regulation of branching involved in ureteric bud morphogenesis, 1/89,18/18614,0.082690341,0.136473422,0.072189789,NOG,1
GO:0099010,modification of postsynaptic structure, 1/89,18/18614,0.082690341,0.136473422,0.072189789,RHOA,1
GO:1900369,negative regulation of post-transcriptional gene silencing by RNA, 1/89,18/18614,0.082690341,0.136473422,0.072189789,ADAR,1
GO:1902548,negative regulation of cellular response to vascular endothelial growth factor stimulus, 1/89,18/18614,0.082690341,0.136473422,0.072189789,ADAMTS12,1
GO:1903242,regulation of cardiac muscle hypertrophy in response to stress, 1/89,18/18614,0.082690341,0.136473422,0.072189789,SMAD3,1
GO:1905209,positive regulation of cardiocyte differentiation, 1/89,18/18614,0.082690341,0.136473422,0.072189789,BMP4,1
GO:2000757,negative regulation of peptidyl-lysine acetylation, 1/89,18/18614,0.082690341,0.136473422,0.072189789,TWIST1,1
GO:0032755,positive regulation of interleukin-6 production, 2/89,100/18614,0.082853196,0.136590853,0.072251906,DHX9/TWIST1,2
GO:0140888,interferon-mediated signaling pathway, 2/89,100/18614,0.082853196,0.136590853,0.072251906,ADAR/IFITM1,2
GO:1902806,regulation of cell cycle G1/S phase transition, 3/89,214/18614,0.083107438,0.136934214,0.072433532,BCL2/MEN1/GLI1,3
GO:0044270,cellular nitrogen compound catabolic process, 5/89,486/18614,0.083420558,0.137374152,0.072666245,HNRNPU/MAPK14/SYNCRIP/DHX9/AXIN2,5
GO:1904062,regulation of monoatomic cation transmembrane transport, 4/89,346/18614,0.084181577,0.138550784,0.073288643,TMEM38B/BCL2/MMP9/TWIST1,4
GO:0046700,heterocycle catabolic process, 5/89,488/18614,0.084546692,0.139074873,0.073565868,HNRNPU/MAPK14/SYNCRIP/DHX9/AXIN2,5
GO:0002532,production of molecular mediator involved in inflammatory response, 2/89,102/18614,0.085700308,0.140816998,0.074487393,HIF1A/MAPK14,2
GO:0006165,nucleoside diphosphate phosphorylation, 2/89,102/18614,0.085700308,0.140816998,0.074487393,HIF1A/GIT1,2
GO:0000028,ribosomal small subunit assembly, 1/89,19/18614,0.087080563,0.14136948,0.074779637,RPL38,1
GO:0001829,trophectodermal cell differentiation, 1/89,19/18614,0.087080563,0.14136948,0.074779637,JUNB,1
GO:0003184,pulmonary valve morphogenesis, 1/89,19/18614,0.087080563,0.14136948,0.074779637,BMP4,1
GO:0016553,base conversion or substitution editing, 1/89,19/18614,0.087080563,0.14136948,0.074779637,ADAR,1
GO:0032026,response to magnesium ion, 1/89,19/18614,0.087080563,0.14136948,0.074779637,BMP6,1
GO:0035372,protein localization to microtubule, 1/89,19/18614,0.087080563,0.14136948,0.074779637,HNRNPU,1
GO:0035930,corticosteroid hormone secretion, 1/89,19/18614,0.087080563,0.14136948,0.074779637,BMP6,1
GO:0036342,post-anal tail morphogenesis, 1/89,19/18614,0.087080563,0.14136948,0.074779637,DCHS1,1
GO:0044070,regulation of monoatomic anion transport, 1/89,19/18614,0.087080563,0.14136948,0.074779637,STC1,1
GO:0045618,positive regulation of keratinocyte differentiation, 1/89,19/18614,0.087080563,0.14136948,0.074779637,FOXC1,1
GO:0046782,regulation of viral transcription, 1/89,19/18614,0.087080563,0.14136948,0.074779637,DHX9,1
GO:0051152,positive regulation of smooth muscle cell differentiation, 1/89,19/18614,0.087080563,0.14136948,0.074779637,SHH,1
GO:0051797,regulation of hair follicle development, 1/89,19/18614,0.087080563,0.14136948,0.074779637,MSX2,1
GO:0051900,regulation of mitochondrial depolarization, 1/89,19/18614,0.087080563,0.14136948,0.074779637,BCL2,1
GO:0055062,phosphate ion homeostasis, 1/89,19/18614,0.087080563,0.14136948,0.074779637,ALPL,1
GO:0060716,labyrinthine layer blood vessel development, 1/89,19/18614,0.087080563,0.14136948,0.074779637,JUNB,1
GO:0071800,podosome assembly, 1/89,19/18614,0.087080563,0.14136948,0.074779637,RHOA,1
GO:1901522,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus, 1/89,19/18614,0.087080563,0.14136948,0.074779637,HIF1A,1
GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway, 1/89,19/18614,0.087080563,0.14136948,0.074779637,HIF1A,1
GO:1904862,inhibitory synapse assembly, 1/89,19/18614,0.087080563,0.14136948,0.074779637,PLXNB1,1
GO:2000434,regulation of protein neddylation, 1/89,19/18614,0.087080563,0.14136948,0.074779637,HIF1A,1
GO:2000678,negative regulation of transcription regulatory region DNA binding, 1/89,19/18614,0.087080563,0.14136948,0.074779637,MSX2,1
GO:0010906,regulation of glucose metabolic process, 2/89,103/18614,0.087134951,0.141380729,0.074785587,IGFBP3/SIRT7,2
GO:0032204,regulation of telomere maintenance, 2/89,104/18614,0.08857685,0.143329949,0.075816658,HNRNPU/CTNNB1,2
GO:0034968,histone lysine methylation, 2/89,104/18614,0.08857685,0.143329949,0.075816658,MEN1/CTNNB1,2
GO:0046939,nucleotide phosphorylation, 2/89,104/18614,0.08857685,0.143329949,0.075816658,HIF1A/GIT1,2
GO:0050773,regulation of dendrite development, 2/89,104/18614,0.08857685,0.143329949,0.075816658,RHOA/BMP7,2
GO:0060291,long-term synaptic potentiation, 2/89,104/18614,0.08857685,0.143329949,0.075816658,NF1/NOG,2
GO:0021549,cerebellum development, 2/89,105/18614,0.090025905,0.145437729,0.076931602,GLI1/FOXC1,2
GO:0032760,positive regulation of tumor necrosis factor production, 2/89,105/18614,0.090025905,0.145437729,0.076931602,DHX9/TWIST1,2
GO:0061387,regulation of extent of cell growth, 2/89,105/18614,0.090025905,0.145437729,0.076931602,SPP1/BMPR2,2
GO:0006700,C21-steroid hormone biosynthetic process, 1/89,20/18614,0.091450008,0.14589129,0.07717152,BMP6,1
GO:0007635,chemosensory behavior, 1/89,20/18614,0.091450008,0.14589129,0.07717152,CASR,1
GO:0021511,spinal cord patterning, 1/89,20/18614,0.091450008,0.14589129,0.07717152,SHH,1
GO:0031998,regulation of fatty acid beta-oxidation, 1/89,20/18614,0.091450008,0.14589129,0.07717152,TWIST1,1
GO:0032211,negative regulation of telomere maintenance via telomerase, 1/89,20/18614,0.091450008,0.14589129,0.07717152,HNRNPU,1
GO:0032495,response to muramyl dipeptide, 1/89,20/18614,0.091450008,0.14589129,0.07717152,MAPK14,1
GO:0036498,IRE1-mediated unfolded protein response, 1/89,20/18614,0.091450008,0.14589129,0.07717152,UFL1,1
GO:0043586,tongue development, 1/89,20/18614,0.091450008,0.14589129,0.07717152,CTNNB1,1
GO:0048670,regulation of collateral sprouting, 1/89,20/18614,0.091450008,0.14589129,0.07717152,SPP1,1
GO:0051546,keratinocyte migration, 1/89,20/18614,0.091450008,0.14589129,0.07717152,MMP9,1
GO:0060216,definitive hemopoiesis, 1/89,20/18614,0.091450008,0.14589129,0.07717152,ADAR,1
GO:0060339,negative regulation of type I interferon-mediated signaling pathway, 1/89,20/18614,0.091450008,0.14589129,0.07717152,ADAR,1
GO:0060749,mammary gland alveolus development, 1/89,20/18614,0.091450008,0.14589129,0.07717152,HIF1A,1
GO:0061377,mammary gland lobule development, 1/89,20/18614,0.091450008,0.14589129,0.07717152,HIF1A,1
GO:0071379,cellular response to prostaglandin stimulus, 1/89,20/18614,0.091450008,0.14589129,0.07717152,SFRP1,1
GO:0097284,hepatocyte apoptotic process, 1/89,20/18614,0.091450008,0.14589129,0.07717152,ADAR,1
GO:1903427,negative regulation of reactive oxygen species biosynthetic process, 1/89,20/18614,0.091450008,0.14589129,0.07717152,RHOA,1
GO:1903975,regulation of glial cell migration, 1/89,20/18614,0.091450008,0.14589129,0.07717152,NF1,1
GO:2000269,regulation of fibroblast apoptotic process, 1/89,20/18614,0.091450008,0.14589129,0.07717152,SFRP1,1
GO:2001185,"regulation of CD8-positive, alpha-beta T cell activation", 1/89,20/18614,0.091450008,0.14589129,0.07717152,RUNX1,1
GO:0006397,mRNA processing, 5/89,500/18614,0.091472972,0.14589129,0.07717152,HNRNPU/ADAR/SYNCRIP/DHX9/ALYREF,5
GO:0009135,purine nucleoside diphosphate metabolic process, 2/89,106/18614,0.091482017,0.14589129,0.07717152,HIF1A/GIT1,2
GO:0009179,purine ribonucleoside diphosphate metabolic process, 2/89,106/18614,0.091482017,0.14589129,0.07717152,HIF1A/GIT1,2
GO:1901890,positive regulation of cell junction assembly, 2/89,106/18614,0.091482017,0.14589129,0.07717152,SMAD3/SFRP1,2
GO:0007596,blood coagulation, 3/89,224/18614,0.092264343,0.147060181,0.077789824,MAPK14/SHH/COMP,3
GO:0090277,positive regulation of peptide hormone secretion, 2/89,107/18614,0.092945087,0.148065997,0.078321866,CASR/HIF1A,2
GO:0002685,regulation of leukocyte migration, 3/89,227/18614,0.095090495,0.150032248,0.079361946,NF1/RHOA/MMP14,3
GO:0002888,positive regulation of myeloid leukocyte mediated immunity, 1/89,21/18614,0.095798773,0.150032248,0.079361946,DDX21,1
GO:0002902,regulation of B cell apoptotic process, 1/89,21/18614,0.095798773,0.150032248,0.079361946,BCL2,1
GO:0007350,blastoderm segmentation, 1/89,21/18614,0.095798773,0.150032248,0.079361946,SHH,1
GO:0010288,response to lead ion, 1/89,21/18614,0.095798773,0.150032248,0.079361946,CAT,1
GO:0014856,skeletal muscle cell proliferation, 1/89,21/18614,0.095798773,0.150032248,0.079361946,SHH,1
GO:0030502,negative regulation of bone mineralization, 1/89,21/18614,0.095798773,0.150032248,0.079361946,HIF1A,1
GO:0030728,ovulation, 1/89,21/18614,0.095798773,0.150032248,0.079361946,MMP2,1
GO:0031290,retinal ganglion cell axon guidance, 1/89,21/18614,0.095798773,0.150032248,0.079361946,BMPR1B,1
GO:0032011,ARF protein signal transduction, 1/89,21/18614,0.095798773,0.150032248,0.079361946,GIT1,1
GO:0032012,regulation of ARF protein signal transduction, 1/89,21/18614,0.095798773,0.150032248,0.079361946,GIT1,1
GO:0035020,regulation of Rac protein signal transduction, 1/89,21/18614,0.095798773,0.150032248,0.079361946,NF1,1
GO:0042790,nucleolar large rRNA transcription by RNA polymerase I, 1/89,21/18614,0.095798773,0.150032248,0.079361946,SIRT7,1
GO:0045821,positive regulation of glycolytic process, 1/89,21/18614,0.095798773,0.150032248,0.079361946,HIF1A,1
GO:0050849,negative regulation of calcium-mediated signaling, 1/89,21/18614,0.095798773,0.150032248,0.079361946,FHL2,1
GO:0051315,attachment of mitotic spindle microtubules to kinetochore, 1/89,21/18614,0.095798773,0.150032248,0.079361946,HNRNPU,1
GO:0051571,positive regulation of histone H3-K4 methylation, 1/89,21/18614,0.095798773,0.150032248,0.079361946,CTNNB1,1
GO:0051882,mitochondrial depolarization, 1/89,21/18614,0.095798773,0.150032248,0.079361946,BCL2,1
GO:0060252,positive regulation of glial cell proliferation, 1/89,21/18614,0.095798773,0.150032248,0.079361946,UFL1,1
GO:0071498,cellular response to fluid shear stress, 1/89,21/18614,0.095798773,0.150032248,0.079361946,MMP2,1
GO:0071605,monocyte chemotactic protein-1 production, 1/89,21/18614,0.095798773,0.150032248,0.079361946,TWIST1,1
GO:0071637,regulation of monocyte chemotactic protein-1 production, 1/89,21/18614,0.095798773,0.150032248,0.079361946,TWIST1,1
GO:0090370,negative regulation of cholesterol efflux, 1/89,21/18614,0.095798773,0.150032248,0.079361946,SHH,1
GO:1901739,regulation of myoblast fusion, 1/89,21/18614,0.095798773,0.150032248,0.079361946,MAPK14,1
GO:1903429,regulation of cell maturation, 1/89,21/18614,0.095798773,0.150032248,0.079361946,BCL2,1
GO:1903579,negative regulation of ATP metabolic process, 1/89,21/18614,0.095798773,0.150032248,0.079361946,GIT1,1
GO:2000047,regulation of cell-cell adhesion mediated by cadherin, 1/89,21/18614,0.095798773,0.150032248,0.079361946,BMP6,1
GO:2000319,regulation of T-helper 17 cell differentiation, 1/89,21/18614,0.095798773,0.150032248,0.079361946,JUNB,1
GO:0002793,positive regulation of peptide secretion, 2/89,109/18614,0.095891709,0.150032248,0.079361946,CASR/HIF1A,2
GO:0018107,peptidyl-threonine phosphorylation, 2/89,109/18614,0.095891709,0.150032248,0.079361946,BCL2/BMP7,2
GO:0019395,fatty acid oxidation, 2/89,109/18614,0.095891709,0.150032248,0.079361946,MAPK14/TWIST1,2
GO:0045833,negative regulation of lipid metabolic process, 2/89,109/18614,0.095891709,0.150032248,0.079361946,SNAI1/SNAI2,2
GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production, 2/89,109/18614,0.095891709,0.150032248,0.079361946,DHX9/TWIST1,2
GO:1904035,regulation of epithelial cell apoptotic process, 2/89,109/18614,0.095891709,0.150032248,0.079361946,BCL2/ADAR,2
GO:0050817,coagulation, 3/89,229/18614,0.096994355,0.151677787,0.08023238,MAPK14/SHH/COMP,3
GO:1901222,regulation of NIK/NF-kappaB signaling, 2/89,110/18614,0.097375067,0.152193245,0.08050504,RHOA/BMP7,2
GO:0007599,hemostasis, 3/89,230/18614,0.097952151,0.152854613,0.080854881,MAPK14/SHH/COMP,3
GO:0050920,regulation of chemotaxis, 3/89,230/18614,0.097952151,0.152854613,0.080854881,SMAD3/CASR/BMPR2,3
GO:1903050,regulation of proteolysis involved in protein catabolic process, 3/89,230/18614,0.097952151,0.152854613,0.080854881,UFL1/SHH/AXIN2,3
GO:0008637,apoptotic mitochondrial changes, 2/89,111/18614,0.098864996,0.154111656,0.081519814,BCL2/MMP9,2
GO:0022618,ribonucleoprotein complex assembly, 3/89,231/18614,0.098913828,0.154111656,0.081519814,RPL38/ADAR/DHX9,3
GO:0048588,developmental cell growth, 3/89,231/18614,0.098913828,0.154111656,0.081519814,SPP1/CTNNB1/BMPR2,3
GO:0000470,maturation of LSU-rRNA, 1/89,22/18614,0.100126957,0.154111656,0.081519814,GTPBP4,1
GO:0001832,blastocyst growth, 1/89,22/18614,0.100126957,0.154111656,0.081519814,SBDS,1
GO:0001919,regulation of receptor recycling, 1/89,22/18614,0.100126957,0.154111656,0.081519814,ACHE,1
GO:0003085,negative regulation of systemic arterial blood pressure, 1/89,22/18614,0.100126957,0.154111656,0.081519814,BMPR2,1
GO:0007530,sex determination, 1/89,22/18614,0.100126957,0.154111656,0.081519814,DHH,1
GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion, 1/89,22/18614,0.100126957,0.154111656,0.081519814,TMEM38B,1
GO:0034104,negative regulation of tissue remodeling, 1/89,22/18614,0.100126957,0.154111656,0.081519814,SFRP1,1
GO:0035089,establishment of apical/basal cell polarity, 1/89,22/18614,0.100126957,0.154111656,0.081519814,RHOA,1
GO:0035313,"wound healing, spreading of epidermal cells", 1/89,22/18614,0.100126957,0.154111656,0.081519814,MSX2,1
GO:0043371,"negative regulation of CD4-positive, alpha-beta T cell differentiation", 1/89,22/18614,0.100126957,0.154111656,0.081519814,RUNX1,1
GO:0045061,thymic T cell selection, 1/89,22/18614,0.100126957,0.154111656,0.081519814,SHH,1
GO:0046597,negative regulation of viral entry into host cell, 1/89,22/18614,0.100126957,0.154111656,0.081519814,IFITM1,1
GO:0051000,positive regulation of nitric-oxide synthase activity, 1/89,22/18614,0.100126957,0.154111656,0.081519814,HIF1A,1
GO:0051151,negative regulation of smooth muscle cell differentiation, 1/89,22/18614,0.100126957,0.154111656,0.081519814,SHH,1
GO:0060713,labyrinthine layer morphogenesis, 1/89,22/18614,0.100126957,0.154111656,0.081519814,BMP7,1
GO:0061318,renal filtration cell differentiation, 1/89,22/18614,0.100126957,0.154111656,0.081519814,BMP4,1
GO:0071359,cellular response to dsRNA, 1/89,22/18614,0.100126957,0.154111656,0.081519814,DHX9,1
GO:0071636,positive regulation of transforming growth factor beta production, 1/89,22/18614,0.100126957,0.154111656,0.081519814,SMAD3,1
GO:0072112,podocyte differentiation, 1/89,22/18614,0.100126957,0.154111656,0.081519814,BMP4,1
GO:1902894,negative regulation of miRNA transcription, 1/89,22/18614,0.100126957,0.154111656,0.081519814,BMP4,1
GO:2000725,regulation of cardiac muscle cell differentiation, 1/89,22/18614,0.100126957,0.154111656,0.081519814,BMP4,1
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity, 2/89,112/18614,0.100361401,0.154111656,0.081519814,MEN1/GTPBP4,2
GO:0006090,pyruvate metabolic process, 2/89,112/18614,0.100361401,0.154111656,0.081519814,HIF1A/GIT1,2
GO:0032611,interleukin-1 beta production, 2/89,112/18614,0.100361401,0.154111656,0.081519814,SMAD3/GIT1,2
GO:0032651,regulation of interleukin-1 beta production, 2/89,112/18614,0.100361401,0.154111656,0.081519814,SMAD3/GIT1,2
GO:0035249,"synaptic transmission, glutamatergic", 2/89,112/18614,0.100361401,0.154111656,0.081519814,NF1/ROR2,2
GO:0042177,negative regulation of protein catabolic process, 2/89,112/18614,0.100361401,0.154111656,0.081519814,SMAD3/SHH,2
GO:1905954,positive regulation of lipid localization, 2/89,112/18614,0.100361401,0.154111656,0.081519814,BMP6/SPP1,2
GO:0018108,peptidyl-tyrosine phosphorylation, 4/89,370/18614,0.101368868,0.155578495,0.082295722,FGFR3/BMP6/SFRP1/ROR2,4
GO:0006939,smooth muscle contraction, 2/89,113/18614,0.101864187,0.156258193,0.082655259,RHOA/COMP,2
GO:0018212,peptidyl-tyrosine modification, 4/89,372/18614,0.102870056,0.157719967,0.083428487,FGFR3/BMP6/SFRP1/ROR2,4
GO:0032410,negative regulation of transporter activity, 2/89,114/18614,0.10337326,0.158165141,0.083663969,MMP9/TWIST1,2
GO:1904659,glucose transmembrane transport, 2/89,114/18614,0.10337326,0.158165141,0.083663969,MAPK14/GPC3,2
GO:0002070,epithelial cell maturation, 1/89,23/18614,0.104434654,0.158165141,0.083663969,HIF1A,1
GO:0003283,atrial septum development, 1/89,23/18614,0.104434654,0.158165141,0.083663969,BMPR2,1
GO:0006353,DNA-templated transcription termination, 1/89,23/18614,0.104434654,0.158165141,0.083663969,DHX9,1
GO:0010560,positive regulation of glycoprotein biosynthetic process, 1/89,23/18614,0.104434654,0.158165141,0.083663969,CTNNB1,1
GO:0010893,positive regulation of steroid biosynthetic process, 1/89,23/18614,0.104434654,0.158165141,0.083663969,BMP6,1
GO:0019430,removal of superoxide radicals, 1/89,23/18614,0.104434654,0.158165141,0.083663969,BMP7,1
GO:0021533,cell differentiation in hindbrain, 1/89,23/18614,0.104434654,0.158165141,0.083663969,NOG,1
GO:0032727,positive regulation of interferon-alpha production, 1/89,23/18614,0.104434654,0.158165141,0.083663969,DHX9,1
GO:0044062,regulation of excretion, 1/89,23/18614,0.104434654,0.158165141,0.083663969,STC1,1
GO:0046716,muscle cell cellular homeostasis, 1/89,23/18614,0.104434654,0.158165141,0.083663969,HIF1A,1
GO:0046823,negative regulation of nucleocytoplasmic transport, 1/89,23/18614,0.104434654,0.158165141,0.083663969,NF1,1
GO:0048169,regulation of long-term neuronal synaptic plasticity, 1/89,23/18614,0.104434654,0.158165141,0.083663969,NF1,1
GO:0050650,chondroitin sulfate proteoglycan biosynthetic process, 1/89,23/18614,0.104434654,0.158165141,0.083663969,XYLT1,1
GO:0051457,maintenance of protein location in nucleus, 1/89,23/18614,0.104434654,0.158165141,0.083663969,HNRNPU,1
GO:0072311,glomerular epithelial cell differentiation, 1/89,23/18614,0.104434654,0.158165141,0.083663969,BMP4,1
GO:0072574,hepatocyte proliferation, 1/89,23/18614,0.104434654,0.158165141,0.083663969,GLI1,1
GO:0072575,epithelial cell proliferation involved in liver morphogenesis, 1/89,23/18614,0.104434654,0.158165141,0.083663969,GLI1,1
GO:1901673,regulation of mitotic spindle assembly, 1/89,23/18614,0.104434654,0.158165141,0.083663969,HNRNPU,1
GO:1901984,negative regulation of protein acetylation, 1/89,23/18614,0.104434654,0.158165141,0.083663969,TWIST1,1
GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator, 1/89,23/18614,0.104434654,0.158165141,0.083663969,BCL2,1
GO:2000178,negative regulation of neural precursor cell proliferation, 1/89,23/18614,0.104434654,0.158165141,0.083663969,NF1,1
GO:2000629,negative regulation of miRNA metabolic process, 1/89,23/18614,0.104434654,0.158165141,0.083663969,BMP4,1
GO:0021761,limbic system development, 2/89,115/18614,0.104888529,0.158691177,0.083942225,NF1/CTNNB1,2
GO:1990748,cellular detoxification, 2/89,115/18614,0.104888529,0.158691177,0.083942225,CAT/BMP7,2
GO:0001824,blastocyst development, 2/89,116/18614,0.106409901,0.160585155,0.084944074,SBDS/JUNB,2
GO:0009185,ribonucleoside diphosphate metabolic process, 2/89,116/18614,0.106409901,0.160585155,0.084944074,HIF1A/GIT1,2
GO:0010633,negative regulation of epithelial cell migration, 2/89,116/18614,0.106409901,0.160585155,0.084944074,RHOA/STC1,2
GO:0034440,lipid oxidation, 2/89,116/18614,0.106409901,0.160585155,0.084944074,MAPK14/TWIST1,2
GO:1904029,regulation of cyclin-dependent protein kinase activity, 2/89,116/18614,0.106409901,0.160585155,0.084944074,MEN1/GTPBP4,2
GO:0071826,ribonucleoprotein complex subunit organization, 3/89,239/18614,0.106744439,0.161008447,0.085167981,RPL38/ADAR/DHX9,3
GO:1903037,regulation of leukocyte cell-cell adhesion, 4/89,378/18614,0.107435307,0.161968512,0.085675823,RHOA/SHH/RUNX1/BMP4,4
GO:0008645,hexose transmembrane transport, 2/89,117/18614,0.107937285,0.162265891,0.085833126,MAPK14/GPC3,2
GO:0002082,regulation of oxidative phosphorylation, 1/89,24/18614,0.10872196,0.162265891,0.085833126,RHOA,1
GO:0008045,motor neuron axon guidance, 1/89,24/18614,0.10872196,0.162265891,0.085833126,NOG,1
GO:0010155,regulation of proton transport, 1/89,24/18614,0.10872196,0.162265891,0.085833126,TWIST1,1
GO:0010839,negative regulation of keratinocyte proliferation, 1/89,24/18614,0.10872196,0.162265891,0.085833126,SNAI2,1
GO:0014850,response to muscle activity, 1/89,24/18614,0.10872196,0.162265891,0.085833126,HIF1A,1
GO:0030859,polarized epithelial cell differentiation, 1/89,24/18614,0.10872196,0.162265891,0.085833126,RHOA,1
GO:0034695,response to prostaglandin E, 1/89,24/18614,0.10872196,0.162265891,0.085833126,SFRP1,1
GO:0035162,embryonic hemopoiesis, 1/89,24/18614,0.10872196,0.162265891,0.085833126,HIF1A,1
GO:0035357,peroxisome proliferator activated receptor signaling pathway, 1/89,24/18614,0.10872196,0.162265891,0.085833126,TWIST1,1
GO:0051923,sulfation, 1/89,24/18614,0.10872196,0.162265891,0.085833126,EXT2,1
GO:0060143,positive regulation of syncytium formation by plasma membrane fusion, 1/89,24/18614,0.10872196,0.162265891,0.085833126,MAPK14,1
GO:0061162,establishment of monopolar cell polarity, 1/89,24/18614,0.10872196,0.162265891,0.085833126,RHOA,1
GO:0061484,hematopoietic stem cell homeostasis, 1/89,24/18614,0.10872196,0.162265891,0.085833126,ADAR,1
GO:0072576,liver morphogenesis, 1/89,24/18614,0.10872196,0.162265891,0.085833126,GLI1,1
GO:0090103,cochlea morphogenesis, 1/89,24/18614,0.10872196,0.162265891,0.085833126,CTHRC1,1
GO:0120255,olefinic compound biosynthetic process, 1/89,24/18614,0.10872196,0.162265891,0.085833126,BMP6,1
GO:0140747,regulation of ncRNA transcription, 1/89,24/18614,0.10872196,0.162265891,0.085833126,SIRT7,1
GO:1900543,negative regulation of purine nucleotide metabolic process, 1/89,24/18614,0.10872196,0.162265891,0.085833126,GIT1,1
GO:1902410,mitotic cytokinetic process, 1/89,24/18614,0.10872196,0.162265891,0.085833126,RHOA,1
GO:0009636,response to toxic substance, 3/89,242/18614,0.109742381,0.163624901,0.086551996,CAT/BCL2/BMP7,3
GO:1901617,organic hydroxy compound biosynthetic process, 3/89,242/18614,0.109742381,0.163624901,0.086551996,SNAI1/BMP6/SNAI2,3
GO:0045333,cellular respiration, 3/89,243/18614,0.110748972,0.165043115,0.087302183,CAT/HIF1A/RHOA,3
GO:0002286,T cell activation involved in immune response, 2/89,119/18614,0.111009726,0.165266353,0.087420269,MEN1/JUNB,2
GO:0018210,peptidyl-threonine modification, 2/89,119/18614,0.111009726,0.165266353,0.087420269,BCL2/BMP7,2
GO:0009205,purine ribonucleoside triphosphate metabolic process, 3/89,244/18614,0.111759165,0.165973445,0.087794296,HIF1A/RHOA/GIT1,3
GO:0002697,regulation of immune effector process, 4/89,384/18614,0.112091748,0.165973445,0.087794296,JUNB/TGFB3/DDX21/TWIST1,4
GO:0015749,monosaccharide transmembrane transport, 2/89,120/18614,0.112554604,0.165973445,0.087794296,MAPK14/GPC3,2
GO:0000027,ribosomal large subunit assembly, 1/89,25/18614,0.112988972,0.165973445,0.087794296,RPL38,1
GO:0003071,renal system process involved in regulation of systemic arterial blood pressure, 1/89,25/18614,0.112988972,0.165973445,0.087794296,RHOA,1
GO:0003081,regulation of systemic arterial blood pressure by renin-angiotensin, 1/89,25/18614,0.112988972,0.165973445,0.087794296,RHOA,1
GO:0006007,glucose catabolic process, 1/89,25/18614,0.112988972,0.165973445,0.087794296,LRP5,1
GO:0006582,melanin metabolic process, 1/89,25/18614,0.112988972,0.165973445,0.087794296,BCL2,1
GO:0010226,response to lithium ion, 1/89,25/18614,0.112988972,0.165973445,0.087794296,SHH,1
GO:0010623,programmed cell death involved in cell development, 1/89,25/18614,0.112988972,0.165973445,0.087794296,BCL2,1
GO:0014047,glutamate secretion, 1/89,25/18614,0.112988972,0.165973445,0.087794296,NF1,1
GO:0030318,melanocyte differentiation, 1/89,25/18614,0.112988972,0.165973445,0.087794296,BCL2,1
GO:0033233,regulation of protein sumoylation, 1/89,25/18614,0.112988972,0.165973445,0.087794296,CTNNB1,1
GO:0034114,regulation of heterotypic cell-cell adhesion, 1/89,25/18614,0.112988972,0.165973445,0.087794296,BMP7,1
GO:0043567,regulation of insulin-like growth factor receptor signaling pathway, 1/89,25/18614,0.112988972,0.165973445,0.087794296,IGFBP3,1
GO:0045649,regulation of macrophage differentiation, 1/89,25/18614,0.112988972,0.165973445,0.087794296,ROR2,1
GO:0045662,negative regulation of myoblast differentiation, 1/89,25/18614,0.112988972,0.165973445,0.087794296,BMP4,1
GO:0045980,negative regulation of nucleotide metabolic process, 1/89,25/18614,0.112988972,0.165973445,0.087794296,GIT1,1
GO:0046039,GTP metabolic process, 1/89,25/18614,0.112988972,0.165973445,0.087794296,RHOA,1
GO:0048714,positive regulation of oligodendrocyte differentiation, 1/89,25/18614,0.112988972,0.165973445,0.087794296,SHH,1
GO:0060706,cell differentiation involved in embryonic placenta development, 1/89,25/18614,0.112988972,0.165973445,0.087794296,SNAI1,1
GO:0061339,establishment or maintenance of monopolar cell polarity, 1/89,25/18614,0.112988972,0.165973445,0.087794296,RHOA,1
GO:0070935,3'-UTR-mediated mRNA stabilization, 1/89,25/18614,0.112988972,0.165973445,0.087794296,MAPK14,1
GO:0071450,cellular response to oxygen radical, 1/89,25/18614,0.112988972,0.165973445,0.087794296,BMP7,1
GO:0071451,cellular response to superoxide, 1/89,25/18614,0.112988972,0.165973445,0.087794296,BMP7,1
GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell, 1/89,25/18614,0.112988972,0.165973445,0.087794296,RHOA,1
GO:2000291,regulation of myoblast proliferation, 1/89,25/18614,0.112988972,0.165973445,0.087794296,CTNNB1,1
GO:0002698,negative regulation of immune effector process, 2/89,122/18614,0.115661234,0.169815089,0.089826395,TGFB3/TWIST1,2
GO:0140694,non-membrane-bounded organelle assembly, 4/89,390/18614,0.116837594,0.170363609,0.090116543,HNRNPU/SBDS/RPL38/RHOA,4
GO:0009144,purine nucleoside triphosphate metabolic process, 3/89,249/18614,0.116863399,0.170363609,0.090116543,HIF1A/RHOA/GIT1,3
GO:0050870,positive regulation of T cell activation, 3/89,249/18614,0.116863399,0.170363609,0.090116543,RHOA/SHH/RUNX1,3
GO:0018022,peptidyl-lysine methylation, 2/89,123/18614,0.11722281,0.170363609,0.090116543,MEN1/CTNNB1,2
GO:0006929,substrate-dependent cell migration, 1/89,26/18614,0.117235783,0.170363609,0.090116543,SNAI2,1
GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling, 1/89,26/18614,0.117235783,0.170363609,0.090116543,TMEM38B,1
GO:0010954,positive regulation of protein processing, 1/89,26/18614,0.117235783,0.170363609,0.090116543,MMP14,1
GO:0021854,hypothalamus development, 1/89,26/18614,0.117235783,0.170363609,0.090116543,CTNNB1,1
GO:0031639,plasminogen activation, 1/89,26/18614,0.117235783,0.170363609,0.090116543,RUNX1,1
GO:0032469,endoplasmic reticulum calcium ion homeostasis, 1/89,26/18614,0.117235783,0.170363609,0.090116543,BCL2,1
GO:0035330,regulation of hippo signaling, 1/89,26/18614,0.117235783,0.170363609,0.090116543,MAPK14,1
GO:0044346,fibroblast apoptotic process, 1/89,26/18614,0.117235783,0.170363609,0.090116543,SFRP1,1
GO:0051446,positive regulation of meiotic cell cycle, 1/89,26/18614,0.117235783,0.170363609,0.090116543,MSX2,1
GO:0060575,intestinal epithelial cell differentiation, 1/89,26/18614,0.117235783,0.170363609,0.090116543,HIF1A,1
GO:0062009,secondary palate development, 1/89,26/18614,0.117235783,0.170363609,0.090116543,TGFB3,1
GO:0099563,modification of synaptic structure, 1/89,26/18614,0.117235783,0.170363609,0.090116543,RHOA,1
GO:1902455,negative regulation of stem cell population maintenance, 1/89,26/18614,0.117235783,0.170363609,0.090116543,BMP7,1
GO:1903020,positive regulation of glycoprotein metabolic process, 1/89,26/18614,0.117235783,0.170363609,0.090116543,CTNNB1,1
GO:1903901,negative regulation of viral life cycle, 1/89,26/18614,0.117235783,0.170363609,0.090116543,IFITM1,1
GO:1905523,positive regulation of macrophage migration, 1/89,26/18614,0.117235783,0.170363609,0.090116543,MMP14,1
GO:2000773,negative regulation of cellular senescence, 1/89,26/18614,0.117235783,0.170363609,0.090116543,TWIST1,1
GO:0033044,regulation of chromosome organization, 3/89,250/18614,0.117894745,0.171237663,0.090578888,HNRNPU/AXIN2/CTNNB1,3
GO:0097237,cellular response to toxic substance, 2/89,124/18614,0.118789779,0.172453583,0.091222068,CAT/BMP7,2
GO:0009199,ribonucleoside triphosphate metabolic process, 3/89,251/18614,0.11892954,0.172572382,0.091284909,HIF1A/RHOA/GIT1,3
GO:0032886,regulation of microtubule-based process, 3/89,252/18614,0.119967761,0.173994139,0.09203697,HNRNPU/RHOA/GIT1,3
GO:0010811,positive regulation of cell-substrate adhesion, 2/89,125/18614,0.120362055,0.17437916,0.092240632,SMAD3/SFRP1,2
GO:0001783,B cell apoptotic process, 1/89,27/18614,0.12146249,0.17437916,0.092240632,BCL2,1
GO:0021801,cerebral cortex radial glia-guided migration, 1/89,27/18614,0.12146249,0.17437916,0.092240632,CTNNB1,1
GO:0022030,telencephalon glial cell migration, 1/89,27/18614,0.12146249,0.17437916,0.092240632,CTNNB1,1
GO:0034643,"establishment of mitochondrion localization, microtubule-mediated", 1/89,27/18614,0.12146249,0.17437916,0.092240632,HIF1A,1
GO:0042133,neurotransmitter metabolic process, 1/89,27/18614,0.12146249,0.17437916,0.092240632,ACHE,1
GO:0045940,positive regulation of steroid metabolic process, 1/89,27/18614,0.12146249,0.17437916,0.092240632,BMP6,1
GO:0047497,mitochondrion transport along microtubule, 1/89,27/18614,0.12146249,0.17437916,0.092240632,HIF1A,1
GO:0048668,collateral sprouting, 1/89,27/18614,0.12146249,0.17437916,0.092240632,SPP1,1
GO:0050996,positive regulation of lipid catabolic process, 1/89,27/18614,0.12146249,0.17437916,0.092240632,TWIST1,1
GO:0051291,protein heterooligomerization, 1/89,27/18614,0.12146249,0.17437916,0.092240632,COL1A2,1
GO:0051984,positive regulation of chromosome segregation, 1/89,27/18614,0.12146249,0.17437916,0.092240632,HNRNPU,1
GO:0060669,embryonic placenta morphogenesis, 1/89,27/18614,0.12146249,0.17437916,0.092240632,BMP7,1
GO:0071549,cellular response to dexamethasone stimulus, 1/89,27/18614,0.12146249,0.17437916,0.092240632,AXIN2,1
GO:0090200,positive regulation of release of cytochrome c from mitochondria, 1/89,27/18614,0.12146249,0.17437916,0.092240632,MMP9,1
GO:0099560,synaptic membrane adhesion, 1/89,27/18614,0.12146249,0.17437916,0.092240632,MAPK14,1
GO:1902932,positive regulation of alcohol biosynthetic process, 1/89,27/18614,0.12146249,0.17437916,0.092240632,BMP6,1
GO:1904357,negative regulation of telomere maintenance via telomere lengthening, 1/89,27/18614,0.12146249,0.17437916,0.092240632,HNRNPU,1
GO:2000108,positive regulation of leukocyte apoptotic process, 1/89,27/18614,0.12146249,0.17437916,0.092240632,NF1,1
GO:2000737,negative regulation of stem cell differentiation, 1/89,27/18614,0.12146249,0.17437916,0.092240632,HNRNPU,1
GO:2001032,regulation of double-strand break repair via nonhomologous end joining, 1/89,27/18614,0.12146249,0.17437916,0.092240632,SIRT7,1
GO:0045471,response to ethanol, 2/89,126/18614,0.121939552,0.174979733,0.092558315,CAT/RHOA,2
GO:0050730,regulation of peptidyl-tyrosine phosphorylation, 3/89,255/18614,0.123102762,0.176563856,0.093396262,FGFR3/BMP6/SFRP1,3
GO:0000303,response to superoxide, 1/89,28/18614,0.125669184,0.17903802,0.094705011,BMP7,1
GO:0010528,regulation of transposition, 1/89,28/18614,0.125669184,0.17903802,0.094705011,SIRT7,1
GO:0010529,negative regulation of transposition, 1/89,28/18614,0.125669184,0.17903802,0.094705011,SIRT7,1
GO:0022011,myelination in peripheral nervous system, 1/89,28/18614,0.125669184,0.17903802,0.094705011,NF1,1
GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway, 1/89,28/18614,0.125669184,0.17903802,0.094705011,BMP6,1
GO:0032292,peripheral nervous system axon ensheathment, 1/89,28/18614,0.125669184,0.17903802,0.094705011,NF1,1
GO:0042634,regulation of hair cycle, 1/89,28/18614,0.125669184,0.17903802,0.094705011,MSX2,1
GO:0045116,protein neddylation, 1/89,28/18614,0.125669184,0.17903802,0.094705011,HIF1A,1
GO:0048679,regulation of axon regeneration, 1/89,28/18614,0.125669184,0.17903802,0.094705011,SPP1,1
GO:0051569,regulation of histone H3-K4 methylation, 1/89,28/18614,0.125669184,0.17903802,0.094705011,CTNNB1,1
GO:0060402,calcium ion transport into cytosol, 1/89,28/18614,0.125669184,0.17903802,0.094705011,BCL2,1
GO:0060765,regulation of androgen receptor signaling pathway, 1/89,28/18614,0.125669184,0.17903802,0.094705011,SFRP1,1
GO:0070269,pyroptosis, 1/89,28/18614,0.125669184,0.17903802,0.094705011,DHX9,1
GO:1903319,positive regulation of protein maturation, 1/89,28/18614,0.125669184,0.17903802,0.094705011,MMP14,1
GO:0006338,chromatin remodeling, 4/89,402/18614,0.126590081,0.18016556,0.095301441,SATB2/SNAI1/SIRT7/DDX21,4
GO:0032874,positive regulation of stress-activated MAPK cascade, 2/89,129/18614,0.126702533,0.18016556,0.095301441,BMP4/CCN2,2
GO:0046683,response to organophosphorus, 2/89,129/18614,0.126702533,0.18016556,0.095301441,STC1/COL1A1,2
GO:0051928,positive regulation of calcium ion transport, 2/89,129/18614,0.126702533,0.18016556,0.095301441,CASR/STC1,2
GO:0007266,Rho protein signal transduction, 2/89,130/18614,0.12830008,0.182263204,0.096411023,RHOA/COL1A2,2
GO:0051028,mRNA transport, 2/89,130/18614,0.12830008,0.182263204,0.096411023,DHX9/ALYREF,2
GO:0000305,response to oxygen radical, 1/89,29/18614,0.129855962,0.183228859,0.096921822,BMP7,1
GO:0007271,"synaptic transmission, cholinergic", 1/89,29/18614,0.129855962,0.183228859,0.096921822,ACHE,1
GO:0010458,exit from mitosis, 1/89,29/18614,0.129855962,0.183228859,0.096921822,SIRT7,1
GO:0010575,positive regulation of vascular endothelial growth factor production, 1/89,29/18614,0.129855962,0.183228859,0.096921822,HIF1A,1
GO:0010800,positive regulation of peptidyl-threonine phosphorylation, 1/89,29/18614,0.129855962,0.183228859,0.096921822,BMP7,1
GO:0021952,central nervous system projection neuron axonogenesis, 1/89,29/18614,0.129855962,0.183228859,0.096921822,CDH11,1
GO:0032607,interferon-alpha production, 1/89,29/18614,0.129855962,0.183228859,0.096921822,DHX9,1
GO:0032647,regulation of interferon-alpha production, 1/89,29/18614,0.129855962,0.183228859,0.096921822,DHX9,1
GO:0035640,exploration behavior, 1/89,29/18614,0.129855962,0.183228859,0.096921822,NOG,1
GO:1900017,positive regulation of cytokine production involved in inflammatory response, 1/89,29/18614,0.129855962,0.183228859,0.096921822,HIF1A,1
GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway, 1/89,29/18614,0.129855962,0.183228859,0.096921822,HIF1A,1
GO:0032612,interleukin-1 production, 2/89,131/18614,0.129902434,0.183228859,0.096921822,SMAD3/GIT1,2
GO:0032652,regulation of interleukin-1 production, 2/89,131/18614,0.129902434,0.183228859,0.096921822,SMAD3/GIT1,2
GO:0051225,spindle assembly, 2/89,131/18614,0.129902434,0.183228859,0.096921822,HNRNPU/RHOA,2
GO:0070304,positive regulation of stress-activated protein kinase signaling cascade, 2/89,131/18614,0.129902434,0.183228859,0.096921822,BMP4/CCN2,2
GO:0016571,histone methylation, 2/89,133/18614,0.133121236,0.187414066,0.099135654,MEN1/CTNNB1,2
GO:0030168,platelet activation, 2/89,133/18614,0.133121236,0.187414066,0.099135654,MAPK14/COMP,2
GO:0034219,carbohydrate transmembrane transport, 2/89,133/18614,0.133121236,0.187414066,0.099135654,MAPK14/GPC3,2
GO:2000779,regulation of double-strand break repair, 2/89,133/18614,0.133121236,0.187414066,0.099135654,SIRT7/TWIST1,2
GO:0006359,regulation of transcription by RNA polymerase III, 1/89,30/18614,0.134022915,0.187443316,0.099151126,DDX21,1
GO:0009048,dosage compensation by inactivation of X chromosome, 1/89,30/18614,0.134022915,0.187443316,0.099151126,HNRNPU,1
GO:0021522,spinal cord motor neuron differentiation, 1/89,30/18614,0.134022915,0.187443316,0.099151126,SHH,1
GO:0032372,negative regulation of sterol transport, 1/89,30/18614,0.134022915,0.187443316,0.099151126,SHH,1
GO:0032375,negative regulation of cholesterol transport, 1/89,30/18614,0.134022915,0.187443316,0.099151126,SHH,1
GO:0035774,positive regulation of insulin secretion involved in cellular response to glucose stimulus, 1/89,30/18614,0.134022915,0.187443316,0.099151126,HIF1A,1
GO:0042744,hydrogen peroxide catabolic process, 1/89,30/18614,0.134022915,0.187443316,0.099151126,CAT,1
GO:0060142,regulation of syncytium formation by plasma membrane fusion, 1/89,30/18614,0.134022915,0.187443316,0.099151126,MAPK14,1
GO:0070168,negative regulation of biomineral tissue development, 1/89,30/18614,0.134022915,0.187443316,0.099151126,HIF1A,1
GO:0072539,T-helper 17 cell differentiation, 1/89,30/18614,0.134022915,0.187443316,0.099151126,JUNB,1
GO:0097254,renal tubular secretion, 1/89,30/18614,0.134022915,0.187443316,0.099151126,STC1,1
GO:0097421,liver regeneration, 1/89,30/18614,0.134022915,0.187443316,0.099151126,GLI1,1
GO:1900101,regulation of endoplasmic reticulum unfolded protein response, 1/89,30/18614,0.134022915,0.187443316,0.099151126,UFL1,1
GO:1902547,regulation of cellular response to vascular endothelial growth factor stimulus, 1/89,30/18614,0.134022915,0.187443316,0.099151126,ADAMTS12,1
GO:0009132,nucleoside diphosphate metabolic process, 2/89,134/18614,0.134737526,0.188265989,0.099586292,HIF1A/GIT1,2
GO:0051224,negative regulation of protein transport, 2/89,134/18614,0.134737526,0.188265989,0.099586292,NF1/SFRP1,2
GO:0010565,regulation of cellular ketone metabolic process, 2/89,135/18614,0.136358301,0.19044134,0.100736979,BMP6/TWIST1,2
GO:0009141,nucleoside triphosphate metabolic process, 3/89,269/18614,0.138120236,0.191356966,0.101221314,HIF1A/RHOA/GIT1,3
GO:0003299,muscle hypertrophy in response to stress, 1/89,31/18614,0.138170136,0.191356966,0.101221314,SMAD3,1
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum, 1/89,31/18614,0.138170136,0.191356966,0.101221314,TMEM38B,1
GO:0014044,Schwann cell development, 1/89,31/18614,0.138170136,0.191356966,0.101221314,NF1,1
GO:0014887,cardiac muscle adaptation, 1/89,31/18614,0.138170136,0.191356966,0.101221314,SMAD3,1
GO:0014898,cardiac muscle hypertrophy in response to stress, 1/89,31/18614,0.138170136,0.191356966,0.101221314,SMAD3,1
GO:0040018,positive regulation of multicellular organism growth, 1/89,31/18614,0.138170136,0.191356966,0.101221314,BCL2,1
GO:0045762,positive regulation of adenylate cyclase activity, 1/89,31/18614,0.138170136,0.191356966,0.101221314,NF1,1
GO:0045987,positive regulation of smooth muscle contraction, 1/89,31/18614,0.138170136,0.191356966,0.101221314,RHOA,1
GO:0048873,homeostasis of number of cells within a tissue, 1/89,31/18614,0.138170136,0.191356966,0.101221314,BCL2,1
GO:0051491,positive regulation of filopodium assembly, 1/89,31/18614,0.138170136,0.191356966,0.101221314,TGFB3,1
GO:0051654,establishment of mitochondrion localization, 1/89,31/18614,0.138170136,0.191356966,0.101221314,HIF1A,1
GO:0060674,placenta blood vessel development, 1/89,31/18614,0.138170136,0.191356966,0.101221314,JUNB,1
GO:0070570,regulation of neuron projection regeneration, 1/89,31/18614,0.138170136,0.191356966,0.101221314,SPP1,1
GO:0071276,cellular response to cadmium ion, 1/89,31/18614,0.138170136,0.191356966,0.101221314,MMP9,1
GO:0095500,acetylcholine receptor signaling pathway, 1/89,31/18614,0.138170136,0.191356966,0.101221314,ACHE,1
GO:1900745,positive regulation of p38MAPK cascade, 1/89,31/18614,0.138170136,0.191356966,0.101221314,BMP4,1
GO:2000316,regulation of T-helper 17 type immune response, 1/89,31/18614,0.138170136,0.191356966,0.101221314,JUNB,1
GO:1904950,negative regulation of establishment of protein localization, 2/89,138/18614,0.141246763,0.1952579,0.103284775,NF1/SFRP1,2
GO:0043547,positive regulation of GTPase activity, 3/89,272/18614,0.141417499,0.1952579,0.103284775,NF1/SFRP1/PLXNB1,3
GO:0002862,negative regulation of inflammatory response to antigenic stimulus, 1/89,32/18614,0.142297718,0.1952579,0.103284775,MAPK14,1
GO:0003382,epithelial cell morphogenesis, 1/89,32/18614,0.142297718,0.1952579,0.103284775,STC1,1
GO:0006298,mismatch repair, 1/89,32/18614,0.142297718,0.1952579,0.103284775,AXIN2,1
GO:0007549,dosage compensation, 1/89,32/18614,0.142297718,0.1952579,0.103284775,HNRNPU,1
GO:0008156,negative regulation of DNA replication, 1/89,32/18614,0.142297718,0.1952579,0.103284775,GTPBP4,1
GO:0010165,response to X-ray, 1/89,32/18614,0.142297718,0.1952579,0.103284775,SFRP1,1
GO:0030204,chondroitin sulfate metabolic process, 1/89,32/18614,0.142297718,0.1952579,0.103284775,XYLT1,1
GO:0031057,negative regulation of histone modification, 1/89,32/18614,0.142297718,0.1952579,0.103284775,TWIST1,1
GO:0031116,positive regulation of microtubule polymerization, 1/89,32/18614,0.142297718,0.1952579,0.103284775,GIT1,1
GO:0032196,transposition, 1/89,32/18614,0.142297718,0.1952579,0.103284775,SIRT7,1
GO:0032770,positive regulation of monooxygenase activity, 1/89,32/18614,0.142297718,0.1952579,0.103284775,HIF1A,1
GO:0034694,response to prostaglandin, 1/89,32/18614,0.142297718,0.1952579,0.103284775,SFRP1,1
GO:0035456,response to interferon-beta, 1/89,32/18614,0.142297718,0.1952579,0.103284775,IFITM1,1
GO:0043552,positive regulation of phosphatidylinositol 3-kinase activity, 1/89,32/18614,0.142297718,0.1952579,0.103284775,FGFR3,1
GO:0045070,positive regulation of viral genome replication, 1/89,32/18614,0.142297718,0.1952579,0.103284775,ADAR,1
GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity, 1/89,32/18614,0.142297718,0.1952579,0.103284775,MEN1,1
GO:0046825,regulation of protein export from nucleus, 1/89,32/18614,0.142297718,0.1952579,0.103284775,SIRT7,1
GO:0050891,multicellular organismal-level water homeostasis, 1/89,32/18614,0.142297718,0.1952579,0.103284775,EXT2,1
GO:1903039,positive regulation of leukocyte cell-cell adhesion, 3/89,273/18614,0.142522533,0.195476347,0.103400325,RHOA/SHH/RUNX1,3
GO:0034341,response to type II interferon, 2/89,139/18614,0.142884704,0.195792794,0.103567715,SYNCRIP/IFITM1,2
GO:0050684,regulation of mRNA processing, 2/89,139/18614,0.142884704,0.195792794,0.103567715,HNRNPU/DHX9,2
GO:1901988,negative regulation of cell cycle phase transition, 3/89,274/18614,0.143630502,0.19672426,0.104060429,BCL2/MEN1/MAPK14,3
GO:0008203,cholesterol metabolic process, 2/89,140/18614,0.144526746,0.197769948,0.104613562,CAT/LRP5,2
GO:1903008,organelle disassembly, 2/89,140/18614,0.144526746,0.197769948,0.104613562,HIF1A/UFL1,2
GO:0017148,negative regulation of translation, 3/89,276/18614,0.145855157,0.198879497,0.105200476,HNRNPU/SYNCRIP/DHX9,3
GO:0042113,B cell activation, 3/89,276/18614,0.145855157,0.198879497,0.105200476,BCL2/SFRP1/MMP14,3
GO:0007269,neurotransmitter secretion, 2/89,141/18614,0.146172812,0.198879497,0.105200476,NF1/GIT1,2
GO:0099643,signal release from synapse, 2/89,141/18614,0.146172812,0.198879497,0.105200476,NF1/GIT1,2
GO:0010664,negative regulation of striated muscle cell apoptotic process, 1/89,33/18614,0.146405753,0.198879497,0.105200476,BMP7,1
GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway, 1/89,33/18614,0.146405753,0.198879497,0.105200476,HIF1A,1
GO:0040020,regulation of meiotic nuclear division, 1/89,33/18614,0.146405753,0.198879497,0.105200476,MSX2,1
GO:0048566,embryonic digestive tract development, 1/89,33/18614,0.146405753,0.198879497,0.105200476,SHH,1
GO:0051085,chaperone cofactor-dependent protein refolding, 1/89,33/18614,0.146405753,0.198879497,0.105200476,HSPE1,1
GO:0060122,inner ear receptor cell stereocilium organization, 1/89,33/18614,0.146405753,0.198879497,0.105200476,CTHRC1,1
GO:0071404,cellular response to low-density lipoprotein particle stimulus, 1/89,33/18614,0.146405753,0.198879497,0.105200476,CASR,1
GO:0090169,regulation of spindle assembly, 1/89,33/18614,0.146405753,0.198879497,0.105200476,HNRNPU,1
GO:1901889,negative regulation of cell junction assembly, 1/89,33/18614,0.146405753,0.198879497,0.105200476,MMP14,1
GO:1904030,negative regulation of cyclin-dependent protein kinase activity, 1/89,33/18614,0.146405753,0.198879497,0.105200476,MEN1,1
GO:1905145,cellular response to acetylcholine, 1/89,33/18614,0.146405753,0.198879497,0.105200476,ACHE,1
GO:1905207,regulation of cardiocyte differentiation, 1/89,33/18614,0.146405753,0.198879497,0.105200476,BMP4,1
GO:0016032,viral process, 4/89,426/18614,0.147083376,0.199708923,0.105639214,BCL2/ADAR/DHX9/IFITM1,4
GO:0038061,NIK/NF-kappaB signaling, 2/89,142/18614,0.147822829,0.200621507,0.10612194,RHOA/BMP7,2
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules, 3/89,278/18614,0.148091286,0.200894326,0.106266252,MAPK14/DCHS1/CDH11,3
GO:0010977,negative regulation of neuron projection development, 2/89,143/18614,0.149476721,0.202220395,0.106967697,RHOA/SPP1,2
GO:0002021,response to dietary excess, 1/89,34/18614,0.150494332,0.202220395,0.106967697,MAPK14,1
GO:0006516,glycoprotein catabolic process, 1/89,34/18614,0.150494332,0.202220395,0.106967697,ADAMTS12,1
GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway, 1/89,34/18614,0.150494332,0.202220395,0.106967697,MEN1,1
GO:0032212,positive regulation of telomere maintenance via telomerase, 1/89,34/18614,0.150494332,0.202220395,0.106967697,CTNNB1,1
GO:0032743,positive regulation of interleukin-2 production, 1/89,34/18614,0.150494332,0.202220395,0.106967697,RUNX1,1
GO:0042044,fluid transport, 1/89,34/18614,0.150494332,0.202220395,0.106967697,EXT2,1
GO:0048841,regulation of axon extension involved in axon guidance, 1/89,34/18614,0.150494332,0.202220395,0.106967697,BMPR2,1
GO:0050869,negative regulation of B cell activation, 1/89,34/18614,0.150494332,0.202220395,0.106967697,SFRP1,1
GO:0051450,myoblast proliferation, 1/89,34/18614,0.150494332,0.202220395,0.106967697,CTNNB1,1
GO:0051973,positive regulation of telomerase activity, 1/89,34/18614,0.150494332,0.202220395,0.106967697,CTNNB1,1
GO:0055094,response to lipoprotein particle, 1/89,34/18614,0.150494332,0.202220395,0.106967697,CASR,1
GO:0060074,synapse maturation, 1/89,34/18614,0.150494332,0.202220395,0.106967697,CHRDL1,1
GO:0086004,regulation of cardiac muscle cell contraction, 1/89,34/18614,0.150494332,0.202220395,0.106967697,STC1,1
GO:0090322,regulation of superoxide metabolic process, 1/89,34/18614,0.150494332,0.202220395,0.106967697,BMP7,1
GO:0098801,regulation of renal system process, 1/89,34/18614,0.150494332,0.202220395,0.106967697,STC1,1
GO:1900181,negative regulation of protein localization to nucleus, 1/89,34/18614,0.150494332,0.202220395,0.106967697,NF1,1
GO:1903846,positive regulation of cellular response to transforming growth factor beta stimulus, 1/89,34/18614,0.150494332,0.202220395,0.106967697,MEN1,1
GO:2000406,positive regulation of T cell migration, 1/89,34/18614,0.150494332,0.202220395,0.106967697,RHOA,1
GO:2000515,"negative regulation of CD4-positive, alpha-beta T cell activation", 1/89,34/18614,0.150494332,0.202220395,0.106967697,RUNX1,1
GO:2000780,negative regulation of double-strand break repair, 1/89,34/18614,0.150494332,0.202220395,0.106967697,TWIST1,1
GO:0033674,positive regulation of kinase activity, 4/89,430/18614,0.150619972,0.202297969,0.107008731,FGFR3/RHOA/AXIN2/ROR2,4
GO:0098754,detoxification, 2/89,144/18614,0.151134416,0.202897442,0.107325832,CAT/BMP7,2
GO:0044843,cell cycle G1/S phase transition, 3/89,281/18614,0.151466599,0.203251802,0.107513276,BCL2/MEN1/GLI1,3
GO:0035264,multicellular organism growth, 2/89,145/18614,0.152795839,0.204850948,0.10835917,BCL2/COMP,2
GO:0050671,positive regulation of lymphocyte proliferation, 2/89,145/18614,0.152795839,0.204850948,0.10835917,BCL2/SHH,2
GO:0010508,positive regulation of autophagy, 2/89,146/18614,0.15446092,0.206107791,0.109023997,HIF1A/UFL1,2
GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum, 1/89,35/18614,0.154563546,0.206107791,0.109023997,TMEM38B,1
GO:0032205,negative regulation of telomere maintenance, 1/89,35/18614,0.154563546,0.206107791,0.109023997,HNRNPU,1
GO:0032228,"regulation of synaptic transmission, GABAergic", 1/89,35/18614,0.154563546,0.206107791,0.109023997,NF1,1
GO:0033146,regulation of intracellular estrogen receptor signaling pathway, 1/89,35/18614,0.154563546,0.206107791,0.109023997,UFL1,1
GO:0045773,positive regulation of axon extension, 1/89,35/18614,0.154563546,0.206107791,0.109023997,BMPR2,1
GO:0045777,positive regulation of blood pressure, 1/89,35/18614,0.154563546,0.206107791,0.109023997,RHOA,1
GO:0048333,mesodermal cell differentiation, 1/89,35/18614,0.154563546,0.206107791,0.109023997,BMP4,1
GO:0051968,"positive regulation of synaptic transmission, glutamatergic", 1/89,35/18614,0.154563546,0.206107791,0.109023997,ROR2,1
GO:0060416,response to growth hormone, 1/89,35/18614,0.154563546,0.206107791,0.109023997,PHEX,1
GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response, 1/89,35/18614,0.154563546,0.206107791,0.109023997,DDX21,1
GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator, 1/89,35/18614,0.154563546,0.206107791,0.109023997,BCL2,1
GO:0002687,positive regulation of leukocyte migration, 2/89,147/18614,0.156129587,0.20791687,0.109980938,RHOA/MMP14,2
GO:0006820,monoatomic anion transport, 2/89,147/18614,0.156129587,0.20791687,0.109980938,CASR/STC1,2
GO:0120161,regulation of cold-induced thermogenesis, 2/89,147/18614,0.156129587,0.20791687,0.109980938,ACHE/ALPL,2
GO:0032946,positive regulation of mononuclear cell proliferation, 2/89,148/18614,0.157801767,0.209817752,0.11098644,BCL2/SHH,2
GO:0106106,cold-induced thermogenesis, 2/89,148/18614,0.157801767,0.209817752,0.11098644,ACHE/ALPL,2
GO:0010614,negative regulation of cardiac muscle hypertrophy, 1/89,36/18614,0.158613487,0.209817752,0.11098644,SMAD3,1
GO:0010922,positive regulation of phosphatase activity, 1/89,36/18614,0.158613487,0.209817752,0.11098644,SMAD3,1
GO:0021696,cerebellar cortex morphogenesis, 1/89,36/18614,0.158613487,0.209817752,0.11098644,GLI1,1
GO:0021799,cerebral cortex radially oriented cell migration, 1/89,36/18614,0.158613487,0.209817752,0.11098644,CTNNB1,1
GO:0030224,monocyte differentiation, 1/89,36/18614,0.158613487,0.209817752,0.11098644,BMP4,1
GO:0031112,positive regulation of microtubule polymerization or depolymerization, 1/89,36/18614,0.158613487,0.209817752,0.11098644,GIT1,1
GO:0045738,negative regulation of DNA repair, 1/89,36/18614,0.158613487,0.209817752,0.11098644,TWIST1,1
GO:0046320,regulation of fatty acid oxidation, 1/89,36/18614,0.158613487,0.209817752,0.11098644,TWIST1,1
GO:0050931,pigment cell differentiation, 1/89,36/18614,0.158613487,0.209817752,0.11098644,BCL2,1
GO:0090218,positive regulation of lipid kinase activity, 1/89,36/18614,0.158613487,0.209817752,0.11098644,FGFR3,1
GO:1903514,release of sequestered calcium ion into cytosol by endoplasmic reticulum, 1/89,36/18614,0.158613487,0.209817752,0.11098644,TMEM38B,1
GO:1903580,positive regulation of ATP metabolic process, 1/89,36/18614,0.158613487,0.209817752,0.11098644,HIF1A,1
GO:1905144,response to acetylcholine, 1/89,36/18614,0.158613487,0.209817752,0.11098644,ACHE,1
GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process, 4/89,439/18614,0.158696673,0.209834616,0.110995361,UFL1/SHH/AXIN2/CTNNB1,4
GO:0022898,regulation of transmembrane transporter activity, 3/89,289/18614,0.160587077,0.212239975,0.112267713,BCL2/MMP9/TWIST1,3
GO:1902652,secondary alcohol metabolic process, 2/89,150/18614,0.161156388,0.212897951,0.11261576,CAT/LRP5,2
GO:0001941,postsynaptic membrane organization, 1/89,37/18614,0.162644244,0.213537771,0.112954203,CHRDL1,1
GO:0008207,C21-steroid hormone metabolic process, 1/89,37/18614,0.162644244,0.213537771,0.112954203,BMP6,1
GO:0009303,rRNA transcription, 1/89,37/18614,0.162644244,0.213537771,0.112954203,SIRT7,1
GO:0014037,Schwann cell differentiation, 1/89,37/18614,0.162644244,0.213537771,0.112954203,NF1,1
GO:0030104,water homeostasis, 1/89,37/18614,0.162644244,0.213537771,0.112954203,EXT2,1
GO:0048536,spleen development, 1/89,37/18614,0.162644244,0.213537771,0.112954203,BCL2,1
GO:0048741,skeletal muscle fiber development, 1/89,37/18614,0.162644244,0.213537771,0.112954203,BCL2,1
GO:0048854,brain morphogenesis, 1/89,37/18614,0.162644244,0.213537771,0.112954203,NF1,1
GO:0050654,chondroitin sulfate proteoglycan metabolic process, 1/89,37/18614,0.162644244,0.213537771,0.112954203,XYLT1,1
GO:0070306,lens fiber cell differentiation, 1/89,37/18614,0.162644244,0.213537771,0.112954203,SMAD3,1
GO:0071312,cellular response to alkaloid, 1/89,37/18614,0.162644244,0.213537771,0.112954203,TMEM38B,1
GO:0071402,cellular response to lipoprotein particle stimulus, 1/89,37/18614,0.162644244,0.213537771,0.112954203,CASR,1
GO:1903146,regulation of autophagy of mitochondrion, 1/89,37/18614,0.162644244,0.213537771,0.112954203,HIF1A,1
GO:1904358,positive regulation of telomere maintenance via telomere lengthening, 1/89,37/18614,0.162644244,0.213537771,0.112954203,CTNNB1,1
GO:0001662,behavioral fear response, 1/89,38/18614,0.166655907,0.217462963,0.115030496,BCL2,1
GO:0007020,microtubule nucleation, 1/89,38/18614,0.166655907,0.217462963,0.115030496,GIT1,1
GO:0014741,negative regulation of muscle hypertrophy, 1/89,38/18614,0.166655907,0.217462963,0.115030496,SMAD3,1
GO:0021955,central nervous system neuron axonogenesis, 1/89,38/18614,0.166655907,0.217462963,0.115030496,CDH11,1
GO:0032435,negative regulation of proteasomal ubiquitin-dependent protein catabolic process, 1/89,38/18614,0.166655907,0.217462963,0.115030496,SHH,1
GO:0032728,positive regulation of interferon-beta production, 1/89,38/18614,0.166655907,0.217462963,0.115030496,DHX9,1
GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress, 1/89,38/18614,0.166655907,0.217462963,0.115030496,HIF1A,1
GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway, 1/89,38/18614,0.166655907,0.217462963,0.115030496,MMP9,1
GO:0045923,positive regulation of fatty acid metabolic process, 1/89,38/18614,0.166655907,0.217462963,0.115030496,TWIST1,1
GO:0046676,negative regulation of insulin secretion, 1/89,38/18614,0.166655907,0.217462963,0.115030496,SFRP1,1
GO:0048846,axon extension involved in axon guidance, 1/89,38/18614,0.166655907,0.217462963,0.115030496,BMPR2,1
GO:0051084,'de novo' post-translational protein folding, 1/89,38/18614,0.166655907,0.217462963,0.115030496,HSPE1,1
GO:0051385,response to mineralocorticoid, 1/89,38/18614,0.166655907,0.217462963,0.115030496,CCN2,1
GO:1902284,neuron projection extension involved in neuron projection guidance, 1/89,38/18614,0.166655907,0.217462963,0.115030496,BMPR2,1
GO:0015850,organic hydroxy compound transport, 3/89,296/18614,0.168703223,0.220038048,0.116392629,BMP6/SHH/SPP1,3
GO:0016125,sterol metabolic process, 2/89,155/18614,0.169599568,0.221013611,0.116908668,CAT/LRP5,2
GO:0030010,establishment of cell polarity, 2/89,155/18614,0.169599568,0.221013611,0.116908668,RHOA/SHH,2
GO:0001990,regulation of systemic arterial blood pressure by hormone, 1/89,39/18614,0.170648565,0.221701734,0.117272661,RHOA,1
GO:0002209,behavioral defense response, 1/89,39/18614,0.170648565,0.221701734,0.117272661,BCL2,1
GO:0007588,excretion, 1/89,39/18614,0.170648565,0.221701734,0.117272661,STC1,1
GO:0030851,granulocyte differentiation, 1/89,39/18614,0.170648565,0.221701734,0.117272661,RUNX1,1
GO:0045823,positive regulation of heart contraction, 1/89,39/18614,0.170648565,0.221701734,0.117272661,CCN2,1
GO:0070316,regulation of G0 to G1 transition, 1/89,39/18614,0.170648565,0.221701734,0.117272661,CCN2,1
GO:0098926,postsynaptic signal transduction, 1/89,39/18614,0.170648565,0.221701734,0.117272661,ACHE,1
GO:0000723,telomere maintenance, 2/89,156/18614,0.171297369,0.22225386,0.117564717,HNRNPU/CTNNB1,2
GO:0008643,carbohydrate transport, 2/89,156/18614,0.171297369,0.22225386,0.117564717,MAPK14/GPC3,2
GO:1903531,negative regulation of secretion by cell, 2/89,156/18614,0.171297369,0.22225386,0.117564717,NF1/SFRP1,2
GO:0010976,positive regulation of neuron projection development, 2/89,157/18614,0.172998069,0.224362755,0.118680251,BMP7/ROR2,2
GO:2000113,negative regulation of cellular macromolecule biosynthetic process, 3/89,301/18614,0.174573588,0.224902661,0.118965843,HNRNPU/SYNCRIP/DHX9,3
GO:0032506,cytokinetic process, 1/89,40/18614,0.174622308,0.224902661,0.118965843,RHOA,1
GO:0032570,response to progesterone, 1/89,40/18614,0.174622308,0.224902661,0.118965843,TGFB3,1
GO:0035886,vascular associated smooth muscle cell differentiation, 1/89,40/18614,0.174622308,0.224902661,0.118965843,COMP,1
GO:0042092,type 2 immune response, 1/89,40/18614,0.174622308,0.224902661,0.118965843,MEN1,1
GO:0045454,cell redox homeostasis, 1/89,40/18614,0.174622308,0.224902661,0.118965843,GIT1,1
GO:0048489,synaptic vesicle transport, 1/89,40/18614,0.174622308,0.224902661,0.118965843,CTNNB1,1
GO:0048753,pigment granule organization, 1/89,40/18614,0.174622308,0.224902661,0.118965843,BCL2,1
GO:0051349,positive regulation of lyase activity, 1/89,40/18614,0.174622308,0.224902661,0.118965843,NF1,1
GO:0070884,regulation of calcineurin-NFAT signaling cascade, 1/89,40/18614,0.174622308,0.224902661,0.118965843,FHL2,1
GO:1901031,regulation of response to reactive oxygen species, 1/89,40/18614,0.174622308,0.224902661,0.118965843,BMP7,1
GO:1901186,positive regulation of ERBB signaling pathway, 1/89,40/18614,0.174622308,0.224902661,0.118965843,MMP9,1
GO:1901532,regulation of hematopoietic progenitor cell differentiation, 1/89,40/18614,0.174622308,0.224902661,0.118965843,FOXC1,1
GO:1903115,regulation of actin filament-based movement, 1/89,40/18614,0.174622308,0.224902661,0.118965843,STC1,1
GO:1903524,positive regulation of blood circulation, 1/89,40/18614,0.174622308,0.224902661,0.118965843,CCN2,1
GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell, 1/89,40/18614,0.174622308,0.224902661,0.118965843,RHOA,1
GO:1901987,regulation of cell cycle phase transition, 4/89,457/18614,0.175320397,0.225704176,0.119389817,BCL2/MEN1/GLI1/MAPK14,4
GO:0051092,positive regulation of NF-kappaB transcription factor activity, 2/89,159/18614,0.176407907,0.227006114,0.120078498,CAT/DHX9,2
GO:0051054,positive regulation of DNA metabolic process, 3/89,303/18614,0.176938072,0.227590034,0.120387371,GLI1/DHX9/CTNNB1,3
GO:0050657,nucleic acid transport, 2/89,160/18614,0.178116915,0.228318262,0.12077258,DHX9/ALYREF,2
GO:0050658,RNA transport, 2/89,160/18614,0.178116915,0.228318262,0.12077258,DHX9/ALYREF,2
GO:0034249,negative regulation of amide metabolic process, 3/89,304/18614,0.178123728,0.228318262,0.12077258,HNRNPU/SYNCRIP/DHX9,3
GO:0014904,myotube cell development, 1/89,41/18614,0.178577224,0.228318262,0.12077258,BCL2,1
GO:0031062,positive regulation of histone methylation, 1/89,41/18614,0.178577224,0.228318262,0.12077258,CTNNB1,1
GO:0045023,G0 to G1 transition, 1/89,41/18614,0.178577224,0.228318262,0.12077258,CCN2,1
GO:0048246,macrophage chemotaxis, 1/89,41/18614,0.178577224,0.228318262,0.12077258,MMP2,1
GO:0072595,maintenance of protein localization in organelle, 1/89,41/18614,0.178577224,0.228318262,0.12077258,HNRNPU,1
GO:0106056,regulation of calcineurin-mediated signaling, 1/89,41/18614,0.178577224,0.228318262,0.12077258,FHL2,1
GO:0140467,integrated stress response signaling, 1/89,41/18614,0.178577224,0.228318262,0.12077258,JUNB,1
GO:0150077,regulation of neuroinflammatory response, 1/89,41/18614,0.178577224,0.228318262,0.12077258,MMP9,1
GO:1901223,negative regulation of NIK/NF-kappaB signaling, 1/89,41/18614,0.178577224,0.228318262,0.12077258,BMP7,1
GO:1902275,regulation of chromatin organization, 1/89,41/18614,0.178577224,0.228318262,0.12077258,HNRNPU,1
GO:2000403,positive regulation of lymphocyte migration, 1/89,41/18614,0.178577224,0.228318262,0.12077258,RHOA,1
GO:0006458,'de novo' protein folding, 1/89,42/18614,0.182513402,0.231957092,0.122697397,HSPE1,1
GO:0007595,lactation, 1/89,42/18614,0.182513402,0.231957092,0.122697397,HIF1A,1
GO:0010453,regulation of cell fate commitment, 1/89,42/18614,0.182513402,0.231957092,0.122697397,BMP4,1
GO:0019320,hexose catabolic process, 1/89,42/18614,0.182513402,0.231957092,0.122697397,LRP5,1
GO:0043551,regulation of phosphatidylinositol 3-kinase activity, 1/89,42/18614,0.182513402,0.231957092,0.122697397,FGFR3,1
GO:0045429,positive regulation of nitric oxide biosynthetic process, 1/89,42/18614,0.182513402,0.231957092,0.122697397,SMAD3,1
GO:0045622,regulation of T-helper cell differentiation, 1/89,42/18614,0.182513402,0.231957092,0.122697397,JUNB,1
GO:0045981,positive regulation of nucleotide metabolic process, 1/89,42/18614,0.182513402,0.231957092,0.122697397,HIF1A,1
GO:0050691,regulation of defense response to virus by host, 1/89,42/18614,0.182513402,0.231957092,0.122697397,DHX9,1
GO:0050999,regulation of nitric-oxide synthase activity, 1/89,42/18614,0.182513402,0.231957092,0.122697397,HIF1A,1
GO:0060338,regulation of type I interferon-mediated signaling pathway, 1/89,42/18614,0.182513402,0.231957092,0.122697397,ADAR,1
GO:0070296,sarcoplasmic reticulum calcium ion transport, 1/89,42/18614,0.182513402,0.231957092,0.122697397,TMEM38B,1
GO:1900544,positive regulation of purine nucleotide metabolic process, 1/89,42/18614,0.182513402,0.231957092,0.122697397,HIF1A,1
GO:2000008,regulation of protein localization to cell surface, 1/89,42/18614,0.182513402,0.231957092,0.122697397,CTNNB1,1
GO:0051236,establishment of RNA localization, 2/89,163/18614,0.183259531,0.232806031,0.123146456,DHX9/ALYREF,2
GO:0008380,RNA splicing, 4/89,466/18614,0.18385236,0.233459583,0.123492163,HNRNPU/SYNCRIP/DHX9/ALYREF,4
GO:0008608,attachment of spindle microtubules to kinetochore, 1/89,43/18614,0.186430929,0.235829188,0.124745603,HNRNPU,1
GO:0016601,Rac protein signal transduction, 1/89,43/18614,0.186430929,0.235829188,0.124745603,NF1,1
GO:0033574,response to testosterone, 1/89,43/18614,0.186430929,0.235829188,0.124745603,SPP1,1
GO:0043507,positive regulation of JUN kinase activity, 1/89,43/18614,0.186430929,0.235829188,0.124745603,ROR2,1
GO:0045687,positive regulation of glial cell differentiation, 1/89,43/18614,0.186430929,0.235829188,0.124745603,SHH,1
GO:0045840,positive regulation of mitotic nuclear division, 1/89,43/18614,0.186430929,0.235829188,0.124745603,LRP5,1
GO:0060236,regulation of mitotic spindle organization, 1/89,43/18614,0.186430929,0.235829188,0.124745603,HNRNPU,1
GO:0071548,response to dexamethasone, 1/89,43/18614,0.186430929,0.235829188,0.124745603,AXIN2,1
GO:0090278,negative regulation of peptide hormone secretion, 1/89,43/18614,0.186430929,0.235829188,0.124745603,SFRP1,1
GO:0001959,regulation of cytokine-mediated signaling pathway, 2/89,165/18614,0.186700308,0.236069702,0.124872827,HIF1A/ADAR,2
GO:0070665,positive regulation of leukocyte proliferation, 2/89,166/18614,0.188424222,0.238148391,0.125972383,BCL2/SHH,2
GO:0001881,receptor recycling, 1/89,44/18614,0.190329892,0.238432611,0.126122725,ACHE,1
GO:0002792,negative regulation of peptide secretion, 1/89,44/18614,0.190329892,0.238432611,0.126122725,SFRP1,1
GO:0021587,cerebellum morphogenesis, 1/89,44/18614,0.190329892,0.238432611,0.126122725,GLI1,1
GO:0021762,substantia nigra development, 1/89,44/18614,0.190329892,0.238432611,0.126122725,RHOA,1
GO:0032691,negative regulation of interleukin-1 beta production, 1/89,44/18614,0.190329892,0.238432611,0.126122725,GIT1,1
GO:0042181,ketone biosynthetic process, 1/89,44/18614,0.190329892,0.238432611,0.126122725,BMP6,1
GO:0042491,inner ear auditory receptor cell differentiation, 1/89,44/18614,0.190329892,0.238432611,0.126122725,BMP4,1
GO:0042596,fear response, 1/89,44/18614,0.190329892,0.238432611,0.126122725,BCL2,1
GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator, 1/89,44/18614,0.190329892,0.238432611,0.126122725,BCL2,1
GO:0043029,T cell homeostasis, 1/89,44/18614,0.190329892,0.238432611,0.126122725,BCL2,1
GO:0043620,regulation of DNA-templated transcription in response to stress, 1/89,44/18614,0.190329892,0.238432611,0.126122725,HIF1A,1
GO:0051602,response to electrical stimulus, 1/89,44/18614,0.190329892,0.238432611,0.126122725,MMP2,1
GO:0060119,inner ear receptor cell development, 1/89,44/18614,0.190329892,0.238432611,0.126122725,CTHRC1,1
GO:0071526,semaphorin-plexin signaling pathway, 1/89,44/18614,0.190329892,0.238432611,0.126122725,PLXNB1,1
GO:0072538,T-helper 17 type immune response, 1/89,44/18614,0.190329892,0.238432611,0.126122725,JUNB,1
GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis, 1/89,44/18614,0.190329892,0.238432611,0.126122725,RHOA,1
GO:0090317,negative regulation of intracellular protein transport, 1/89,44/18614,0.190329892,0.238432611,0.126122725,NF1,1
GO:0120178,steroid hormone biosynthetic process, 1/89,44/18614,0.190329892,0.238432611,0.126122725,BMP6,1
GO:1903573,negative regulation of response to endoplasmic reticulum stress, 1/89,44/18614,0.190329892,0.238432611,0.126122725,UFL1,1
GO:1904407,positive regulation of nitric oxide metabolic process, 1/89,44/18614,0.190329892,0.238432611,0.126122725,SMAD3,1
GO:1905521,regulation of macrophage migration, 1/89,44/18614,0.190329892,0.238432611,0.126122725,MMP14,1
GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules, 2/89,168/18614,0.191878796,0.240271934,0.127095665,DCHS1/CDH11,2
GO:0001825,blastocyst formation, 1/89,45/18614,0.194210379,0.242478088,0.128262645,JUNB,1
GO:0010677,negative regulation of cellular carbohydrate metabolic process, 1/89,45/18614,0.194210379,0.242478088,0.128262645,GIT1,1
GO:0010799,regulation of peptidyl-threonine phosphorylation, 1/89,45/18614,0.194210379,0.242478088,0.128262645,BMP7,1
GO:0014003,oligodendrocyte development, 1/89,45/18614,0.194210379,0.242478088,0.128262645,SHH,1
GO:0030890,positive regulation of B cell proliferation, 1/89,45/18614,0.194210379,0.242478088,0.128262645,BCL2,1
GO:0033173,calcineurin-NFAT signaling cascade, 1/89,45/18614,0.194210379,0.242478088,0.128262645,FHL2,1
GO:1900744,regulation of p38MAPK cascade, 1/89,45/18614,0.194210379,0.242478088,0.128262645,BMP4,1
GO:0034765,regulation of monoatomic ion transmembrane transport, 4/89,478/18614,0.195439376,0.243910306,0.129020239,TMEM38B/BCL2/MMP9/TWIST1,4
GO:0006790,sulfur compound metabolic process, 3/89,319/18614,0.196165912,0.244714511,0.129445636,XYLT1/EXT2/CTNNB1,3
GO:0019058,viral life cycle, 3/89,320/18614,0.197384899,0.246132112,0.130195499,BCL2/ADAR/IFITM1,3
GO:0003254,regulation of membrane depolarization, 1/89,46/18614,0.198072476,0.246267907,0.13026733,BCL2,1
GO:0014911,positive regulation of smooth muscle cell migration, 1/89,46/18614,0.198072476,0.246267907,0.13026733,BCL2,1
GO:0031297,replication fork processing, 1/89,46/18614,0.198072476,0.246267907,0.13026733,ALYREF,1
GO:0032467,positive regulation of cytokinesis, 1/89,46/18614,0.198072476,0.246267907,0.13026733,RHOA,1
GO:0042551,neuron maturation, 1/89,46/18614,0.198072476,0.246267907,0.13026733,BCL2,1
GO:2000273,positive regulation of signaling receptor activity, 1/89,46/18614,0.198072476,0.246267907,0.13026733,HIF1A,1
GO:2000300,regulation of synaptic vesicle exocytosis, 1/89,46/18614,0.198072476,0.246267907,0.13026733,GIT1,1
GO:0010970,transport along microtubule, 2/89,172/18614,0.19881326,0.246982778,0.130645472,HNRNPU/HIF1A,2
GO:1990138,neuron projection extension, 2/89,172/18614,0.19881326,0.246982778,0.130645472,CTNNB1/BMPR2,2
GO:0031647,regulation of protein stability, 3/89,322/18614,0.199828553,0.248140583,0.131257911,BCL2/SMAD3/GTPBP4,3
GO:0007264,small GTPase mediated signal transduction, 4/89,483/18614,0.200334587,0.248665306,0.131535472,NF1/RHOA/GIT1/COL1A2,4
GO:0002861,regulation of inflammatory response to antigenic stimulus, 1/89,47/18614,0.201916269,0.249588616,0.132023872,MAPK14,1
GO:0010837,regulation of keratinocyte proliferation, 1/89,47/18614,0.201916269,0.249588616,0.132023872,SNAI2,1
GO:0021517,ventral spinal cord development, 1/89,47/18614,0.201916269,0.249588616,0.132023872,SHH,1
GO:0021575,hindbrain morphogenesis, 1/89,47/18614,0.201916269,0.249588616,0.132023872,GLI1,1
GO:0032369,negative regulation of lipid transport, 1/89,47/18614,0.201916269,0.249588616,0.132023872,SHH,1
GO:0046677,response to antibiotic, 1/89,47/18614,0.201916269,0.249588616,0.132023872,ALPL,1
GO:0050919,negative chemotaxis, 1/89,47/18614,0.201916269,0.249588616,0.132023872,RHOA,1
GO:0090199,regulation of release of cytochrome c from mitochondria, 1/89,47/18614,0.201916269,0.249588616,0.132023872,MMP9,1
GO:0090224,regulation of spindle organization, 1/89,47/18614,0.201916269,0.249588616,0.132023872,HNRNPU,1
GO:1900271,regulation of long-term synaptic potentiation, 1/89,47/18614,0.201916269,0.249588616,0.132023872,NF1,1
GO:0032409,regulation of transporter activity, 3/89,324/18614,0.202279636,0.249845983,0.13216001,BCL2/MMP9/TWIST1,3
GO:0030216,keratinocyte differentiation, 2/89,174/18614,0.202292216,0.249845983,0.13216001,FOXC1/MSX2,2
GO:1905475,regulation of protein localization to membrane, 2/89,175/18614,0.204034425,0.251893307,0.133242975,GPC3/MMP14,2
GO:0003044,regulation of systemic arterial blood pressure mediated by a chemical signal, 1/89,48/18614,0.205741844,0.253266509,0.133969352,RHOA,1
GO:0007520,myoblast fusion, 1/89,48/18614,0.205741844,0.253266509,0.133969352,MAPK14,1
GO:0031641,regulation of myelination, 1/89,48/18614,0.205741844,0.253266509,0.133969352,CTNNB1,1
GO:0046596,regulation of viral entry into host cell, 1/89,48/18614,0.205741844,0.253266509,0.133969352,IFITM1,1
GO:0048066,developmental pigmentation, 1/89,48/18614,0.205741844,0.253266509,0.133969352,BCL2,1
GO:1903426,regulation of reactive oxygen species biosynthetic process, 1/89,48/18614,0.205741844,0.253266509,0.133969352,RHOA,1
GO:2000404,regulation of T cell migration, 1/89,48/18614,0.205741844,0.253266509,0.133969352,RHOA,1
GO:0002440,production of molecular mediator of immune response, 3/89,328/18614,0.207203415,0.254960336,0.134865329,TGFB3/DDX21/TWIST1,3
GO:0010469,regulation of signaling receptor activity, 2/89,177/18614,0.207524022,0.255249406,0.135018237,HIF1A/NOG,2
GO:0019221,cytokine-mediated signaling pathway, 4/89,492/18614,0.209239895,0.25651915,0.135689888,HIF1A/ADAR/FOXC1/IFITM1,4
GO:0032635,interleukin-6 production, 2/89,178/18614,0.2092713,0.25651915,0.135689888,DHX9/TWIST1,2
GO:0032675,regulation of interleukin-6 production, 2/89,178/18614,0.2092713,0.25651915,0.135689888,DHX9/TWIST1,2
GO:0007528,neuromuscular junction development, 1/89,49/18614,0.209549286,0.25651915,0.135689888,TNC,1
GO:0030838,positive regulation of actin filament polymerization, 1/89,49/18614,0.209549286,0.25651915,0.135689888,RHOA,1
GO:0032968,positive regulation of transcription elongation by RNA polymerase II, 1/89,49/18614,0.209549286,0.25651915,0.135689888,CTNNB1,1
GO:0033628,regulation of cell adhesion mediated by integrin, 1/89,49/18614,0.209549286,0.25651915,0.135689888,SNAI2,1
GO:0042149,cellular response to glucose starvation, 1/89,49/18614,0.209549286,0.25651915,0.135689888,BCL2,1
GO:0043114,regulation of vascular permeability, 1/89,49/18614,0.209549286,0.25651915,0.135689888,BMP6,1
GO:0046580,negative regulation of Ras protein signal transduction, 1/89,49/18614,0.209549286,0.25651915,0.135689888,NF1,1
GO:0097720,calcineurin-mediated signaling, 1/89,49/18614,0.209549286,0.25651915,0.135689888,FHL2,1
GO:0016042,lipid catabolic process, 3/89,330/18614,0.209675774,0.25651915,0.135689888,SPP1/CYP24A1/TWIST1,3
GO:0045861,negative regulation of proteolysis, 3/89,330/18614,0.209675774,0.25651915,0.135689888,MMP9/SHH/GPC3,3
GO:0001659,temperature homeostasis, 2/89,179/18614,0.211020157,0.258057901,0.136503835,ACHE/ALPL,2
GO:0051048,negative regulation of secretion, 2/89,180/18614,0.21277054,0.260091685,0.137579637,NF1/SFRP1,2
GO:0038084,vascular endothelial growth factor signaling pathway, 1/89,50/18614,0.213338681,0.260358841,0.137720954,FOXC1,1
GO:0045776,negative regulation of blood pressure, 1/89,50/18614,0.213338681,0.260358841,0.137720954,BMPR2,1
GO:0046365,monosaccharide catabolic process, 1/89,50/18614,0.213338681,0.260358841,0.137720954,LRP5,1
GO:0048009,insulin-like growth factor receptor signaling pathway, 1/89,50/18614,0.213338681,0.260358841,0.137720954,IGFBP3,1
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation, 2/89,181/18614,0.214522394,0.261696237,0.138428391,FGFR3/BMP6,2
GO:0006479,protein methylation, 2/89,182/18614,0.216275666,0.263128977,0.139186261,MEN1/CTNNB1,2
GO:0008213,protein alkylation, 2/89,182/18614,0.216275666,0.263128977,0.139186261,MEN1/CTNNB1,2
GO:0006111,regulation of gluconeogenesis, 1/89,51/18614,0.217110113,0.263128977,0.139186261,SIRT7,1
GO:0010662,regulation of striated muscle cell apoptotic process, 1/89,51/18614,0.217110113,0.263128977,0.139186261,BMP7,1
GO:0019083,viral transcription, 1/89,51/18614,0.217110113,0.263128977,0.139186261,DHX9,1
GO:0021515,cell differentiation in spinal cord, 1/89,51/18614,0.217110113,0.263128977,0.139186261,SHH,1
GO:0043113,receptor clustering, 1/89,51/18614,0.217110113,0.263128977,0.139186261,CHRDL1,1
GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling, 1/89,51/18614,0.217110113,0.263128977,0.139186261,RHOA,1
GO:0043392,negative regulation of DNA binding, 1/89,51/18614,0.217110113,0.263128977,0.139186261,MSX2,1
GO:0045761,regulation of adenylate cyclase activity, 1/89,51/18614,0.217110113,0.263128977,0.139186261,NF1,1
GO:0045912,negative regulation of carbohydrate metabolic process, 1/89,51/18614,0.217110113,0.263128977,0.139186261,GIT1,1
GO:0051489,regulation of filopodium assembly, 1/89,51/18614,0.217110113,0.263128977,0.139186261,TGFB3,1
GO:0051646,mitochondrion localization, 1/89,51/18614,0.217110113,0.263128977,0.139186261,HIF1A,1
GO:1900047,negative regulation of hemostasis, 1/89,51/18614,0.217110113,0.263128977,0.139186261,COMP,1
GO:1901799,negative regulation of proteasomal protein catabolic process, 1/89,51/18614,0.217110113,0.263128977,0.139186261,SHH,1
GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process, 1/89,51/18614,0.217110113,0.263128977,0.139186261,SHH,1
GO:0015980,energy derivation by oxidation of organic compounds, 3/89,337/18614,0.218381139,0.264561779,0.139944165,CAT/HIF1A/RHOA,3
GO:0046578,regulation of Ras protein signal transduction, 2/89,184/18614,0.219786254,0.266155793,0.140787344,NF1/GIT1,2
GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules, 1/89,52/18614,0.220863665,0.266724459,0.141088148,DCHS1,1
GO:0010656,negative regulation of muscle cell apoptotic process, 1/89,52/18614,0.220863665,0.266724459,0.141088148,BMP7,1
GO:0021695,cerebellar cortex development, 1/89,52/18614,0.220863665,0.266724459,0.141088148,GLI1,1
GO:0021872,forebrain generation of neurons, 1/89,52/18614,0.220863665,0.266724459,0.141088148,RHOA,1
GO:0032692,negative regulation of interleukin-1 production, 1/89,52/18614,0.220863665,0.266724459,0.141088148,GIT1,1
GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity, 1/89,52/18614,0.220863665,0.266724459,0.141088148,RHOA,1
GO:0098813,nuclear chromosome segregation, 3/89,339/18614,0.220882591,0.266724459,0.141088148,HNRNPU/RHOA/SIRT7,3
GO:0000910,cytokinesis, 2/89,185/18614,0.221543466,0.267197565,0.141338406,RHOA/GIT1,2
GO:0032640,tumor necrosis factor production, 2/89,185/18614,0.221543466,0.267197565,0.141338406,DHX9/TWIST1,2
GO:0032680,regulation of tumor necrosis factor production, 2/89,185/18614,0.221543466,0.267197565,0.141338406,DHX9/TWIST1,2
GO:1903169,regulation of calcium ion transmembrane transport, 2/89,186/18614,0.223301887,0.269209357,0.142402575,TMEM38B/BCL2,2
GO:0007129,homologous chromosome pairing at meiosis, 1/89,53/18614,0.224599423,0.270064732,0.142855039,SIRT7,1
GO:0010874,regulation of cholesterol efflux, 1/89,53/18614,0.224599423,0.270064732,0.142855039,SHH,1
GO:0033047,regulation of mitotic sister chromatid segregation, 1/89,53/18614,0.224599423,0.270064732,0.142855039,HNRNPU,1
GO:0048146,positive regulation of fibroblast proliferation, 1/89,53/18614,0.224599423,0.270064732,0.142855039,DHX9,1
GO:0050982,detection of mechanical stimulus, 1/89,53/18614,0.224599423,0.270064732,0.142855039,CTNNB1,1
GO:1902930,regulation of alcohol biosynthetic process, 1/89,53/18614,0.224599423,0.270064732,0.142855039,BMP6,1
GO:0016311,dephosphorylation, 3/89,342/18614,0.22464599,0.270064732,0.142855039,BCL2/SMAD3/ALPL,3
GO:0019722,calcium-mediated signaling, 2/89,187/18614,0.225061467,0.270346012,0.143003827,TMEM38B/FHL2,2
GO:0032200,telomere organization, 2/89,187/18614,0.225061467,0.270346012,0.143003827,HNRNPU/CTNNB1,2
GO:0002040,sprouting angiogenesis, 2/89,188/18614,0.226822154,0.272351148,0.144064475,RHOA/BMP4,2
GO:0006383,transcription by RNA polymerase III, 1/89,54/18614,0.228317469,0.273155719,0.144490066,DDX21,1
GO:0030520,intracellular estrogen receptor signaling pathway, 1/89,54/18614,0.228317469,0.273155719,0.144490066,UFL1,1
GO:0031113,regulation of microtubule polymerization, 1/89,54/18614,0.228317469,0.273155719,0.144490066,GIT1,1
GO:0043550,regulation of lipid kinase activity, 1/89,54/18614,0.228317469,0.273155719,0.144490066,FGFR3,1
GO:0051452,intracellular pH reduction, 1/89,54/18614,0.228317469,0.273155719,0.144490066,BCL2,1
GO:0071320,cellular response to cAMP, 1/89,54/18614,0.228317469,0.273155719,0.144490066,STC1,1
GO:0072698,protein localization to microtubule cytoskeleton, 1/89,54/18614,0.228317469,0.273155719,0.144490066,HNRNPU,1
GO:0097479,synaptic vesicle localization, 1/89,54/18614,0.228317469,0.273155719,0.144490066,CTNNB1,1
GO:1903170,negative regulation of calcium ion transmembrane transport, 1/89,54/18614,0.228317469,0.273155719,0.144490066,BCL2,1
GO:0071706,tumor necrosis factor superfamily cytokine production, 2/89,190/18614,0.230346653,0.27536223,0.145657235,DHX9/TWIST1,2
GO:1903555,regulation of tumor necrosis factor superfamily cytokine production, 2/89,190/18614,0.230346653,0.27536223,0.145657235,DHX9/TWIST1,2
GO:0002043,blood vessel endothelial cell proliferation involved in sprouting angiogenesis, 1/89,55/18614,0.232017886,0.276251209,0.146127475,BMP4,1
GO:0002686,negative regulation of leukocyte migration, 1/89,55/18614,0.232017886,0.276251209,0.146127475,NF1,1
GO:0010518,positive regulation of phospholipase activity, 1/89,55/18614,0.232017886,0.276251209,0.146127475,FGFR3,1
GO:0010658,striated muscle cell apoptotic process, 1/89,55/18614,0.232017886,0.276251209,0.146127475,BMP7,1
GO:0014888,striated muscle adaptation, 1/89,55/18614,0.232017886,0.276251209,0.146127475,SMAD3,1
GO:0042743,hydrogen peroxide metabolic process, 1/89,55/18614,0.232017886,0.276251209,0.146127475,CAT,1
GO:0050805,negative regulation of synaptic transmission, 1/89,55/18614,0.232017886,0.276251209,0.146127475,ACHE,1
GO:0052372,modulation by symbiont of entry into host, 1/89,55/18614,0.232017886,0.276251209,0.146127475,IFITM1,1
GO:2000772,regulation of cellular senescence, 1/89,55/18614,0.232017886,0.276251209,0.146127475,TWIST1,1
GO:0032271,regulation of protein polymerization, 2/89,191/18614,0.232110365,0.276251209,0.146127475,RHOA/GIT1,2
GO:0050777,negative regulation of immune response, 2/89,191/18614,0.232110365,0.276251209,0.146127475,ADAR/MAPK14,2
GO:0010506,regulation of autophagy, 3/89,348/18614,0.232211173,0.276260817,0.146132557,BCL2/HIF1A/UFL1,3
GO:0000381,"regulation of alternative mRNA splicing, via spliceosome", 1/89,56/18614,0.235700758,0.279408101,0.147797363,HNRNPU,1
GO:0032608,interferon-beta production, 1/89,56/18614,0.235700758,0.279408101,0.147797363,DHX9,1
GO:0032648,regulation of interferon-beta production, 1/89,56/18614,0.235700758,0.279408101,0.147797363,DHX9,1
GO:0035088,establishment or maintenance of apical/basal cell polarity, 1/89,56/18614,0.235700758,0.279408101,0.147797363,RHOA,1
GO:0045005,DNA-templated DNA replication maintenance of fidelity, 1/89,56/18614,0.235700758,0.279408101,0.147797363,ALYREF,1
GO:0045071,negative regulation of viral genome replication, 1/89,56/18614,0.235700758,0.279408101,0.147797363,IFITM1,1
GO:0051058,negative regulation of small GTPase mediated signal transduction, 1/89,56/18614,0.235700758,0.279408101,0.147797363,NF1,1
GO:0055078,sodium ion homeostasis, 1/89,56/18614,0.235700758,0.279408101,0.147797363,EXT2,1
GO:0061245,establishment or maintenance of bipolar cell polarity, 1/89,56/18614,0.235700758,0.279408101,0.147797363,RHOA,1
GO:0031334,positive regulation of protein-containing complex assembly, 2/89,195/18614,0.239173831,0.28262854,0.149500865,RHOA/GIT1,2
GO:0031345,negative regulation of cell projection organization, 2/89,195/18614,0.239173831,0.28262854,0.149500865,RHOA/SPP1,2
GO:0071902,positive regulation of protein serine/threonine kinase activity, 2/89,195/18614,0.239173831,0.28262854,0.149500865,RHOA/ROR2,2
GO:0007080,mitotic metaphase plate congression, 1/89,57/18614,0.239366165,0.28262854,0.149500865,HNRNPU,1
GO:0031060,regulation of histone methylation, 1/89,57/18614,0.239366165,0.28262854,0.149500865,CTNNB1,1
GO:0032768,regulation of monooxygenase activity, 1/89,57/18614,0.239366165,0.28262854,0.149500865,HIF1A,1
GO:0048016,inositol phosphate-mediated signaling, 1/89,57/18614,0.239366165,0.28262854,0.149500865,FHL2,1
GO:0050881,musculoskeletal movement, 1/89,57/18614,0.239366165,0.28262854,0.149500865,COMP,1
GO:0051932,"synaptic transmission, GABAergic", 1/89,57/18614,0.239366165,0.28262854,0.149500865,NF1,1
GO:0061756,leukocyte adhesion to vascular endothelial cell, 1/89,57/18614,0.239366165,0.28262854,0.149500865,RHOA,1
GO:0032535,regulation of cellular component size, 3/89,354/18614,0.239823921,0.283056839,0.149727421,RHOA/SPP1/BMPR2,3
GO:0140013,meiotic nuclear division, 2/89,196/18614,0.240941613,0.284263393,0.150365647,MSX2/SIRT7,2
GO:0007286,spermatid development, 2/89,197/18614,0.242710068,0.285803109,0.151180104,GLI1/DHH,2
GO:0030258,lipid modification, 2/89,197/18614,0.242710068,0.285803109,0.151180104,MAPK14/TWIST1,2
GO:0006767,water-soluble vitamin metabolic process, 1/89,58/18614,0.243014191,0.285803109,0.151180104,ALPL,1
GO:0043616,keratinocyte proliferation, 1/89,58/18614,0.243014191,0.285803109,0.151180104,SNAI2,1
GO:0044380,protein localization to cytoskeleton, 1/89,58/18614,0.243014191,0.285803109,0.151180104,HNRNPU,1
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation, 1/89,58/18614,0.243014191,0.285803109,0.151180104,SFRP1,1
GO:0050879,multicellular organismal movement, 1/89,58/18614,0.243014191,0.285803109,0.151180104,COMP,1
GO:0099024,plasma membrane invagination, 1/89,58/18614,0.243014191,0.285803109,0.151180104,RHOA,1
GO:0099504,synaptic vesicle cycle, 2/89,198/18614,0.244479149,0.287412543,0.15203144,GIT1/CTNNB1,2
GO:0000070,mitotic sister chromatid segregation, 2/89,199/18614,0.24624881,0.289273703,0.15301593,HNRNPU/RHOA,2
GO:0001961,positive regulation of cytokine-mediated signaling pathway, 1/89,59/18614,0.246644916,0.289273703,0.15301593,HIF1A,1
GO:0006611,protein export from nucleus, 1/89,59/18614,0.246644916,0.289273703,0.15301593,SIRT7,1
GO:0010574,regulation of vascular endothelial growth factor production, 1/89,59/18614,0.246644916,0.289273703,0.15301593,HIF1A,1
GO:0031122,cytoplasmic microtubule organization, 1/89,59/18614,0.246644916,0.289273703,0.15301593,RHOA,1
GO:2001258,negative regulation of cation channel activity, 1/89,59/18614,0.246644916,0.289273703,0.15301593,MMP9,1
GO:0070588,calcium ion transmembrane transport, 3/89,360/18614,0.24747996,0.290138843,0.15347356,TMEM38B/BCL2/CCN2,3
GO:0010639,negative regulation of organelle organization, 3/89,362/18614,0.250040865,0.292820047,0.154891825,HNRNPU/BMP4/BMP7,3
GO:0002886,regulation of myeloid leukocyte mediated immunity, 1/89,60/18614,0.250258422,0.292820047,0.154891825,DDX21,1
GO:0019748,secondary metabolic process, 1/89,60/18614,0.250258422,0.292820047,0.154891825,BCL2,1
GO:0021545,cranial nerve development, 1/89,60/18614,0.250258422,0.292820047,0.154891825,CTNNB1,1
GO:0032007,negative regulation of TOR signaling, 1/89,60/18614,0.250258422,0.292820047,0.154891825,HIF1A,1
GO:0006836,neurotransmitter transport, 2/89,202/18614,0.251560823,0.294228383,0.155636787,NF1/GIT1,2
GO:0043087,regulation of GTPase activity, 3/89,364/18614,0.252605959,0.295334832,0.156222061,NF1/SFRP1/PLXNB1,3
GO:0015800,acidic amino acid transport, 1/89,61/18614,0.253854789,0.295981768,0.156564268,NF1,1
GO:0034113,heterotypic cell-cell adhesion, 1/89,61/18614,0.253854789,0.295981768,0.156564268,BMP7,1
GO:0035306,positive regulation of dephosphorylation, 1/89,61/18614,0.253854789,0.295981768,0.156564268,SMAD3,1
GO:0043903,regulation of biological process involved in symbiotic interaction, 1/89,61/18614,0.253854789,0.295981768,0.156564268,IFITM1,1
GO:0050994,regulation of lipid catabolic process, 1/89,61/18614,0.253854789,0.295981768,0.156564268,TWIST1,1
GO:0060042,retina morphogenesis in camera-type eye, 1/89,61/18614,0.253854789,0.295981768,0.156564268,LRP5,1
GO:1903409,reactive oxygen species biosynthetic process, 1/89,61/18614,0.253854789,0.295981768,0.156564268,RHOA,1
GO:0048515,spermatid differentiation, 2/89,204/18614,0.255104245,0.297172241,0.157193988,GLI1/DHH,2
GO:0006066,alcohol metabolic process, 3/89,366/18614,0.25517509,0.297172241,0.157193988,CAT/BMP6/LRP5,3
GO:0045860,positive regulation of protein kinase activity, 3/89,366/18614,0.25517509,0.297172241,0.157193988,RHOA/AXIN2/ROR2,3
GO:0000768,syncytium formation by plasma membrane fusion, 1/89,62/18614,0.257434099,0.299101474,0.158214486,MAPK14,1
GO:0032387,negative regulation of intracellular transport, 1/89,62/18614,0.257434099,0.299101474,0.158214486,NF1,1
GO:0032481,positive regulation of type I interferon production, 1/89,62/18614,0.257434099,0.299101474,0.158214486,DHX9,1
GO:0045428,regulation of nitric oxide biosynthetic process, 1/89,62/18614,0.257434099,0.299101474,0.158214486,SMAD3,1
GO:0046902,regulation of mitochondrial membrane permeability, 1/89,62/18614,0.257434099,0.299101474,0.158214486,BCL2,1
GO:0140253,cell-cell fusion, 1/89,62/18614,0.257434099,0.299101474,0.158214486,MAPK14,1
GO:0051701,biological process involved in interaction with host, 2/89,206/18614,0.258648922,0.300395766,0.158899122,ALYREF/IFITM1,2
GO:1902115,regulation of organelle assembly, 2/89,207/18614,0.260421625,0.302062301,0.159780663,HNRNPU/RHOA,2
GO:0001885,endothelial cell development, 1/89,63/18614,0.26099643,0.302062301,0.159780663,STC1,1
GO:0010573,vascular endothelial growth factor production, 1/89,63/18614,0.26099643,0.302062301,0.159780663,HIF1A,1
GO:0032623,interleukin-2 production, 1/89,63/18614,0.26099643,0.302062301,0.159780663,RUNX1,1
GO:0032663,regulation of interleukin-2 production, 1/89,63/18614,0.26099643,0.302062301,0.159780663,RUNX1,1
GO:0032731,positive regulation of interleukin-1 beta production, 1/89,63/18614,0.26099643,0.302062301,0.159780663,SMAD3,1
GO:0033692,cellular polysaccharide biosynthetic process, 1/89,63/18614,0.26099643,0.302062301,0.159780663,EXT2,1
GO:0051353,positive regulation of oxidoreductase activity, 1/89,63/18614,0.26099643,0.302062301,0.159780663,HIF1A,1
GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress, 1/89,63/18614,0.26099643,0.302062301,0.159780663,BCL2,1
GO:0001818,negative regulation of cytokine production, 3/89,371/18614,0.261614584,0.302660134,0.160096896,GIT1/TGFB3/TWIST1,3
GO:0002285,lymphocyte activation involved in immune response, 2/89,208/18614,0.262194513,0.303213298,0.160389501,MEN1/JUNB,2
GO:0045732,positive regulation of protein catabolic process, 2/89,209/18614,0.263967546,0.304862749,0.161262004,GPC3/AXIN2,2
GO:0006303,double-strand break repair via nonhomologous end joining, 1/89,64/18614,0.264541862,0.304862749,0.161262004,SIRT7,1
GO:0006940,regulation of smooth muscle contraction, 1/89,64/18614,0.264541862,0.304862749,0.161262004,RHOA,1
GO:0033059,cellular pigmentation, 1/89,64/18614,0.264541862,0.304862749,0.161262004,BCL2,1
GO:0040014,regulation of multicellular organism growth, 1/89,64/18614,0.264541862,0.304862749,0.161262004,BCL2,1
GO:0045143,homologous chromosome segregation, 1/89,64/18614,0.264541862,0.304862749,0.161262004,SIRT7,1
GO:0051445,regulation of meiotic cell cycle, 1/89,64/18614,0.264541862,0.304862749,0.161262004,MSX2,1
GO:0071300,cellular response to retinoic acid, 1/89,64/18614,0.264541862,0.304862749,0.161262004,COL1A1,1
GO:1905953,negative regulation of lipid localization, 1/89,64/18614,0.264541862,0.304862749,0.161262004,SHH,1
GO:1903828,negative regulation of protein localization, 2/89,210/18614,0.265740682,0.306125866,0.16193015,NF1/SFRP1,2
GO:0010324,membrane invagination, 1/89,65/18614,0.268070475,0.307738707,0.162783288,RHOA,1
GO:0030888,regulation of B cell proliferation, 1/89,65/18614,0.268070475,0.307738707,0.162783288,BCL2,1
GO:0032507,maintenance of protein location in cell, 1/89,65/18614,0.268070475,0.307738707,0.162783288,HNRNPU,1
GO:0046888,negative regulation of hormone secretion, 1/89,65/18614,0.268070475,0.307738707,0.162783288,SFRP1,1
GO:0051339,regulation of lyase activity, 1/89,65/18614,0.268070475,0.307738707,0.162783288,NF1,1
GO:0072577,endothelial cell apoptotic process, 1/89,65/18614,0.268070475,0.307738707,0.162783288,BMPR2,1
GO:0080164,regulation of nitric oxide metabolic process, 1/89,65/18614,0.268070475,0.307738707,0.162783288,SMAD3,1
GO:0098781,ncRNA transcription, 1/89,65/18614,0.268070475,0.307738707,0.162783288,SIRT7,1
GO:0098930,axonal transport, 1/89,65/18614,0.268070475,0.307738707,0.162783288,HIF1A,1
GO:0030705,cytoskeleton-dependent intracellular transport, 2/89,212/18614,0.269287097,0.30889729,0.163396139,HNRNPU/HIF1A,2
GO:0099111,microtubule-based transport, 2/89,212/18614,0.269287097,0.30889729,0.163396139,HNRNPU/HIF1A,2
GO:0050821,protein stabilization, 2/89,213/18614,0.271060297,0.310811633,0.164408761,SMAD3/GTPBP4,2
GO:0006949,syncytium formation, 1/89,66/18614,0.271582348,0.310812069,0.164408992,MAPK14,1
GO:0010517,regulation of phospholipase activity, 1/89,66/18614,0.271582348,0.310812069,0.164408992,FGFR3,1
GO:0031100,animal organ regeneration, 1/89,66/18614,0.271582348,0.310812069,0.164408992,GLI1,1
GO:0050771,negative regulation of axonogenesis, 1/89,66/18614,0.271582348,0.310812069,0.164408992,SPP1,1
GO:1903051,negative regulation of proteolysis involved in protein catabolic process, 1/89,66/18614,0.271582348,0.310812069,0.164408992,SHH,1
GO:0016051,carbohydrate biosynthetic process, 2/89,214/18614,0.272833437,0.312123966,0.165102941,EXT2/SIRT7,2
GO:1903046,meiotic cell cycle process, 2/89,215/18614,0.274606478,0.314031746,0.166112091,MSX2/SIRT7,2
GO:0034605,cellular response to heat, 1/89,67/18614,0.275077559,0.314208607,0.166205645,NF1,1
GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein, 1/89,67/18614,0.275077559,0.314208607,0.166205645,FGFR3,1
GO:1901224,positive regulation of NIK/NF-kappaB signaling, 1/89,67/18614,0.275077559,0.314208607,0.166205645,RHOA,1
GO:0042180,cellular ketone metabolic process, 2/89,216/18614,0.276379382,0.315574618,0.166928218,BMP6/TWIST1,2
GO:0006406,mRNA export from nucleus, 1/89,68/18614,0.278556186,0.317330355,0.167856943,ALYREF,1
GO:0016925,protein sumoylation, 1/89,68/18614,0.278556186,0.317330355,0.167856943,CTNNB1,1
GO:0035914,skeletal muscle cell differentiation, 1/89,68/18614,0.278556186,0.317330355,0.167856943,SHH,1
GO:1902808,positive regulation of cell cycle G1/S phase transition, 1/89,68/18614,0.278556186,0.317330355,0.167856943,GLI1,1
GO:2000144,positive regulation of DNA-templated transcription initiation, 1/89,68/18614,0.278556186,0.317330355,0.167856943,TWIST1,1
GO:2000401,regulation of lymphocyte migration, 1/89,68/18614,0.278556186,0.317330355,0.167856943,RHOA,1
GO:0046034,ATP metabolic process, 2/89,219/18614,0.28169688,0.320785553,0.169684625,HIF1A/GIT1,2
GO:0010611,regulation of cardiac muscle hypertrophy, 1/89,69/18614,0.282018307,0.32090624,0.169748464,SMAD3,1
GO:0061077,chaperone-mediated protein folding, 1/89,69/18614,0.282018307,0.32090624,0.169748464,HSPE1,1
GO:0099003,vesicle-mediated transport in synapse, 2/89,220/18614,0.283468849,0.322433639,0.170556406,GIT1/CTNNB1,2
GO:0044282,small molecule catabolic process, 3/89,388/18614,0.283659278,0.322527095,0.170605841,CYP24A1/LRP5/TWIST1,3
GO:0015931,nucleobase-containing compound transport, 2/89,221/18614,0.285240489,0.323591041,0.171168632,DHX9/ALYREF,2
GO:0000271,polysaccharide biosynthetic process, 1/89,70/18614,0.285464,0.323591041,0.171168632,EXT2,1
GO:0032206,positive regulation of telomere maintenance, 1/89,70/18614,0.285464,0.323591041,0.171168632,CTNNB1,1
GO:0034394,protein localization to cell surface, 1/89,70/18614,0.285464,0.323591041,0.171168632,CTNNB1,1
GO:0043112,receptor metabolic process, 1/89,70/18614,0.285464,0.323591041,0.171168632,ACHE,1
GO:0046847,filopodium assembly, 1/89,70/18614,0.285464,0.323591041,0.171168632,TGFB3,1
GO:0051881,regulation of mitochondrial membrane potential, 1/89,70/18614,0.285464,0.323591041,0.171168632,BCL2,1
GO:2000379,positive regulation of reactive oxygen species metabolic process, 1/89,70/18614,0.285464,0.323591041,0.171168632,MAPK14,1
GO:0032922,circadian regulation of gene expression, 1/89,71/18614,0.288893341,0.327105003,0.173027399,HNRNPU,1
GO:0033344,cholesterol efflux, 1/89,71/18614,0.288893341,0.327105003,0.173027399,SHH,1
GO:0072678,T cell migration, 1/89,71/18614,0.288893341,0.327105003,0.173027399,RHOA,1
GO:0006487,protein N-linked glycosylation, 1/89,72/18614,0.292306408,0.330216454,0.17467325,EXT2,1
GO:0014743,regulation of muscle hypertrophy, 1/89,72/18614,0.292306408,0.330216454,0.17467325,SMAD3,1
GO:0051310,metaphase plate congression, 1/89,72/18614,0.292306408,0.330216454,0.17467325,HNRNPU,1
GO:0071677,positive regulation of mononuclear cell migration, 1/89,72/18614,0.292306408,0.330216454,0.17467325,RHOA,1
GO:1900046,regulation of hemostasis, 1/89,72/18614,0.292306408,0.330216454,0.17467325,COMP,1
GO:2000036,regulation of stem cell population maintenance, 1/89,72/18614,0.292306408,0.330216454,0.17467325,BMP7,1
GO:0007163,establishment or maintenance of cell polarity, 2/89,226/18614,0.294092484,0.33210823,0.175673935,RHOA/SHH,2
GO:0042246,tissue regeneration, 1/89,73/18614,0.295703276,0.333547921,0.176435482,RUNX1,1
GO:0045109,intermediate filament organization, 1/89,73/18614,0.295703276,0.333547921,0.176435482,SHH,1
GO:0070527,platelet aggregation, 1/89,73/18614,0.295703276,0.333547921,0.176435482,COMP,1
GO:0006801,superoxide metabolic process, 1/89,74/18614,0.299084022,0.336851153,0.17818278,BMP7,1
GO:0032732,positive regulation of interleukin-1 production, 1/89,74/18614,0.299084022,0.336851153,0.17818278,SMAD3,1
GO:1901616,organic hydroxy compound catabolic process, 1/89,74/18614,0.299084022,0.336851153,0.17818278,CYP24A1,1
GO:2000573,positive regulation of DNA biosynthetic process, 1/89,74/18614,0.299084022,0.336851153,0.17818278,CTNNB1,1
GO:0016239,positive regulation of macroautophagy, 1/89,75/18614,0.302448721,0.339741606,0.179711731,HIF1A,1
GO:0030968,endoplasmic reticulum unfolded protein response, 1/89,75/18614,0.302448721,0.339741606,0.179711731,UFL1,1
GO:0034637,cellular carbohydrate biosynthetic process, 1/89,75/18614,0.302448721,0.339741606,0.179711731,EXT2,1
GO:0042058,regulation of epidermal growth factor receptor signaling pathway, 1/89,75/18614,0.302448721,0.339741606,0.179711731,MMP9,1
GO:0043536,positive regulation of blood vessel endothelial cell migration, 1/89,75/18614,0.302448721,0.339741606,0.179711731,HIF1A,1
GO:0051899,membrane depolarization, 1/89,75/18614,0.302448721,0.339741606,0.179711731,BCL2,1
GO:0070192,chromosome organization involved in meiotic cell cycle, 1/89,75/18614,0.302448721,0.339741606,0.179711731,SIRT7,1
GO:0043270,positive regulation of monoatomic ion transport, 2/89,231/18614,0.302930875,0.340154948,0.179930375,CASR/STC1,2
GO:0006635,fatty acid beta-oxidation, 1/89,76/18614,0.305797448,0.342985918,0.181427862,TWIST1,1
GO:0086003,cardiac muscle cell contraction, 1/89,76/18614,0.305797448,0.342985918,0.181427862,STC1,1
GO:0150076,neuroinflammatory response, 1/89,76/18614,0.305797448,0.342985918,0.181427862,MMP9,1
GO:0051651,maintenance of location in cell, 2/89,233/18614,0.306461457,0.34360131,0.181753383,TMEM38B/HNRNPU,2
GO:0016358,dendrite development, 2/89,234/18614,0.308225591,0.345449223,0.182730866,RHOA/BMP7,2
GO:0001937,negative regulation of endothelial cell proliferation, 1/89,77/18614,0.30913028,0.345812656,0.18292311,NF1,1
GO:0006809,nitric oxide biosynthetic process, 1/89,77/18614,0.30913028,0.345812656,0.18292311,SMAD3,1
GO:0032508,DNA duplex unwinding, 1/89,77/18614,0.30913028,0.345812656,0.18292311,DHX9,1
GO:0050853,B cell receptor signaling pathway, 1/89,77/18614,0.30913028,0.345812656,0.18292311,BCL2,1
GO:0090559,regulation of membrane permeability, 1/89,77/18614,0.30913028,0.345812656,0.18292311,BCL2,1
GO:0034764,positive regulation of transmembrane transport, 2/89,235/18614,0.30998891,0.346643004,0.183362335,MAPK14/GPC3,2
GO:0010466,negative regulation of peptidase activity, 2/89,236/18614,0.311751381,0.348215666,0.18419422,MMP9/GPC3,2
GO:0002200,somatic diversification of immune receptors, 1/89,78/18614,0.312447289,0.348215666,0.18419422,ADAR,1
GO:0002437,inflammatory response to antigenic stimulus, 1/89,78/18614,0.312447289,0.348215666,0.18419422,MAPK14,1
GO:0032720,negative regulation of tumor necrosis factor production, 1/89,78/18614,0.312447289,0.348215666,0.18419422,TWIST1,1
GO:0042274,ribosomal small subunit biogenesis, 1/89,78/18614,0.312447289,0.348215666,0.18419422,RPL38,1
GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, 1/89,78/18614,0.312447289,0.348215666,0.18419422,MMP9,1
GO:0045824,negative regulation of innate immune response, 1/89,78/18614,0.312447289,0.348215666,0.18419422,ADAR,1
GO:0050709,negative regulation of protein secretion, 1/89,78/18614,0.312447289,0.348215666,0.18419422,SFRP1,1
GO:0061045,negative regulation of wound healing, 1/89,78/18614,0.312447289,0.348215666,0.18419422,SMAD3,1
GO:0032371,regulation of sterol transport, 1/89,79/18614,0.315748551,0.351369045,0.18586225,SHH,1
GO:0032374,regulation of cholesterol transport, 1/89,79/18614,0.315748551,0.351369045,0.18586225,SHH,1
GO:0045913,positive regulation of carbohydrate metabolic process, 1/89,79/18614,0.315748551,0.351369045,0.18586225,HIF1A,1
GO:0050688,regulation of defense response to virus, 1/89,79/18614,0.315748551,0.351369045,0.18586225,DHX9,1
GO:0002720,positive regulation of cytokine production involved in immune response, 1/89,80/18614,0.31903414,0.353967487,0.187236737,DDX21,1
GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway, 1/89,80/18614,0.31903414,0.353967487,0.187236737,CASR,1
GO:0042440,pigment metabolic process, 1/89,80/18614,0.31903414,0.353967487,0.187236737,BCL2,1
GO:0043537,negative regulation of blood vessel endothelial cell migration, 1/89,80/18614,0.31903414,0.353967487,0.187236737,RHOA,1
GO:0051966,"regulation of synaptic transmission, glutamatergic", 1/89,80/18614,0.31903414,0.353967487,0.187236737,ROR2,1
GO:0090049,regulation of cell migration involved in sprouting angiogenesis, 1/89,80/18614,0.31903414,0.353967487,0.187236737,RHOA,1
GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production, 1/89,80/18614,0.31903414,0.353967487,0.187236737,TWIST1,1
GO:2000142,regulation of DNA-templated transcription initiation, 1/89,80/18614,0.31903414,0.353967487,0.187236737,TWIST1,1
GO:0030595,leukocyte chemotaxis, 2/89,241/18614,0.320549928,0.355516841,0.188056293,SBDS/MMP2,2
GO:0036465,synaptic vesicle recycling, 1/89,81/18614,0.322304128,0.357196427,0.188944737,GIT1,1
GO:1902117,positive regulation of organelle assembly, 1/89,81/18614,0.322304128,0.357196427,0.188944737,RHOA,1
GO:0010921,regulation of phosphatase activity, 1/89,82/18614,0.325558589,0.359999643,0.190427542,SMAD3,1
GO:0042509,regulation of tyrosine phosphorylation of STAT protein, 1/89,82/18614,0.325558589,0.359999643,0.190427542,FGFR3,1
GO:0050848,regulation of calcium-mediated signaling, 1/89,82/18614,0.325558589,0.359999643,0.190427542,FHL2,1
GO:0051279,regulation of release of sequestered calcium ion into cytosol, 1/89,82/18614,0.325558589,0.359999643,0.190427542,TMEM38B,1
GO:1901184,regulation of ERBB signaling pathway, 1/89,82/18614,0.325558589,0.359999643,0.190427542,MMP9,1
GO:1905897,regulation of response to endoplasmic reticulum stress, 1/89,82/18614,0.325558589,0.359999643,0.190427542,UFL1,1
GO:0000209,protein polyubiquitination, 2/89,244/18614,0.325816894,0.360151587,0.190507915,BCL2/CTNNB1,2
GO:0032392,DNA geometric change, 1/89,83/18614,0.328797597,0.363176878,0.192108191,DHX9,1
GO:0046209,nitric oxide metabolic process, 1/89,83/18614,0.328797597,0.363176878,0.192108191,SMAD3,1
GO:0000281,mitotic cytokinesis, 1/89,84/18614,0.332021223,0.366194455,0.193704386,RHOA,1
GO:0006094,gluconeogenesis, 1/89,84/18614,0.332021223,0.366194455,0.193704386,SIRT7,1
GO:0051303,establishment of chromosome localization, 1/89,84/18614,0.332021223,0.366194455,0.193704386,HNRNPU,1
GO:2001057,reactive nitrogen species metabolic process, 1/89,84/18614,0.332021223,0.366194455,0.193704386,SMAD3,1
GO:0051259,protein complex oligomerization, 2/89,248/18614,0.332823657,0.366943624,0.194100672,COL1A2/COMP,2
GO:0010660,regulation of muscle cell apoptotic process, 1/89,85/18614,0.335229539,0.36932278,0.195359164,BMP7,1
GO:0072524,pyridine-containing compound metabolic process, 1/89,85/18614,0.335229539,0.36932278,0.195359164,ALPL,1
GO:0000819,sister chromatid segregation, 2/89,250/18614,0.336319722,0.370386859,0.195922025,HNRNPU/RHOA,2
GO:0007260,tyrosine phosphorylation of STAT protein, 1/89,86/18614,0.338422619,0.372289875,0.196928656,FGFR3,1
GO:0021954,central nervous system neuron development, 1/89,86/18614,0.338422619,0.372289875,0.196928656,CDH11,1
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle, 1/89,86/18614,0.338422619,0.372289875,0.196928656,BCL2,1
GO:0001960,negative regulation of cytokine-mediated signaling pathway, 1/89,87/18614,0.341600533,0.374955043,0.198338439,ADAR,1
GO:0010507,negative regulation of autophagy, 1/89,87/18614,0.341600533,0.374955043,0.198338439,BCL2,1
GO:0019319,hexose biosynthetic process, 1/89,87/18614,0.341600533,0.374955043,0.198338439,SIRT7,1
GO:0033627,cell adhesion mediated by integrin, 1/89,87/18614,0.341600533,0.374955043,0.198338439,SNAI2,1
GO:0046785,microtubule polymerization, 1/89,87/18614,0.341600533,0.374955043,0.198338439,GIT1,1
GO:0046889,positive regulation of lipid biosynthetic process, 1/89,87/18614,0.341600533,0.374955043,0.198338439,BMP6,1
GO:0021675,nerve development, 1/89,88/18614,0.344763352,0.377730793,0.199806716,CTNNB1,1
GO:0031110,regulation of microtubule polymerization or depolymerization, 1/89,88/18614,0.344763352,0.377730793,0.199806716,GIT1,1
GO:0032413,negative regulation of ion transmembrane transporter activity, 1/89,88/18614,0.344763352,0.377730793,0.199806716,MMP9,1
GO:0051453,regulation of intracellular pH, 1/89,88/18614,0.344763352,0.377730793,0.199806716,BCL2,1
GO:0071277,cellular response to calcium ion, 1/89,88/18614,0.344763352,0.377730793,0.199806716,JUNB,1
GO:0007059,chromosome segregation, 3/89,435/18614,0.345216393,0.378088102,0.19999572,HNRNPU/RHOA/SIRT7,3
GO:0007589,body fluid secretion, 1/89,89/18614,0.347911148,0.380899415,0.201482809,HIF1A,1
GO:0010657,muscle cell apoptotic process, 1/89,90/18614,0.35104399,0.383624375,0.20292422,BMP7,1
GO:0030516,regulation of axon extension, 1/89,90/18614,0.35104399,0.383624375,0.20292422,BMPR2,1
GO:0033555,multicellular organismal response to stress, 1/89,90/18614,0.35104399,0.383624375,0.20292422,BCL2,1
GO:0048525,negative regulation of viral process, 1/89,90/18614,0.35104399,0.383624375,0.20292422,IFITM1,1
GO:0071103,DNA conformation change, 1/89,90/18614,0.35104399,0.383624375,0.20292422,DHX9,1
GO:0034976,response to endoplasmic reticulum stress, 2/89,259/18614,0.351984864,0.384511518,0.203393489,BCL2/UFL1,2
GO:0007029,endoplasmic reticulum organization, 1/89,91/18614,0.35416195,0.386464633,0.20442662,TMEM38B,1
GO:0072384,organelle transport along microtubule, 1/89,91/18614,0.35416195,0.386464633,0.20442662,HIF1A,1
GO:2000117,negative regulation of cysteine-type endopeptidase activity, 1/89,91/18614,0.35416195,0.386464633,0.20442662,MMP9,1
GO:0000422,autophagy of mitochondrion, 1/89,92/18614,0.357265097,0.388995878,0.205765562,HIF1A,1
GO:0045104,intermediate filament cytoskeleton organization, 1/89,92/18614,0.357265097,0.388995878,0.205765562,SHH,1
GO:0045185,maintenance of protein location, 1/89,92/18614,0.357265097,0.388995878,0.205765562,HNRNPU,1
GO:0050000,chromosome localization, 1/89,92/18614,0.357265097,0.388995878,0.205765562,HNRNPU,1
GO:0060761,negative regulation of response to cytokine stimulus, 1/89,92/18614,0.357265097,0.388995878,0.205765562,ADAR,1
GO:0061726,mitochondrion disassembly, 1/89,92/18614,0.357265097,0.388995878,0.205765562,HIF1A,1
GO:0009150,purine ribonucleotide metabolic process, 3/89,445/18614,0.358316811,0.389856019,0.206220548,HIF1A/RHOA/GIT1,3
GO:0051656,establishment of organelle localization, 3/89,445/18614,0.358316811,0.389856019,0.206220548,HNRNPU/HIF1A/CTNNB1,3
GO:0030641,regulation of cellular pH, 1/89,93/18614,0.3603535,0.391072159,0.206863844,BCL2,1
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process, 1/89,93/18614,0.3603535,0.391072159,0.206863844,AXIN2,1
GO:0045103,intermediate filament-based process, 1/89,93/18614,0.3603535,0.391072159,0.206863844,SHH,1
GO:0045995,regulation of embryonic development, 1/89,93/18614,0.3603535,0.391072159,0.206863844,CTNNB1,1
GO:0061912,selective autophagy, 1/89,93/18614,0.3603535,0.391072159,0.206863844,UFL1,1
GO:0070301,cellular response to hydrogen peroxide, 1/89,93/18614,0.3603535,0.391072159,0.206863844,CAT,1
GO:2001251,negative regulation of chromosome organization, 1/89,93/18614,0.3603535,0.391072159,0.206863844,HNRNPU,1
GO:0006869,lipid transport, 3/89,447/18614,0.360933564,0.391559026,0.20712138,BMP6/SHH/SPP1,3
GO:0006835,dicarboxylic acid transport, 1/89,94/18614,0.363427229,0.393977335,0.208400583,NF1,1
GO:0016575,histone deacetylation, 1/89,94/18614,0.363427229,0.393977335,0.208400583,SIRT7,1
GO:0019217,regulation of fatty acid metabolic process, 1/89,95/18614,0.366486353,0.396860358,0.209925604,TWIST1,1
GO:0042982,amyloid precursor protein metabolic process, 1/89,95/18614,0.366486353,0.396860358,0.209925604,ACHE,1
GO:0046330,positive regulation of JNK cascade, 1/89,95/18614,0.366486353,0.396860358,0.209925604,CCN2,1
GO:0002042,cell migration involved in sprouting angiogenesis, 1/89,96/18614,0.369530941,0.399286424,0.21120891,RHOA,1
GO:0032091,negative regulation of protein binding, 1/89,96/18614,0.369530941,0.399286424,0.21120891,NOG,1
GO:0043502,regulation of muscle adaptation, 1/89,96/18614,0.369530941,0.399286424,0.21120891,SMAD3,1
GO:0044264,cellular polysaccharide metabolic process, 1/89,96/18614,0.369530941,0.399286424,0.21120891,EXT2,1
GO:0045807,positive regulation of endocytosis, 1/89,96/18614,0.369530941,0.399286424,0.21120891,GPC3,1
GO:0046364,monosaccharide biosynthetic process, 1/89,96/18614,0.369530941,0.399286424,0.21120891,SIRT7,1
GO:0016079,synaptic vesicle exocytosis, 1/89,97/18614,0.37256106,0.402268719,0.212786443,GIT1,1
GO:0034109,homotypic cell-cell adhesion, 1/89,97/18614,0.37256106,0.402268719,0.212786443,COMP,1
GO:0034620,cellular response to unfolded protein, 1/89,98/18614,0.375576778,0.40508444,0.214275863,UFL1,1
GO:0043279,response to alkaloid, 1/89,98/18614,0.375576778,0.40508444,0.214275863,TMEM38B,1
GO:1902476,chloride transmembrane transport, 1/89,98/18614,0.375576778,0.40508444,0.214275863,CASR,1
GO:0003300,cardiac muscle hypertrophy, 1/89,99/18614,0.378578165,0.408026177,0.215831942,SMAD3,1
GO:0042632,cholesterol homeostasis, 1/89,99/18614,0.378578165,0.408026177,0.215831942,LRP5,1
GO:0051258,protein polymerization, 2/89,276/18614,0.381222617,0.410354868,0.21706374,RHOA/GIT1,2
GO:0006641,triglyceride metabolic process, 1/89,100/18614,0.381565286,0.410354868,0.21706374,CAT,1
GO:0019080,viral gene expression, 1/89,100/18614,0.381565286,0.410354868,0.21706374,DHX9,1
GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway, 1/89,100/18614,0.381565286,0.410354868,0.21706374,TGFB3,1
GO:0034446,substrate adhesion-dependent cell spreading, 1/89,100/18614,0.381565286,0.410354868,0.21706374,RHOA,1
GO:0055092,sterol homeostasis, 1/89,100/18614,0.381565286,0.410354868,0.21706374,LRP5,1
GO:0002831,regulation of response to biotic stimulus, 3/89,463/18614,0.381809645,0.410469481,0.217124366,BMP6/ADAR/DHX9,3
GO:0009259,ribonucleotide metabolic process, 3/89,464/18614,0.383110287,0.411719172,0.21778541,HIF1A/RHOA/GIT1,3
GO:0043255,regulation of carbohydrate biosynthetic process, 1/89,101/18614,0.384538208,0.413104696,0.218518305,SIRT7,1
GO:0014897,striated muscle hypertrophy, 1/89,102/18614,0.387496999,0.415833415,0.219961705,SMAD3,1
GO:0042472,inner ear morphogenesis, 1/89,102/18614,0.387496999,0.415833415,0.219961705,CTHRC1,1
GO:1990830,cellular response to leukemia inhibitory factor, 1/89,102/18614,0.387496999,0.415833415,0.219961705,HNRNPU,1
GO:0006885,regulation of pH, 1/89,103/18614,0.390441725,0.418390611,0.221314374,BCL2,1
GO:0042100,B cell proliferation, 1/89,103/18614,0.390441725,0.418390611,0.221314374,BCL2,1
GO:1903076,regulation of protein localization to plasma membrane, 1/89,103/18614,0.390441725,0.418390611,0.221314374,MMP14,1
GO:1990823,response to leukemia inhibitory factor, 1/89,103/18614,0.390441725,0.418390611,0.221314374,HNRNPU,1
GO:0014896,muscle hypertrophy, 1/89,104/18614,0.393372452,0.420774339,0.222575285,SMAD3,1
GO:0032479,regulation of type I interferon production, 1/89,104/18614,0.393372452,0.420774339,0.222575285,DHX9,1
GO:0032606,type I interferon production, 1/89,104/18614,0.393372452,0.420774339,0.222575285,DHX9,1
GO:0033045,regulation of sister chromatid segregation, 1/89,104/18614,0.393372452,0.420774339,0.222575285,HNRNPU,1
GO:0070252,actin-mediated cell contraction, 1/89,104/18614,0.393372452,0.420774339,0.222575285,STC1,1
GO:0019693,ribose phosphate metabolic process, 3/89,473/18614,0.394789461,0.421994346,0.223220627,HIF1A/RHOA/GIT1,3
GO:0051321,meiotic cell cycle, 2/89,284/18614,0.394796321,0.421994346,0.223220627,MSX2/SIRT7,2
GO:0009062,fatty acid catabolic process, 1/89,105/18614,0.396289246,0.423134646,0.223823807,TWIST1,1
GO:0042102,positive regulation of T cell proliferation, 1/89,105/18614,0.396289246,0.423134646,0.223823807,SHH,1
GO:0070828,heterochromatin organization, 1/89,105/18614,0.396289246,0.423134646,0.223823807,SNAI1,1
GO:0072659,protein localization to plasma membrane, 2/89,285/18614,0.396483889,0.423190794,0.223853507,DCHS1/MMP14,2
GO:0005976,polysaccharide metabolic process, 1/89,107/18614,0.402081295,0.428857923,0.226851225,EXT2,1
GO:0034308,primary alcohol metabolic process, 1/89,107/18614,0.402081295,0.428857923,0.226851225,BMP6,1
GO:0033138,positive regulation of peptidyl-serine phosphorylation, 1/89,108/18614,0.404956681,0.431615726,0.228310009,BCL2,1
GO:0048024,"regulation of mRNA splicing, via spliceosome", 1/89,108/18614,0.404956681,0.431615726,0.228310009,HNRNPU,1
GO:0045132,meiotic chromosome segregation, 1/89,109/18614,0.407818394,0.434355022,0.229759003,SIRT7,1
GO:0120034,positive regulation of plasma membrane bounded cell projection assembly, 1/89,109/18614,0.407818394,0.434355022,0.229759003,TGFB3,1
GO:0019932,second-messenger-mediated signaling, 2/89,292/18614,0.408237144,0.434645622,0.229912721,TMEM38B/FHL2,2
GO:0002444,myeloid leukocyte mediated immunity, 1/89,110/18614,0.410666498,0.43691982,0.231115694,DDX21,1
GO:0009408,response to heat, 1/89,110/18614,0.410666498,0.43691982,0.231115694,NF1,1
GO:0018958,phenol-containing compound metabolic process, 1/89,111/18614,0.413501057,0.439308006,0.232378963,BCL2,1
GO:0051341,regulation of oxidoreductase activity, 1/89,111/18614,0.413501057,0.439308006,0.232378963,HIF1A,1
GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process, 1/89,111/18614,0.413501057,0.439308006,0.232378963,AXIN2,1
GO:2001252,positive regulation of chromosome organization, 1/89,111/18614,0.413501057,0.439308006,0.232378963,CTNNB1,1
GO:0002366,leukocyte activation involved in immune response, 2/89,296/18614,0.414904806,0.440642217,0.233084715,MEN1/JUNB,2
GO:0007229,integrin-mediated signaling pathway, 1/89,112/18614,0.416322135,0.441989893,0.23379759,CCN2,1
GO:0051056,regulation of small GTPase mediated signal transduction, 2/89,298/18614,0.418224973,0.443851868,0.234782512,NF1/GIT1,2
GO:0006821,chloride transport, 1/89,113/18614,0.419129795,0.444337245,0.23503926,CASR,1
GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway, 1/89,113/18614,0.419129795,0.444337245,0.23503926,CASR,1
GO:0061640,cytoskeleton-dependent cytokinesis, 1/89,113/18614,0.419129795,0.444337245,0.23503926,RHOA,1
GO:0002263,cell activation involved in immune response, 2/89,300/18614,0.421535857,0.446663787,0.236269921,MEN1/JUNB,2
GO:0007173,epidermal growth factor receptor signaling pathway, 1/89,114/18614,0.421924101,0.446663787,0.236269921,MMP9,1
GO:0031532,actin cytoskeleton reorganization, 1/89,114/18614,0.421924101,0.446663787,0.236269921,RHOA,1
GO:0051963,regulation of synapse assembly, 1/89,114/18614,0.421924101,0.446663787,0.236269921,CTNNB1,1
GO:0010876,lipid localization, 3/89,497/18614,0.425648013,0.450445979,0.238270571,BMP6/SHH/SPP1,3
GO:0006302,double-strand break repair, 2/89,303/18614,0.426484504,0.451170929,0.238654045,SIRT7/TWIST1,2
GO:0006476,protein deacetylation, 1/89,116/18614,0.427472899,0.451735284,0.23895257,SIRT7,1
GO:0032006,regulation of TOR signaling, 1/89,116/18614,0.427472899,0.451735284,0.23895257,HIF1A,1
GO:0071346,cellular response to type II interferon, 1/89,116/18614,0.427472899,0.451735284,0.23895257,SYNCRIP,1
GO:0043406,positive regulation of MAP kinase activity, 1/89,117/18614,0.430227516,0.454323917,0.240321869,ROR2,1
GO:1901800,positive regulation of proteasomal protein catabolic process, 1/89,117/18614,0.430227516,0.454323917,0.240321869,AXIN2,1
GO:0035967,cellular response to topologically incorrect protein, 1/89,118/18614,0.432969029,0.457056958,0.241767554,UFL1,1
GO:0048675,axon extension, 1/89,119/18614,0.435697497,0.459774298,0.243204934,BMPR2,1
GO:0018105,peptidyl-serine phosphorylation, 2/89,309/18614,0.436316664,0.46026464,0.243464308,BCL2/MAPK14,2
GO:0007006,mitochondrial membrane organization, 1/89,120/18614,0.438412984,0.462312311,0.244547457,BCL2,1
GO:0043500,muscle adaptation, 1/89,121/18614,0.441115549,0.46475708,0.245840656,SMAD3,1
GO:1901989,positive regulation of cell cycle phase transition, 1/89,121/18614,0.441115549,0.46475708,0.245840656,GLI1,1
GO:0060326,cell chemotaxis, 2/89,312/18614,0.441199403,0.46475708,0.245840656,SBDS/MMP2,2
GO:0044403,biological process involved in symbiotic interaction, 2/89,313/18614,0.442821952,0.466301377,0.246657537,ALYREF/IFITM1,2
GO:0071675,regulation of mononuclear cell migration, 1/89,122/18614,0.443805254,0.466841756,0.246943378,RHOA,1
GO:0072676,lymphocyte migration, 1/89,122/18614,0.443805254,0.466841756,0.246943378,RHOA,1
GO:0098661,inorganic anion transmembrane transport, 1/89,122/18614,0.443805254,0.466841756,0.246943378,CASR,1
GO:0000077,DNA damage checkpoint signaling, 1/89,123/18614,0.446482159,0.46949183,0.248345177,MAPK14,1
GO:0030301,cholesterol transport, 1/89,124/18614,0.449146325,0.472126642,0.249738903,SHH,1
GO:0002832,negative regulation of response to biotic stimulus, 1/89,125/18614,0.451797811,0.47441159,0.250947563,ADAR,1
GO:0031623,receptor internalization, 1/89,125/18614,0.451797811,0.47441159,0.250947563,ACHE,1
GO:0098656,monoatomic anion transmembrane transport, 1/89,125/18614,0.451797811,0.47441159,0.250947563,CASR,1
GO:0043414,macromolecule methylation, 2/89,320/18614,0.454108027,0.476669419,0.252141878,MEN1/CTNNB1,2
GO:0031109,microtubule polymerization or depolymerization, 1/89,127/18614,0.457062983,0.479264564,0.253514621,GIT1,1
GO:0035303,regulation of dephosphorylation, 1/89,127/18614,0.457062983,0.479264564,0.253514621,SMAD3,1
GO:0035601,protein deacylation, 1/89,127/18614,0.457062983,0.479264564,0.253514621,SIRT7,1
GO:0016236,macroautophagy, 2/89,322/18614,0.45730918,0.479353993,0.253561926,HIF1A/UFL1,2
GO:0006639,acylglycerol metabolic process, 1/89,128/18614,0.459676787,0.481496887,0.254695444,CAT,1
GO:1904375,regulation of protein localization to cell periphery, 1/89,128/18614,0.459676787,0.481496887,0.254695444,MMP14,1
GO:0006638,neutral lipid metabolic process, 1/89,129/18614,0.462278148,0.483881449,0.255956795,CAT,1
GO:0007127,meiosis I, 1/89,129/18614,0.462278148,0.483881449,0.255956795,SIRT7,1
GO:0030833,regulation of actin filament polymerization, 1/89,130/18614,0.464867125,0.485908479,0.257029026,RHOA,1
GO:0045739,positive regulation of DNA repair, 1/89,130/18614,0.464867125,0.485908479,0.257029026,DHX9,1
GO:0051209,release of sequestered calcium ion into cytosol, 1/89,130/18614,0.464867125,0.485908479,0.257029026,TMEM38B,1
GO:1903305,regulation of regulated secretory pathway, 1/89,130/18614,0.464867125,0.485908479,0.257029026,GIT1,1
GO:0002833,positive regulation of response to biotic stimulus, 2/89,327/18614,0.465265528,0.485983874,0.257068907,BMP6/DHX9,2
GO:0018209,peptidyl-serine modification, 2/89,327/18614,0.465265528,0.485983874,0.257068907,BCL2/MAPK14,2
GO:0030048,actin filament-based movement, 1/89,131/18614,0.467443777,0.487234084,0.257730225,STC1,1
GO:0038127,ERBB signaling pathway, 1/89,131/18614,0.467443777,0.487234084,0.257730225,MMP9,1
GO:0051283,negative regulation of sequestering of calcium ion, 1/89,131/18614,0.467443777,0.487234084,0.257730225,TMEM38B,1
GO:0051983,regulation of chromosome segregation, 1/89,131/18614,0.467443777,0.487234084,0.257730225,HNRNPU,1
GO:0072329,monocarboxylic acid catabolic process, 1/89,131/18614,0.467443777,0.487234084,0.257730225,TWIST1,1
GO:0098732,macromolecule deacylation, 1/89,131/18614,0.467443777,0.487234084,0.257730225,SIRT7,1
GO:0031570,DNA integrity checkpoint signaling, 1/89,132/18614,0.470008161,0.48973568,0.259053484,MAPK14,1
GO:0051282,regulation of sequestering of calcium ion, 1/89,133/18614,0.472560334,0.49222281,0.260369091,TMEM38B,1
GO:0000018,regulation of DNA recombination, 1/89,134/18614,0.475100355,0.494349968,0.261494285,ALYREF,1
GO:0002702,positive regulation of production of molecular mediator of immune response, 1/89,134/18614,0.475100355,0.494349968,0.261494285,DDX21,1
GO:0061982,meiosis I cell cycle process, 1/89,134/18614,0.475100355,0.494349968,0.261494285,SIRT7,1
GO:0007098,centrosome cycle, 1/89,136/18614,0.480144168,0.4994237,0.264178117,CTNNB1,1
GO:0008277,regulation of G protein-coupled receptor signaling pathway, 1/89,137/18614,0.482648074,0.501153229,0.265092978,GIT1,1
GO:0031929,TOR signaling, 1/89,137/18614,0.482648074,0.501153229,0.265092978,HIF1A,1
GO:0051208,sequestering of calcium ion, 1/89,137/18614,0.482648074,0.501153229,0.265092978,TMEM38B,1
GO:0061041,regulation of wound healing, 1/89,137/18614,0.482648074,0.501153229,0.265092978,SMAD3,1
GO:1903052,positive regulation of proteolysis involved in protein catabolic process, 1/89,137/18614,0.482648074,0.501153229,0.265092978,AXIN2,1
GO:0008360,regulation of cell shape, 1/89,138/18614,0.485140055,0.503389837,0.266276068,PLXNB1,1
GO:0015918,sterol transport, 1/89,138/18614,0.485140055,0.503389837,0.266276068,SHH,1
GO:0009581,detection of external stimulus, 1/89,139/18614,0.487620166,0.505787073,0.267544124,CTNNB1,1
GO:0046165,alcohol biosynthetic process, 1/89,140/18614,0.490088464,0.508170391,0.268804818,BMP6,1
GO:0051346,negative regulation of hydrolase activity, 2/89,345/18614,0.493339926,0.511185962,0.270399952,MMP9/GPC3,2
GO:1990778,protein localization to cell periphery, 2/89,345/18614,0.493339926,0.511185962,0.270399952,DCHS1/MMP14,2
GO:0009582,detection of abiotic stimulus, 1/89,142/18614,0.494989842,0.512717225,0.271209938,CTNNB1,1
GO:0051235,maintenance of location, 2/89,347/18614,0.496402815,0.51400208,0.271889583,TMEM38B/HNRNPU,2
GO:0033135,regulation of peptidyl-serine phosphorylation, 1/89,143/18614,0.497423033,0.514700666,0.272259111,BCL2,1
GO:1902600,proton transmembrane transport, 1/89,143/18614,0.497423033,0.514700666,0.272259111,TWIST1,1
GO:0046942,carboxylic acid transport, 2/89,352/18614,0.504009401,0.521334724,0.275768302,CASR/NF1,2
GO:0015849,organic acid transport, 2/89,353/18614,0.505521979,0.522717798,0.2764999,CASR/NF1,2
GO:0006865,amino acid transport, 1/89,147/18614,0.507040419,0.524105971,0.277234197,NF1,1
GO:0002705,positive regulation of leukocyte mediated immunity, 1/89,148/18614,0.509416192,0.526196545,0.278340039,DDX21,1
GO:0006119,oxidative phosphorylation, 1/89,148/18614,0.509416192,0.526196545,0.278340039,RHOA,1
GO:0008064,regulation of actin polymerization or depolymerization, 1/89,149/18614,0.511780644,0.528455646,0.279535026,RHOA,1
GO:0030832,regulation of actin filament length, 1/89,152/18614,0.518806599,0.535339404,0.2831763,RHOA,1
GO:0031023,microtubule organizing center organization, 1/89,152/18614,0.518806599,0.535339404,0.2831763,CTNNB1,1
GO:0006352,DNA-templated transcription initiation, 1/89,153/18614,0.521126295,0.537360759,0.284245528,TWIST1,1
GO:0046718,viral entry into host cell, 1/89,153/18614,0.521126295,0.537360759,0.284245528,IFITM1,1
GO:0050729,positive regulation of inflammatory response, 1/89,154/18614,0.523434932,0.539189255,0.28521274,DHX9,1
GO:2001257,regulation of cation channel activity, 1/89,154/18614,0.523434932,0.539189255,0.28521274,MMP9,1
GO:0032259,methylation, 2/89,365/18614,0.52344254,0.539189255,0.28521274,MEN1/CTNNB1,2
GO:0008037,cell recognition, 1/89,155/18614,0.525732564,0.541360978,0.286361507,VCAN,1
GO:0050905,neuromuscular process, 1/89,157/18614,0.53029502,0.545870375,0.288746825,COMP,1
GO:0120254,olefinic compound metabolic process, 1/89,158/18614,0.532559946,0.548012463,0.289879916,BMP6,1
GO:0016241,regulation of macroautophagy, 1/89,159/18614,0.534814073,0.550141962,0.291006349,HIF1A,1
GO:0045088,regulation of innate immune response, 2/89,373/18614,0.535149997,0.550297495,0.29108862,ADAR/DHX9,2
GO:0006261,DNA-templated DNA replication, 1/89,160/18614,0.537057451,0.551687637,0.291823958,ALYREF,1
GO:0010951,negative regulation of endopeptidase activity, 1/89,160/18614,0.537057451,0.551687637,0.291823958,MMP9,1
GO:0044409,entry into host, 1/89,160/18614,0.537057451,0.551687637,0.291823958,IFITM1,1
GO:1901653,cellular response to peptide, 2/89,375/18614,0.538046532,0.552513139,0.292260621,CASR/MEN1,2
GO:0030041,actin filament polymerization, 1/89,162/18614,0.541512165,0.555880338,0.294041754,RHOA,1
GO:2001022,positive regulation of response to DNA damage stimulus, 1/89,167/18614,0.552464369,0.566927784,0.299885476,DHX9,1
GO:0055088,lipid homeostasis, 1/89,172/18614,0.563157821,0.577702186,0.305584768,LRP5,1
GO:0006631,fatty acid metabolic process, 2/89,394/18614,0.564950684,0.579341855,0.306452097,MAPK14/TWIST1,2
GO:0007259,receptor signaling pathway via JAK-STAT, 1/89,173/18614,0.565265995,0.579465726,0.306517621,FGFR3,1
GO:1901136,carbohydrate derivative catabolic process, 1/89,175/18614,0.569452211,0.583556291,0.30868139,ADAMTS12,1
GO:0009451,RNA modification, 1/89,177/18614,0.573598565,0.587401212,0.310715222,ADAR,1
GO:0015718,monocarboxylic acid transport, 1/89,177/18614,0.573598565,0.587401212,0.310715222,CASR,1
GO:0007204,positive regulation of cytosolic calcium ion concentration, 1/89,179/18614,0.577705433,0.591200441,0.312724885,BCL2,1
GO:0015698,inorganic anion transport, 1/89,179/18614,0.577705433,0.591200441,0.312724885,CASR,1
GO:0043484,regulation of RNA splicing, 1/89,182/18614,0.583792508,0.597224547,0.315911432,HNRNPU,1
GO:0043254,regulation of protein-containing complex assembly, 2/89,409/18614,0.585398363,0.598661765,0.316671671,RHOA/GIT1,2
GO:0009266,response to temperature stimulus, 1/89,183/18614,0.585802191,0.598663714,0.316672702,NF1,1
GO:0031503,protein-containing complex localization, 1/89,183/18614,0.585802191,0.598663714,0.316672702,HNRNPU,1
GO:0097696,receptor signaling pathway via STAT, 1/89,184/18614,0.587802278,0.60050171,0.317644939,FGFR3,1
GO:0044000,movement in host, 1/89,185/18614,0.589792815,0.602328692,0.31861135,IFITM1,1
GO:2000045,regulation of G1/S transition of mitotic cell cycle, 1/89,186/18614,0.591773847,0.604144719,0.319571967,BCL2,1
GO:0000075,cell cycle checkpoint signaling, 1/89,188/18614,0.595707575,0.607744132,0.321475934,MAPK14,1
GO:0040029,epigenetic regulation of gene expression, 1/89,188/18614,0.595707575,0.607744132,0.321475934,HNRNPU,1
GO:0007018,microtubule-based movement, 2/89,417/18614,0.596015417,0.607850026,0.321531948,HNRNPU/HIF1A,2
GO:0006839,mitochondrial transport, 1/89,189/18614,0.597660361,0.609319033,0.322309002,BCL2,1
GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains, 1/89,190/18614,0.59960382,0.611091269,0.323246455,JUNB,1
GO:0051260,protein homooligomerization, 1/89,191/18614,0.601537996,0.612852835,0.324178263,COMP,1
GO:0008154,actin polymerization or depolymerization, 1/89,192/18614,0.603462933,0.614603787,0.325104457,RHOA,1
GO:0017157,regulation of exocytosis, 1/89,194/18614,0.607285265,0.618074071,0.326940119,GIT1,1
GO:1901991,negative regulation of mitotic cell cycle phase transition, 1/89,194/18614,0.607285265,0.618074071,0.326940119,BCL2,1
GO:0120032,regulation of plasma membrane bounded cell projection assembly, 1/89,195/18614,0.609182747,0.619793512,0.327849645,TGFB3,1
GO:0051650,establishment of vesicle localization, 1/89,197/18614,0.612950556,0.623201265,0.32965223,CTNNB1,1
GO:0060491,regulation of cell projection assembly, 1/89,197/18614,0.612950556,0.623201265,0.32965223,TGFB3,1
GO:0015711,organic anion transport, 2/89,433/18614,0.616645933,0.626744535,0.331526499,CASR/NF1,2
GO:0007626,locomotory behavior, 1/89,201/18614,0.620378752,0.630108524,0.333305935,GIT1,1
GO:0050851,antigen receptor-mediated signaling pathway, 1/89,201/18614,0.620378752,0.630108524,0.333305935,BCL2,1
GO:0071674,mononuclear cell migration, 1/89,202/18614,0.622213667,0.631756821,0.334177828,RHOA,1
GO:0002819,regulation of adaptive immune response, 1/89,205/18614,0.627665958,0.637075601,0.336991281,JUNB,1
GO:0007623,circadian rhythm, 1/89,207/18614,0.631257518,0.640502775,0.338804139,HNRNPU,1
GO:0030100,regulation of endocytosis, 1/89,214/18614,0.643560306,0.652763415,0.3452896,GPC3,1
GO:0051648,vesicle localization, 1/89,215/18614,0.645284389,0.654289379,0.346096783,CTNNB1,1
GO:0071805,potassium ion transmembrane transport, 1/89,217/18614,0.648707856,0.657536817,0.347814567,TMEM38B,1
GO:0006457,protein folding, 1/89,220/18614,0.653781892,0.66222926,0.35029671,HSPE1,1
GO:0007601,visual perception, 1/89,220/18614,0.653781892,0.66222926,0.35029671,COL1A1,1
GO:0044242,cellular lipid catabolic process, 1/89,222/18614,0.657124253,0.665388562,0.351967873,TWIST1,1
GO:0044772,mitotic cell cycle phase transition, 2/89,467/18614,0.657823206,0.665869973,0.352222523,BCL2/SIRT7,2
GO:0050953,sensory perception of light stimulus, 1/89,224/18614,0.660434707,0.668286342,0.353500699,COL1A1,1
GO:0006486,protein glycosylation, 1/89,226/18614,0.663713554,0.671148227,0.355014539,EXT2,1
GO:0043413,macromolecule glycosylation, 1/89,226/18614,0.663713554,0.671148227,0.355014539,EXT2,1
GO:0046777,protein autophosphorylation, 1/89,227/18614,0.665341218,0.672565826,0.355764401,FGFR3,1
GO:0045055,regulated exocytosis, 1/89,228/18614,0.666961093,0.673974592,0.356509589,GIT1,1
GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway, 1/89,234/18614,0.676518802,0.683400987,0.361495832,CASR,1
GO:0006813,potassium ion transport, 1/89,241/18614,0.687327111,0.694083886,0.367146721,TMEM38B,1
GO:0022604,regulation of cell morphogenesis, 1/89,245/18614,0.69334215,0.699683694,0.370108829,PLXNB1,1
GO:0070085,glycosylation, 1/89,245/18614,0.69334215,0.699683694,0.370108829,EXT2,1
GO:0002703,regulation of leukocyte mediated immunity, 1/89,246/18614,0.694827944,0.70094563,0.37077635,DDX21,1
GO:0006470,protein dephosphorylation, 1/89,249/18614,0.69924275,0.705160512,0.373005879,BCL2,1
GO:0006959,humoral immune response, 1/89,250/18614,0.700700273,0.705913464,0.373404164,BCL2,1
GO:0016054,organic acid catabolic process, 1/89,250/18614,0.700700273,0.705913464,0.373404164,TWIST1,1
GO:0046395,carboxylic acid catabolic process, 1/89,250/18614,0.700700273,0.705913464,0.373404164,TWIST1,1
GO:0000082,G1/S transition of mitotic cell cycle, 1/89,251/18614,0.70215081,0.707135654,0.374050661,BCL2,1
GO:0008654,phospholipid biosynthetic process, 1/89,255/18614,0.707883777,0.712668392,0.376977291,TMEM38B,1
GO:0006898,receptor-mediated endocytosis, 1/89,256/18614,0.709299886,0.713852824,0.377603815,ACHE,1
GO:0002699,positive regulation of immune effector process, 1/89,267/18614,0.724436067,0.728839934,0.385531486,DDX21,1
GO:0032412,regulation of monoatomic ion transmembrane transporter activity, 1/89,278/18614,0.738792534,0.743032735,0.393038994,MMP9,1
GO:0045089,positive regulation of innate immune response, 1/89,300/18614,0.765323254,0.769455948,0.407015973,DHX9,1
GO:0002429,immune response-activating cell surface receptor signaling pathway, 1/89,302/18614,0.767598677,0.771483286,0.408088366,BCL2,1
GO:0071375,cellular response to peptide hormone stimulus, 1/89,308/18614,0.77429487,0.7779509,0.411509513,MEN1,1
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains, 1/89,311/18614,0.777571064,0.780979164,0.413111362,JUNB,1
GO:0002768,immune response-regulating cell surface receptor signaling pathway, 1/89,329/18614,0.79626367,0.79948415,0.422899868,BCL2,1
GO:0006310,DNA recombination, 1/89,332/18614,0.799224359,0.802186444,0.42432929,ALYREF,1
GO:0006887,exocytosis, 1/89,351/18614,0.817011912,0.819763721,0.43362707,GIT1,1
GO:1901990,regulation of mitotic cell cycle phase transition, 1/89,357/18614,0.822298334,0.824790147,0.436285879,BCL2,1
GO:0016050,vesicle organization, 1/89,368/18614,0.831600868,0.833840116,0.441073004,BCL2,1
GO:0006644,phospholipid metabolic process, 1/89,375/18614,0.837268226,0.839240257,0.443929494,TMEM38B,1
GO:0046486,glycerolipid metabolic process, 1/89,385/18614,0.845038731,0.846744157,0.447898802,CAT,1
GO:0002443,leukocyte mediated immunity, 1/89,401/18614,0.856715196,0.858155538,0.453935033,DDX21,1
GO:0002757,immune response-activating signaling pathway, 1/89,423/18614,0.871361931,0.87253351,0.46154049,BCL2,1
GO:0042391,regulation of membrane potential, 1/89,433/18614,0.877520305,0.878404902,0.464646256,BCL2,1
GO:0031349,positive regulation of defense response, 1/89,441/18614,0.882236338,0.882829039,0.466986474,DHX9,1
GO:0002764,immune response-regulating signaling pathway, 1/89,450/18614,0.887327504,0.887625465,0.46952362,BCL2,1
GO:0002253,activation of immune response, 1/89,495/18614,0.909695843,0.909695843,0.481198098,BCL2,1